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werd dit een ongelooflijke ervaring dat ik voor geen geld van de wereld had willen missen. 
 
Beste Philippe, ik ben je eeuwig dankbaar, want mede dankzij onze succesvolle samenwerking kreeg 
mijn doctoraat toch wat meer glans ;-)! Wij zijn het levende bewijs dat de ‘scientific salads’ wel 
werken, want uit het niets vormde deze verplichte poging tot het uitlokken van departementale 
discussies de basis voor onze samenwerking. Dankzij jouw medewerking en expertise werd ik 
gelanceerd in de wondere wereld van RIPK4 kinase. Kunnen samen werken met jou maakte het niet 
alleen veel boeiender, maar ook plezanter. Talrijke uren hebben we samen versleten bij het maken 
van paraffinesecties of aan de confocale microscoop, maar we amuseerden ons in de naam van de 
wetenschap. Jouw gepassioneerde manier van werken motiveerde me om er telkens weer in te 
vliegen. Het was me een waar genoegen om samen met jou te mogen werken en ik kijk vol van 
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diegene die al glimlachend de verhitte situaties kon milderen, en toch bleef je geloven in me. Je hebt 
me telkenmale geholpen zonder daar ogenschijnlijk moeilijk over te doen. Je bleef telkens 
enthousiast en stond altijd voor me klaar. Ik kan je hiervoor eigenlijk nooit niet genoeg bedanken 
maar ik hoop dat je beseft dat het lab zonder jou in elkaar zakt zoals een kaartenhuisje. Ik ga je 
missen.  
 
Oh Sylvie, wat was het leuk om met jou samen te werken. Ik stond eigenlijk vanaf het begin versteld 
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eerste keer kwam solliciteren bij Kris en dat ik (samen met Michael) je gespot hadden in de 
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1 General Summary 
General Summary 
Apoptosis or programmed cell death (PCD) is a fundamental cellular response that regulates tissue 
homeostasis by eliminating excessive cells (Penaloza et al., 2006). The coordinated cell demise is 
highly controlled by several apoptotic mediators, which include the highly conserved key regulators, 
called the caspases (Salvesen and Riedl, 2008). These ‘lethal’ cysteine proteases are involved in a 
proteolytic cascade leading to the cleavage of numerous substrates, which are necessary for the 
removal of the cell. However, growing evidence shows that these mediators exhibit besides their 
pro-apoptotic activities, also functions unrelated to cell death. The caspases in particular seem to 
play also indispensable roles in processes like proliferation and differentiation of various cell types 
(Lamkanfi et al., 2007). Although these studies have tremendously changed our classic perception of 
caspase function, it remains a big challenge to understand the mechanism of how their proteolytic 
activity contributes to these distinct signaling events.  
In PART I, we have fulfilled the common need to monitor caspase-activity during early embryonic 
development in a living organism by successfully developing and validating transgenic reporter 
systems that allow straightforward detection of the caspase-activity during the development of 
Xenopus. We made use of these transgenic lines to explore the dynamic and reproducible patterns of 
caspase activation and found a novel role for caspase-9 in primitive blood formation. Unlike a 
requirement of both caspase-9 and the executioner caspases-3 and -7 in myelopoiesis, we have 
shown that caspase-9 seems to function independently of these executioner caspases in 
erythropoiesis. Although we were not able to clarify the underlying mechanism, we strongly believe 
that we have given important new insight to stimulate future research that deals with the non-
apoptotic proteolytic events of caspases, and in particularly of caspase-9.  
As part of a collaboration, we described in PART II  the functional characterization of RIPK4 during 
Xenopus development. RIPK4 was previously reported as a member of the receptor-interacting 
protein (RIP) kinase family and was found to be required for proper skin differentiation (Holland et 
al., 2002). Besides its function in keratinocyte differentiation, RIPK4 signaling might also be 
implicated in cell adhesion considering that the RIPK4 deficient mice embryos display severe fusions 
of their external orifices that may be the result of abnormal interephitelial cell-cell adhesions 
(Holland et al., 2002). In our search to elucidate the role of RIPK4 signaling in Xenopus, we have 
effectively underlined the necessity of RIPK4 signaling during early development. In Xenopus, it 
appears that maternal RIPK4 is required for the execution of proper gastrulation movements, 
whereas zygotic RIPK4 seems to be indispensable for mouth or cloaca formation. Furthermore, using 
rescue experiments with mutant proteins, we could prove that for its function during gastrulation 
RIPK4 depends on its kinase activity. 
 
In conclusion, we trust that our research in this thesis contributes to the general understanding of 
the role of caspase- and RIPK4-signaling during early development. In addition, we have developed a 
valuable reporter tool to detect caspase-activity during the development of a model system.  
  
 
3 Algemene Samenvatting 
Algemene Samenvatting 
Apoptose of geprogrammeerde celdood (PCD) wordt algemeen beschouwd als een fundamenteel 
cellulair proces dat de homeostase van de weefsels reguleert o.a. door het verwijderen van 
overbodige cellen (Penaloza et al., 2006). De geprogrammeerde celdood wordt streng gecontroleerd 
door verschillende apoptotische regulatoren waaronder ook de sterk geconserveerde caspasen 
(Salvesen and Riedl, 2008). Deze zogenaamde ‘dodelijke’ cysteine afhankelijke proteasen zijn 
betrokken in een proteolytische cascade die resulteert in de verknipping van een groot aantal 
cellulaire substraten, wat bijdraagt tot het verwijderen van de cel. Er zijn echter steeds meer 
toenemende aanwijzigen die erop wijzen dat verschillende apoptotische spelers naast hun pro-
apoptotische activiteiten, ook functies bevatten die niet gerelateerd zijn met celdood. Vooral de 
caspasen blijken ook essentieel te zijn in processen zoals de proliferatie en de differentiatie van 
uiteenlopende celtypes. Alhoewel deze observaties hebben bijgedragen tot een recente verandering 
van het aloude functioneringsconcept van de caspasen, blijft het een grote uitdaging om de 
onderliggende manier te begrijpen waarmee de caspasen betrokken zijn in deze processen. In deel I 
van deze thesis hebben we succesvol een transgeen rapporteersysteem ontwikkeld en gevalideerd 
dat ons toelaat de caspase-activiteit te detecteren tijdens de ontwikkeling van Xenopus. We hebben 
gebruikt gemaakt van deze transgene lijnen om de dynamische en reproduceerbare patronen van 
caspase-activatie te verkennen en vonden een nieuwe rol voor caspase-9 in primitieve bloedvorming. 
Terwijl myelopoiese de activiteit vereiste van zowel caspase-9 als van caspase-3 en -7, hebben we 
aangetoond dat enkel de onafhankelijke caspase-9-functie noodzakelijk is voor erythropoiese. 
Ondanks het feit dat we niet in staat waren om het onderliggende mechanisme hiervan te 
verduidelijken, geloven we toch dat we een verrijkend inzicht hebben geleverd voor het toekomstige 
onderzoek over de niet-apoptotische functies van caspasen, in het bijzonder van caspase-9.  
Als een onderdeel van een succesvolle samenwerking binnen het departement, hebben we ook onze 
aandacht gevestigd op de exploratie van RIPK4 in Xenopus. Dit wordt beschreven in deel II. RIPK4 
werd eerder beschreven als een lid van de serine/threonine kinase familie en blijkt noodzakelijk te 
zijn bij de differentiatie van de huid. Naast de rol in de differentiatie van de keratinocyten, is RIPK4 
mogelijks ook betrokken bij celadhesie daar de externe openingen van de RIPK4 knockout muizen 
fusies vertonen die mogelijks een gevolg zijn van een verhoogde inter-epitheliale celadhesie. 
Betreffende de karakterisering van RIPK4 in Xenopus, hebben we daadkrachtig het belang van de 
RIPK4-signalisatie tijdens de vroege ontwikkeling onderstreept. Uit de Xenopus-data blijkt dat de 
maternale gecodeerde RIPK4 nodig is voor de correcte uitvoering van de gastrulatiebewegingen en 
dat de zygotisch gecodeerde RIPK4 onmisbaar is voor de mond- en cloacavorming. Tevens hebben 
we kunnen bewijzen dat tijdens gastrulatie RIPK4 afhankelijk is van zijn kinase-activiteit.  
In conclusie vertrouwen we erop dat de resultaten in deze thesis een substantiële bijdrage leveren 
tot de algemene kennis over de caspase- en RIPK4-signalisatie tijdens de vroege ontwikkeling. 
Bovendien hebben we een nuttig en doeltreffend rapporteersysteem ontwikkeld die ons toelaat om 
de caspase-activiteit te detecteren tijdens de ontwikkeling van een modelsysteem.  
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Chapter I.1. Introduction to caspase signaling 
Before introducing the reader to the complex signaling network of cell death, I would first like to 
raise some thoughts and questions, which we all take for granted. For instance, billions of cells die 
every day in our body and are carefully replaced by new ones. How is this process kept in balance to 
maintain homeostasis? During development, one fertilized cell ultimately generates a multi-cellular 
organism with numerous complex tissues and organs. What determines the number of cells and 
shape for each of those multi-cellular organs? In addition, several devastating auto-immune diseases 
and cancers are associated with malfunctioning of the cell death machinery. What mechanisms 
coordinate this uncontrolled massive cell death and which signals are essential to protect us against 
exaggerated loss of cells? During the last decades, a lot of research has been performed and many 
scientists tried to answer these seemingly obvious questions. However, cell death appears to be 
mediated by hundreds of components of which some also seem to have functions independently of 
cell death signaling. The more recent discovery of these multi-functional mediators have seriously 
complicated the straightforward concept of cell death and demonstrate that still a lot of research is 
required to unravel the complexity of cell death. Therefore, the field of cell death stays a fascinating 
and intriguing continuous research domain where numerous answers are still waiting to be solved.  
 
I.1.1. Classification of cell death 
Correctly defining the type of cell death is a crucial element in the interpretation of dying cells during 
experiments. In the past, there were no clear and consistent definitions about the different ways to 
die. Therefore, the Nomenclature Committee on Cell Death (NCCD) proposed in 2009 a generally 
accepted classification of the different types of cell death (Kroemer et al., 2009). These can be 
described according to their morphological appearance (classified as apoptotic, necrotic, autophagic 
or associated with mitosis), on enzymological criteria (with and without the involvement of nucleases 
or different classes of proteases, such as caspases, calpains, cathepsins and transglutaminases), on 
the functional aspects (programmed or accidental, physiological or pathological) or on immunological 
characteristics (immunogenic or non-immunogenic) (Galluzzi et al., 2007). Considering a cell to be 
‘dead’ means that the engaged process in the dying cell, which is at first instance a reversible event, 
trespassed an irreversible phase and has reached the point-of-no-return. It has been proposed that 
this step could be represented by massive caspase activation (Cohen, 1997), loss of ΔΨm 
(mitochondrial transmembrane potential) (Green and Kroemer, 1998) , complete permeabilization of 
the mitochrondrial outer membrane (Green and Kroemer, 2004) or exposure of phosphatidylserine 
(PS) residues that emit ‘eat me’ signals for normal neighboring cells. These representations of a 
restriction point for cell death should definitely not be taken stringently because there are several 
documented examples in which caspases are activated in the context of non-lethal processes like 
differentiation (Galluzzi et al., 2008). Also PS exposure can be reversible in neutrophilic granulocytes 
(Yang et al., 2002) and the disruption of the ΔΨm by protonophores does not necessarily lead to cell 
death (de Graaf et al., 2004). In the absence of a clearly defined biochemical event that can be 
8  
 
Introduction to caspase signaling 
considered as the point-of-no-return, the NCCD proposes that a cell should be considered dead when 
any of the following molecular or morphological criteria is met: (1) incorporation of vital dyes (e.g. 
Propidium Iodide (PI)) due to loss of the plasma membrane integrity in vitro; (2) complete 
fragmentation of the cell and its nucleus into distinct bodies (frequently referred to as ‘apoptotic 
bodies’); and/or (3) engulfment of its corps (or its fragments) by an adjacent cell in vivo. Thus, when 
dying cells have initiated a cell death process, they are still able to some extent to decide their 
demise which can occur through a variety of biochemically distinct pathways and therefore they 
cannot be considered as actual dead cells (Kroemer et al., 2009).  
Before focusing on apoptotic cell death, like it was proposed by NCCD in 2009, a new 
recommendation by the committee was recently reported (July 2011) (Galluzzi et al., 2011). The 
committee advises to switch from morphological to molecular definitions of cell death modalities, 
defined by a series of precise, measurable biochemical features. The new functional classification of 
cell death routines should apply to both in vitro and in vivo settings and includes extrinsic apoptosis, 
caspase-dependent or -independent apoptosis, regulated necrosis, autophagic cell death and mitotic 
catastrophe. They believe biochemical methods for assessing cell death have many advantages over 
morphological techniques in that they are quantitative, and hence less prone to operator-dependent 
misinterpretations. However, it should always be kept in mind that single biochemical readouts 
cannot be used as unmistakable indicators of a precise way to die. Interpretation of a cell death-
associated biochemical process can sometimes mislead the investigator because the analyzed marker 
is implicated in distinct cell death pathways. For example, excessive generation of reactive oxygen 
species (ROS) and reactive nitrogen species has been associated with several cases of apoptosis 
(Bonfoco et al., 1995; Melino et al., 1997; Nicotera et al., 1999), nevertheless it also occurs during 
regulated necrosis (Vandenabeele et al., 2010). Thus, even though a substantial progress in the 
biochemical and genetic exploration of cell death was made, caution should be always taken into 
account while interpreting cell death modalities .   
The present understanding is that caspase-dependent apoptosis is the predominant cell death 
pathway and that the caspase-independent mechanisms rather serve as a fail-safe mechanism in the 
execution of lethal signaling pathways. Secondly, the regulated necrotic cell death pathway cannot 
exclusively be considered anymore as an accidental cell death modality and is recognized by the 
implicated serine/threoning kinases receptor interacting protein 1 (RIPK1) and 3 (RIPK3) 
(Vandenabeele et al., 2010). Thirdly, pyroptosis, mediated by caspase-1, is part of the host defense 
system to fight off pathogens (Duprez et al., 2009). Finally, normally autophagy preserves 
intracellular homeostasis but upon prolonged starvation autophagic cell death takes place together 
with (but not necessarily by) autophagic vacuolization (Tanida, 2010). 
Besides the earlier mentioned major cell death pathways, several definitions for other cell death 
modalities are known, including anoikis, entosis, parthanatos, netosis and cornification. Without 
going into detail, they are all specialized types of cell death associated with distinct physiological 
processes and/or cell types. A better understanding of the various cell death modalities will broaden 
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our insights into several pathological conditions which are often linked to a dysfunctional cell death 
signaling. Also the development of new therapeutic strategies for treatment of cell death-related 
diseases will eventually benefit from the efforts taken to study the complex signaling cascades 
involved in cell death.  
 
I.1.2. Apoptotic cell death 
Already in 1972, Kerr et al. (Kerr et al., 1972) introduced the Greek expression ‘apoptosis’ (Greek: 
apo - off, ptosis - falling/dropping) to describe a form of cell death associated with morphological 
features to assure the homeostasis during development of an organism. Apoptosis is accompanied by 
cell shrinkage, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin 
condensation, nuclear fragmentation (karyorrhexis), classically little or no ultrastructural 
modifications of cytoplasmic organelles, plasma membrane blebbing (but maintenance of its integrity 
until the final stages of the process) and engulfment by resident phagocytes (in vivo). This controlled 
breakdown of the cell into apoptotic bodies is the result of a tightly regulated and programmed cell-
intrinsic suicide mechanism. Two main evolutionary conserved protein families are involved in this 
mechanism, namely the Bcl-2 family of proteins (Youle and Strasser, 2008), which control 
mitochondrial integrity, and the cysteinyl aspartate-specific proteases or caspases, which mediate 
the execution phase of apoptosis (Fuentes-Prior and Salvesen, 2004). 
I.1.2.1. Caspase classification and activation 
Although apoptosis consists of several biochemical events, the most fundamental aspect is the 
participation of the caspases. The name caspase originates from the enzymatic properties that 
determine the stringent specificity for protein substrates containing the aspartic acid residue (Asp or 
D) and from the use of the amino acid cysteine (Cys or C) in the catalytic cleft for catalyzing the 
peptide bond cleavage. The use of a Cys side chain as a nucleophile during peptide bond hydrolysis is 
common to several protease families (Salvesen and Riedl, 2008). Caspases cleave a number of 
cellular proteins (Timmer and Salvesen, 2007), and in comparison with the proteasome, the process 
is a limited proteolysis where only a small number of cuts, often only one, are made. Cleavage can 
results in the activation of the substrate protein or in the inactivation, but presumably not in 
degradation. Their substrate specificity distinguishes the caspases as some of the most restricted of 
endopeptidases. To date, a number of caspases have been identified in various vertebrate and 
invertebrate species. In humans, twelve caspases belonging to the apoptotic and the inflammatory 
subfamilies of caspases have been recognized. Several additional caspases, including caspase-11, 
caspase-12 and caspase-13 have been detected in other mammals such as rodents and the cow Bos 
Taurus. Together, these fifteen mammalian caspases are classified into several groups according to 
their phylogenic relationships, which are correlated with related functions (Lamkanfi et al., 2002). 
Apoptotic caspases can be further subdivided into initiator (caspase-2, -8, -9 and -10) and 
executioner (caspase-3, -6 and -7) caspases. Caspase-1, -4, -5, -11, -12 and -13 are generally 
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considered as the inflammatory caspases. Caspase-14 is rather a unique caspase as it belongs to 
neither apoptotic caspases nor inflammatory caspases (Lippens et al., 2000).  
All the caspases have in common that they are synthesized as single-chain inactive zymogens 
composed of a N-terminal prodomain of variable length, followed by a large subunit (p20) and a 
small C-terminal subunit (p10) (Pop and Salvesen, 2009). The consistent long prodomain of the 
initiator caspases contains protein-protein interaction motifs grouped to the death domain 
superfamily, namely death effector domains (DEDs), and caspase activation and recruitment domains 
(CARDs). In the off-state, initiator caspases are inert monomers that require homodimerization for 
activation. Through interaction motifs in their prodomains, they are able to interact with adaptor 
proteins to form high molecular complexes, which subsequently leads to activation by 
oligomerization (Pop and Salvesen, 2009). The recruitment enforces a local increase in caspase 
concentration and generates activity by proximity-induced dimerization. Each initiator caspase has its 
own activation platform: the death-inducing signaling complex (DISC) recruits and activates caspase-
8 and -10 and the apoptosome activates caspase-9. The inflammatory caspases are activated by a 
similar induced dimerization mechanism. The multiprotein activation platforms are called 
inflammasomes, with affinity for the CARD prodomains of caspase-1, -4 and -5 (Martinon and 
Tschopp, 2007).  
In contrast to the initiator caspases that are monomeric as zymogens, short prodomain caspases or 
executioner caspases reside as preformed inactive dimers in the cytosol and require proteolytic 
maturation by the action of upstream caspases to become fully enzymatically responsive. Crystal 
structures of the zymogen form of caspase-7 revealed the molecular details of the catalytic 
conformation upon activation (Riedl et al., 2001). Proteolytic processing of the linker between the 
small and large subunit allows rearrangement of mobile loops, favoring formation of the catalytic 
site. The active site comprises four surface loops, L1-L4, all from the same monomer and is highly 
conserved among all the active caspases including the initiator caspases (Shi, 2004). L1 and L4 
constitute the two sides of the substrate binding groove, L3 forms the base. The catalytic cysteine 
resides in loop L2, ready for catalysis. The L2’ loop from the adjacent monomer plays a significant 
role in stabilizing the ‘activated’ conformation of the active site through intimate interactions with 
loops L2 and L4. Interestingly, this backbone configuration of the active site, including the L2’ loop, is 
highly similar for all inhibitor bound caspases (Shi, 2002). The major difference of this inhibited 
conformation is that the L2’ loop is flipped by 180 degrees, causing a conformational switch which 
results in disruption of the interactions with loops L2 and L4. Also the L2 loop is twisted making the 
catalytic cysteine inaccessible to solvent. Indeed, removing of the critical L2’ loop rendered the 
resulting caspase-3 and -7 largely inactive (Chai et al., 2001).  
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I.1.2.2. A closer look at the intrinsic and extrinsic apoptotic pathways 
In humans and in mice, the apoptotic caspases can generally be activated by two major signaling 
pathways, namely the intrinsic pathway and the extrinsic pathway. Although these pathways have 
their own distinct and independent regulatory processes, they show a significant cross-talk in many 
situations.  
 
I.1.2.2.1. Intrinsic pathway 
The intrinsic or mitochondrial pathway is activated by various stimuli, such as DNA damage and other 
cytotoxic events like viral infection and growth-factor deprivation. This pathway acts consistently 
through the mitochondria and is controlled by the Bcl-2 family of proteins which have opposing 
apoptotic activities (Youle and Strasser, 2008). The name of the family relates to the discovery that 
they are genetically altered in B-cell lymphomas (Adams and Cory, 2007; Adams and Cory, 2007). The 
Bcl-2 family members have classically been grouped into three classes. One class inhibits apoptosis 
(Bcl-2, Bcl-Xl, Bcl-W, Mcl1, Bcl-B and A1), whereas a second class promotes apoptosis (e.g. Bax and 
Bak). Finally, the third class is the Bcl-2-homology 3 (BH3)-only group (Bad, Bik, Bid, Hrk, Bim, Noxa, 
Puma, BMF), which has only sequence homology with the rest of the family through their BH3 
domain. In homeostatic conditions, the anti-apoptotic Bcl-2 family members maintain mitochondrial 
integrity by preventing the pro-apoptotic Bax and Bad from causing mitochondrial damage. Following 
an apoptotic stimulus, the BH3-only proteins are sensitized and transmit the signal to the other Bcl-2 
family members (Fig.1). However, there is some controversy about how exactly the stress signals are 
translated by these BH3-only proteins into an apoptotic response (Leibowitz and Yu, 2010). A great 
amount of evidence is present stating that BH3-only proteins facilitate this response by competitively 
binding to the anti-apoptotic Bcl-2 family members and displacing them from the pro-apoptotic 
members, Bax and Bak (Cheng et al., 2001; Willis et al., 2007). Nevertheless, there is emerging 
evidence that some BH3-only proteins can directly interact with Bax and Bak to activate them under 
specific circumstances. This is indeed the case for the interaction of the truncated Bid fragment (tBid) 
with Bax which subsequently results in apoptosis (Walensky et al., 2006). Also the BH3-only protein 
PUMA possesses the possibility to displace the anti-apoptotic Bcl-2 members or to bind directly the 
pro-apoptotic members (Yu and Zhang, 2008; Zhang et al., 2009). Regardless of the exact pathway 
that leads to activation of Bax and/or Bak, the end result is pore-formation which induces 
mitochondrial outer membrane permeabilization (MOMP). As a consequence, several pro-apoptotic 
proteins are released into the cytoplasm, including cytochrome c, Smac/DIABLO, HtrA2/Omi and the 
apoptosis inducing factor (AIF) (Leibowitz and Yu, 2010). Cytochrome c, in particular, is a crucial 
mediator of the intrinsic pathway, as it activates yet another adaptor protein, known as apoptotic 
protease-activating factor-1 (Apaf-1), which homo-oligomerizes into a caspase-activating complex, 
called the apoptosome, which sequentially recruits and activates the initiator caspase-9. The 
activated caspase-9 remains associated with the apoptosome and exhibits a catalytic activity that is 
three orders of magnitude higher than that of the isolated caspase-9, prompting the concept of a 
holoenzyme (Rodriguez and Lazebnik, 1999; Pop et al., 2006; Bratton and Salvesen, 2010).  
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The apoptosome comprises seven molecules of Apaf-1 arranged in a symmetric, wheel-shaped 
structure (Shi, 2006; Bratton and Salvesen, 2010). Apaf-1 contains a N-terminal caspase recruitment 
domain (CARD), which is responsible for recruiting caspase-9, a nucleotide-binding oligomerization 
domain (NOD), and 13 WD40 repeats (WDRs), which are thought to interact with cytochrome c. 
Structural studies of the NOD indicate that it contains an AAA+ ATPase domain (with Walker A and B 
boxes that bind to (d)ATP and Mg2+), a winged-helix domain that contributes to nucleotide binding, 
and a superhelical domain (Riedl et al., 2005). Apaf-1 is normally present as a monomer in an 
inactive, locked conformation bound to ATP. However, upon cytochrome c binding to its WDRs, Apaf-
1 is thought to undergo conformational changes, driven by  ATP hydrolysis. This conformational 
change further directs the oligomerization of multiple Apaf-1 proteins into a circular heptameric 
apoptosome complex that recruits caspase-9 (Fig.1).  
The first proposed mechanism of caspase-9 activation suggested that autocatalytic cleavage was a 
requirement for its activity. But now it seems obvious that this auto-cleavage is not required for 
caspase-9 activation but rather for lowering the affinity of the processed caspase-9 for the 
apoptosome. The higher affinity of procaspase-9 for the apoptosome and the rapid autocatalytic 
activity render the function of the apoptosome more like a proteolytic-based ‘molecular timer’. This 
implicates that the intracellular concentration of procaspase-9 sets the overall length of the timer, 
procaspase-9 auto-processing activates the timer, and the rate at which a single processed caspase-9 
dissociates from the complex dictates how fast the timer ‘ticks’ over (Malladi et al., 2009). Moreover, 
upon procaspase-9 processing, the processed protease possesses a neo-epitope that allows direct 
inhibition by X-linked inhibitor of apoptosis (XIAP), a member of the IAP protein family. The inhibition 
by XIAP prevents the protease from undergoing dimerization through its baculovirus IAP repeat 3 
(BIR3) domain (Shiozaki et al., 2003). Normally active caspase-9 bound to the apoptosome cleaves 
and activates the downstream executioner caspases-3, and -7, which are crucial for execution of 
apoptotic cell death. But also this process can be inhibited by XIAP, which can use its BIR2 domain for 
binding and inhibiting these active effector caspases.  
Importantly, there is growing evidence that caspases are activated for non-apoptotic purposes, such 
as the induction of differentiation in numerous tissues (Lamkanfi et al., 2007). Whether the 
apoptosome plays a role in this process is fairly unknown, but if it does, how it could do so without 
killing the cell remains a puzzle (Bratton and Salvesen, 2010). In addition to cytochrome c, other pro-
apoptotic proteins, like Smac/DIABLO and HtrA2/Omi, are released from the mitochondria and 
contribute to the cellular suicide mechanism (Fig.1). Smac/DIABLO antagonizes the action of the IAPs 
such as XIAP, cIAP1, and cIAP2 by relieving their inhibitory interaction with the caspases (LaCasse et 
al., 2008). Unlike XIAP, cIAP1 and cIAP2 do not directly inhibit caspases but instead they interact with 
tumor necrosis factor receptor (TNFR)-associated factor 2 (TRAF2), which leads to their recruitment 
to TNFR1. There, they contribute to TNF-induced NF-κB activation by mediating the ubiquitination of 
RIPK1 (LaCasse et al., 2008) (Fig.1). NF-κB mediated expression of anti-apoptotic genes might explain 
the anti-apoptotic function of cIAP1 and cIAP2. Similar to the pro-apoptotic function of 
Smac/DIABLO, the serine protease HtrA2/Omi promotes apoptotic cell death by the proteolytic 
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removal of the natural inhibitors (i.e. the IAPs) of caspase-3,-7 and -9 (Vande Walle et al., 2008). 
RNAi-mediated downregulation of HtrA2/Omi effectively diminished the degradation of XIAP and 
cIAP1 in cells undergoing apoptosis in response to etoposide, staurosporine and TRAIL (Srinivasula et 
al., 2003; Yang et al., 2003).   
 
I.1.2.2.2. Extrinsic pathway 
The extrinsic pathway of apoptosis is induced upon stimulation of death receptors belonging to the 
TNF family of receptors, such as TNFR, Fas (CD95) and TRAIL-R. Signaling by these receptors can 
induce a variety of cellular responses, including proliferation, differentiation, inflammation and cell 
death (Duprez et al., 2009). The receptors are expressed on the surface of cells as preassociated 
homotrimers. Fas is the best-characterized member of this TNFR superfamily and its main function 
upon binding of its ligand (FasL/CD98L) is the induction of apoptosis via the formation of a death-
inducing signaling complex (DISC). This multi-component protein complex basically contains three 
indispensable interacting components: the receptor with a cytoplasmic protein-protein interacting 
death domain (DD), the adaptor molecule Fas-associated DD containing protein (FADD) and caspase-
8 or caspase-10.  In the DISC, FADD is bound to the receptor through homotypic interaction of its DD 
with the DD of Fas. At the N-terminus, FADD contains another protein-protein domain termed the 
death effector domain (DED), which is required for the recruitment of caspases containing these DED 
domains to the DISC. After assembling in the complex and again through the high local 
concentration, caspase-8 is autoproteolytically cleaved and activated (Muzio et al., 1998). After 
maturation, the active tetrameric caspase-8 is released into the cytosol to propagate the apoptotic 
signal. A similar mechanism is deployed upon TRAIL-R activation (Fig.1). 
In contrast to signaling induced by Fas and TRAIL-R, TNFR1 aggregation leads to the sequential 
formation of two complexes (Wilson et al., 2009). Complex I is assembled at the plasma membrane 
where TRADD provides a scaffold through binding of RIPK1, TRAF2 (or TRAF5) and cIAPs 1 and 2. This 
assembly triggers cIAPs mediated polyubiquitination of RIPK1, resulting in NF-κB signaling which 
induces transcription of many genes. Among these genes are several proinflammatory cytokines and 
chemokines as well as anti-apoptotic factors such as cIAPs and c-FLIP. Complex I also activates JNK 
and p38, stimulating genes that regulate proliferation, differentiation, inflammation or apoptosis 
(Wilson et al., 2009).  After internalization of TNFR1 via endocytosis, complex II is formed through 
conformational changes in RIPK1 and TRAF2 facilitating their dissociation from TRADD. Thus allowing 
TRADD to recruit caspase-8 via FADD, which is analogous to the receptor-proximal DISC complex. 
Subsequently, caspase-8 and/or caspase-10 are processed and activate the downstream executioner 
caspases (Chang et al., 2006). In some cell types, for example in B-cells, the stimulus towards the 
effector caspases is insufficient for apoptosis and therefore they require further amplification by 
means of caspase-8-mediated processing of the Bcl-2 family BH3-only protein Bid. The truncated Bid 
fragment (tBid) amplifies the death receptor-induced cell death program by engaging the cell-
intrinsic mitochondrial pathway of apoptosis via direct or indirect interaction with the pro-apoptotic 
Bax protein (Luo et al., 1998; Walensky et al., 2006) (Fig.1).  
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Figure 1. Schematic representation of extrinsic and intrinsic apoptotic signaling.  
Triggering of the death receptor initiates the extrinsic pathway. For example, the TNF ligand engages the TNFR1 to form 
complex I which leads to NF-κB activation and subsequent transcription of inflammatory and anti-apoptotic genes.  After 
internalization of the TNFR1 via endocytosis, the death-inducing signaling complex (DISC) or complex II is formed. The 
adaptor TRADD recruits and activates caspase-8 through interaction with FADD and c-FLIPL. This is followed by the 
activation of the executioner caspases that cleave various substrates resulting in apoptotic cell death. On the other hand, 
the intrinsic pathway is stimulated upon intracellular stress at the mitochondrial level. As a consequence of the activation of 
the pro-apoptotic Bax and Bad proteins, several mitochondrial apoptotic mediators are released into the cytosol. This 
results in the formation of the apoptosome complex that activates caspase-9. Eventually, the downstream executioner 
caspases are activated by caspase-9.  The caspase-8-mediated cleavage of Bid amplifies the extrinsic pathway of apoptosis 
by the triggering of the mitochondrial pathway.  
 
I.1.2.3. Caspase substrate specificity  
Caspases are responsible for the majority of the specific proteolytic events that create the typical 
morphological cellular hallmarks of apoptosis. An important question is what decides the preference 
of their targets. The availability of crystal structures for nearly all the members of the caspase family 
bound to the same or highly similar substrate-analogue peptidyl inhibitors (acetyl-DEVD-CHO), allows 
detailed comparison of the specificity determinants which make every caspase unique (or not?) (Wei 
et al., 2000). As reviewed in (Fuentes-Prior and Salvesen, 2004), the catalytic site of the caspases 
mostly consists of four substrate pockets which carefully determine the possible processing of a 
putative substrate (Fig.2). Caspases are among the proteases with the most stringent specificity for a 
P1 residue. Their S1 pockets are almost identical, and consist of side chains with the strictly 
conserved residues Arg-179, Arg-341 and Gln-283. This deep, highly basic pocket is ideally shaped to 
accommodate an aspartate side chain, explaining their preference for the cleavage of a peptide with 
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an aspartate residue at the P1 position (Stennicke et al., 2000). The S2 pocket also contributes to 
substrate selectivity but its properties can differ slightly between the different caspase subclasses, 
and makes it a more flexible determinant for specificity. Moreover, residue Arg-341 in the S3 pocket 
plays not only a role in main-chain-main-chain hydrogen bonds with the P3 residue, but it is also 
engaged in the S1 pocket, where it contributes to its substrate anchoring. In addition, its guanidinium 
group interacts with the carboxylate group of a P3 glutamate, explaining the preference for this 
residue in small peptide substrates and inhibitors (Talanian et al., 1997; Wei et al., 2000). While 
pocket S1 and S3 have a similar character in all caspases, the S4 pockets provide major selective 
elements among the different subclasses. The inflammatory caspases (caspase-1, -4, -5) have an 
extended, shallow hydrophobic depression that best accommodates large aromatic side chains. 
These properties justify their optimal processing of substrates after Trp-Glu-Xaa-Asp sequence (Xaa 
denotes any amino acid residue). Apoptotic caspases possess a bulky Trp residue at position 348, 
which reduces considerably the size of the S4 pocket and results in a preference for short branched 
aliphatic side chains or the carboxylate group of a P4 aspartate residue (Blanchard et al., 2000; 
Stennicke et al., 2000). Caspase-2 is currently exceptional in its requirement for an additional 
occupied S5 pocket for efficient cleavage (Schweizer et al., 2003) (Fig.2). As depicted in Fig.2, the 
DEVD tetrapeptide is generally considered to be the preferred consensus sequence for the 
functionally redundant caspase-3 and caspase-7. However, the authors in Demon et al. performed a 
proteome-wide screen on a mouse macrophage lysate and identified 46 shared, three caspase-3-
specific, and six caspase-7-specific cleavage sites (Demon et al., 2009). One possible explanation for 
this differential specificity could be the distinct organization of the S5 pocket in these caspases. 
Unlike the hydrophobic S5 pocket of caspase-3, allows the rather hydrophilic S5 pocket of caspase-7 
a Lysine (K) amino acid at the P5 position of the substrate (Fu et al., 2008; Demon et al., 2009). 
Further in-depth analysis of the 40S ribosomal protein S18, a caspase-7 specific substrate, revealed 
that also the P6, P2’ and P3’ positions are required for fine tuning the caspase-7-specific cleavage. 
These extra positional requirements rather seem to exclude the caspase-3 recognition than to 
increase the binding specificity of the substrate by caspase-7 (Demon et al., 2009).  
Taken together, a peptide of sequence P4-P3-P2-P1↓-P1’ is a caspase substrate when 1) the P1 
residue is Asp; 2) the P1’ residue is small and uncharged (Gly, Ser, Ala); 3) P4-P3-P2 residues are 
complementary for interactions with the catalytic groove, whereby optimal residues in P4-P2 decide 
whether a substrate will be excellent or moderate.  
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Figure 2. Schematic presentation of caspase substrate binding site.  
The substrate specificities of caspases are shown in the table where X refers to any amino acid. 
 
Targeted proteomics approaches revealed more or less 400 cellular proteins that are cleaved in a 
caspase-specific manner following induction of apoptosis in cell culture (Dix et al., 2008; Mahrus et 
al., 2008). The list of annotated caspase substrates continues to increase, but most candidates lack 
functional evidence linking cleavage to a role in apoptosis (Pop and Salvesen, 2009). These substrates 
include proteins involved in cell structure, signaling, cell cycle control, and DNA repair. Substrate 
cleavage does not necessarily lead to protein degradation because a number of substrates become 
constitutively activated on proteolytic separation from regulatory domains (Fischer et al., 2003). 
Although the apoptotic machinery is well conserved from worms to mammals, the subset of possible 
substrates and cleavage sites can be very species- and cell-specific. For instance, cyclin A is cleaved 
during apoptosis of Xenopus oocytes, but the caspase cleavage site is not present in mammalian 
orthologues (Stack and Newport, 1997). One strategy to determine the function of a certain caspase 
during various processes is to use a series of peptide-based substrates and inhibitors developed as 
specific probes for caspase activity that are based on the favored substrates of the caspases (Talanian 
et al., 1997; Thornberry et al., 1997). Apart from the restrictions and preferences concerning the 
cleavage specificities, several amino acids could be tolerated in the cleavage motif. Single amino 
acids are rarely crucial for specificity at any given position, with the exception of the defining 
aspartate residue located N-terminally adjacent to the cleavage site. The authors in (Garcia-Calvo et 
al., 1998) determined the specificity of peptide-based inhibitors using a variety of sequences, and 
revealed that some of the inhibitors were able to inhibit more than one caspase, with little 
selectivity. These peptide-based substrates and inhibitors have been used extensively to monitor 
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caspase dependency of cell death and to identify caspases involved in different scenarios of 
apoptosis. However, problems of specificity have been reported for these reagents (Berger et al., 
2006; Timmer and Salvesen, 2007). First, McStay, Salvesen and Green demonstrated that caspase-3 
was able to cleave most substrates more efficiently than those caspases to which the substrates are 
supposed to be specific. Secondly, cells lacking caspase-9 displayed caspase-mediated substrate 
cleavage of a putative caspase-9-specific (LEHD) substrate, likely because of its possible cross-
reaction with active caspase-3, -6 and -8 (McStay et al., 2008).  As a consequence, the studies where 
these peptide-based substrates and inhibitors were used, may have implicated the wrong target 
caspase in an environment where multiple caspases exist. Interpreting these data needs caution 
when only these reagents were used to address specific caspase involvement. 
 
I.1.2.4. Caspase compensating mechanisms  
Genetic elimination of caspases has been instructive, and has helped to bring insight in their complex 
roles during development. Animals ablated in caspase-1 or -11 are deficient in cytokine processing, 
but are without any evident developmental or apoptotic phenotype (Kuida et al., 1995; Wang et al., 
1998). However, the phenotypes of some caspase knockouts are very severe and vary from early 
embryonic lethality (caspase-8) to perinatal lethality (caspase-3 and -9) (Kuida et al., 1996; Kuida et 
al., 1998; Varfolomeev et al., 1998), to relatively mild (e.g. defects in the process of normal oocyte 
removal for caspase-2) (Morita et al., 2001) (see also Table 1 for detailed description). Apparently, 
caspase-6 and -7 knockout mice manifest no obvious developmental phenotype (Zheng et al., 1999; 
Lakhani et al., 2006; Lamkanfi and Kanneganti, 2010). Linking this lack of phenotype to a less 
important physiological role is not without risk because one has to take into account the influence of 
strain background. For example, on a 129×1/SvJ genetic background, caspase-3 null mice are 
uniformly affected with a severe and perinatal lethal neurodevelopmental phenotype characterized 
by massive expansion of neuronal progenitor cells in the forebrain, consistent with failed apoptosis. 
Nevertheless, in a C57BL/6J background, caspase-3 null mice reach adulthood and have a minimal 
neuronal phenotype (Leonard et al., 2002). Several possible explanations exist for this strain-specific 
outcome of caspase-3 deficiency. One feasible reasoning is that compensatory activation of other 
caspase effectors (e.g. caspase-6) in the caspase-3-deficient C57BL/6J, but not in the 129X1/SvJ 
nervous system, could selectively circumvent the need for caspase-3 activation. Indeed, 
compensatory activation of caspase-6, caspase-7, and caspase-9 has been observed in caspase-3-
deficient hepatocytes (Zheng et al., 2000). Also, the nervous systems of caspase-2-deficient mice 
seem unaffected, but experiments with explanted primary neurons suggest that caspase-9 can 
compensate for the role of caspase-2 in inducing  programmed cell death by trophic factor 
withdrawal (Troy et al., 2001). Another intriguing possibility is that strain-specific expression of 
endogenous inhibitors of apoptosis proteins (IAPs) underlies the variable caspase-3-deficient 
phenotype. The IAP family includes not only XIAP, cIAP-1, cIAP-2, but also some neuronal apoptosis 
inhibitory proteins (NAIPs). A coincidence or not, there are significant differences in the naip gene 
array between C57BL/6J and 129X1/SvJ mouse strains (Growney and Dietrich, 2000). Thus, strain-
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dependent inhibition of caspase activity could influence the severity of neurodevelopmental 
pathology in caspase-3-deficient mice. These observations obviously complicate the assessment of 
the physiological role for caspases using mice genetics. The answers are simply more complex and 
may extend many current interpretations, and one can conclude that the roles of individual caspases 
are strain-dependent, cell type-dependent, and even context-dependent.  
 
Table I. Phenotypes of caspase-, FADD-, Cytochrome c-, AIF- and Apaf-1-deficient mice 
Mediator Development and cytokine 
expression 
  Apoptosis References 
caspase-1 
No developmental defects; Resistant to 
LPS-induced septic shock; Increased 
survival in experimental pancreatitis; No 
IL-1β and IL-18 processing, impaired 
production of IL-1 , IL-6, TNF-α and IFN-γ 
Sensitive to most apoptotic inducers; 
Reduced ischemic brain injury; CD95-
induced apoptosis attenuated in 
thymocytes; Neurons resistant to 
trophic factor withdrawal; resistant to 
LPS-induced mortality 
(Kuida et al., 1995; Li et 
al., 1995; Friedlander 
et al., 1997; Li et al., 
1997; Fantuzzi et al., 
1998; Schielke et al., 
1998) 
caspase-2 Viable, no marked abnormalities; Excess 
numbers of female germ cells 
Oocytes resistant to drug-induced death; 
Defective B cell death in response to 
granzyme B; Lymphocytes sensitive to 
drugs and anti-CD95; Increased 
susceptibility of sympathetic neurons to 
trophic factor withdrawal 
(Bergeron et al., 
1998) 
caspase-3 Mice born at lower frequency and with 
smaller size; perinatal lethality on the 
genetic 129 BALB/c background. Viable 
on C57BL/6 background. Disturbed brain 
development with excessive numbers of 
postmitotic cells, marked cataracts at the 
anterior lens pole 
No membrane blebbing and nuclear 
fragmentation in hepatocytes and 
thymocytes; Cleavage of caspase 
substrates delayed or absent; Reduced 
apoptosis in diverse settings including 
activation-induced T cell death and drug-
induced apoptosis of fibroblasts 
(Kuida et al., 1996; 
Woo et al., 1998; 
Zheng et al., 1998; 
Walsh et al., 2008) 
caspase-6 Normal development, defects in B cell 
development 
Slight protection against Fas induced cell 
death 
(Zheng et al., 2000; 
Watanabe et al., 
2008) 
caspase-7 Normal development on the genetic 129 
BALB/c background 
Caspase-7 deficient MEFs resistant to 
FasL- and UV-induced apoptosis; Failure 
of caspase-7 activation in caspase-1 
deficient macrophages; caspase-7 null 
mice resistant to lethal intraperitoneal 
injections of LPS (similar to caspase-1 
knockouts) 
(Leonard et al., 
2002; Houde et al., 
2004; Lakhani et al., 
2006; Walsh et al., 
2008; Lamkanfi and 
Kanneganti, 2010) 
caspase-8 Lethal in utero; Embryos of smaller size; 
Impaired heart muscle devlepment; 
Congested accumulation of erythrocytes 
and massive hemorrhage; Decreased 
number of hematopoietic stem cells 
Fibroblasts resistant to TNF-RI, CD-95, 
and DR3 but sensitive to drug-induced 
apoptosis; Normal JNK and NF-κB 
activation 
(Varfolomeev et al., 
1998) 
caspase-9 Perinatal lethality; Enlarged and 
malformed cerebrum due to reduced 
apoptosis during brain development; Lack 
of caspase-3 activation in embryonic 
brains 
Embryonic stem cells and fibroblasts 
resistant to several apoptotic stimuli; 
Thymocytes resistant to 
dexamethasone- and γ-irradiation and 
CD95; Splenocytes not protected against 
drug-induced apoptosis 
(Hakem et al., 1998; 
Kuida et al., 1998; 
Zheng et al., 2000; 
Leonard et al., 2002) 
caspase-11 No developmental defects; similar to 
caspase-1 deficiency; Resistant to 
endotoxic shock; Lack of IL-1α and IL-1β 
production due to blocked caspase-1 
activation 
 
Cells resistant to apoptosis induced by 
overexpression of caspase-1 
(Wang et al., 1998; 
Kang et al., 2000) 
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Mediator Development and cytokine 
expression 
  Apoptosis References 
caspase-12 No developmental abnormalities Resistance to ER/Golgi-stress 
(tunicamycin, thapsigargin, brefeldin A)- 
induced apoptosis; Normal response to 
death receptor-, or apoptosome-
dependent death stimuli; Reduced renal 
toxicity upon intraperitoneal injection of 
tunicamycin; Partial resistance of 
cortical neurons to amyloid-β, or 
excitotoxicity-induced death, normal 
response to other apoptotic stimuli such 
as staurosporine or trophic factor 
deprivation  
(Nakagawa et al., 
2000; Zheng and 
Flavell, 2000) 
caspase-14 Reduced epidermal barrier function; 
defective keratinocyte differentiation  
Increased sensitivity to UVB radiation (Eckhart et al., 2000; 
Lippens et al., 2000; 
Hoste et al., 2011) 
FADD Cardiac failure and massive hemorrhage; 
Phenotype similar to caspase-8-/- mice; IL-2 
expression of thymocytes intact 
Fibroblasts resistant to death receptor- 
but sensitive to drug, E1A- and c-Myc-
induced apoptosis; Thymocytes of RAG-1 
chimeras show impaired survival and 
proliferation 
(Yeh et al., 1998; 
Zhang et al., 1998) 
Apaf-1 Lethal at E16.5; Brain overgrowth, 
exencephaly; Severe craniofacial and 
ossification defects; Strong alterations of 
the lens and retina; Persistence of 
interdigital webs 
Embryonic fibroblasts exhibit reduced 
response to various apoptotic stimuli; 
Thymocytes sensitive to CD95-, but 
resistant to drug- and irradiation-
induced apoptosis 
(Cecconi et al., 
1998; Yoshida et al., 
1998) 
Cytochrome c Death in utero during mid-gestation; no 
obvious developmental abnormalities 
Resistance to death induced by UV-
irradiation or proapoptotic drugs such as 
staurosporine, partial resistance to 
serum withdrawal-induced apoptosis 
(Li et al., 2000) 
AIF Very early developmental cell death 
(during blastulation) 
Embryonic stem cells resistant to cell 
death after serum deprivation, essential 
role in programmed cell death during 
cavitation of embryoid bodies, the first 
wave of cell death crucial for early 
morphogenesis 
 
(Joza et al., 2001) 
Table was taken from (Sadowski-Debbing et al., 2002) and adapted with new insights.  
 
I.1.3. The non-apoptotic functions of caspases 
While caspases were at first solely associated with apoptotic cell death and inflammation, the 
observation of caspase activity in the absence of cell death, has recently changed our perception of 
caspase signaling in cellular responses beyond apoptosis. Detailed functional analysis of caspase-
deficient mice (table I) or cells derived from these animals confirmed the pleiotropic roles of these 
proteases in survival, differentiation, proliferation and NF-κB activation of specialized cell types. The 
non-apoptotic function of caspases leads to the cleavage of a specific subset of substrates without 
inducing an apoptotic cascade. These substrates include members of diverse protein families such as 
cytokines, kinases, transcription factors and polymerases. How the cell regulates this differential 
proteolytic outcome of the engaged caspases is often cell-type specific and until now highly 
speculative. The involvement of so-called ‘lethal’ caspases in cellular differentiation and immune and 
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inflammatory responses demonstrates that therapeutic inhibition of caspase activity to prevent cell 
death may have broader implications than initially conceived. Thus, any contribution to the 
understanding of the versatile and broad functions of caspases will lead to the development of novel 
pharmaceutical strategies to prevent inflammation or to control autoimmune diseases. A detailed 
description of the non-apoptotic functions of caspases involved in hematopoiesis, is given in Chapter 
I.I.5 which is dealing with the ontogeny of hematopoiesis in vertebrates.   
 
I.1.3.1. Caspases in cell proliferation and cell cycle control 
Cell proliferation has been intensively studied in developmental biology and it is noted that caspases 
are closely involved in several features of cell proliferation. Several studies demonstrated a crucial 
role for caspase-8 in the proliferation of immune cells (Chun et al., 2002; Salmena et al., 2003; 
Beisner et al., 2005; Su et al., 2005). Patients with homozygous caspase-8 mutations show defective T 
lymphocyte, B lymphocyte, and natural killer cell proliferation (Chun et al., 2002). Similarly, mice with 
a conditional caspase-8 deletion in the peripheral T cells also endure an impaired proliferation 
following TcR (T-cell receptor) activation (Salmena et al., 2003). It has been suggested that the 
catalytic activity of caspase-8 in TcR induced proliferation is required for the activation of NF-κB 
signaling (Su et al., 2005). Whether the outcome of caspase-8 activation is apoptotic or non-
apoptotic may be determined by the extent of its activation. Apparently, caspase-8 remains 
unprocessed and becomes only weakly activated in proliferating cells (Su et al., 2005). In strong 
contrast, caspase-8 is processed and strongly activated upon FasL-induced apoptosis (Peter and 
Krammer, 2003). It is conceivable that c-FLIP, a caspase-8-like molecule that lacks caspase activity, 
regulates the level of activation of caspase-8 at the DISC complex (Tschopp et al., 1998; Micheau et 
al., 2002). However, besides the implication of c-FLIP, the crucial factor or cellular condition 
determining the switch between caspase-8 mediated proliferation and caspase-8 induced apoptosis 
is still unresolved. Likely it depends as well on the accessibility and specific proteolysis of caspase-8 
substrates. Also the short prodomain caspases, in particular caspase-3, were shown to deploy several 
non-apoptotic functions associated with the modulation of cell growth. It has been shown that 
caspase-3 mediated cleavage of the cyclin-dependent kinase (CDK) inhibitor p27KIP1 promotes 
lymphoid cell proliferation (Frost et al., 2001). However, hyperproliferation of B cells is observed in 
caspase-3 knockout mice, suggesting that caspase-3 may act as a negative regulator of B-cell cycling 
(Woo et al., 2003). Although the CDK inhibitor p21 is a known inhibitor of cell cycle progression, p21 
can also promote cell proliferation when associated with PCNA, a cofactor for the DNA polymerase δ. 
The anti-proliferative effect of caspase-3 in B cells is explained by the caspase-3 mediated cleavage of 
the C-terminal PCNA-binding site of p21, which consequently abolishes the interaction of p21 with 
PCNA (Woo et al., 2003).  
It has also been shown that caspases are capable to integrate a combination of opposing pro-
apoptotic and proliferative signals from the same cell. For example, when a large number of cells in 
the wing disc of Drosophila are lost through injury, the loss of cells is compensated through the 
proliferation of the adjacent cells. This phenomenon is called compensatory proliferation (Milan et 
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al., 1997). Although the Drosophila caspase-9 orthologue Dronc was found to be required for the 
secretion of the growth-stimulating factors wingless and decapentaplegic, the molecular signaling 
cascade that connects this pro-apoptotic caspase to the proliferation of neighbouring cells remains to 
be uncovered (Kondo et al., 2006; Wells et al., 2006). More evidence for this mitogenic signaling 
hypothesis comes from regeneration processes in Hydra and mouse models, in which caspase-
signaling seems to be necessary for proper regeneration. Also in these organisms, caspases are 
apparently required for the release of several growth and differentiation factors (i.e. Wnt, Hh and 
PGE2), which subsequently induce compensatory proliferation and promote regeneration (Bergmann 
and Steller, 2010). In addition, caspase-3 was recently shown to be involved in a prostaglandin E2 
(PGE2) induced repopulation pathway of tumor cells following cancer radiotherapy (Huang et al., 
2011).  
 
I.1.3.2. Caspases in cell differentiation 
Extensive research determined the involvement of several caspases in the terminal differentiation of 
a variety of cell types involving enucleation processes during lens cell differentiation, erythrocyte and 
platelet formation as well as the terminal differentiation of keratinocytes (Lamkanfi et al., 2007; 
Crawford and Wells, 2011). Evidently, cell organelle degradation and enucleation exhibit many 
hallmarks of apoptotic cell death, like the proteolytic cleavage of PARP, nuclear lamins and spectrin. 
As a consequence, this type of differentiation has been characterized as a specialized form of 
apoptosis. Evidence for this ‘incomplete’ apoptosis comes from experiments with synthetic inhibitors 
that claimed a role for executioner caspases in the enucleation of differentiating lens epithelial cells 
(Ishizaki et al., 1998; Dahm, 1999). Contradicting to the role in enucleation, the authors in Zandy et 
al. demonstrated that caspase-3 activity is only required for the maintenance of lens transparency, 
since caspase-3-/- mice exhibit marked cataracts at the anterior lens pole (Zandy et al., 2005). Genetic 
evidence revealed that neither loss of any single executioner caspase (-3,-7,-6) nor simultaneous loss 
of caspase-3 and -6 prevents organelle loss during lens development. Another caspase 
differentiation-related observation is the Notch1 dependent activation of caspase-3 in the embryonic 
epidermis, but not in newborn epidermis (Okuyama et al., 2004). Upon activation, caspase-3 is able 
to cleave and activate protein kinase C (PKC)-δ, which is a positive regulator of keratinocyte 
differentiation. This was further demonstrated by mice deficient for caspase-3, which showed an 
increased proliferation and a reduced differentiation of embryonic keratinocytes (Okuyama et al., 
2004). In addition, it has been suggested that the expression and processing of caspase-14 is 
associated with the terminal differentiation of keratinocytes into enucleated corneocytes (Eckhart et 
al., 2000; Lippens et al., 2000). Caspase-14 does not participate in apoptotic signaling provoked by 
treatment of differentiated keratinocytes by various death-inducing stimuli, in contrast to caspase-3. 
Caspase-14 deficient mice display reduced epidermal barrier function and increased sensitivity to 
UVB radiation, probably  due to a defect in the terminal filaggrin degradation pathway (Hoste et al., 
2011). Thus, it appears that the proteolytical cleavage of filaggrin by caspase-14 is necessary for 
providing hydration and UVB protection. In contrast to its function in the epidermis, the function of 
22  
 
Introduction to caspase signaling 
caspase-14 was negatively correlated with the differentiation of trophoblasts in the fetal placenta, 
although the exact mechanism still remains to be elucidated (White et al., 2009).   
 
Besides the differentiation role of caspases in certain cell types that lose their nucleus, the caspases 
can also promote differentiation without any structural similarity to a specialized form of apoptosis.  
One example is the differentiation of monocytes into macrophages, a process that is blocked by 
synthetic caspase inhibitors (Sordet et al., 2002) (for a detailed description see also section I.1.5.5.3). 
Additional studies suggested a comparable role for the executioner caspases in the differentiation 
process of other tissue-specific macrophage-like cells, including the osteoclast in bone tissue and the 
microglia in the brain (Szymczyk et al., 2006; Burguillos et al., 2011). The recent study regarding the 
microglia proved that the ordered activation of these caspases, including caspase-8, is required for 
the regulation of microglia activation through again a PKC-δ-dependent pathway (Burguillos et al., 
2011). Another report established a role for caspase-3 in skeletal muscle differentiation. The primary 
myoblasts from a caspase-3 null mice displayed a severe lack of myotube and myofiber formation 
and a reduced expression of muscle specific genes (Fernando et al., 2002). Also in this cellular setting, 
caspase-3 activity was correlated with the proteolytic activation of a kinase, called the Mammalian 
Sterile Twenty-like kinase (MST1). The cleaved fragment of MST1 was able to rescue the 
differentiation defect of caspase-3 deficient myoblasts (Fernando et al., 2002). Furthermore, the 
caspase-3 knockout mice exhibit a delayed ossification and a decreased bone mineral density due to 
a reduced osteogenic differentiation of the bone marrow stromal stem cells (Miura et al., 2004).  
Besides the implication of caspase-3 in bone marrow stromal stem cells, it has been suggested that 
the protease also contribute to the differentiation of other stem cell lineages including the neural 
stem cells and embryonic stem cells (ESCs) (Fernando et al., 2005; Fujita et al., 2008). The authors 
showed that ESCs lacking caspase-3 had marked defects in differentiation and identified Nanog as a 
target substrate of caspase-3. Since the expression of a caspase-3-resistant Nanog promoted ESC 
self-renewal while inhibiting differentiation, they reasoned that the targeted cleavage of this 
pluripotent factor is necessary to allow differentiation (Fujita et al., 2008). In addition, in vitro 
experiments showed that caspase-3 is as well required for the differentiation of Bergmann glia in 
neural cells (Oomman et al., 2006). Using antisense oligonucleotides and caspase inhibitors, it was 
further shown that Caspase-8 is required for the syncytial fusion of human placental villous 
trophoblasts (Black et al., 2004). Besides all these roles of caspases as positive regulators of cell 
differentiation, constitutive caspase-3 activity in immature dendritic cells was found to interfere with 
the adaptor protein 1 (AP1), which prevented dendritic cell maturation and cell-surface expression of 
peptide-loaded major histocompatibility complex (MHC) class II molecules (Santambrogio et al., 
2005).   
  
  Introduction to caspase signaling 23 
I.1.3.3. Concluding remarks 
For many years caspases were solely considered as central mediators of apoptotic signaling or 
inflammation, but the emerging number of reports that confirm the non-apoptotic functions of 
caspases have recently changed this widely accepted paradigm. The underlying molecular 
mechanisms of how caspase-activity can lead to supposedly two opposing outcomes remains a topic 
for intensive research. Further insight on the caspase-target proteins (i.e. kinases, cytoskelet 
proteins, polymerases, transcription factors,…) will lead the way to a better understanding of the 
pleiotropic functions of caspases. In addition, it will be essential to further extend our knowledge 
about the interplay between the pro-survival proteins which are able to influence the caspase-
activity (e.g. IAPs, chaperones, NF-κB,..) and the pro-apoptotic mediators responsible for high levels 
of caspase activation leading to apoptosis.  
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I.1.4. Xenopus as a model organism for the study of programmed cell 
death during development  
I.1.4.1. Introduction 
Cell death is a fundamental aspect of embryonic and post-embryonic development of almost all 
organisms. Historically, cell death was mostly noticed in developing systems and was for many years 
considered to be important only in development. However, intense research during the last decades 
has documented the involvement of cell death in several other processes that are crucial for the 
viability of adult organisms. Therefore, the focus has largely shifted from embryonic cell death to the 
involvement of different types of cell death in numerous diseases and cancers. Nevertheless, the 
study of developmental cell death still has much to reveal about the complex cellular interaction that 
take place during organogenesis and tissue formation. This will be of major importance for future 
applications in stem cell therapies and tissue or organ reconstructions.  
Embryonic development is dynamic, well-orchestrated and often species specific. However, all 
embryos have a certain need to sacrifice cells during their development. In the early days, all the 
dying cells observed during development were considered to be sentenced to death by a regulated 
genetic suicide program, which led to the introduction of the term programmed cell death (PCD). 
Soon after the discovery of apoptosis as a major sculpting force in the development of 
Caenorhabtidis elegans, it became clear that several members of the caspase family play a pivotal 
role in PCD (Yuan et al., 1993; Yuan and Horvitz, 2004). Hence, PCD was primarily considered as an 
apoptotic type of cell death regulating homeostasis throughout development. Nowadays, abundant 
evidence shows that PCD is not exclusively dependent on the apopotic machinery. For example, mice 
lacking the key elements of the core machinery of apoptosis (including multiple caspase mutants, 
Apaf-1-/-, Bax-/-, Bak-/-) can complete embryonic development and become apparently normal 
adulthood (Chautan et al., 1999; Lindsten and Thompson, 2006). Interestingly, none of these 
apoptosis-deficient mutant mice manifested severe syndactyly, even though interdigital cell death 
during development was often used as an example to underscore the importance of apoptotic cell 
death as a sculpting force during morphogenesis. Moreover, Apaf-1 null mice exhibit cells dying with 
necrotic features in the developing digits (Chautan et al., 1999). This led to the discovery that other 
types of cell death, (necrosis and autophagy) take over when the apoptotic machinery is inhibited. 
Therefore these other forms of cell death should be considered more as a backup mechanism rather 
than a unique form of dying during development. The crosstalk among the different organelles 
probably allows communication between the different types of cell death and thereby serves as a 
fail-save mechanism so that cell death is propagated in the ordered manner needed for correct 
embryogenesis.  
In the following review, we will summarize current knowledge of the different mediators of 
programmed cell death in Xenopus. Furthermore, we will highlight the presence of cell death during 
the different developmental stages of the frog starting from the unfertilized egg and focus on its 
function throughout development. 
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I.1.4.2. Mediators of programmed cell death in Xenopus 
In general, two key signaling apoptotic mechanisms have been characterized in mammals and other 
vertebrates: the cell-intrinsic (or mitochondrial) pathway and the cell-extrinsic (or death receptor) 
pathway. The intrinsic pathway can be triggered by different stimuli, including cellular damage, 
growth factor withdrawal, and chemotherapeutic drugs. It acts consistently through the 
mitochondria and is controlled by the Bcl-2 family of proteins, which determine the activation 
response of the initiator protease caspase-9 (Youle and Strasser, 2008). The extrinsic pathway of 
apoptosis is induced by stimulation of death receptors of the tumor necrosis factor (TNF) family of 
receptors, such as TNFR, Fas (CD95) and TRAIL-R. Signaling by these receptors can induce different 
cellular responses, including proliferation, differentiation, and cell death (Duprez et al., 2009). These 
receptors function through a death-inducing signaling complex (DISC) that includes the initiator 
protease caspase-8 or -10. The extrinsic pathway is linked to the intrinsic pathway via Bid, a Bcl-2 
family protein that can be cleaved and activated by caspase-8 (Walensky et al., 2006). Both signaling 
cascades converge at the level of the effector caspases (caspase-3, -6 and -7), which carry out the 
specific molecular proteolytic events that create the typical morphological cellular hallmarks of 
apoptosis (Timmer and Salvesen, 2007) (Fig.4).  
Because of the necessity of apoptosis during animal development, it has been proposed that the 
apoptotic machinery is conserved throughout evolution. Indeed, Bcl-2 family orthologues have been 
identified in all metazoans analyzed to date (Youle and Strasser, 2008), suggesting that the intrinsic 
pathway has evolved at about the same time as multicellular organisms. Although the function of 
caspases is not limited to vertebrates (Lamkanfi et al., 2002), an indication that the extrinsic pathway 
is a more recent evolutionary development was deduced from the death receptors that have been 
reported exclusively in this phylum. Since the discovery of developmental cell death, most of the 
research on this topic has been performed on mammals, flies and nematodes. However, the last 
decade has witnessed a growing general interest in studying apoptosis in the fish and frog model 
organisms. A recently published, detailed review about zebrafish and cell death proves the utility of 
that model organism in the study of apoptosis (Eimon and Ashkenazi, 2010). An interesting argument 
for using frogs is that it is a tetrapod and that amphibian metamorphosis might correspond to the 
human perinatal period because they are both coordinated by an abrupt increase in the levels of the 
thyroid hormone (TH). Many reported cell death studies in Xenopus have been focusing on the 
extensive death of cells during the remodeling of the tadpole at the time of metamorphosis. TH 
signals through its receptor (THR), which activates the transcription of TH responsive genes, including 
several pro-apoptotic and anti-apoptotic genes (Buckbinder and Brown, 1992; Shi and Brown, 1993; 
Wang and Brown, 1993; Denver et al., 1997; Amano, 1998; Helbing et al., 2003; Das et al., 2006; 
Buchholz et al., 2007).  
In table 2, we summarize the known mediators of the apoptotic machinery in Xenopus. Although only 
a few apoptotic mediators have been functionally characterized, it seems that orthologues of nearly 
every member of the apoptotic machinery are present in the Xenopus genome. A phylogenetic 
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analysis of Caspases, based on protein sequences retrieved from the NCBI Entrez Genes database 
proves the strong conservation of caspases among different vertebrates from man (Hs) and mouse 
(Mm) to frog (Xl/Xt) and zebrafish (Dr) (Fig. 3). To date, ten caspase-like genes in total have been 
found in X. tropicalis and eleven genes in X. laevis. They all share with their human counterparts the 
pentapeptide QACXG (where X is R,Q or G), which serves as the active-site motif. However, no 
orthologues have been found in the Xenopus genome for the mammalian inflammatory caspase-4,-
5,-12 and the skin related caspase-14. These caspases seem to have evolved in the mammalian 
genome after the evolutionary bifurcation between mammals and amphibians, which is a strong 
argument that the mammalian immune system became more complex during evolution and needed 
extra regulators in order to function properly. Nevertheless, the proIL-1β processing inflammatory 
xcaspase-1 variant is preserved in Xenopus. But its role is not yet clear because the Xenopus proIL-1β 
orthologue seems to lack a caspase-sensitive cleavage site at the appropriate position (Zou et al., 
2000).  
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Yaoita et al. were the first to characterize the Xenopus caspase orthologues. They showed that 
xcaspase-1,-8 and -10 are more divergent between frog and human than the other caspases (i.e. the 
catalytic protease domain shares less than 50% homology) (Yaoita and Nakajima, 1997; Nakajima et 
al., 2000). They also concluded that although the amino acids sequences and functions 
(overexpression studies) of Xenopus caspase orthologues are fairly well conserved from Amphibia to 
mammals, some regulation mechanisms of human caspases are not conserved in frog. For example, 
in contrast to human caspase-9, Xenopus caspase-9 cannot be inactivated by Akt phosphorylation 
(Cardone et al., 1998). Corresponding sequences of the Akt phosphorylation motif in xcaspase-9 do 
Figure 3.  Phylogenetic analysis of Caspases from man (Hs), mouse (Mm), frog (Xl/Xt) and zebrafish (Dr).  
Protein sequences were retrieved from NCBI Entrez Genes and aligned using the clustal algorithm. The phylogenetic tree 
was generated using the Neighbor-Joining method with a bootstrap of 1000 replicates. Finally the tree was visualized with 
iTOL. 
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not fulfill the requirements of the consensus sequence and indicate that regulation of xcaspase-9 by 
Akt is not conserved (Nakajima et al., 2000). Rowe and her colleagues made similar observations 
when they assessed the functional role of xcaspase-9 during apoptosis of tail muscle during 
amphibian metamorphosis (Rowe et al., 2005).  
Despite the moderate sequence conservation of xcaspase-9, it appears that the primary function of 
xcaspase-9 is preserved in Xenopus, and this implies the conservation of the intrinsic apoptosis 
pathway. In fact, orthologues of nearly every member of the Bcl-2 family have been characterized in 
extracts of Xenopus eggs (Tsuchiya and Yamashita, 2011). Several studies also highlight the possible 
regulation of the balance between apoptosis and proliferation during metamorphosis by the anti-
apoptotic XR11 protein (i.e. the Xenopus homologue of the mammalian Bcl-xL) and the pro-apoptotic 
xBax protein (Sachs et al., 1997; Coen et al., 2001; Johnston et al., 2005; Rowe et al., 2005; Coen et 
al., 2007). Moreover, xApaf-1 and xcaspase-9 were recently implicated in apoptosis in the developing 
Xenopus neural retina (Walker and Harland, 2009). A number of proteins released from mitochondria 
also play a central role in the execution of the intrinsic apoptotic pathway (van Loo et al., 2002). In 
Xenopus, mitochondrial apoptotic regulators such as apoptosis-inducing factor (AIF), endonuclease G 
and HtrA/Omi have all been identified in the expressed sequence tag (EST) databases (Xenbase). In 
addition, the pro-apoptotic Xenopus homologue of Smac/DIABLO is expressed during early 
embryogenesis and is capable of enhancing γ-irradiation-induced apoptosis in HeLa cells (Montesanti 
et al., 2007). Hence, the intrinsic apoptotic mediators do seem to be fully conserved and functional in 
the Xenopus system (Fig.4). 
Obviously, the remaining question is whether the components of the extrinsic pathway of apoptosis 
are also preserved and if they can execute receptor mediated cell death. The several Xenopus death 
receptors (xDR-M1, xDR-M2 and xTNFR1) that have been identified can induce apoptosis when 
overexpressed in vitro (Tamura et al., 2004; Mawaribuchi et al., 2008). Besides activating xcaspase-8, 
which leads to apoptosis, the receptors also activated NF-κB and JNK signaling via xRIPK1 and xFADD 
in X. laevis cells (Tamura et al., 2004; Ishizawa et al., 2006; Mawaribuchi et al., 2008). A recent study 
identified the two ligands for the death receptors xDR-M1 and xDR-M2, namely xTRAIL1 and xTRAIL2, 
and elucidated their roles in the transition of red blood cells from the larval to adult type during 
metamorphosis (Tamura et al., 2010). Furthermore, triggering of the xTNFR1 receptor by its xTNFα 
ligand protected XLgoo cells (tadpole-tail vascular endothelial cells) from TH-induced apoptosis 
(Mawaribuchi et al., 2008). Finally, cross-talk between the extrinsic and intrinsic apoptotic pathways 
was demonstrated by the functional characterization of the Xenopus Bid protein, a BH3-only member 
of the Bcl-2 family (Du Pasquier et al., 2006; Du Pasquier et al., 2007; Saitoh et al., 2009) (Fig.4).  
Among the other apoptotic factors, members of the inhibitor of apoptosis protein (IAP) family 
contain the highly conserved baculoviral IAP repeats (BIR) and are known to inhibit apoptosis, in 
some cases, by directly binding caspases. Four maternal BIR family proteins have been identified in 
Xenopus, of which only XLX and xXIAP have been shown to inhibit apoptosis in X. laevis egg extract 
(Tsuchiya et al., 2005; Du Pasquier et al., 2006; Greenwood and Gautier, 2007). In contrast, neither of 
the two identified Xenopus survivin orthologues (xSvv1 and xSvv2) showed anti-apoptotic activity in 
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this cell-free assay. Both genes are related to the single survivin gene in mammals but have a 
differential spatio-temporal transcription pattern in Xenopus. Overexpression of xSvv2 induced 
endothelial proliferation, while augmented expression of xSvv1 was inexplicably lethal (Du Pasquier 
et al., 2006). 
In conclusion, the machinery involved in apoptotic signaling appears to be evolutionarily conserved 
between mammals and Xenopus. The apoptotic mediators are first expressed early in embryogenesis 
and also regulate the remodeling events during metamorphosis. The extrinsic and intrinsic apoptotic 
pathways seem to play distinct physiological roles during development, depending on which 
apoptotic mediator is involved.  
 
 
Figure 4. Comparison of the apoptotic cell death pathways in Xenopus and mammals. 
The schematic representation illustrates the core components of the intrinsic and extrinsic apoptotic pathways in Xenopus 
and mammals. In Xenopus, some of the depicked interactions between the different characterized components are not yet 
proven (quenstion marks), but are rather based on the known interactions of the apoptotic signaling pathway in the 
mammalian systems. For example, the exact mechanism of xcaspase-8 activation in Xenopus is not yet described and needs 
to be further investigated. However, it seems that every apoptotic core component is at least present in the genome of 
Xenopus (see also Table 2).  
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Table 2. Summary of apoptotic mediators characterized/identified in Xenopus 
Gene family Xenopus gene Mammalian 
homologue 
Function or role in 
Xenopus 
References 
TNF xTNFα TNF Protection against TH-
induced apoptosis 
(Mawaribuchi et al., 2008) 
 xTRAIL1 Apo/TRAIL Transition of RBCs at 
metamorphosis 
(Tamura et al., 2010) 
 xTRAIL2 Apo/TRAIL Ligand Xenopus death 
receptor 
(Tamura et al., 2010) 
TNFR xTNFR TNFR1 
(TNFRSF1A) 
caspase-8 activation, NF-κB 
and JNK signaling 
(Mawaribuchi et al., 2008) 
 xDR-M1 DR5 
(TNFRSF10B) 
caspase-8 activation, NF-κB 
and JNK signaling 
(Tamura et al., 2004) 
 xDR-M2 DR5 
(TNFRSF10B) 
caspase-8 activation, NF-κB 
and JNK signaling 
(Tamura et al., 2004) 
Adaptor xFADD FADD Apoptosis and NF-κB and 
JNK signaling 
(Sakamaki et al., 2004; 
Ishizawa et al., 2006) 
 xRIPK1 RIPK1 NF-κB and JNK signaling (Ishizawa et al., 2006) 
 xcFlar c-FLIP Homology with human but 
not characterized yet 
Xenbase 
 xTRADD TRADD Homology with human but 
not characterized yet 
Xenbase 
 xTRAF6 TRAF6 NF-κB signaling (Inoue et al., 2005) 
Caspase xcaspase-1 caspase-1 Processing of proIL-1β? 
Apoptosis in tail? 
(Yaoita and Nakajima, 1997; 
Zou et al., 2000; Rowe et al., 
2005) 
 xcaspase-2 caspase-2 Metabolic regulation of 
oocyte cell death, cleavage 
of xBid, apoptosis in tail and 
intestine 
(Nakajima et al., 2000; Nutt 
et al., 2005; Rowe et al., 
2005; Du Pasquier et al., 
2006; Nutt et al., 2009) 
 xcaspase-3 caspase-3 Apoptosis in tail and 
intestine, tail regeneration 
(Yaoita and Nakajima, 1997; 
Nakajima et al., 2000; Das et 
al., 2002; Schreiber and 
Brown, 2003; Tseng et al., 
2007) 
 xcaspase-6 caspase-6 Apoptosis in tail and 
intestine 
(Nakajima et al., 2000; Rowe 
et al., 2005) 
 xcaspase-7 caspase-7 Apoptosis in tail and 
intestine 
(Nakajima et al., 2000; Rowe 
et al., 2005) 
 xcaspase-8 caspase-8 Cleavage of xBid, apoptosis 
in tail and intestine 
(Rowe et al., 2005; Du 
Pasquier et al., 2006) 
 xcaspase-9 caspase-9 Apoptosis in tail and 
intestine, regulation of 
balance between 
proliferation and apoptosis 
in brain 
(Rowe et al., 2005; Coen et 
al., 2007) 
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Gene family Xenopus gene Mammalian 
homologue 
Function or role in 
Xenopus 
References 
 xcaspase-10 caspase-10 Expressed during 
remodeling of tail and 
intestine, apoptosis in 
mammalian cells 
(Nakajima et al., 2000; 
Sakamaki et al., 2004) 
 xcaspase-10β caspase-10 Cleavage of xBid, apoptosis 
in mammalian cells 
(Kominami et al., 2006) 
Bcl-2 
Superfamily 
(pro-apoptotic) 
xBax Bax Pro-apototic, regulation of 
proliferation versus 
apoptosis 
(Sachs et al., 1997; 
Finkielstein et al., 2001; 
Tribulo et al., 2004; Rowe et 
al., 2005; Coen et al., 2007; 
Kloc et al., 2007; Tsuchiya 
and Yamashita, 2011) 
 xBcl-xs Bcl-xs Pro-apoptotic, expression 
induces oocyte death by a 
caspase-dependent 
mechanism 
(Braun et al., 2003) 
 xBcl-G Bcl-G Pro-apoptotic in egg 
extracts, mRNA expressed in 
occyte 
(Tsuchiya and Yamashita, 
2011) 
 xBak Bak Pro-apoptotic in extracts, 
mRNA expressed in occyte 
(Tsuchiya and Yamashita, 
2011) 
 xBok Bok Inactive when 
overexpressed in oocyte 
(Tsuchiya and Yamashita, 
2011) 
BH3-only xBid Bid Pro-apoptotic, cleaved by 
caspase-2,-8-10 
(Du Pasquier et al., 2006; 
Kominami et al., 2006; Du 
Pasquier et al., 2007; Saitoh 
et al., 2009; Tsuchiya and 
Yamashita, 2011) 
BH3-only xBimα1 Bim Pro-apoptotic in egg extract, 
weak expression in oocyte 
(Tsuchiya and Yamashita, 
2011) 
BH3-only xBimα2 Bim Pro-apoptotic, weak 
expression in oocyte 
(Tsuchiya and Yamashita, 
2011) 
BH3-only xBimβ Bim Inactive in egg extract, 
mRNA expressed in oocyte 
(Tsuchiya and Yamashita, 
2011) 
BH3-only xBmf Bmf Inactive in egg extracts, 
mRNA expressed in oocyte 
(Tsuchiya and Yamashita, 
2011) 
BH3-only xNoxa Noxa Pro-apoptotic in egg 
extracts, mRNA expressed in 
oocyte 
(Tsuchiya and Yamashita, 
2011) 
Bcl-2 
Superfamily 
(anti-apoptotic) 
xBcl-w/xR1 Bcl-w Anti-apoptotic in egg 
extracts, mRNA expressed in 
oocyte 
(Tsuchiya and Yamashita, 
2011) 
 xBcl-2 Bcl-2 Anti-apoptotic in egg 
extracts, mRNA expressed in 
oocyte 
(De Marco et al.; Tsuchiya 
and Yamashita, 2011) 
 
xBcl-B Bcl-B Anti-apoptotic in egg 
extracts, mRNA not 
expressed in oocyte 
(Tsuchiya and Yamashita, 
2011) 
32  
 
Introduction to caspase signaling in Xenopus 
Gene family Xenopus gene Mammalian 
homologue 
Function or role in 
Xenopus 
References 
 xMcl-1 Mcl-1 Anti-apoptotic in egg 
extracts, mRNA expressed in 
oocyte, counteracts xbid in 
eggs extracts 
(Tsuchiya and Yamashita, 
2011) 
 xBcl-xL/XR11 Bcl-xL Anti-apoptotic, balance 
between proliferation and 
apoptosis 
(Coen et al., 2001; Tribulo et 
al., 2004; Johnston et al., 
2005; Rowe et al., 2005; 
Zhang et al., 2006; Kloc et 
al., 2007) 
IAP xXIAP (Birc4) XIAP (Birc4) Recombinant xXIAP delayed 
apoptotic execution in egg 
extracts 
(Tsuchiya et al., 2005; 
Tsuchiya and Yamashita, 
2011) 
 xEIAP/XLX Birc7 Poor inhibitor of apoptosis 
in egg extracts 
(Tsuchiya et al., 2005) 
 xSurvivin1 (Birc 
5.1) 
Birc5 Mitotic spindle, no apoptotic 
inhibition in egg extracts 
(Tsuchiya et al., 2005; Du 
Pasquier et al., 2006; 
Canovas and Guadagno, 
2007) 
 xSurvivin2 (Birc 
5.2) 
Birc5 No apoptotic inhibition in 
egg extracts, induction of 
endothelial proliferation 
(Tsuchiya et al., 2005; Du 
Pasquier et al., 2006) 
 xcIAP1 (Birc2) cIAP1 (Birc2) Synteny with human but not 
characterized yet 
Xenbase 
 xNaip (Birc1) NAIP Synteny with human but not 
characterized yet 
Xenbase 
Other xSmac/DIABLO Smac/DIABLO Expression of xSmac enhances  
γ- irradiation-induced apoptosis 
in HeLa cells 
(Montesanti et al., 2007) 
 xApaf-1 Apaf-1 miR-24a negatively 
regulates xApaf-1 in retina 
(Rowe et al., 2005; Walker 
and Harland, 2009) 
 Cytochrome c Cytochrome c Released from 
mitochondria, induces 
apoptosis 
(Bhuyan et al., 2001; Braun 
et al., 2003; Deming and 
Kornbluth, 2006; Johnson et 
al., 2010; Tsuchiya and 
Yamashita, 2011) 
 
xAifm1 AIFm1 Homology with human but 
not characterized yet 
Xenbase 
 xAifm2 AIFm2 Homology with human but 
not characterized yet 
Xenbase 
 xAifm3 AIFm3 Homology with human but 
not characterized yet 
Xenbase 
 Omi/HtrA2 Omi/HtrA2 Homology with human but 
not characterized yet 
Xenbase 
 endonuclease G endonuclease G Homology  with human but 
not characterized yet 
Xenbase 
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I.1.4.3. Developmental programmed cell death in Xenopus  
I.1.4.3.1. Early embryogenesis  
 
Pre-gastrula 
Following fertilization, embryonic cells of the fly, frog and fish begin to divide rapidly. At this stage of 
development, cell cycles consist of only S- and M-phases and are driven by maternally stored mRNAs 
and proteins. Hence, zygotic transcription is absent in the early embryo. In the frog, zygotic 
transcription is consistently initiated at the mid-blastula transition (MBT) (Newport and Kirschner, 
1982). At this stage (8,5) gap phases are introduced into embryonic cell cycles, cell division becomes 
asynchronous, and cell motility is first observed. Even though zygotic transcription is initiated at the 
MBT, full zygotic control over cell cycle progression does not occur until maternal RNA is degraded, 
which occurs three divisions later at the onset of gastrulation. This transition from maternal to 
zygotic control is called the maternal/zygotic transition (MZT). A similar MZT has been detected in 
Drosophila embryos, also at the onset of gastrulation (Edgar and Datar, 1996). The timing of the MBT 
is regulated by the nucleus-to-cytoplasm volume ratio (Newport and Kirschner, 1982). Apparently, a 
developmental timing mechanism measures the time elapsed since fertilization and then activates 
the maternal mRNA degradation pathways at the onset of gastrulation (Cooke and Smith, 1990; 
Howe and Newport, 1996). By the onset of gastrulation, maternal cell cycle regulators have been 
removed and zygotic control over the cell cycles begins (Howe and Newport, 1996). Caspase-
mediated cell death has been reported in mammalian embryos as early as the 16-cell stage directly 
after compaction of the morula embryo (Spanos et al., 2002). In contrast, no developmental 
apoptotic PCD has been described in C.elegans, fly, zebrafish or frog between fertilization and 
gastrulation (Greenwood and Gautier, 2005).  
Though the apoptotic machinery is present, apoptosis cannot be induced before gastrulation in frog 
and fish. The ability to undergo apoptosis coincides with the introduction of cell cycle check-points in 
the early embryo. Treatment of frog or fish embryos with several death inducing insults before MBT 
results in rapid and synchronous cell death at the onset of gastrulation. Indeed, several treatments 
during early cleavage stages can trigger cell death in the early embryo directly after MBT. These 
treatments include those that induce DNA damage (gamma-irradiation or camptothecin), inhibit 
microtubule polymerization (nocodazole), block DNA replication (hydroxyurea and aphidicolin), 
inhibit transcription (α-amantine) or prevent protein synthesis (cycloheximide). These findings 
indicate that apoptotic competence can be mediated by maternal protein components (Hensey and 
Gautier, 1997; Ikegami et al., 1997; Sible et al., 1997; Stack and Newport, 1997; Ikegami et al., 1999; 
Johnston et al., 2005). Inhibitors of executioner caspases or overexpression of Bcl-2 can delay this 
initiation of apoptosis (Hensey and Gautier, 1997; Ikegami et al., 1999). Overexpression of a 
constitutively active form of Akt, which promotes survival in mammalian cells, also delays the onset 
of apoptosis in irradiated Xenopus embryos (Finkielstein et al., 2001). The absence of apoptosis 
before gastrulation is counter-intuitive, because the rapid, unchecked, embryonic cell cycles are 
more likely to yield damaged genomes, normally a potent apoptotic trigger. Although the exact 
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nature of the resistance of the Xenopus embryo to apoptosis is still unknown, two explanations could 
account for it. First, because embryos depend on a maternal stock of proteins and do not perform 
transcription, there is no selective pressure for early embryos to keep the genome intact or to 
eliminate damaged cells. Second, the rapidly dividing cells of the early embryo lack check-points that 
normally monitor genomic integrity. Evidently, this prohibits the necessary cross-talk between the 
check-point machinery and the cell death machinery.  
Although apoptosis in pre-gastrulating Xenopus embryos is absent, the functional and individual 
apoptotic mediators are present in these early embryos. Indeed, cell-free systems derived from 
Xenopus unfertilized eggs can be used to study the biochemical regulation of apoptosis (Newmeyer 
et al., 1994; Kornbluth, 1997). Shiokawa et al. (Shiokawa et al., 2000) noted that the maternal 
program of apoptosis might serve as a surveillance and ‘fail-safe’ mechanism to find and eliminate 
damaged cells, and thereby it permits the rest of the embryo to continue with development. During 
the first G1 phase, which appears shortly after MBT, cells can probably check their readiness to 
proceed to the next morphogenetic process, namely gastrulation. Strikingly, a recently developed, 
commercially available, near-infrared substrate that emits fluorescence only after proteolytic 
cleavage by active effector caspases was used to monitor several features of programmed cell death 
in intact Xenopus oocytes and in early embryos (blastula stage). Microinjecting cytochrome c into 
oocytes resulted in rapid caspase activation (< 5 min) and consequently caused the embryo to die. 
Moreover, caspase activity was detected before any morphological feature of apoptosis was 
manifested (Johnson et al., 2010). That study did not just reconfirm the presence of the maternal 
apoptotic machinery in oocytes, but also proved that oocytes can be impelled to die before 
gastrulation. Thus, forced apoptosis in the early embryo might occur only when the available 
apoptotic mediators are directly activated and not by a deleterious insult that is exposed only when 
check-points come into play.   
 
Post-gastrulation and neurulation 
Apoptotic cells are detected in various organs and tissues of Xenopus embryos after gastrulation. 
Hensey and Gautier used the whole mount TUNEL method to detect DNA fragmentation and made a 
spatio-temporal analysis of programmed cell death throughout Xenopus development (Hensey and 
Gautier, 1998). One should take into account that TUNEL staining only gives a snapshot of cell death 
at the moment of fixation and represents no more than a small time-window of the cell death 
process. Moreover, PCD is considered very dynamic because dead cells are rapidly cleared form the 
embryo. Cells that die are usually degraded rapidly within 1 h or less (Jacobson et al., 1997).  
The earliest TUNEL positivity was detected at stage 10.5, at the beginning of gastrulation. At this 
stage, dying cells appear to be randomly distributed, as in other organisms such as chicken and 
mouse (Sanders et al., 1997). This randomness likely represents the removal of the damaged cells 
that have been accumulating since fertilization. At later stages, this random cell death occurs in 
different areas in the embryos, especially in the region of the developing tail, where scattered 
TUNEL-positive cells were detected throughout the elongating tail tip, including the spinal cord, 
notochord and fin. In contrast, reproducible patterns of PCD were detected in the developing 
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nervous system from the earliest stages of neural induction (i.e. neural plate, stage 13-17) to the 
remodeling of the central nervous system (CNS) at later stages (i.e. brain region, stage 26-35). 
Additionally, cell death was consistently detected in the developing eye (stage 26-35), otic vesicle 
(stage 29-35), and spinal cord (stage 26-35). Similar patterns of developmental apoptosis have been 
observed in zebrafish and the medaka fish (Oryuzias latipes) (Cole and Ross, 2001; Iijima and 
Yokoyama, 2007). The existence of these highly reproducible patterns in neuronal developing regions 
suggests a central role for PCD in primary neurogenesis. 
 
Neurogenesis 
Studies of cell death in the developing nervous system have focused on the role of neurotrophic 
factors in regulating neuronal survival. About half of the original cell population produced during 
nervous system development is eliminated by apoptosis to optimize synaptic connections and to 
remove unnecessary neurons (D'Amelio et al.). However, Hensey and Gaultier observed cell death in 
the developing nervous system during developmental stages preceding axonogenesis or the 
establishment of synaptic connections. Thus, elimination of neurons during these early stages is likely 
independent of target-derived neurotrophic signals. However, some proliferating neural cells might 
also compete for limited amounts of neurotrophic factors as a mechanism to adjust their numbers 
(Boya and de la Rosa, 2005).  
Regulation of neuronal survival at this stage is poorly understood, and multiple mechanisms might be 
involved in the regulation of cell survival. Mice deficient in casp-3, casp-9 or apaf-1 show defects in 
PCD and die perinatally, suggesting that PCD is essential for proper embryonic development 
(D'Amelio et al.). The embryonic lethality of these deficiencies could be due to the hyperplasia in the 
brain, a possible direct consequence of the lack of PCD in both undifferentiated neural precursors at 
the early stages and neuronal precursors that do not establish the right synaptic connection at the 
later stages (de la Rosa and de Pablo, 2000; Kuan et al., 2000). Yeo and Gautier demonstrated that 
PCD inhibition by overexpression of xBcl-2 in Xenopus during early neural development results in 
increased numbers of both neural and neuronal cell types (Yeo and Gautier, 2003). A similar gain-of-
function experiment with Bcl-2 was performed in neurons of transgenic mice, and the outcome was 
similar (Martinou et al., 1994).  
The effect of PCD inhibition could be cell-autonomous, non-cell-autonomous, or both. A cell-
autonomous effect of PCD inhibition could be adoption of an alternative cell fate by the rescued 
cells. A non-cell-autonomous effect implies that the rescued cells influence neighboring cells to adopt 
alternative cell fates (Ruiz i Altaba, 1994). Either possibility predicts that the rescued cells can 
perform biological functions rather than remaining nonfunctional. In addition, it has been suggested 
that PCD does not function solely to regulate absolute cell numbers in the neuroectoderm. For 
example, PCD inhibition by overexpression of hBcl-2 did not only disrupt normal neurogenesis but 
also increased the expression of the Xenopus neuronal gene-markers Sox-2, Zincr-2, MyT-1, N-tub 
and Ngnr-1. Furthermore, that study (Yeo and Gautier, 2003) proposed that PCD regulates primary 
neurogenesis at the level of neuronal determination, a process that is coordinated by Ngnr-1. This 
hypothesis was further supported by experiments on constitutive activation of Notch signaling in 
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Xenopus embryos, mediated by overexpression of xNotchICD, which diverted neuronal cells from 
differentiation and maintained them in an uncommitted state. Preserving this undifferentiated status 
abrogated PCD, which confirmed that PCD likely participates in neuronal determination (Yeo and 
Gautier, 2003). Taken together, these findings show that normal cell death in the neuroectoderm 
might determine the fate of undifferentiated neuronal cells and is essential for the development of 
Xenopus neural tissue.  
Still, the question remains whether there is indeed a link between PCD and cell division to maintain 
homeostasis (Evan et al., 1995; Conlon and Raff, 1999). In other words, does PCD also play a role in 
regulating cell number in the neuroectoderm? The spatio-temporal pattern of proliferation in 
Xenopus is similar to that of PCD, suggesting a possible connection between these two processes 
(Saka and Smith, 2001). This is reminiscent of PCD occurring in the proliferative and newly post-
mitotic areas of the neuroproliferative regions in the CNS of mouse embryos (Blaschke et al., 1996; 
Blaschke et al., 1998). However, Yeo et al. do not believe that the primary role of PCD is to maintain 
absolute cell numbers in the developing neuroectoderm of Xenopus (Yeo and Gautier, 2003). 
Blocking DNA synthesis in embryos by treatment with HUA (hydroxyurea with aphidicolin) did not 
affect the patterned PCD. Furthermore, the number of cell divisions does not determine the 
occurrence of PCD within the neuroectoderm and it seems that cell fate determination during 
primary neurogenesis is independent of cell division as well (Yeo and Gautier, 2003). This confirms 
cell death interacts more intimately with the process of differentiation than with proliferation (Harris 
and Hartenstein, 1991).  
 
Organogenesis 
Developmental apoptosis is also widespread among neurons of the mammalian retina, in which two 
consecutive phases of apoptosis have been described. The earlier phase occurs during neurogenesis 
and cell migration, whereas the later phase occurs during target innervations (Vecino et al., 2004; 
Guerin et al., 2006). A similar pattern of apoptosis is seen in the developing zebrafish retina, with an 
initial phase peaking at 3–4 dpf and a second phase at 6–7 dpf. The first phase is restricted to the 
ganglion cell layer (GCL) and the inner nuclear layer (INL), whereas the second phase encompasses 
cells of the outer nuclear layer (ONL) in addition to the GCL and INL (Biehlmaier et al., 2001). 
However, pioneering studies of cell death in the Xenopus retina performed by Glucksmann 
postulated that there are likely three successive waves of developmental cell death occur in the frog 
eye (Glucksmann, 1965).  In the first wave, mitotic cells confined to the center of the retina become 
pyknotic and degenerate before the onset of cell differentiation. Next, after the formation of the 
ganglion cell layer and the inner plexiform layer, many cells in the region of the incipient INL die. 
Finally, a third wave of cell death is observed in the outer and inner nuclear layers in the periphery of 
the retina. This third wave occurs after formation of the outer plexiform layer and maturation of the 
central retina (Glucksmann, 1965; Vecino et al., 2004). It has been estimated that 40–70% of the 
retina ganglion cells (RGCs) die by caspase-mediated apoptosis during development. Moreover, upon 
inhibition of the activated caspases, the ganglion cell layer becomes thickened and enlarged 
(Mayordomo et al., 2003). Recently, Walker et al. proposed a role for miR-24a as a negative regulator 
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of apoptosis during retinal development. Knocking down miR-24a resulted in an increase in 
apoptosis, while proliferation, patterning, and differentiation of the eye remained unchanged 
(Walker and Harland, 2009). Apparently, loss of miR-24a function leads to an increase in xcaspase-9 
protein levels without altering mRNA levels. Furthermore, the phenotype seems to be dependent on 
a functional xcaspase-9 and it was found that miR-24a can repress xcaspase-9 and xApaf-1 by 
interacting with their 3’ untranslated regions (UTRs). Similar miRNA regulation may be important for 
other neural structures that also require precise levels of apoptosis during development, including 
the brain and spinal cord (De Pietri Tonelli et al., 2008).  
Hensey and Gaultier also reported apoptotic cells at the notochord of the Xenopus tadpole (stage 29-
35) (Hensey and Gautier, 1998). A similar phenomenon has been described in zebrafish embryos 
(beginning at 14 hpf) (Cole and Ross, 2001) and in chick embryos (stage 9) (Hirata and Hall, 2000). 
The notochord develops at the midline during gastrulation and persists as a long, flexible rod that 
underlies the neural tube and extends through most of the length of the embryo. The notochord 
plays crucial roles throughout embryonic development by acting as a signaling center that provides 
position and fate information for all three embryonic germ layers (Cunliffe and Ingham, 1999; Cleaver 
et al., 2000; Stemple, 2005), and structurally as a primitive skeleton (Adams et al., 1990). In most 
vertebrates, the notochord is a transient structure, the remnants of which form the nucleus pulposus 
of the intervertebral discs of the spine. In Xenopus, developmental cell death in the notochord could 
be prevented by the overexpression of the anti-apoptotic mediator xBcl-2, suggesting that it occurs 
via the intrinsic (mitochondrial) apoptotic pathway (Yeo and Gautier, 2003). Another study pointed 
out that the extrinsic death-receptor pathway might also be implicated in apoptosis in the notochord 
(Morgan et al., 2004).  Preventing the removal of cell corpses by inhibiting the phosphatidylserine 
receptor in zebrafish resulted in a variety of developmental defects, including malformation of the 
notochord (Hong et al., 2004). Interestingly, Malikova et al. (Malikova et al., 2007) identified a new 
role for apoptosis in the development of the notochord in Xenopus. These authors reported that 
apoptosis in the notochord actually appears much earlier (at stage 18) and starts at the anterior 
notochord. The number of dying cells increases until stage 25 and cell death spreads out posteriorly. 
The appearance of apoptotic cells coincides with the normal vacuolization of the notochord. If 
apoptosis was inhibited by xBcl-2, the length of the notochord was significantly increased in axial 
mesoderm explants and severely kinked in whole embryos. These observations suggest that cell 
death in the notochord could be linked with the process of vacuolization, but the mechanism is not 
known. One possibility could be that apoptosis is used to remove damaged cells, perhaps injured by 
the double or triple increase in internal pressure during vacuolization (Adams et al., 1990). 
Alternatively, apoptosis might regulate cell number following the overproliferation during the rapid 
elongation and vacuolization of the notochord. Interestingly, signals from the notochord are also 
essential for the formation and patterning of the neural tube and somites (Fleming et al., 2001). The 
somites in xBcl-2-injected embryos are disorganized but whether this is due to disruption of a 
biomechanical process or to aberrant cell signaling is not clear (Malikova et al., 2007). 
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In some cases, developmental apoptosis underlies processes that have not been evolutionarily 
conserved between frogs and other vertebrates. For example, in the inner ear of birds and mammals, 
an apoptotic ‘hot spot’ has been characterized in the ventromedial wall of the developing ear, 
adjacent to the auditory ganglion (Lang et al., 2000). Thorough examination of apoptotic cell death in 
the developing ears of both zebrafish and Xenopus laevis did not reveal a similar hot spot. Apoptosis 
still occurred in the statoacoustic ganglion, the developing sensory patches, and in various locations 
in the otocyst wall, as has been reported for birds and mammals (Bever and Fekete, 1999). 
 
Figure 5. Schematic representation of the reported cell death patterns during early embryogenesis of 
Xenopus.  
 
I.1.4.3.2. Metamorphosis  
Analogous to the TUNEL-stainings performed by Hensey and Gautier on early embryos (stage 10.5-
35), Estabel et al. monitored cell death in Xenopus tadpoles from stages 35-46 to metamorphosis 
(stages 55-65). These larval stages represent the end of morphogenesis that leads to the 
development of the organs necessary for aquatic life, including functional eyes, cement gland and 
gills. Besides substantial cell death in the larval nervous system, apoptotic cells could also be 
detected in the skin, the differentiating digestive tract, and the somites. Neither the lens nor the 
retina showed TUNEL positive cells. During the subsequent growth period, there was no extensive 
cell death, but some sporadic dying cells were still detected throughout the different organs of the 
tadpole (Estabel et al., 2003). The next wave of apoptosis was seen during metamorphosis. 
Amphibian metamorphosis represents dynamic and systematic changes by which larval organs are 
replaced by adult organs to enable transition from an aquatic life style to a more terrestrial life style. 
This extensive reorganization is triggered by a surge of thyroid hormone (TH) and corresponds to the 
human perinatal period, which is marked by an abrupt increase of thyroid hormone after birth (Tata, 
1993; van Wassenaer and Kok, 2004). Metamorphosis is composed of three developmental periods, 
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premetamorphosis (from hatching to stage 54), prometamorphosis (stage 55-57) and metamorphic 
climax (stage 58-66). Endogenous thyroid hormone levels start to rise in the plasma during 
prometamorphosis, and an orderly succession of morphological changes occurs (e.g. development of 
the hind limbs). At the climax, when the concentration of TH is at its peak, tadpoles undergo a rapid 
and temporally ordered metamorphic transition, including eruption of front limbs, shrinkage of the 
head, resorption of gills, remodeling of intestine and skin, and absorption of the tail. This rapid and 
extensive remodeling or regression of organs is associated with programmed cell death, which occurs 
in response to the increased levels of thyroid hormone (Schreiber et al., 2001; Nakajima et al., 2005). 
A more detailed description of the apoptotic events in different larva-specific and larval-to-adult 
organ remodeling during metamorphosis was recently reviewed (Ishizuya-Oka et al.). Obviously, this 
current section also deals with cell death during metamorphosis, but the emphasis is rather on the 
possible involvement of the known mediators of apoptotic signaling.    
 
Tail 
The tail resorption process involves loss of epidermal cells, fibroblasts, nerve cells and muscles. 
Elimination of these different cell types occurs virtually simultaneously. This coordinated elimination 
of different tissues is mediated by various cell death mechanisms. Some tissues are directly removed 
by cell-autonomous programs (the suicide model) (Rowe et al., 2002), while others are killed by 
proteases in the extracellular matrix (the murder model) (Berry et al., 1998). For example, it has been 
suggested that in muscle there is first (stages 57 to 62) only a suicide mechanism, induced by TH in 
the tail. However, between stages 62 and 64, during which the tail disappears completely, it seems 
that both the murder and the suicide mechanisms are involved in tail resorption (Nakajima and 
Yaoita, 2003; Nakajima et al., 2005). An interesting observation is that the number of macrophages in 
the tail region coincides with muscle cell death and peaks at late climax (stage 63) (Nishikawa et al., 
1998). This implies that macrophage-mediated removal of apoptotic bodies is important in tail 
regression.  
Several studies point to the possible involvement of the mitochondrial pathway in muscle cell death 
in metamorphosing Xenopus tadpoles. First, it was shown that xBax and XR11 genes, members of the 
Bcl-2 family, participate in the elimination of muscle cells in the tail. Indeed, the level of the 
proapoptotic xBax transcripts under the control of TH increases in the tail during metamorphosis 
(Sachs et al., 1997). Second, overexpression of XR11, an anti-apoptotic member of the Bcl-2 family, 
can counteract the effect of xBax in muscle when the two proteins are expressed together (Coen et 
al., 2001) as well as protect muscle from death during metamorphosis (Rowe et al., 2002). Because 
xBax and XR11 probably act by controlling the mitochondrial permeability and the release of pro-
apoptotic factors such as cytochrome c, it has been proposed that the downstream activation of 
xcaspase-9 is also involved in muscle cell apoptosis during metamorphosis (Rowe et al., 2005). To 
test this hypothesis, these authors determined xcaspase-9 mRNA and protein levels before and 
during metamorphosis. Indeed, in accordance with previous data (Nakajima et al., 2000), strong 
expression of xcaspase-9 was found in various tissues, especially in the tail and brain, throughout 
Xenopus metamorphosis. Also xApaf-1 transcripts, coding for an adaptor protein necessary for 
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xcaspase-9 activity, followed the expression pattern of xcaspase-9 (Rowe et al., 2005). Active 
xcaspase-9 was detected in tail muscle cells at the onset of metamorphosis, peaked at climax (stage 
59) and decreased from stage 61 to the end of metamorphosis (Rowe et al., 2005). Reduced levels of 
xcaspase-9 at the end is likely the result of widespread cell loss due to the increased tail regression. 
This finding agrees with the large increase in TUNEL-positive cells between stage 61 and the end of 
metamorphosis (Rowe et al., 2002; Estabel et al., 2003). During this period, muscle mass decreases 
drastically and muscle fibers are eliminated by apoptosis. Loss-of-function experiments with a 
dominant-negative form of xcaspase-9 confirmed the dependence of this massive muscle fiber cell 
death on the intrinsic apoptotic pathway (Rowe et al., 2005).  
The next question is whether there are factors acting upstream of these mitochondrial apoptotic 
mediators. A strong argument for the potential cross-talk with the extrinsic apoptotic pathway was 
demonstrated by functional characterization of the Xenopus Bid protein, a BH3-only member of the 
Bcl-2 family. During metamorphosis, xBid mRNA levels increase in tissues in which there is substantial 
cell death (skin, intestine, spleen, and tail) but remain constant elsewhere, such as kidney and liver. 
Ubiquitous overexpression of a xBid-GFP fusion protein in a transgenic setting appeared to accelerate 
TH-induced regression of the tail, while transgenic animals develop normally. In these transgenic 
tadpoles, xBid is functionally processed to the truncated active tBid protein in several tissues during 
metamorphosis. During natural or TH-induced tail regression, xBid cleavage correlates with 
heightened expression and increased activity of xcaspase-2 and xcaspase-8. Based on the use of 
different caspase inhibitors, it was deduced that only caspase-8 is required for apoptotic cell death in 
the regressing tail (Du Pasquier et al., 2006). However, as mentioned before, a preceding observation 
questions the early involvement of xcaspase-8, because it seems that xcaspase-8 is not significantly 
up-regulated until metamorphic climax at stage 63. This implies that it is the intrinsic xcaspase-9 
mediated signaling that plays a primary role during muscle cell death, and this signaling might engage 
independently of the upstream extrinsic apoptotic factors only during the earlier stages of tail 
regression (Rowe et al., 2005). Because the expression profiles of the individual caspases were based 
on semi-quantitative RT-PCR experiments and certain concerns were raised about the selectivity of 
the caspase inhibitors used (McStay et al., 2008), these seemingly incompatible observations should 
be interpreted with caution. In any case, the expression and activity of the effector xcaspase-3 and 
xcaspase-7 definitely correlate with the late increase of apoptotic cells in the tail; consequently, 
these caspases are believed to be the downstream effectors of this metamorphic cell death (Yaoita 
and Nakajima, 1997; Nakajima et al., 2000; Das et al., 2002; Rowe et al., 2002; Rowe et al., 2005).   
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Nervous system 
The nervous system too undergoes extensive remodeling in order to adapt to the different life style 
after metamorphosis. Around stage 58, cell death was detected in the adapting dorsal part of the 
spinal cord, including the Rohon-Beard cells and the sensory interneurons. Rohon-Beard cells are 
mechanosensory cells with peripheral neurites innervating the tail skin (Roberts and Clarke, 1982). 
These cells begin to degenerate just before metamorphosis and few, if any, survive at climax (Coen et 
al., 2001). From stage 61 (metamorphic climax when tail regression starts), cell death shifts towards 
the ventral part of the spinal cord, where the motor neurons and the ependymal cells reside. A gain-
of-function study with the XR11 protein, a homologue of the anti-apoptotic mammalian Bcl-XL, 
prolonged Robon-Beard neuron survival up to the metamorphic climax, even in the regressing 
tadpole tail. However, XR11 expression did not modify the death rate of the ventral spinal cord 
motor neurons; this points to the engagement of cell- or tissue-specific apoptotic pathways. 
Furthermore, the mRNA levels of XR11 increase abruptly in the brain during mid- and post-
metamorphosis (Cruz-Reyes and Tata, 1995), which is concomitant with the reported transcriptional 
increase of several caspases (e.g. xcaspase-9 and -3) and xApaf-1 (Rowe et al., 2005; Coen et al., 
2007). Coen et al. correlated the amplified activity of xcaspase-9 with reduced cell proliferation at 
climax. Interestingly, interfering with xcaspase9-mediated signaling or overexpression of XR11 did 
not simply abrogate apoptosis but also maintained the neurogenic pool in a proliferative state, 
presumably by increasing the rate of mitosis in the neuroblast population. This observation points to 
a direct link between cell death and the cell-cycle-controlling mechanisms. Such a link would enable 
the modulation of the number of neuronal cells in the CNS during metamorphosis.  
  
Intestine 
As anurans metamorphose from a omnivorous tadpole to a carnivorous frog, the long small intestine, 
consisting predominantly of a single tubular layer of larval epithelium with very little connective 
tissue or muscle, is shortened by about 90% (Marshall and Dixon, 1978). The adult epithelium after 
metamorphosis acquires a cell-renewal system along the trough-crest axis of intestinal folds 
(Ishizuya-Oka and Ueda, 1996), analogous to the mammalian crypt-villus axis. The replacement of 
larval intestine by an adult complex organ comprised of a multiple folded epithelium with elaborate 
connective tissue and muscle, is simultaneously accompanied by programmed cell death in the larval 
epithelium (Bonneville, 1963). The number of apoptotic cells suddenly increases around the 
beginning of the metamorphic climax (stage 59-61) and decreases after stage 62. When the 
apoptotic larval cells coexist with the adult cells, the number of macrophages rapidly increases only 
in the larval epithelium undergoing apoptosis. After engulfing apoptotic bodies derived from larval 
epithelial cells, the enlarged macrophages are finally extruded in the intestinal lumen (Ishizuya-Oka 
and Shimozawa, 1992). Although the intestine is one of the best-studied remodeling organs, not 
much was known about the molecular mechanism of cell death in this tissue. However, as recently 
reviewed by Ishizuya-Oka (Ishizuya-Oka, 2011), a growing body of evidence indicates that apoptosis 
during the intestinal remodeling occurs not only via a cell-autonomous pathway but also via cell–cell 
and/or cell–extracellular matrix (ECM) interactions. The cell-autonomous pathway upregulates 
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apoptotic genes directly by TR/RXR receptor signaling (9-cis retinoic acid receptor) or indirectly 
through other TH response genes in the larval epithelial cell. At the same time, stromelysin-3, a 
matrix metalloproteinase that alters cell–ECM interactions by cleaving a laminin receptor, can also 
induce apoptosis in the larval intestinal epithelium (Ishizuya-Oka et al., 2000). Morphological studies 
have shown that lymphocytes as well as macrophages frequently reside in both the larval and adult 
intestinal epithelia throughout metamorphosis (Marshall and Dixon, 1978; McAvoy and Dixon, 1978). 
Although the precise role of residence is unknown, the residual larval epithelial cells might be 
removed by adult lymphocytes to assure proper intestinal remodeling. A similar theory was proposed 
for the skin of the tail during metamorphosis (Izutsu and Yoshizato, 1993; Mukaigasa et al., 2009).    
 
Blood 
In anuran amphibians, the circulating larval red blood cells (RBCs) that originate from primitive 
erythropoiesis are replaced by adult RBCs (the so-called hemoglobin switching) during 
metamorphosis (Dorn and Broyles, 1982). The molecular mechanisms by which the primitive (larval) 
blood cells are specifically removed from circulation are not fully understood. Tamura et al. came up 
with a strong argument that the recently identified Xenopus TNF-related apoptosis-inducing ligand 1 
(xTrail1) could be involved in this transition (Tamura et al., 2010). They showed that xTrail1 induced 
apoptosis in larval RBCs but had little effect on adult RBCs in vitro. Their results suggest that part of 
the mechanism of RBC switching is apoptosis caused by xTrail1, probably mediated through xDR-Ms 
(death receptors) in larval RBCs. This process might not kill adult RBCs, possibly due to PKC activation 
(Tamura et al., 2010). 
 
Skin 
Finally, a morphological study of the regressing tail skin indicated that also tail epidermal cells 
undergo apoptosis during metamorphosis (Kerr et al., 1974). Immunohistochemical analysis with an 
active xcaspase-3 antibody provided more evidence and revealed abundant cell death in the larval 
epidermal skin during the climax of metamorphosis (Schreiber and Brown, 2003). The observation 
that expression of the dominant-negative thyroid receptor protects larval epidermal cells from TH-
induced cell death indicates that the larval apical skin cells are direct targets of TH and die cell-
autonomously via the suicide model (Schreiber and Brown, 2003).  
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Figure 6. Schematic representation of the reported cell death patterns during the metamorphosis of 
Xenopus. 
 
I.1.4.3.3. Apoptosis in tail regeneration 
The Xenopus tadpole can regenerate its tail, including restoration of its nerves, muscle, skin and 
blood vessels (Deuchar, 1975). Regeneration is a complex process that occurs in several distinct 
phases (Gardiner et al., 2002). In a nutshell, soon after amputation and wound healing, an initial 
swelling gives rise to a regeneration bud in which proliferating cells rapidly rebuild the tail. Despite 
the massive tissue proliferation needed to reconstitute the tail, an endogenous early apoptotic event 
seems to be required for proper regeneration. Tseng et al. (Tseng et al., 2007) gained mechanistic 
insight into why apoptosis is needed during tail regeneration by using xcaspase-3 inhibitors. Caspase 
activity was detected in the nascent regeneration bud within 12 hours after amputation and 
appeared to be required for the early phase of regeneration in which proliferation occurs, because 
caspase inhibition 24 hours after amputation had no effect on regeneration. Interestingly, caspase 
inhibition within the first 24 hours also decreased the number of mitotic cells in the regeneration 
bud. Thus, failure to initiate the increase in mitosis is likely to be at least part of the mechanism by 
which caspase inhibition abrogates tail regeneration. Surprisingly, regeneration failed to start after 
caspase inhibition in tissues that do not show xcaspase-3 activity. This implies that tail regeneration 
in all parts of the tail might depend on signals from a smaller cell population. One possible 
explanation could be is the presence of a native cell subpopulation that normally inhibits growth and 
regeneration and must be eliminated for regeneration to take place. Alternatively, a subpopulation 
of the apoptotic cells might send out signals to stimulate proliferation in the other parts of the tail. 
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Evidence for this latter mitogenic signaling hypothesis comes from regeneration processes in 
Drosophila, Hydra and mouse models, in which caspase-signaling seems to be also necessary for 
proper regeneration. In these organisms, caspases are apparently required for the release of several 
growth and differentiation factors (i.e. Wnt, Hh and PGE2). In this way, apoptotic cells can induce 
compensatory proliferation and promote regeneration in invertebrates and vertebrates (Bergmann 
and Steller, 2010).  
 
I.1.4.4. Amphibians as a model for apoptosis - Concluding remarks 
Pioneering studies in the nematode, Caenorhabditis elegans, took advantage of the highly 
reproducible pattern of PCD in the developing hermaphrodite and of its amenability to forward 
genetic screens to identify several key components of the molecular apoptotic signaling pathway. 
Therefore, they have been used widely and successfully to study the basic mechanisms of apoptosis 
(Peden et al., 2008). The fly has also been useful for gaining critical insights into the apoptotic 
process (Mollereau, 2009). Despite the ease of identifying and characterizing these core components 
of the apoptotic machinery by genetic manipulation, the invertebrate models cannot replicate all 
aspects of apoptosis known to be important in vertebrates. For example, apoptosis that occurs as a 
normal part of embryogenesis and adult tissue homeostasis is often specific to organs and tissues 
that lack analogs in invertebrate species (e.g. the fly does not have an adaptive immune system 
(Kurata, 2010)). In other cases, apoptosis arises in pathologies that cannot be modeled in nematodes 
and flies. Additionally, apoptotic pathways have evolved to a far greater degree of complexity and 
diversity in mammals and other vertebrates (Oberst et al., 2008; Wang and Youle, 2009). For 
instance, cell death research on C. elegans taught us that the intrinsic apoptosis pathway appears to 
have evolved around the same time as multicellular organisms. Indeed, Bcl-2 family orthologues have 
been identified in all metazoans (Youle and Strasser, 2008). However, while more than 25 Bcl-2 
superfamily members have been identified in humans (Aouacheria et al., 2005), only three exist in C. 
elegans (Egl-1, Ced-9, and Ced-13) (Nehme and Conradt, 2008) and two in Drosophila (Buffy and 
Debcl) (Krieser and White, 2009). Furthermore, no tumor necrosis factor (TNF) or TNF receptor 
(TNFR) superfamily members have been found in C. elegans. Death receptors with a death domain 
motif have been reported almost exclusively in vertebrates, although recently a death-domain-
containing TNFR has been identified in the Zhikong scallop (Chlamys farreri) (Li et al., 2009). This lack 
of initiators of the extrinsic apoptotic pathway implies that this part of the signaling pathway is a 
more recent evolutionary development restricted to vertebrates. Apparently, while the core 
components are conserved in higher eukaryotes, additional regulatory control mechanisms have 
been added to the apoptotic pathway throughout evolution (Danial and Korsmeyer, 2004). Finally, 
several fundamental aspects of the apoptotic pathways differ between invertebrates and 
vertebrates, and in this way the nematode and the fly fail again do not possess the complexity of the 
vertebrate systems. For instance, Drosophila homologues of FADD (dFADD) and caspase-8 (Dredd) 
have not been linked to the extrinsic pathway and instead appear to promote transcription of 
antimicrobial peptide genes following bacterial infection (Kuranaga and Miura, 2007). Thus, a 
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convenient vertebrate model is required for further comprehensive research on apoptotic signaling 
events. As reviewed in (Eimon and Ashkenazi, 2010), the zebrafish turns out to be a vertebrate model 
of apoptosis that is genetically tractable, amenable to analysis during early development, and 
suitable for experimental approaches with relatively high throughput. All of these criteria are fulfilled 
by Xenopus. Like the fish, the frog has a diversity of apoptosis-related genes comparable to those of 
mammals. Functional genomics approaches, especially the use of antisense morpholino 
oligonucleotides to knock down gene function transiently in embryos (Eisen and Smith, 2008), 
enables the characterization of apoptosis related processes during development. Hence, besides the 
well-known usefulness of Xenopus egg extracts and the ease of overexpression experiments in 
oocytes, which have contributed in a major way to our biochemical understanding of the apoptotic 
process, three unique properties of Xenopus embryos can broaden our understanding of the role of 
apoptosis during development. For example, (1) the frog model provides an exceptional platform for 
unraveling the components necessary for the tight regulation and execution of programmed cell 
death during early embryonic development, as well as for discovering the regulators required for the 
remodeling of different organs during metamorphosis. (2) From an evolutionary point of view, 
amphibian metamorphosis is often compared to mammalian postembryonic development, the 
period around birth. It is known that TH levels in mammalian plasma increase transiently, and these 
high levels are critical for late embryonic and postnatal development such as organ maturation, a 
period that bears many similarities to anuran metamorphosis (Tata, 1993). (3) The frog also serves as 
a convenient vertebrate animal model for studying apoptotic cell death in response to a variety of 
external stimuli, which are often used during drug screens. In fact, Xenopus has a long history in the 
fields of teratology and toxicology (Wheeler and Brandli, 2009). The Frog Embryo Teratogenesis 
Assay–Xenopus (FETAX) is a 96-hr whole-embryo developmental toxicity test that uses late blastula 
stage embryos to measure the effects of chemicals on mortality, malformation, and growth inhibition 
(Courchesne and Bantle, 1985). These standard FETAX assays can now be extended by the use of 
transgenic reporter lines instead of wild type frogs. The use of embryos and tadpoles derived from 
these lines on automated stage fluorescent microscopes offers great perspectives, for example, for 
semi-high throughput screenings to identify novel drugs designed to induce apoptosis for the 
treatment of cancer. In comparison to zebrafish larvae, the greater similarities of the tissues and 
organs of Xenopus tadpoles to their mammalian counterparts translates into a higher predictive 
power of findings made in Xenopus for our understanding of human biology. 
In conclusion, the Xenopus is ideal for modeling cell death and it is likely that the general interest will 
continue to grow if the several advantages, which come along with the organism are properly 
exploited. Obviously, it will be important to identify and characterize the other core components of 
the intrinsic and extrinsic apoptosis pathways and to further optimize the different readouts to 
understand or confirm the roles of these components in apoptotic cell death.  
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I.1.5. Hematopoiesis in vertebrates 
Blood development or hematopoiesis is the dynamic and complex formation of new blood cells from 
all blood cell lineages, originating from the versatile multipotent hematopoietic stem cells (HSCs) 
(Orkin, 2000). Hematopoiesis has been highly conserved during evolution. A common feature of the 
mammalian, amphibian and fish hematopoietic cells is that they emerge and progressively 
differentiate in several locations (Galloway and Zon, 2003; Cumano and Godin, 2007). Amphibian 
hematopoiesis and immune system development are very similar to mammals. Hence, the frog 
embryos have been extensively used for the elucidation of the distinct origins of embryonic and adult 
hematopoietic cells, as well as for their migration pathways and organ colonization behaviors. The 
ease of tissue transplantation and lineage labeling experiments in frog embryos was extremely 
beneficial for our current understanding of the cellular and genetic basis of the ontogeny of 
hematopoiesis. In the meantime, the zebrafish embryos have emerged as an additional powerful 
model system superior to the frog for both genetic analysis and imaging.  
 
In general, two stages of hematopoiesis are recognized, namely primitive and definitive 
hematopoiesis, which occurs before and after the development of the fetal liver, respectively. 
Primitive hematopoiesis in mammals and birds occurs in blood islands located in the extraembryonic 
yolk sac (EYS) and predominantly generates eythroid cells and some megakaryocytes (Tober et al., 
2007). The homologous sites in Xenopus and zebrafish are respectively the ventral blood island (VBI) 
and the intermediate cell mass (ICM) (Turpen et al., 1981; Paik and Zon, 2010) (Fig.7). The primary 
function for primitive hematopoiesis is production of red blood cells that facilitate tissue oxygenation 
as the embryo undergoes rapid growth (Orkin and Zon, 2008). Later in development, when the fetal 
liver is formed, definitive hematopoiesis kicks in and constitute the various blood lineages. The 
switch to definitive blood formation takes place rather smoothly because the EYS/VBI/ICM also 
partially contribute to definitve blood cells. In amphibians the early definitive blood cells arise from 
the dorsal lateral plate (DLP) (Turpen et al., 1981) (Fig.7). However, this transient blood formation 
site is eventually replaced by the liver, spleen, pronephros and the thymus. The equivalent early 
localization of definitive hematopoietic potential in mice and birds is termed the aorta-gonad 
mesonephros region (AGM) (Nishikawa et al., 2001). Later, definitive blood cells are formed in places 
like the spleen, the lymph nodes and the bone marrow and compose the main site of hematopoiesis 
in mice and humans (Fig.7).  
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I.1.5.1. Ontogeny of hematopoiesis in mammals 
In the early mammalian embryo, the earliest differentiated cell types are the primitive hematopoietic 
and endothelial cells formed within the blood islands which arise from the yolk sac mesodermal 
progenitor induced during gastrulation (Mikawa et al., 2004). In the mouse, blood islands formation 
begins form the epiblast on embryonic day 7.25 (E7.25). At E7.5, the inner mesodermal layer 
adjacent to the endoderm is thickened and encompasses the hematopoietic progenitors, which 
subsequently bud off of the endodermal base and form a blood island (Orkin and Zon, 2008).  At this 
stage the first HSCs can be detected (Palis and Yoder, 2001). In humans, the primitive hematopoiesis 
is morphologically detectable between the second and third week of human gestation (Peault and 
Tavian, 2003). It has been argued that the endothelial and hematopoietic cells arise in close spatio-
temporal association in the yolk sac form a common mesodermal progenitor, the hemangioblast 
(Dzierzak and Speck, 2008). These hemangioblasts migrate to the yolk sac, at which point they 
become committed endothelial and hematopoietic progenitors and eventually contribute to the 
formation of each blood island (Ferkowicz and Yoder, 2005). Thus, during mammalian embryonic 
development, the earliest cohort of mesodermal cells emigrating from the primitive streak take on 
endothelial and hematopoietic fate prior to blood island formation, and give rise to primitive red 
blood cells and some of the yolk sac vasculature (Jones et al., 2004; Ferkowicz and Yoder, 2005).  
It was suggested in the 1970s that cells of the yolk sac were the primary source of the hematopoietic 
system in the adult mammal and that yolk sac cells emigrate to the fetal liver and thereafter to the 
bone marrow where they reside throughout adulthood (Moore and Metcalf, 1970). However, tissue 
grafting approaches conclusively demonstrated that the yolk sac was not the source of adult blood in 
non-mammalian vertebrates (Dieterlen-Lievre, 1975; Turpen et al., 1981). From these experiments it 
was concluded that the adult hematopoietic system in mammals originates from cells within the 
body of the embryo (also called the aorta-gonad-mesonephros (AGM) region) and from the extra-
embryonic allantois, but not from the yolk sac (Dieterlen-Lievre, 1975; Caprioli et al., 2001) (Fig.7). 
This spatial separation of primitive and adult hematopoiesis was also demonstrated in Xenopus in 
which the VBI (equivalent for the yolk sac) is the source of the primitive hematopoietic cells and the 
DLP (equivalent for the AGM region in mammals) the source of the adult hematopoietic cells (Turpen 
et al., 1981). Thus, definitive hematopoiesis in mammals kicks in at the AGM region at E10.5 and the 
AGM-derived HSCs are thought to seed the liver and ultimately provide long-term hematopoiesis in 
the bone marrow (Muller et al., 1994; Medvinsky and Dzierzak, 1996) (Fig.7). However, it has been 
shown that the residing HSCs in the fetal liver do not exclusively originate from the AGM but rather 
form two exogenous sources. The first one being derived from the yolk sac that generate transient 
waves of committed hematopoietic progenitors, which is then followed by a second wave of HSCs 
originating in the AGM region (Bertrand et al., 2005). 
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Additional hematopoietic activity in the mouse embryo was detected in the umbilical arteries and the 
allantois (Inman and Downs, 2007). Moreover, significant numbers of HSCs are also found  in the 
mouse placenta (Ottersbach and Dzierzak, 2009). The relative contribution of each of the above sites 
to the final pool of adult HSCs remains largely unknown. Subsequent definitive hematopoiesis 
involves the colonization of the thymus, spleen, and ultimately the bone marrow (Fig.7). It is believed 
that none of these sites is accompanied by de novo HSC generation. Rather, their niches support 
expansion of populations of HSCs that have migrated to these new sites (Cumano and Godin, 2007; 
Orkin and Zon, 2008).  
Other classes of hematopoietic cells derived from these HSCs are also generated in the mouse 
conceptus between the time primitive erythrocytes and HSCs appear, including the myeloid 
progenitors and the lymphoid-myeloid (multipotent) progenitors. At E8.25, following the first wave 
of primitive erythropoiesis and before the circulation is established, the primitive myeloid 
progenitors are detected in the yolk sac (Ferkowicz et al., 2003). By E9, more potent myeloid 
progenitors (CFU-S) capable of forming colonies on the spleen following injection into irradiated mice 
are present in both the yolk sac and the AGM (Medvinsky et al., 1993). Quantitative analyses show 
more CFU-S in the AGM than in the yolk sac, suggesting that the AGM generates these cells 
(Medvinsky et al., 1993). 
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Figure 7. Developmental regulation of hematopoiesis in the Mouse and comparison with Xenopus. 
(A) Hematopoiesis occurs first in the yolk sac (YS) blood islands and later at the aorta-gonad mesonephros (AGM) region, 
placenta, and fetal liver (FL). YS blood islands are visualized by LacZ staining of transgenic embryo expression GATA-1- 
driven LacZ. AGM and FL are stained by LacZ in Runx1-LacZ knockin mice. (B) Hematopoiesis in each location favors the 
production of specific blood lineages. (C) Developmental timewindows for shifting sites of hematopoiesis in mouse and in 
Xenopus. Abbreviations: ECs, endothelial cells; RBCs, red blood cells; LTHSC, long-term hematopoietic stem cell; ST-HSC, 
short-term hematopoietic stem cell; CMP, common myeloid progenitor; CLP, common lymphoid progenitor; MEP, 
megakaryocyte/erythroid progenitor; GMP, granulocyte/macrophage progenitor; VBI, ventral blood island; DLP, dorsal 
lateral plate (adapted from (Orkin and Zon, 2008)). 
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I.1.5.2. Ontogeny of hematopoiesis in amphibians 
Early fate mapping experiments showed that both the ventral (VMZ) and dorsal marginal zones 
(DMZ) of the lateral plate mesoderm contribute to the VBI. Injection of a lineage tracer into the 
marginal zone of 4-cell embryos conclusively demonstrated that the DMZ contributes to the most 
anterior portion of the VBI, referred to as aVBI, whereas the VMZ contributes to the posterior 
portion, namely the pVBI (Tracey et al., 1998). This finding was confirmed by fate mapping 
blastomeres of the 32-cell embryo which showed that the aVBI derives from the dorsal blastomeres, 
C1 and D1, and the pVBI derives from the ventral blastomere, D4, in normal dividing embryos 
(Fig.8A). Knowledge of these early mesodermal precursors of embryonic blood at 32-cell stage 
blastomeres has been very instructive for target expression studies (Ciau-Uitz et al., 2000). Before 
gastrulation, the precursors of the hematopoietic lineage are located in the dorsal blastopore lip, a 
zone that is free of BMP (Bone Morphogenetic Protein) activity. As gastrulation proceeds, they 
invaginate to become part of the mesodermal leading edge which migrates under the roof of the 
blastocoel (bcl) (Fig.8B). At the end of gastrulation, while they encounter the ventral mesodermal 
leading edge, they are exposed to BMPs which induce expression of hematopoietic and endothelial 
genes (Walmsley et al., 2002). After gastrulation is complete, a population of hemangioblasts in the 
prospective aVBI can be first identified in the most ventral aspect of the neurula (stage 14) embryo. 
This early VBI region in the neurula embryos was described as a monolayer or bilayered sheet of cells 
extending along the ventral region of the embryo. The island is anteriorly bordered by hepatic 
endoderm, which is believed to secrete erythropoietin-like activity that is responsible for the 
anterior-to-posterior wave of hemoglobinization (Mangia et al., 1970). The anterior hemagioblast 
population (located at the aVBI) gives rise to a minority of the VBI erythrocytes but to a large number 
of myeloid cells (Costa et al., 2008; Walmsley et al., 2008). On the other hand, the pVBI gives rise to 
early and late larval erythrocytes, leukocytes (myeloid) and a few, short term lymphoid cells (e.g. T-
cells) (Rollins-Smith and Blair, 1990; Turpen et al., 1997).  
A general notion is that genes associated with erythroid differentiation, such as globin, are expressed 
first in the aVBI and only later in the pVBI. The same is true for myelogenesis which is initiated and 
most pronounced at the aVBI. These aVBI generated myeloid cells start to patrol the embryo at stage 
22 and act as some kind of  guards protecting the early embryo (Costa et al., 2008). The pVBI 
originated myeloid cells are not seen until the initiation of heart beating in the tadpole (Tashiro et al., 
2006). These observations are in analogy with the two successive waves of hematopoiesis in the 
mouse yolk sac (Fig.7). The first yolk sac wave gives rise to embryonic erythrocytes and myeloid cells 
whereas the second wave gives rise to multipotent progenitors and definitive erythrocytes 
expressing adult globin chains. Finally, larval erythrocytes enter the circulation from stages 33-34 in 
an anterior-posterior wave. The larval immune system begins to develop between stages 42-45 when 
the thymus becomes histologically visible.  
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Figure 8. Ontogeny and hematopoietic potential of the ventral blood island (VBI). 
(A) The aVBI and its precursors (blue), the embryonic hemangioblasts, derive from the dorsal C1-D1 blastomeres of the 32-
cell stage embryo, while the pVBI and its precursors (green) originate from the ventral D4 blastomere of the 32-cell stage 
embryo. Blastomere C3 (yellow) is fated to become the DLP. (B) Anterior embryonic hemangioblast are specified during 
gastrulation when their mesodermal precursors (blue cells) encounter BMP signaling from the overlying ectoderm during 
their migration from dorsal to ventral. Abbreviations: DLP, dorsal lateral plate; VBI, ventral blood island; V, ventral; D, 
dorsal; AP, animal pole; VP, vegetal pole; BMP, Bone Morphogenetic Protein. (adapted from Ciau-Uitz et al., 2010). 
 
Chimeric transplantation studies also revealed a second source of blood cells apart from the VBI in 
amphibian embryos (Turpen et al., 1981; Kau and Turpen, 1983; Maeno et al., 1985). The location 
was found to be the dorsal lateral plate mesoderm (DLP) that contains definitive hemangioblasts that 
are able to constitute all the hematopoietic lineages of the adult (Turpen and Knudson, 1982; 
Walmsley et al., 2002) (Fig.8). The DLP is located at the level of the pronephros in association with 
the dorsal aorta and post cardinal vein (Turpen et al., 1981). Ciau-Uitz and colleagues narrowed 
down the distinct origin of the adult blood cells and could assign the source of the HSCs in the DLP 
and the ones associated with the ventral wall of the dorsal aorta (DA) to the blastomere C3 (Ciau-Uitz 
et al., 2000; Walmsley et al., 2002). Thus, the existence of different hematopoietic compartments 
suggests that the progeny of these cells are influenced by spatially and temporally distinct signaling 
events during embryonic blood patterning (Walmsley et al., 2002). These hematopoietic signaling 
events are ultimately controlled by transcription factors (TFs) regulating gene expression. To date, a 
substantial number of TFs have been implicated in hematopoietic development, including RUNX1, 
SCL, LMO2 and GATA-2 (Burns et al., 2005; Patterson et al., 2005; Liu et al., 2008). The TFs affect 
both primitive and definitive hematopoiesis and play multiple roles in hemangioblast emergence. 
Obviously, a tight lineage and stage specific regulation of these TFs is required for proper 
hematopoiesis. 
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I.1.5.3. Various functions of caspases in hematopoiesis 
In the recent years, several apoptotic and non-apoptotic functions of caspases in hematopoietic cells 
were identified. Caspases seem to be required for specific differentiation pathways like 
erythropoiesis, myelogenesis and the formation of proplatelets by megakaryocytes. Also the 
regulation of maturation and proliferation of specific lymphocytes implicate non-apoptotic caspase 
signaling. On the other hand, the apoptotic functions of caspases play a crucial role in the modulation 
of the life span of various blood cell types (Mason et al., 2007). Multiple studies have indicated that 
tight regulation of apoptosis is indispensable for the homeostasis of the HSCs pool. This was first 
demonstrated by the ectopic expression of the anti-apoptotic Bcl-2 protein in HSCs of transgenic 
mice, which resulted in a two-fold increase in the number of HSCs (Ogilvy et al., 1999; Domen and 
Weissman, 2000). In addition, inducible deletion of the anti-apoptotic mcl-1 gene in mice led to bone 
marrow ablation through loss of HSCs and early progenitors, suggesting that Mcl-1 promotes survival 
of the hematopoietic precursors (Opferman et al., 2005).  
Here, the main focus is set on the new insights of the non-apoptotic caspase-mediated signaling 
events that are associated with distinct hematopoietic differentiation processes.  
 
I.1.5.3.1. Caspases and platelet formation 
Blood platelets originate from the cytoplasm of bone-marrow precursors known as megakaryocytes 
and mediate blood clotting through adherence to altered endothelial cells or ECM as a consequence 
of a vascular injury (Patel et al., 2005). Erythrocytes and blood platelets share the common myeloid 
progenitor (CFU-GEMM) but their terminal differentiation is dissimilar. Unlike the erythroid cells, the 
megakaryocytes do not arrest the cell-cycle and no nuclear condensation is occurring. Eventually, 
platelets are pinched off at the cytoplasmic extensions of the megakaryocyte. Before proplatelet 
formation active caspase-9 and caspase-3 are identified in localized cytoplasmic compartments of 
mature megakaryocytes (De Botton et al., 2002; Clarke et al., 2003). Overexpression of either Bcl-2 
(De Botton et al., 2002) or Bcl-XL (Kaluzhny et al., 2002) seem to limit proplatelet formation. These 
data are in agreement with the earlier study whereby overexpression of Bcl-2 in the hematopoietic 
cells of transgenic mice led to a severe reduction in the number of blood platelets without affecting 
the number of megakaryocytes residing in the bone marrow (Ogilvy et al., 1999). Interestingly, a 
similar reduction was observed in mice with a homozygous deletion of Bim, which could indicate that 
shedding of platelets depends on this pro-apoptotic BH3-only protein (Bouillet et al., 1999). Although 
Fas ligation and the subsequent activation of caspase-8 appeared to stimulate the proplatelet 
extension, the exact mechanism of how these cell death modulators are involved is still unknown 
(Clarke et al., 2003)(Fig.9). Furthermore, it remains a question why the typical caspase substrates like 
gelsolin and poly(ADP-ribose)polymerase 1 (PARP1) are cleaved during the process of platelet 
formation (Fig.9). How their cleavage products are contributing to the formation of cytoplasmic 
extensions which are likely the result of cytoskeletal changes, is still unclear and needs to be further 
investigated (De Botton et al., 2002). 
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In conclusion, it is still unclear whether proplatelet formation involves a specific independent 
pathway in which some apoptotic mediators play a role, or if the differentiation of platelets is just a 
consequence of a modified cell death pathway leading to senescent ‘death’-like megakaryocytes 
(Zauli et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Caspase signaling in platelet formation. 
Fas ligation and subsequent caspase-8 activation stimulates proplatelet extension. Whereas overexpression of Bcl-2 or Bcl-
XL seem to limit proplatelet formation. A similar reduction in the number of blood platetes was observed in Bim depleted 
mice. Localized activation of caspases-3 and -9 was found in cytoplasmic compartments of mature megakaryocytes.  
 
 
I.1.5.3.2. Caspases in erythroid differentiation   
The process of erythropoiesis involves the progressive differentiation of pro-erythroblasts to mature 
erythrocytes. Along this process, red cell precursors become progressively sensitive to the 
glycoprotein hormone erythropoietin (EPO), which stimulates the expression of erythroid-specific 
transcription factors such as GATA-1 (Pevny et al., 1991). At these stages, EPO seems to be crucial for 
erythroblast survival because the withdrawal of EPO activates the intrinsic caspase-dependent 
apoptosis pathway (Koury and Bondurant, 1990). This protective role of EPO against cell death is at 
least partially mediated by the increased expression of the anti-apoptotic Bcl-XL through the 
activation of the transcription factor Stat5 (Motoyama et al., 1995; Motoyama et al., 1999; 
Socolovsky et al., 1999; Kieslinger et al., 2000; Dolznig et al., 2002) (Fig.10). Also, the stem cell factor 
(SCF) protects the erythroid precursors from apoptosis and up-regulates the expression of both Bcl-XL 
and Bcl-2 (Sui et al., 2000; Endo et al., 2001). Apparently, Bcl-XL is able to bind and to inhibit the pro-
apoptotic BH3-protein Nix which act as a negative regulator of terminal erythrocyte differentiation 
(Diwan et al., 2007).  Several observations argue for a negative regulatory role for death receptors 
and caspase-8 in erythropoiesis. Morpholino knockdown of the death receptor gene zDR in zebrafish, 
increased the hemoglobin content in embryos (Kwan et al., 2006). In mice, caspase-8 knockout 
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embryos exhibited congested erythrocyte accumulation in most blood vessels and in various organs 
(Varfolomeev et al., 1998). Both Fas- and TRAIL-mediated signaling are able to induce apoptosis in 
immature erythroblast (De Maria et al., 1999; Zamai et al., 2000), whereby GATA-1 was targeted for 
caspase-mediated cleavage (De Maria et al., 1999) (Fig.10). However, besides its role in apoptosis, 
TRAIL triggered as well eythroid differentiation through activation of the kinases ERK1 and ERK2 
(Secchiero et al., 2004). An essential role in erythroid differentiation was also put forward for several 
caspases, because multiple studies have revealed that caspase-inhibitors or more specifically 
caspase-3 down regulation, arrest erythroblast differentiation at the basophilic stage (Zermati et al., 
2001; Kolbus et al., 2002; Carlile et al., 2004). The transient activation of caspase-3 during erythroid 
differentiation resulted in cleavage of the nuclear proteins such as lamin B and acinus but the key 
transcription factor GATA-1 stayed intact due to its interaction with the chaperone heat shock 
protein 70 (HSP70). However, when the erythroblasts were deprived from EPO, the chaperone 
protein stopped shielding GATA-1 and as a consequence GATA-1 was degraded by caspases (Fig.10) 
(Ribeil et al., 2007). Another target of caspase-3 in cells undergoing erythroid differentiation might 
be the MEKK1 kinase which is involved in pro-survival signaling (Dasse et al., 2007). 
  
 
Figure 10. Caspase signaling in Erythroid formation.  
Two distinct caspase-dependent pathways are involved in the control of erythropoiesis. The first is negative feedback loop 
regulating the total number of the erythroblast population through death receptor signaling that involves caspase-8 and 
caspase-3 activation. Hereby the GATA-1 TF is degraded bij caspase-3. The second is a positive role for caspase-3 in 
erythroid differentiation whereby Epo signaling seems to be essential for the expression of the pro-erythropoiesis TFs like 
SCL and GATA-1. Also the upregulation of Bcl-XL garantees the survival of the differentiating blood cells. During 
differentiation the cleavage of GATA-1 by caspase-3 is blocked by the chaperone Hsp70 protein.    
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A characteristic event of terminal erythroid differentiation in mammals is the extrusion of the 
nucleus, the mitochondria and other organelles at the end of the differentiation process. Previous 
studies suggested that caspases function in the process of lens epithelial and keratinocyte 
enucleation because the process resembled some of the nuclear structural reorganization events 
during late apoptosis (Ishizaki et al., 1998; Weil et al., 1999). However still controversial, it becomes 
more and more clear that caspase activation remains transient along erythroblast differentiation and 
occurs probably before the process of enucleation. Until now, no conclusive evidence was found for 
caspase-induced cleavage of major nuclear subcompartment proteins during late erythropoiesis 
(Krauss et al., 2005), confirming that the observed caspase-activity in differentiating erythroblasts 
might be required for the more earlier phases of erythropoiesis. In addition, caspase-3 also cleaves 
ICAD (inhibitor of caspase-activated DNase) during erythroid differentiation without resulting in DNA 
fragmentation (Lui and Kong, 2006). Normally, cleavage of ICAD during apoptotic signaling results in 
the downstream activation of CAD (caspase-activated DNase), which is responsible for the 
degradation of the DNA. It has been suggested that the lack of DNA fragmentation during the 
induced differentiation of human erythroid-like TF-1 cells is due to the downregulation of CAD at the 
mRNA and protein level. This study provides for the first time a mechanism how cells can avoid DNA 
degradation when caspase-3 is activated (Lui and Kong, 2006).   
Together, a significant amount of evidence demonstrates that transient caspase-activity, in particular 
caspase-3, is indispensable for the red blood cell formation.  
 
I.1.5.3.3. Caspases and monocyte differentiation in macrophages 
Monocytes originate from HSCs differentiation in the bone marrow and circulate as committed 
precursors in transit between the marrow and their sites of action. They can cross the endothelium 
and differentiate into a variety of phagocytes, including macrophages and dentritic cells, osteoclast in 
the bone, microglia in the CNS and Kupffer cells in the liver (Swirski, 2011). Ex vivo differentiation of 
monocytes in macrophages in response to macrophage colony-stimulating factor (M-CSF), was 
associated with the activation of caspase-8 without causing apoptosis (Sordet et al., 2002). Caspase-8 
dependent differentiation was also observed in myeloid leukemia cell lines whose differentiation was 
induced by phorbol esters (Pandey et al., 2000; Sordet et al., 2002) of by TRAIL (Secchiero et al., 
2002) (Fig.11). Further confirmation came from the conditional knockout of caspase-8 in the mouse 
myelomonocytic precursors that abrogated the formation of macrophages without affecting the 
formation of dendritic cells and granulocytes (Kang et al., 2004). Interestingly, deletion of the mouse 
bid gene, which links the caspase-8 activation to the intrinsic cell death pathway, provoked an 
accumulation of monocytes in peripheral-blood and spleen (Zinkel et al., 2003). Nevertheless, no 
evidence was found so far for the cleavage of Bid in monocytes undergoing M-CSF-induced 
differentiation (Droin et al., 2009).  
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Figure 11. Caspase signaling in monocytes differentiation. 
Stimulating monocytes with M-CSF leads to the formation of multi-molecular complex in which caspase-8 is activated and 
cleaves RIPK1. The cleaved RIPK1 fragment prevents NF-κB activation. Although there is no conclusive evidence for the 
caspase-8 mediated cleavage of Bid, experiments with the bid null mice suggested a possible link with the intrinsic 
apoptotic pathway through the Bid protein. Eventually, caspase-3 can be activated via caspase-8 or caspase-9 and 
subsequently processes several distinct substrates like HPK1, hnRNPs, NPM, PAK-2, PAI-2 and vinculin.  
 
But what is known about the underlying caspase-8 dependent signaling mechanism in the 
differentiating monocytes? In response to M-CSF, it appears that caspase-8 interacts with the 
adaptor FADD, RIPK1 and the long isoform of FLIP without the involvement of any death receptor. 
When the complex is formed, caspase-8 cleaves RIPK1 and generates an inhibitory protein fragment 
that prevented NF-κB activation (Fig.11). That is probably why the NF-κB activation in differentiating 
macrophage is only transient, which is in sharp contrast with the sustained levels of NF-κB activation 
during dendritic cell differentiation (Rebe et al., 2007). Besides the essential role of caspase-8 in 
macrophage differentiation, a similar activation of caspase-3 and caspase-9 was demonstrated in 
human peripheral blood monocytes undergoing differentiation in response to M-CSF (Sordet et al., 
2002)(Fig.11). Caspase-3 seems to be also activated in differentiating mouse monocytes where it 
cleaves and activates the kinase HPK1 (hematopoietic progenitor kinase 1) that subsequently triggers 
JNK (c-Jun kinase) signaling (Arnold et al., 2007). Other identified caspase targets during the human 
monocytical differentiation process, include several nuclear RNA binding proteins (hnRNPs), 
nucleophosmin (NPM), p21-activated kinase-2 (PAK-2), α-tubulin, plasminogen activator-inhibitor-2 
(PAI-2) and vinculin (Cathelin et al., 2006) (Fig.11). Most of them seem to be involved in cytoskeletal 
regulation and cell adhesion. The proteolytical cleavage of nucleophosmin (NPM) protein, a 38 kDa 
phospoprotein, is especially interesting because it regulates various cellular functions, including 
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centrosome duplication, gene transcription, and cell proliferation (Lim and Wang, 2006; Okuwaki, 
2008). Recently, its role in macrophage differentiation was fine-tuned, whereby the authors 
suggested that its proteolysis participates in the establishment of a mature macrophage phenotype. 
On the other hand, in response to inflammatory stimuli, the full-length protein negatively regulates 
inflammatory cytokine production (Guery et al., 2011). Thus, substrate identification during the 
macrophage differentiation process led to a diversified panel of proteins involved in transcription 
regulation, cytoskeletal regulation and cell adhesion, which points out to the highly complex and 
coordinated non-apoptotic functions of the involved caspases. Strinkingly, additional studies 
suggested a comparable role for the executioner caspases in the differentiation process of other 
tissue-specific macrophage-like cells, including the osteoclast in bone tissue and the microglia in the 
brain (Szymczyk et al., 2006; Burguillos et al., 2011). The recent study regarding the microglia proved 
that the ordered activation of these caspases, including caspase-8, is required for the regulation of 
microglia activation through a protein kinase C (PKC)-δ-dependent pathway.  
 
I.1.5.4. Concluding remarks 
Multiple studies have shown the involvement of various caspases during hematopoiesis. 
Nevertheless, and despite the various efforts, the scientific community did not yet succeed in the 
unraveling of the underlying mechanisms of caspase activation in the different hematopoietic cell 
lineages. It also remains a puzzle why some proteins such as PARP-1 and lamin B are protected from 
caspase-mediated proteolysis during macrophage differentiation (Sordet et al., 2002), while they are 
being cleaved by caspases during erythroid differentiation (Zermati et al., 2001). This subtle 
difference in the regulation of caspase-activity in distinct cell lineages might be explained by the 
presence of members of the inhibitor of apoptosis protein (IAP) family. For one member in 
particularly, namely survivin, it was already shown that the anti-apoptotic protein is differentially 
required in erythrocyte and platelet formation (Gurbuxani et al., 2005; Leung et al., 2007). Survivin 
not only seems to be indispensable for steady-state hematopoiesis but also for proper erythroid 
differentiation. In strong contrast, survivin needs to be down-regulated for platelet formation. 
However, the exact mechanism of how survivin modulates caspases, together with its function in 
mitosis, is still part of a controversial debate. Another possibility for the deployment of distinct 
subsets of substrates could rely on the specific protection of the substrates by chaperone proteins, 
which is indeed the case for GATA-1 during erythropoiesis (Ribeil et al., 2007).  
Future research with the focus on the differential regulations of caspases in differentiation processes 
might uncover a whole new perceptive of the so-called ‘lethal’ mediators of cell death. Furthermore, 
an improved understanding of these caspase functions will also provide better insights in the 
pathophysiology of several hematological diseases. Evidently, therapeutic strategies related to 
hematological diseases should take into account these essential non-apoptotic caspase signaling 
events when developing new drugs. 
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Chapter I.2. Research Aims PART 1 
Apoptosis or programmed cell death (PCD) is a fundamental cellular response that regulates tissue 
homeostasis by eliminating excessive cells (Penaloza et al., 2006). The coordinated cell demise is 
highly controlled by several apoptotic mediators, which include the highly conserved key regulators 
called the caspases (Salvesen and Riedl, 2008). These ‘lethal’ cysteine proteases are involved in a 
proteolytic cascade leading to the cleavage of numerous substrates, which are necessary for the 
removal of the cell. Intriguingly, it is generally believed that the predominant contribution of cell 
death during early embryonic development can be assigned to the process of apoptosis. This is 
consistent with the severe developmental abnormalities seen in mice deficient for specific apoptotic 
mediators (Zheng and Flavell, 2000) (see also table 1, section I.1.2.4). However, growing evidence 
shows that these mediators exhibit besides their pro-apoptotic activities, also functions unrelated to 
cell death. The caspases in particular seem to play also indispensable roles in processes like 
proliferation and differentiation of various cell types (Lamkanfi et al., 2007). Although these studies 
have tremendously changed our classic perception of caspase function, it remains a big challenge to 
understand the mechanism of how their proteolytic activity contributes to these distinct signaling 
events. Also, the general impact of caspase-signaling during development remains greatly 
underestimated.  
To fulfill the common need to track caspase-activity during early embryonic development in a living 
organism, we aimed to develop non-invasive reporter systems that are based on the generation of a 
fluorescent signal in the presence of specific caspase-activity in the Xenopus tropicalis model 
organism (described in Results - Caspase-9 in blood formation). In order to pursue the activity of the 
primary executioners caspase-3 and caspase-7 and the mitochondrial associated initiator caspase-9, 
we implemented the DEVD and LEHD tetrapeptide caspase-recognition sequences, respectively. After 
approving the functionality of the reporter systems in vitro and in vivo in transgenic Xenopus 
tadpoles, our second aim was to exploit the newly generated transgenic caspase-reporter lines for 
the detection of novel functions of the targeted caspases during early embryogenesis. Therefore, we 
have carefully compared the highly dynamic and reproducible activity patterns between the two 
reporter systems and noted that only the LEHD-containing reporter system was activated in the 
ventral blood island (VBI), which in Xenopus is the source of primitive blood. As a third objective, we 
further investigated and confirmed the potential non-apoptotic implication of caspase-9 in early 
blood formation. Finally, we aimed to explore the involvement of caspases in the process of 
myelopoiesis, a process in which pro-differentiation signaling events of several caspases have already 
been suggested (Sordet et al., 2002).  
The results section that deals with a novel role of caspase-9 in blood formation is written in the 
format of a manuscript, to be submitted shortly, while Chapter I.I. Introduction to caspase signaling 
serves as the main prelude for this research topic.  
         
 
 
 
RESULTS - A novel role for Caspase-9 in             
blood formation 
 
 Results 
  
65 
Chapter I.3. Results - A novel role for caspase-9 in blood 
formation 
Mathias Fransen12, Nicolas Willemarck and Kris Vleminckx12 
1. Department for Molecular Biomedical Research, VIB, Ghent, Belgium 
2. Department of Biomedical Molecular Biology, Ugent, Ghent, Belgium 
(in preparation) 
I.3.1. Introduction 
Intensive research during the last two decades has made it clear that cell death is a fundamental 
aspect of development of almost all multicellular organisms. Cell death is essential to control tissue 
homeostasis, to eliminate aged or damaged cells and to shape the embryo (Penaloza et al., 2006).  
Classification of the different types of cell death, defined by several criteria, lead to 4 major forms of 
cell death i.e. apoptosis, necrosis, pyroptosis and autophagy (Kroemer et al., 2009). The predominant 
contribution of cell death during early embryonic development can be attributed to the process of 
apoptosis. This is a cell-intrinsic programmed suicide mechanism that results in the controlled 
breakdown of the cell into apoptotic bodies, which are subsequently recognized and engulfed by 
surrounding cells and phagocytes (Duprez et al., 2009). Therefore, this type of cell death is also 
known as programmed cell death (PCD). Two main evolutionarily conserved protein families are 
involved in apoptosis, namely the Bcl-2 family of proteins, which control mitochondrial integrity 
(Youle and Strasser, 2008), and the cysteinyl aspartate-specific proteases or caspases, which mediate 
the execution phase of apoptosis (Fuentes-Prior and Salvesen, 2004). However, a paradigm shift has 
recently occurred as it becomes clear that proteins involved in the induction of apoptosis or in the 
apoptotic dismantling of cells also exhibit cell death-unrelated functions (Galluzzi et al., 2008). There 
is a growing body of evidence that implicates the cell death machinery as vital components of the 
differentiation program (Fernando and Megeney, 2007). Indeed, several caspases are shown to be 
indispensable for cell maintenance and differentiation processes of diverse cell types (Lamkanfi et al., 
2007). This is best documented for the executioner caspase-3, which aside from its central role in 
PCD, also appears to be involved in the terminal differentiation of lens fiber cells and keratinocytes 
(Weil et al., 1999; Wride et al., 1999).  In addition, non-apoptotic caspase-3 signaling seems to be as 
well required for the rather early steps in monocyte, erythroblast and osteoblast differentiation (Weil 
et al., 1999; Wride et al., 1999; Zermati et al., 2001; Sordet et al., 2002; Miura et al., 2004). 
Furthermore, the initiator caspase-9 is involved in most differentiation processes in which caspase-3 
has been implicated and points out the importance of the highly conserved mitochondrial death 
effectors in these cell death unrelated functions (Galluzzi et al., 2008). It can be expected that 
caspases are involved in additional processes during organogenesis and tissue formation, both in the 
adult and in the embryo.  
66  
 
Results 
Here we describe the development of a sensitive and highly dynamic fluorescent reporter system to 
detect the spatio-temporal pattern of caspase activation in transgenic Xenopus embryos. With the 
help of this reporter system we uncovered a novel non-apoptotic role for caspase-9 activation in the 
formation of primitive blood cells in Xenopus embryos. The observed caspase-9 activity in the ventral 
blood island (VBI), turns out to be independent on the activity of the downstream effector caspases-
3/-7. Loss of function experiments combined with rescue studies show that caspase-9 is specifically 
required for the proper expression of erythroid markers. In conclusion, the exploration of the 
caspase-activity during early embryonic development led to the discovery of a new non-apoptotic 
caspase-9 function that contributes to the primitive erythropoiesis in Xenopus.  
 
I.3.2. Results 
Not much is known about the dynamic functions of caspases during early vertebrate development in 
time and space. To assess their role and to identify possible new functions, we designed and 
characterized a non-invasive reporter system that is based on the generation of a fluorescent signal 
in the presence of specific caspase activity. This system should enable us to gain insight in the 
temporal and spatial dynamics of caspases activity in living organisms. 
I.3.2.1. Basic design of the reporter system 
The caspase-reporting system is based on the transcriptional induction of the eGFP gene in a manner 
that is dependent on the activity of a chimeric exogenous transcription factor (Fig.12A), which 
translocates to the nucleus when it is processed by caspases. The chimeric transcription factor is 
fused to a membrane anchor consisting of the extracellular and transmembrane domains of the 
interleukin 2 receptor (IL2R). A tetra-peptide sequence is inserted between the transmembrane 
domain and the transcription factor. This tetra-peptide can be recognized and cleaved by specific 
caspases, which frees the transcription factor and allows it to translocate to the nucleus, where it 
induces the expression of the eGFP reporter gene (Fig.12A).  
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Figure 12. Schematic representation of the reporter system.  
(A) The GAL4/VP16 TF is anchored in the membrane by the extracellular and transmembrane domain of the IL2R and the 
caspases are residing in the cytosol as inactive pro-caspases. Upon stimulation, caspases become proteolytically active and 
cleave their recognition site which frees the chimeric GAL4/VP16 TF. As a consequence the TF translocates to the nucleus 
where it initiates the transcription of the eGFP reporter gene. (B) general lay-out of the three designed reporter systems 
with their distinct DNA and AA sequences. The DEVD tetrapeptide is preferentially  recognized by the executioner caspase-3 
and -7. The LEHD sequence is known as a recognition motive for caspase-9. The DEVA reporter system serves as a control 
for the non-specific cleavage of the reporter system because caspases need the defining aspartate residue adjacent the 
cleavage site.  
 
We used yeast GAL4 as an exogenous transcription factor. GAL4 can drive the expression of genes 
placed under control of the GAL4 Upstream Activating Sequence (UAS). GAL4-based binary systems 
controlling transgene expression have been used successfully in different organisms, including 
Drosophila, zebrafish and Xenopus (Fischer et al., 1988; Xu et al., 1993; Grabher and Wittbrodt, 2004; 
Halpern et al., 2008)). However, the transactivation domain of GAL4 is a potential substrate for 
caspases (van Criekinge et al., 1999); and so it was replaced by the transactivation domain of the 
VP16 gene of the Herpes simplex virus, which is not sensitive to caspase cleavage (van Criekinge et 
al., 1999). Note that the GAL4 UAS is not activated by any transcription factor of any organism other 
than yeast (Brand and Perrimon, 1993).  
We were primarily interested in the activity of the executioner caspases-3 (C3) and caspase-7 (C7) 
and the initiator caspase-9 (C9). Hence, we introduced the tetra-peptides DEVD and LEHD as putative 
substrate for C3/7 and C9, respectively. Also, we designed a DEVA-containing reporter system that 
lacks the defining aspartate residue located N-terminally and adjacent to the cleavage site in the 
recognition motive. Deletion of this aspartate makes this site unrecognizable for any caspases. 
Constructs based on the DEVA tetra-peptide served as a control for non-specific proteolytic cleavage, 
and hence non-specific activation, of the system (McStay et al., 2008) (Fig.12B).  
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I.3.2.2. The reporter system is responsive to exogenous mouse caspases in 
vitro 
Before implementing the reporter systems in living animals, they were validated in vitro. First, we 
determined whether the tetra-peptide containing GAL4-based chimeric transcription factors can be 
cleaved by particular caspases. To that end, we produced radioactively labeled protein in a cell-free 
reticulocyte lysate by a combined transcription and translation (TNT) reaction. Recombinant active 
C3 or C9 protein were added to the reaction mixture, and cleavage was analyzed by gel 
electrophoresis and visualized by radiography. Known C3 and C9 substrates were used as positive 
controls for caspase activation, i.e. hPARP for C3 and RAF-1 for C9 (Cornelis et al., 2005). Addition of 
C3 to the DEVD based reporter induced a cleavage fragment of 30 kDa in addition to a 60 kDa 
protein, which likely represents the uncleaved chimeric transcription factor (Fig.13B). Likewise, 
addition of C9 to the IL2R-LEHD-GAL4VP16 protein induced a 30 kDa protein (Fig.13A). The control 
IL2R-DEVA-GAL4VP16 protein was resistant to cleavage by C3 and C9. We noticed cleavage of the 
IL2R-DEVD-GAL4VP16 protein in lysates treated with C9 (Fig.13A). However, this probably represents 
the non-specific activation of endogenous C3 or C7 by the recombinant C9, because adding the 
caspase 3/7 inhibitor DEVD-cmk to the C9 reaction hampered this cleavage (Fig.13C).  
 
Figure 13. The reporter systems can be proteolytically cleaved by exogenous mouse caspases in a TNT assay. 
Our three reporter systems were in vitro transcribed and translated and subsequently exposed to recombinant mouse 
caspase-3 and caspase-9 proteins. (A) RAF-1 protein was used as a positive control for cleavage with caspase-9 (Cornelis et 
al., 2005) (arrowheads). Both the LEHD and the DEVD constructs are cleaved by caspase-9 resulting in a 30 kDa fragment 
(closed arrows). (B) human PARP protein was used as a positive control for cleavage with caspase-3 (arrowheads). Only the 
DEVD construct is proteolytically processed by caspase-3 (closed arrow). (C) The addition of the caspase-3 inhibitor DEVD-
cmk (10 µM) severly affected the cleavage of the DEVD construct and not the LEHD construct (closed arrow), suggesting 
that the observed cleavage of DEVD by caspase-9 in panel (A) is more a result of the caspase-9-mediated activation of 
caspase-3 present in the lysate as an inactive procaspase. The DEVA reporter seems to be insensitive to recombinant 
caspase-3 and caspase-9. Open arrows show the uncleaved fragments (60 kDa).  
 
 Results 
  
69 
To investigate whether the caspase reporter systems can also be activated in cell lines, they were 
transiently transfected in 293T cells with or without vectors expressing a concentration gradient of 
mouse C3, C7 or C9.  Lysates were prepared 24 h after transfection and immunoblotted with 
antibodies against the Myc-tag, which is present between the tetra-peptide and the GAL4/VP16 
transcription factor. An uncleaved fragment of 65 kDa and a cleaved fragment of about 30 kDa were 
detected in cells transfected with the DEVD reporter system together with C3 or C7 (Fig.14A-B). The 
predicted size of the chimeric IL2R-DEVD-GAL4VP16 protein is only 44 KDa, but it is likely modified by 
glycosylation, as can be expected for the IL2R extracellular domain. No cleaved fragment was 
observed in cells co-transfected with the DEVA control construct and C3 or C7, even at the highest 
concentrations of exogenous caspase (Fig.14A). This shows that proper cleavage requires the 
presence of the defining aspartate residue in the reporter constructs. Importantly, the LEHD reporter 
system did not show any response to exogenous C3 and C7 (Fig.S1).  Unfortunately we could not 
document the response of the LEHD detection systems to C9 because transfection of exogenous C9 
caused the death of 293T cells. This forced cell death probably rapidly blocks the transcription and 
translation machinery and hence prevents the detection of the reporter system.  Nevertheless, the 
combination of TNT data and cell culture experiments show that the DEVD and LEHD reporter 
constructs are cleaved by exogenous C3/7 or C9, respectively. Importantly, the DEVA control reporter 
is resistant to caspase cleavage. 
 
Figure 14. The DEVD reporter system is proteolytically cleaved by mouse caspases-3 and caspase-7 in 293t 
HEK cells. Anti-Myc tag western blot analysis of reporter cleavage products in response to transfected mouse caspases in 
293t HEK cells. Cells were transfected with Fugene 6 Transfection Reagent and lysed after 24h. Actin was used as a loading 
control. (A) Only the DEVD reporter and not the DEVA control reporter was found to be sensitive to the exogenous caspase-
3 (black arrows). 200 ng of the DNA coding for the distinct reporter constructs was combined with a DNA gradient (50 ng, 
100 ng, 150 ng, 250 ng) coding for caspase-3 (B) No proteolytic response of the DEVD reporter was observed when caspase-
6 or caspase-9 were cotransfected. 500 ng of the DNA coding for the DEVD reporter construct was combined with a DNA 
gradient (100 ng and 200 ng) coding for the various caspases.  
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I.3.2.3. Highly dynamic and specific regions of caspase activity are detected 
in transgenic Xenopus embryos 
Transgenic Xenopus lines were generated using a slightly modified method of restriction-enzyme-
mediated integration (REMI). Transgenic F0 tadpoles could be easily selected due to the expression of 
the DsRed gene, which is present on all constructs under control of the human E-cadherin promoter. 
DsRed expression is detectable in the ectoderm of gastrula-stage embryos. In transgenic early 
tadpoles expressing the DEVD reporter, dynamic GFP patterns were detected, especially in the brain 
and the spinal cord (Fig.15).  In contrast, no GFP signals were visible in tadpoles transgenic for the 
DEVA control reporter, which could be identified by their expression of DsRed (Fig.15).  
 
 
 
 
Figure 15. Embryos transgenic for the DEVA reporter do not display eGFP expression. 
The transgenic X. tropicalis embryos can be easily selected by their DsRed expression. However, the transgenic DEVA 
reporter embryos failed to generate a GFP signal despite strong DsRed expression.  
 
The spatio-temporal pattern of GFP expression was further documented in living embryos, tadpoles 
and post-metamorphic transgenic frogs expressing the DEVD reporter. Similar patterns were 
observed in X. laevis and X. tropicalis lines. Interestingly, the GFP patterns observed with the DEVD 
reporter embryos were strikingly similar to the TUNEL positive regions described by Hensey et al. 
(Hensey and Gautier, 1998) (see also Fig.S5). Starting from the neural fold stage (Nieuwkoop stages 
14–19), an intense GFP signal emerged in defined stripes on each side of the dorsal midline. The GFP 
signal fanned out posteriorly and was most intense in the future brain region as well as in the 
anterior patches corresponding to optic vesicle. These patterns were visible throughout the 
neurulation stages. At tailbud stage (stages 26–28), the GFP-signal was present throughout the 
developing central nervous system (CNS), including all areas of the brain, the retina and the spinal 
cord. GFP was detected as two bilaterally symmetrical regions in the forebrain and midbrain and 
extended towards the hindbrain and spinal cord (Fig.17). During tadpole stages 40–42, besides the 
GFP-positivity in the derivatives of the CNS, the GFP signal was evident in sensory organs, such as the 
nasal pits and the otic vesicle. The developing kidneys were also positive (Fig.17).  
The signal in the developing retina was examined in greater detail in cryosections (Fig.16). During 
retinogenesis (stages 35–36), many cells were GFP positive in the ganglion cell layer (GCL), the inner 
nuclear layer (INL) and the outer nuclear layer (ONL). This pattern likely reflects the three successive 
waves of cell death observed in these layers (Vecino et al., 2004). It has been estimated that 40–70% 
of the retina ganglion cells (RGCs) die by apoptosis (Vecino et al., 2004). This apoptosis is caspase-
dependent, and inhibition of caspases results in an enlargement of the ganglion cell layer 
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(Mayordomo et al., 2003). Sections of the post-embryonic eye at stage 45 no longer showed GFP 
positivity in the retinal nuclear layers, with the exception of some cells in the photoreceptor layer 
(Fig.16F). However, the flattened lens fiber cells turned out to be GFP positive, in line with the 
reported activity of caspase-3 in differentiating lens fiber cells (Weber and Menko, 2005). This major 
shift in GFP expression from the retina towards these differentiated lens fiber cells proves the 
dynamic involvement of caspase activity, which can be followed during development with the 
caspase detection system (Fig.16). 
 
Figure 16. Highly dynamic caspase activity during eye development.  
Cryosections of the eyes in DEVD-reporter X. laevis tadpoles at stages 36 (A-C) and stage 45+ (D-F). Nuclei are 
counterstained with DAPI. (A-C) A DEVD transgenic embryo at stage 36 showed consistent GFP signals in all retinal layers 
including the ganglion cell layer, the inner nuclear layer and the outer nuclear layer.  At this stage nuclei are still present in 
the differentiating lens fiber cells. (B) A higher magnification of the individual GFP positive photoreceptors. (C) A blow up of 
the GFP positive neuronal network between the different retinal layers. (D-E) GFP is expressed in the enucleated lens fibers 
cells of stage 45+ embryos (a closer view is shown in (E)). A few GFP+ cells were still observed in the fully developed retina 
(i.e. photoreceptor layer (closer view in (F)).).  
 
Later in development, before and during metamorphosis (stage 58–63), GFP was expressed in the 
bone structures of the legs, especially in the growth zone of the long bones (Fig.17 K-L), where 
hyperthropic chondrocytes die by apoptosis and are replaced by differentiating osteoblasts (Xing and 
Boyce, 2005). Also the teeth and some cranial structures, including the skull and the jawbone, were 
GFP positive. Somewhat surprisingly, we could not detect any GFP signal during tail regression even 
though this process involves apoptosis and caspase activation (Rowe et al., 2005). We suspect that 
those apoptotic events occur too rapidly to be detected by the reporter system, which is dependent 
on transcription, translation and GFP maturation (see also later).  
In summary, the DEVD reporter system shows dynamic spatio-temporal patterns of GFP expression in 
regions in which apoptotic cell death is known to occur.   
A B
C
B
C
D E
F
F
E
st.45+st.36
GFP
Hoecht
GFP
Hoecht
72  
 
Results 
 
Figure 17. Transgenic embryos and larvae carrying the DEVD reporter construct show dynamic spatio-
temporal GFP expression patterns during their development.   
(A) Dorsal view or (B) anterior view of a stage 18-19 X. tropicalis embryo at neural fold stage. At this stage, GFP signals are 
first visible. The GFP expression emerges in defined stripes on each side of the dorsal midline and are most intense in the 
future brain region as well as in the anterior patches corresponding to the eye vesicle (ev). (C) Similar patterns are visible at 
stage 24 of a X. tropicalis tailbud embryo. (D-J) Dynamic and diversified expression of GFP signal in reporter embryos as 
development proceeds. Particular high expression levels were observed in the developing neural tissues. (F) Stage 45-47 X. 
laevis tadpoles show GFP-positivity in kidney cells (closer view in (H)), in the brain, in the nasal pits (closer view in (G)) and 
in muscle fibers (I). (J) Also the eye was still positive for GFP signal. (K-L) Around metamorphosis (X. laevis, stages 60-64), 
GFP is expressed in the bone structures of the legs, especially in the growth zones of the long bones. (M) Also the teeth and 
some cranial structures, including the skull and the jawbone, were GFP positive. Abbreviations: nt, neural tube; ev, eye 
vesicle; sc, spinal cord; h, heart; b, brain; e, eye; k, kidney cells; np, nasal pits; bo, bone; c, cranial structures; t, teeth.   
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I.3.2.4. In vivo validation of the DEVD reporter system  
To correlate the observed dynamic spatio-temporal GFP patterns with cell death in the embryo, we 
processed cryosections of transgenic embryos with terminal deoxynucleotidyl transferase-mediated 
dUTP nick end labeling (TUNEL staining). We focused our analysis on the developing retina 
(Valenciano et al., 2009). Individual retinal ganglion cells where the GFP co-localizes with the TUNEL 
staining were clearly seen (arrowheads Fig.18A). This indicates the ability of our reporter system to 
detect apoptotic cells. Nevertheless, some of the GFP positive cells did not show any TUNEL staining.  
This is expected, because the TUNEL assay is based on DNA strand breaks caused by DNAses 
activated indirectly by the upstream executioner caspases. Hence, TUNEL is a late marker for cell 
death. Because of the time difference between caspase activation and DNA breakage, we postulate 
that the reporter system detects earlier events in the cell death process. Evidently, caspase activation 
events unrelated to apoptosis could also explain this incomplete co-localization. Vice versa, some 
TUNEL positive cells were not GFP positive. We speculate that if massive and rapid caspase activity 
occurs, activation of an irreversible cascade immediately shuts down the transcription and 
translation machinery. Evidently, the reporter system needs sufficient time for expression and 
maturation of the GFP protein, which makes it impossible to detect cells that die rapidly.   
In addition to TUNEL assays, we also performed an immunostaining against active caspase-3 to 
determine the amount of co-localization with the GFP expression coming from the activated reporter 
system. As depicted in Fig.18B, we found substantial overlap between GFP positive cells and caspase-
3 active cells. Yet again, some GFP positive cells that were not stained with the antibody were 
present. We suspect that this is mainly due to the activity of other caspases activating the reporter, 
possibly caspase-7. Furthermore, some caspase-3 active cells did not show any GFP expression. 
Again, this is expected, because there is considerable interval between the proteolytic event and the 
full expression and maturation of the GFP protein in our system.  
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Figure 18. DEVD reporter colocalizes  with TUNEL and active caspase-3 staining.  
Confocal images of cryo-sectioned eyes isolated at stages 32 and 36 when massive cell death is occurring in the developing 
retina (X. tropicalis). (A) Several GFP positive retinal ganglion cells co-localize with TUNEL-positive cells (arrowheads). (B) 
Also some GFP expressing retinal ganglion cells were positive for active caspase-3 staining (arrowheads).  
 
In conclusion, the GFP signals generated via the reporter system do not always coincide perfectly 
with the exact timing of caspase activity or with the moment when DNA strands break. This is likely 
because the detection methods we used, i.e. TUNEL staining and strong active caspase-3 
immunostaining, indicate only the final stages of the apoptotic process. In contrast, our reporter 
system can expose lower levels of caspase activity over a longer period of time. In addition, we have 
to take into consideration that a fluorescent GFP signal will not be generated if caspase activation 
leads to rapid shut down of transcription or translation. This is an evident shortcoming of our system. 
 
I.3.2.5. The DEVD reporter system is dependent on the expression of 
caspases-3/-7 
To assess whether the GFP patterns observed in our DEVD reporter system are actually due to 
specific caspase activity, we used morpholinos to specifically knock down the expression of caspase-3 
and -7.  Fertilized eggs were injected with the translation-blocking morpholinos targeting caspase-3 
(C3MOATG) and caspase-7 (C7MOATG), either alone or in combination. At stages 18-20, lysates were 
made and subjected to a DEVD-linked coumarin-based fluorescent compound (AMC). Injection of 40 
ng of either morpholino resulted in little or no decrease in the DEVDase activity (Fig.19). However, 
combining the two morpholinos at a dose of 10 ng each decreased the activity by 50%. This 
synergistic response demonstrates the redundancy between the two caspases (Fig.19). 
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Figure 19. Combined depletion of caspase-3 and caspase-7 results in a synergistic reduction of the DEVDase 
activity. X. tropicalis embryos were injected at 1 cell stage with the translational blocking morpholinos directed against 
caspase-3 and/or caspase-7, lysed at stages 20-21 and subjected to a DEVD-linked coumarin-based fluorescent compound 
(AMC). Only the combined injection of the two morpholinos was able to decrease the DEVDase activity with 50%, 
confirming the functional redundancy between these two executioner caspases. For each injection 6 groups of 15 embryos 
were dissolved in a NP-40 lysis buffer (70 µl) and individually measured. Error bars are SEMs (standard errors of the mean) 
whereby n represents the 6 groups of embryos/sample and an unpaired student t-test indicated a P value of 0,0054 (p< 
0,05 **, Graphpad Prism).  Abbreviations: NI, non injected wild type embryos. 
 
Next, we injected the combined morpholinos into embryos transgenic for the DEVD reporter system. 
We targeted the morpholinos unilaterally at the two-cell stage, together with a fluorescent tracer. 
The uninjected half of the embryo served as an internal control. The targeted knockdown of caspase-
3 and caspase-7 almost completely abolished GFP expression at the injected site in stage 28 embryos 
(Fig.20). No changes in GFP expression were observed upon injection of a control morpholino at the 
same concentration. Hence, the GFP signals obtained in the DEVD reporter line were specific for the 
activities of caspase-3 and -7.  
 
Figure 20. Reduced GFP expression by the combined knockdown of caspase-3 and caspase-7.  
Transgenic DEVD-reporter embryos (X. tropicalis) were unilaterally injected at two cell stage with the combination of 3 ng 
C3MO and 3 ng C7MO or 6 ng control MO (CoMO). 2 ng of the CoMo conjugated with the lissamine tracer (red) was 
included in every injection mix to verify the side of injection. The combined depletion of caspase-3 and caspase-7 resulted 
in a clear reduction of the GFP expression only at the injection side (arrowhead). This was not the case when the control 
MO was injected. The activation of our DEVD reporter system during development seems to rely on the activity of these 
effector caspases.  
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I.3.2.6. Activation of the LEHD reporter system in the ventral blood island  
In addition to the DEVD reporter, we also generated transgenic X. laevis and X. tropicalis with the 
LEHD reporter system. Unfortunately, so far we have not been able to generate stable transgenic 
lines with high GFP expression. Hence, this analysis relies on recurrent patterns observed in different 
F0 animals. Overall, the GFP patterns in embryos and tadpoles transgenic for the LEHD reporter 
showed great resemblance to the DEVD reporter pattern, particularly in the regions of the brain, 
spinal cord and eye (Fig.21). However, we detected strong GFP expression in the ventral zone of 
embryos from stage 28–32 onwards. Interestingly, GFP signals were never detected in this particular 
region of DEVD reporter animals. This ventral GFP-positive zone corresponds to the ventral blood 
island (VBI). At stage 28-32 the central domain of this region forms the primitive erythroid lineages of 
the primitive blood (Ciau-Uitz et al., 2000). At the periphery, vascular lineages are specified. The 
dynamics of GFP expression in the VBI was monitored by live time lapse analysis. The first GFP 
fluorescent signals appeared at about stage 30 and the signal intensified until stage 37, when cells 
start to leave the VBI through the developing vitelline veins and begin to circulate throughout the 
whole embryo. Circulation of GFP-positive blood cells could be seen until stage 44-45. Microscopic 
analysis of blood collected at stage 42 showed that most GFP-positive cells had the morphology of 
erythrocytes (Fig.21F). Together, these data indicate that the initiator caspase-9 is activated in the 
VBI while the executioner capsases-3 and/or -7 are not.  
 
Figure 21. Activation of the LEHD reporter in the ventral blood island (VBI).  
(A-B) Comparison between the transgenic DEVD- and the LEHD-reporter embryos (X. tropicalis) revealed overlapping GFP 
positive regions, like the brain and eye. However, only the LEHD embryos exposed GFP expression at the VBI, the place 
where the primitive blood is formed (arrowheads). (C-D) As development continues, the GFP positive cells at the VBI 
intensify and localized in the typical outline of the VBI (see ventral view in D). (E) At stage 38-40, the GFP positive blood cells 
enter the blood circulation via the vitteline veins. Circulating GFP expressing blood cells can be detected throughout the 
embryo (arrowhead). (F) Individual GFP expressing erythrocytes were collected and imaged at stage 42.   
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I.3.2.7. Caspase-9 activity is required for primitive blood formation 
To analyze whether caspase-9 plays a role in primitive blood formation, we designed a translation-
blocking morpholino (C9MOatg1). The efficiency of this MO was evaluated by coinjecting a Myc-tagged 
X. tropicalis caspase-9 transcript containing the MO targeting sequence. Western blot analysis 
showed efficient depletion of the tagged caspase (Fig.S2).  As caspase-9 expression is not restricted 
to the VBI, general caspase-9 depletion affected the overall morphology of the embryo. Hence, we 
targeted the region of the embryo that contributes to the VBI. In Xenopus this compartment has a 
dual origin. The anterior part (aVBI) is derived from the dorsal mesoderm and can be traced back to 
the CD1 blastomeres in the 16-cell stage embryo. In contrast, the posterior compartment of the VBI 
(pVBI) originates in the ventral-most mesoderm and can be targeted by injecting the CD4 
blastomeres (Ciau-Uitz et al., 2000). Injecting C9MOatg1 in CD4 blastomeres resulted in complete loss 
of the typical erythroid marker genes GATA-1 and αT3-globin in the pVBI (Fig.22A). In contrast, CoMO 
injection at the same dose only moderately affected the expression of these two markers. 
 
 
 
Figure 22. Knockdown of xcaspase-9 depletes the expression of early blood markers (T3-Globin and GATA-
1).  X. tropicalis embryos were injected in the two CD4 blastomeres at 16-cell stage with 2,5 ng C9MO
atg1
; 4 ng CoMO or a 
combination of 2 ng C3MO
atg
 and 2 ng C7MO
atg
 in each blastomere. 10 pg RNA of cytoplasmic β-Gal was coinjected as 
lineage tracer. (A) Whole mount in situ hybridization analysis of T3 globin and GATA-1 expression in the posterior part of 
the VBI. Both T3-globin and GATA-1 expression were affected upon depletion of caspase-9. This was not the case with the 
combined depletion of caspases-3 and -7. (B-C) Graphs representing the percentage of embryos injected at CD4 
blastomeres at 16-cell stage exposing the defects in the marker expression. The embryos were scored using the phenotype 
in (A) as a reference. 
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To confirm the specificity of the observed depletion of the primitive blood markers, we designed 
another translation blocking morpholino (C9MOatg2) and a splicing morpholino (C9MOE2I2). The 
second translation blocking morpholino was directed to the 5’-UTR region of the X. tropicalis 
caspase-9 gene. The splicing morpholino was directed against the boundary of exon 2 and intron 2 
and its efficacy was monitored by RT-PCR. This analysis showed a reduction of the wild type caspase-
9 transcript (442bp) and the appearance of a higher molecular weight fragment (579 bp), reflecting 
intron retention by the injected C9MOE2I2 (Fig.S3). This retention caused a shift in the open reading 
frame of the caspase-9 mRNA leading to an incorrectly translated protein and a premature stop. 
Targeting these morpholinos to the CD4 blastomeres resulted once more in severe reduction in the 
expression of the erythroid marker gene αT3-globin (Fig.S4). Consistent depletion of this primitive 
blood marker by using three different morpholinos confirmed the specificity of our knockdown for 
embryonic blood formation.  
Finally, we performed a rescue experiment in which we coinjected C9MOatg1 with synthetic caspase-9 
mRNA from X. laevis.  This transcript has four mismatches in the target sequence of the antisense 
C9MOatg1. Accordingly, C9 protein level obtained from this RNA were not reduced by the C9MOatg1, 
which makes it  ideal for rescue experiments (Fig.S2). Coinjection of C9MOatg1 with the X. laevis C9 
RNA decreased the percentage of embryos with reduced expression of the T3 globin marker from 
78% (n = 43) to 34% (n = 51) (Fig.23B). Rescue of the erythroid marker expression further shows that 
the defects in erythropoiesis seen when C9MOatg1 is used are specific.  
In conclusion, the activation pattern and the functional data show that caspase-9 activity is needed 
for the formation of primitive erythrocytes during Xenopus development. 
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Figure 23. Depletion of T3-globin expression could be rescued by Xenopus laevis caspase-9 RNA. 
X. tropicalis embryos were injected in the two CD4 blastomeres at 16 cell stage with 2,5 ng CoMO, 2,5 ng C9MO
atg1
 or 2,5 ng 
C9MO
atg1 
combined with 100 pg of Xenopus laevis caspase-9 RNA in each blastomere. 10 pg RNA of cytoplasmic β-Gal was 
coinjected as lineage tracer. (A) Whole mount in situ hybridization analysis of T3 globin expression in the posterior part of 
the VBI. The overexpression of Xlcaspase-9 could rescue the defect in T3 globin expression induced by caspase-9 depletion. 
(B) Graph representing the precentages of embryos injected at CD4 blastomeres at 16-cell stage showing the defect in the 
T3 globin marker expression. The embryos were scored using the phenotype in (A) as a reference. 
 
I.3.2.8. Caspases-3 and -7 depletion does not interfere with primitive 
erythropoiesis 
Because the DEVD reporter was not activated in the VBI and no TUNEL staining has been found in the 
VBI (Fig.S5), we wanted to determine whether the activity of caspase-9 in the VBI is independent of 
the activation of the executioner caspases-3 and -7. Morpholinos depleting the two caspases were 
targeted to the pVBI, and expression of erythroid markers was analyzed.  In contrast to depletion of 
caspase-9, depletion of caspase-3 and caspase-7 in the posterior VBI had only a mild or no effect on 
the expression of erythroid marker genes (Fig.22).  
Together, our data indicate that the involvement of caspase-9 in the process of primitive blood 
formation is a non-apoptotic event and is independent of the two downstream executioner caspases-
3 and -7.  
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I.3.3. Discussion 
We here describe a novel caspase-reporter system, which enables us to specifically detect caspase-
activity during Xenopus development. The reporter was validated using a combination of assays: 
cleavage of the putative recognition motives (i.e. DEVD and LEHD) present in the reporter constructs 
by the corresponding recombinant caspases in cell free lysates, transient transfection studies in HEK 
293t cells and morpholino experiments in Xenopus. Transgenic implementation of the constructs in 
Xenopus embryos revealed unique and highly dynamic spatio-temporal patterns of GFP expression. 
Interestingly, the GFP patterns observed were largely similar to the TUNEL positive regions described 
by Hensey et al. and most of those patterns referred to earlier described apoptotic processes during 
development like cell death during retina formation and neuronal cell death in developing brain 
tissue (Hensey and Gautier, 1998; Vecino et al., 2004). To date, only a couple of non-invasive 
reporter systems that are based on the cleavage of a recognition peptide have been developed to 
monitor the real time activation of caspases in living cells and oocytes in vitro (Luo et al., 2001; Wu et 
al., 2006) as well as in vivo in organisms like yeast, the fly and plants (Hawkins et al., 1999; Bardet et 
al., 2008; Johnson et al., 2009; Zhang et al., 2009). Briefly, these reporters make use of the 
fluorescence resonance energy transfer (FRET) technology, which comprises two fluorophores or of a 
surface plasmon resonance (SPR) imaging system where the fluorescent signal is lost after caspase 
cleavage (Park et al., 2008). Evidently these systems require complex technology to differentiate 
between the two wavelengths of the fluorophores and have to deal with the presence of a 
ubiquitous fluorescent signal in the absence of caspase activity. This makes large scale assessment of 
caspase activity rather difficult. Recently, some improvements to cell permeable fluorogenic 
substrate molecules were applied, which make them applicable to detect caspase-activity in cells 
(Wang et al., 2005; Cen et al., 2008). These probes do not make use of the FRET technology, making 
them easy to apply and to analyze. However, these systems have not yet been implemented in an in 
vivo setting. Our transcription factor based reporter system is actually an amplification system which 
increases the sensitivity and allows to monitor low levels of caspase activity in cells of a developing 
organism. Moreover, activation of the reporter can be assessed on a regular fluorescent 
stereomicroscope, allowing the continuous evaluation of several embryos during  all stages of 
developmental. Evidently, our system has some limitations that have to be taken into account when 
assessing the fluorescent patterns. These are dealing with the dependence of the system on 
transcription, translation and GFP maturation. This implies that there will be a delay in the 
occurrence of the fluorescent signal upon caspase activation. In addition, a characteristic feature of 
the apoptotic process is the eventual shut down of the transcription and translation machinery 
(Saelens et al., 2001). Hence cells undergoing rapid apoptotic cell death are not able to generate a 
fluorescent signal. This may explain our inability to detect reporter activity in the regressing tail as 
well as the presence of TUNEL-positive, GFP-negative cells in the retina. The redundant activities of 
caspase-3 and -7 likely explains the incomplete overlap between GFP signal and the staining for 
activated caspase-3 in the DEVD reporter line. Indeed, it appeared mandatory to deplete both 
caspase-3 and -7 to abrogate the generation of a GFP signal  in these embryos. Finally, we reason 
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that besides the obvious functions of caspases in cell death, our reporter system may also pick up a 
certain amount of activity related to non-apoptotic functions of the investigated caspases (Lamkanfi 
et al., 2007).  
Interestingly, the LEHD transgenic embryos at stage 28-32 displayed strong GFP expression in a 
position corresponding to the ventral blood island, an activity not seen with the DEVD reporter. 
Later, theses GFP positive cells started to circulate throughout the vitelline veins and formed the 
primitive erythrocytes. This observation suggests a novel non-apoptotic function for caspase-9 in 
blood formation. Indeed, targeted depletion of caspase-9 in the VBI seriously affected the mRNA 
expression levels of the early erythroid markers GATA-1 and T3-globin. Non-apoptotic functions for 
caspase-9 during blood formation have so far not been described. Surprisingly, caspase-3 has been 
shown to play a role in different aspects of blood formation. During erythroblast differentiation, 
caspase-3 is shown to be transiently activated through the mitochondrial pathway where it cleaves 
proteins involved in nuclear envelope integrity (e.g lamin B) and chromatin condensation (e.g. 
acinus), but spares other potential substrates like GATA-1, which is presumably protected by the 
interaction with HSP70 (Zermati et al., 2001; Ribeil et al., 2007). In contrast, it has been suggested 
that caspase-3 involvement in erythropoiesis in the mouse is restricted to the early phases of 
proerythroblast differentiation, with no major roles in the nuclear substructure reorganization and 
nuclear extrusion that characterize the late phases of the process (Krauss et al., 2005). In any case, 
these data suggest an essential role for caspase-3 in erythropoiesis, which we cannot reconcile with 
our data. Not only did we not observe any GFP expression at the VBI of the DEVD transgenic 
embryos, but we also did we notice a severe effect on the expression of the eythroid markers after 
combined depletion of caspase-3/-7.  
One possible reason for the absence in activity of the effector caspases-3 and -7 might be that they 
are kept inactive by IAPs (Inhibitor of Apotosis). We speculate that survivin, a member of the IAP 
family, is ideally positioned to do this job. Survivin can not only directly inhibit caspase-3/-7 through 
direct interaction but its function is also associated with survival and proliferation of the 
hematopoietic progenitors cells (Tamm et al., 1998; Shin et al., 2001; Fukuda et al., 2002; Fukuda and 
Pelus, 2002). Furthermore, upon knock down of survivin in zebrafish, primitive erythropoiesis is 
clearly affected (Delvaeye et al., 2009). Another possibility is the protective role for RAF-1, a 
serine/threonine kinase, implicated in cell survival. Kolbus et al. described that RAF-1 can antagonize 
erythroid differentiation by restraining caspase activation (Kolbus et al., 2002). On top of that, it 
turns out that caspase-9 can cleave and subsequently activate RAF-1 to regulate the negative 
feedback of hematopoietic cell apoptosis induced by growth factor depletion (Cornelis et al., 2005). 
Another putative target of caspase-9 during erythropoiesis could be the tumor suppressor 
retinoblastoma protein (Rb). It has been shown that the caspase-9-mediated  cleavage of Rb results 
in a truncated form called p76Rb, which antagonizes p53-mediated apoptosis (Lemaire et al., 2005).  
Moreover, the loss of Rb in the erythroid compartment of conditional knockout mice leads to a 
stable anemia that is attributable to an ineffective erythropoiesis (Sankaran et al., 2008). These 
authors further narrowed down the function of Rb in eythropoiesis and suggested that Rb is 
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necessary for the terminal maturation of erythroblasts that occurs concomitantly with the cell cycle 
exit.  
Besides the plausible involvement of a member of the IAP family and the protective role for a 
potential  caspase-9 substrate, there exists another way how the cell can use certain caspases in a 
differentiation related manner without causing cell death. It appears that certain crucial substrates 
involved in a differentiation process can be shielded from the caspase-activity, which guarantees 
there function. This is the case for the chaperone protein HSP70 which acts as a guardian of the 
GATA-1 transcription factor towards the activity of caspase-3 (Ribeil et al., 2007).  This chaperone 
(and/or others) may actually also shield additional substrates in the erythroblasts and possibly also 
the DEVD reporter. Supposedly, there are other protective mechanisms that act downstream of 
signaling pathways involved in erythrocyte differentiation like the Wnt and/or EPO pathways. For 
instance, Wnt signaling was demonstrated to be crucial for erythropoiesis, potentially via the 
induction of pro-survival factors (Tran et al., 2010). Likewise EPO signaling is obviously correlated 
with the erythropoiesis and preserves the correct differentiation of these cells (Ingley et al., 2004). 
Extended comprehension of these pathways will inevitably broaden our insight on how these ‘lethal’ 
caspases are balanced to promote survival and differentiation instead of leading to cell death. 
Although not much is known about the non-apoptotic functions of caspases in general, and caspase-9 
in particular, it has been demonstrated that caspase-9 is implicated in controlling the proliferative 
status of neuroblasts in the metamorphosing Xenopus brain (Coen et al., 2007) and in the 
differentiation of myoblasts into myotubes in the C2C12 mouse myoblast cell line (Murray et al., 
2008). Furthermore, the initiator caspase-9 is involved in most differentiation processes in which 
caspase-3 has been implicated, which points out the importance of the highly conserved 
mitochondrial death effectors in these cell death unrelated functions (Galluzzi et al., 2008).  
Another outstanding question is how caspase-9 is actually cleaving substrates important for primitive 
blood formation. It is generally assumed that caspase-9 is activated in the apoptosome complex. 
Hence it may be interesting to investigate whether apoptosome components like Apaf-1 (Apoptotic 
protease associated factor 1) are also required for primitive blood formation. Studies with the apaf-1 
null mouse together with loss of function experiments in Xenopus may confirm this hypothesis.  
In summary, we designed and evaluated highly efficient and reliable transgenic reporter systems 
which are able to detect caspase activity in reproducible and dynamic patterns during early and late 
embryonic development. This system provided us with unique evidence for the involvement of 
caspase-9 in primitive blood formation. We report that this novel function of caspase-9 is a non-
apoptotic event which is likely independent of the two downstream executioner caspases-3 and -7.  
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I.3.4. Material and Methods - Supplemental Figures 
I.3.4.1. Material and Methods 
Plasmid constructions 
Standard cloning techniques were used to generate the different constructs. A multiple element 
transgenesis vector was built onto the backbone of pBluescript IISK (Stratagene, La Jolla, CA). The X. 
laevis EF-1α promoter and the carp E1b basal promoter preceded by a 14-mer of UAS Gal4-binding 
sites were isolated from the plasmids EF-GVP and UG described by Köster and Fraser (Koster and 
Fraser, 2001) and kindly provided by these authors. In addition, EF-GVP was used for Gal4-VP16 
fusion. First, the DEVD sequence was inserted behind the EF-1α promotor with XmaI and NdeI. Next, 
a synthetic oligo coding for the c-Myc epitope tag, EQKLISEEDL, was ligated adjacent to the DEVD 
sequence with AatI and NcoI. The transmembranal domain of IL-2 receptor was isolated from the 
pCMV-IL-2R construct, which was kindly provided by the Gumbiner laboratory (University of Virginia 
School of Medicine, Charlottesville, USA) and cloned in between the DEVD-Myc sequence and the EF-
1α promoter with SmaI. The Gal4-VP16 fusion from EF-GVP was amplified with PCR and placed 
behind the IL-2R-DEVD-Myc sequence with BglII and NcoI. Subsequently, this intermediate construct 
was combined with the UG construct via SacII ligation. The ubiquitous fluorescent reporter, DsRed-
Express-1 (Clontech, BD Biosciences, Erembodegem, Belgium) under control of the minimal human 
Ecadherin promotor (Denayer et al., 2006) was also inserted into the backbone construct opened 
with EcoRV. This resulted in the plasmid pEF-1α-IL2R-DEVD-Myc-GAL4/VP16-pEcad-DsRed-UAS-eGFP, 
or further called pCDSI-DEVD as from caspase Detection System I with the recognition sequence 
DEVD. To generate the constructs pCDSI-DEVA and pCDSI-LEHD, the DEVD recognition sequence was 
changed by site directed mutagenesis (Stratagene, La Jolla, CA). Used primers for the DEVA sequence 
were 5’-GTCGCTTCCTCCAGCCACCTCATCTCC-3’ and 5’-GGAGATGAGGtGGCTGGAGGAAGCGAC-3’. For 
LEHD, the primers were 5’-GGGAGCGGAGGACTTGAGCACGATGGAGGAAGC-3’ and 5’-
GGGAGCGGAGGACTTGAGCACGATGGAGGAAGC-3’. Furthermore, we added I-SceI Meganuclease 
restriction sites to the reporter constructs which allows easy isolation of the transgenic fragment. I-
SceI restriction sites were isolated form a I-SceI-pBlueSK+ construct with an EcoRI digest and ligated 
in the backbone vectors of our reporter systems with a MfeI digest.     
For TNT analysis, the reporter IL2R-XEXX-Myc-GAL4/VP16 fragments were picked up with PCR and 
cloned in the mammalian expression vector pcDNA3 via ApaI and NheI digestion (Life Technologies 
Invitrogen, Merelbeke, Belgium). Xlcaspase-9 cDNA and Xtcaspase-9 cDNA were amplified by PCR 
from Xenopus laevis and Xenopus tropicalis cDNA batches, and subsequently introduced via the 
TOPO cloning technology (Life Technologies Invitrogen) into the pCR2.1-TOPO vector. Next, the 
caspase coding fragments were isolated and ligated in the pCS2-Myc tag vector which was opened 
with XbaI for the Xlcaspase-9 sequence and with EcoRI for the Xtcaspase-9 sequence, leading to the 
expression vectors pCS2-Myc-Xlcaspase-9 and pCS2-Myc-Xtcaspase-9 respectively.   
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Immunostaining Cryo-sections 
Transgenic embryos were fixed in 1% paraformaldehyde for 1h at room temperature, washed with 
PBS, embedded in 30% sucrose overnight, and then transferred into a mold with cryo-embedding 
compound. Samples were snapfrozen on dry-ice and stored for long term at -80°C. Cryo-sections of 
10 µm thickness were prepared on a cryotome at -20°C and embedding compound was washed away 
with PBS. The sections were directly stained with Hoechst (1:10000) or for co-localization 
experiments with active caspase-3, the sections were incubated with polyclonal rabbit anti-active 
caspase-3 (1:2000, Abcam, Cat.No. ab13847) and revealed with anti-rabbit IgG Alexa 633 (far red).  
All coverslips were mounted with 1% n-propylgallate glycerol and imaged with a confocal laser 
scanning microscope TCS SP5 (Leica).  
 
In Vitro Transcription/Translation (TNT) 
pSV-Sport-Raf-1 (from (Cornelis et al., 2005), LMBP# 5264), pCMV-SPORT6-hPARP1 (kind gift from 
Prof. P. Vandenabeele, Ghent University) and the 3 reporter system based constructs pcDNA3-IL2R-
DEVD-GAL4/VP16, pcDNA3-IL2R-DEVA-GAL4/VP16, pcDNA3-IL2R-LEHD-GAL4/VP16, described under 
‘Plasmids Construction’ were used as templates for *35S+ methionine (PerkinElmer Life Sciences)-
radiolabeled in vitro coupled transcription/translation in a rabbit reticulocyte lysate system according 
to the manufacturer’s instructions (Promega). The translated proteins (10 µl) were subsequently 
incubated for 1.5 h at 37 °C in CFS buffer with the recombinant mouse caspases in a total volume of 
30 µl. Next, samples were boiled for 10 min after addition of Laemmli buffer, separated by 15% SDS-
PAGE, which was dried before exposing to a film (Amersham Biosciences HyperfilmTM ECL) for 
radiography.  
 
Cell culture and transfection assay 
293T cells were grown at 37°C in DMEM (Life Technologies, Ghent, Belgium) supplemented with 10% 
FCS (fetal calf serum), 2mM L-Gln, 100 U/ml penicillin and 0.1 mg/ml streptomycin, and seeded in 6-
well plates. Transient transfections were performed using Fugene 6 Transfection Reagent (Roche 
Applied Sciences). The expressed mouse caspase constructs were all based on the mammalian 
pCAGGS expression vector. Cells were lysed after 24h in NP-40 lysis buffer (0.5% NP-40, 150 mM 
NaCl, 50 mM Tris pH 7.5, 2 mM EDTA) supplemented with Complete Protease Inhibitor Cocktail 
(Roche) and cleared by centrifugation at 4°C. Lysates were finally dissolved in Laemmli sample buffer 
and further analyzed by western blotting. 
 
Western blotting 
Antibodies used were polyclonal rabbit anti-myc IgG (1:2000, Immuno Source, Code No. 562); 
monoclonal rabbit anti-actin (1:10000, MP Biomedicals, Cat.No. 69100). Total protein lysates 
(embryos or cells) were prepared by homogenizing with NP-40 supplemented with protease 
inhibitors. Following centrifugation, equal amounts of protein were separated by 12% or 15% 
polyacrylamide gel electrophoresis (PAGE), blotted on Immobilon-FL PVDF membrane (Millipore), 
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blocked in Odyssey blocking buffer (Li-cor) diluted 1:2 with PBS and incubated with the required 
primary antibodies. Secondary antibodies used were IRDye 800CW goat anti-mouse IgG, IRDye 
800CW goat anti-rabbit IgG, IRDye 680 goat anti-mouse, IRDye 680 goat anti-rabbit from Li-cor. 
Protein expression was analyzed by using the Odyssey Infrared Imaging System.  
 
Morpholino design and RNA injections 
 X. tropicalis embryos were collected from natural mating couples and dejellied in 3% cystein in 1× 
MMR buffer. Embryos were injected while submerged in 0.1× MMR/6% Ficol and cultured at 22 °C. 
The following antisense morpholino oligonucleotides (MO) were obtained against Xenopus tropicalis 
caspase-9 (GeneTools): C9MOatg1: GAATGTCCCTGTATTCCGGCTCCAT; C9MOatg2: 
CATCCGCTCATCGCTTCCGTACATG; C9MOEI:GACAATGGCAGAAATTTACCTCCGC. As control, a standard 
morpholino CoMO (Genetools) was used. They were dissolved and stored according to the 
manufacturer’s instructions and in injected at the doses indicated in the figure legends. The 
expression constructs pCS2-Myc-Xlcaspase-9 and pCS2-Myc-Xtcaspase-9  were linearized with Not I, 
and in vitro synthesis of capped RNA was performed using the SP6 mMESSAGE mMACHINE® High 
Yield Capped RNA Transcription kit (Cat# AM1340 Applied Biosystems). In addition, also the C7MOatg: 
CTGCTCCTCCATCATTTGCTGAATC and C3MOatg: TACACCATTGTGGGATTCTTCCATC were ordered at 
GeneTools.   
 
Whole mount in situ hybridization (WISH) and β-gal staining 
Antisense RNA probes for GATA-1 (T7) and αT3-globin (SP6) were synthesized from cDNA using 
digoxygenin as a label (Roche Molecular Biochemicals). Embryos were prepared, hybridized and 
stained as described (Harland, 1991). For detection, BM purple was used as a substrate for the 
alkaline phosphatase. For β-gal staining, the embryos were histochemically stained at 37°C in 1x PBS 
containing 5 mM K3Fe(CN)6, 5 mMK4Fe(CN)6, 2 mM MgCl2, and 1 mg/mL Xgal. The embryos were 
then washed in 1x PBS, refixed for 1h in 1x MEMFA (0.1 M Mops pH 7.4, 2 mM EGTA, 1 mM MgSO4, 
and 3.7% formaldehyde), dehydrated in 100% MeOH, and either stored at -20°C or processed 
immediately for WISH.  
 
TUNEL staining 
Cell apoptosis on sections was assayed using the In Situ Cell Death Detection kit, TM red (Roche 
Molecular Biochemicals, Cat.No. 12 156 792 910). Briefly, the sections were refixed, washed and 
permeabilized on ice. Next, they were incubated with the TUNEL reaction mixture in a humidified 
chamber for 60 min at 37°C in the dark. After washing with PBS the nuclei were stained in Hoechst 
33342 (1:10000, H21492) solution for 15 min. Sections were mounted in 1% n-propylgallate glycerol 
and pictured with the confocal laser scanning microscope TCS SP5 (Leica) or with the automated 
upright CellM fluorescence microscope (Olympus BX61). Whole-mount TUNEL staining of X. tropicalis 
embryos was based on the method described by Hensey and Gauthier (Hensey and Gautier, 1998). In 
short, first the embryos were gradually rehydrated in 1x SSC buffer. Next, the embryos were 
incubated in the TdT buffer (supplied with the enzyme). Terminal ends were labeled overnight with 
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the Terminal Deoxynucleotidyl Transferase (TdT) (Invitrogen Cat #: 10533-065). The enzyme was 
washed away with several EDTA/PBS steps and eventually the embryos were transferred in a 2% 
blocking buffer. The terminal ends were stained with 1/3000 anti-digoxygenin AP antibody (Roche, 
Cat #:11-093-274-910). The next day, the antibody was washed away with several MNT wash steps, 
followed by an Alkaline Phosphatase buffer (AP buffer) treatment. The staining was performed with 
Nitro-Blue Tetrazolium (NBT) and Bromo-4-chloro-3-indolyl-phosphate (BCIP) (tablets).  
 
Transgenesis in Xenopus tropicalis 
X. tropicalis frogs were obtained from Nasco (http://www.enasco.com) and X. laevis from African 
Reptile Park, South Africa. Transgenesis was performed as described in detail in Hirsch et al., 2002. 
Briefly, to induce ovulation in X. tropicalis frogs, they were primed with 20 U of human chorionic 
gonadotropin (HCG; Sigma-Aldrich, Bornem, Belgium) and 36-48h later boosted with 120 U. Eggs 
were harvested by squeezing the frogs 4 h after boosting. Eggs were semi-dejellied with 2% cysteine 
in low calcium 1x MMR (0.1 M NaCl, 2 mM KCl, 0.2 mM CaCl2,1 mM MgCl2, 5 mM HEPES, pH 7.5), 
washed five times with 1x low calcium MMR, then transferred to agarose-coated dishes containing 
8% Ficol in 0.1x low calcium MMR for injection. 200ng of transgene fragment was mixed with the 
prepared sperm nuclei and 2 µl of oocyte extract, which decondenses the sperm nuclei and facilitates 
the integration of the transgene. The reaction mixture was back-filled into a capillary needle and 
injected into the collected eggs at 1 sperm nucleus/second. Normal dividing embryos were selected 
at the four cell stage (1.5 h after injection), cultured overnight in 6% Ficoll/0.1x MMR, and 
transferred to 0.1x MMR without Ficoll. Transgenic embryos were screened for fluorescence signal 
using a Zeiss fluorescence stereomicroscope. Transgenic founder tadpoles were raised to maturity, 
and at the age of about six months they were crossed with wild type Nasco frogs to obtain an F1 
generation. 
 
RNA Extraction and semiquantitative or quantitative RT-PCR 
Total RNA was isolated using the Aurum Total RNA fatty and fibrous tissue kit (Biorad). For each RNA 
sample at least 10 embryos were pooled. cDNA was prepared with oligo (dT) and random hexamer 
primers using the iScript cDNA Synthesis Kit (Biorad) according to the manufacturer’s instructions. 
Sequences of forward and reverse primers were as follows (5’ to 3’ orientation): 
ATCATCTGGAGGAACTTGCTG and AGACGAATTCTACGCTGCGCTACACTGCGCA for Xtcaspase-9, 
CAGCCTCGACATTCAATGGA and TCAGGGAGAATGCCATGTTCT for ornithine decarboxylase (ODC) as a 
house keeping gene. Semiquantitive amplified fragments were seperated on a 2% agarose gel and 
visualized using a Molecular Imager FX (Bio-Rad).  
Real-time qPCR analysis was performed using the SYBR green PCR master mix (Applied Biosystems) 
on a LightCycler® 480 Real-Time PCR System (Roche). Primers for measuring gene expression levels 
were designed using Primer express 1.0 software (Perkin-Elmer applied Biosystems). For all primer 
pairs, a “no-template control” was included. For measuring gene expression, a “no-amplification 
control” was also included and all values were normalized to the level of the housekeeping gene 
ornithine decarboxylase (ODC). 
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I.3.4.2. Supplemental figures 
 
Figure S1. The LEHD reporter system is not responsive to mouse caspases in 293t cells.  
Anti-Myc tag western blot analysis of reporter cleavage products in response to transfected mouse caspases in 293t HEK 
cells. Approximatly 200.000 cells were seeded in a 6 well plate, followed by transfection after 24 h with Fugene 6 
Transfection Reagent and lysed after 24 h (A) No proteolytic cleavage of the LEHD reporter was observed when 
cotransfected with caspase-9, probably due the rapid cell death following the transfection (white arrows). 200 ng of the 
DNA coding for the distinct reporter constructs was combined with a DNA gradient (100 ng, 150 ng, 250 ng and 350 ng) of 
caspase-9 (B) Increased concentration (50 ng, 150 ng, 250 ng and 350 ng) of exogenous caspase-9 resulted in a 
concentration dependent decrease in the unprocessed LEHD reporter system (65 kDa). In addition, neither caspase-8 (150 
ng), caspase-3 (150 ng) or caspase-7 (150 ng) could cleave the LEHD reporter system (white arrows).  No proteolytic 
response of the DEVD reporter was observed when caspase-6 or caspase-9 were cotransfected. 500 ng of the DNA coding 
for the DEVD reporter construct was combined with a DNA gradient (100 ng and 200 ng) coding for the various caspases. 
 
 
 
 
Figure S2. C9MOatg1 does not target Xenopus laevis caspase-9 RNA.  
Western blot analysis of exogenous caspase-9 levels after depletion with the translation blocking morpholino C9MO
atg1
. 
Embryos were injected at 2-cell stage with 10 ng  C9MO
atg1
 and 10 ng CoMO alone or combined with 250 pg RNA coding for 
Xenopus laevis caspase-9 (Myc-tagged) or Xenopus tropicalis caspase-9 (Myc-tagged). The functionality of C9MO
atg1
 was 
proven by the clear reduction in Xtcaspase-9  protein levels upon depletion. However, the four mismatches in the 
morpholino target sequence of the Xlcaspase-9 mRNA seem to be sufficient for blocking the binding with the morpholino 
and make the Xlcaspase-9 transcripts suited for rescue experiments.      
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Figure S3. Splice blocking morpholino C9MOE2I2 retained intron I in the X. tropicalis caspase-9 transcripts. 
RT-PCR analysis of Xtcaspase-9 levels after depletion with the splice blocking morpholino (C9MO
E2I2
). Embryos were injected 
at 2-cell stage with 20 ng C9MO
E2I2
 or 20 ng CoMO and lysed at stage 20. Blockage of the exon2 and intron2 boundary by 
the morpholino resulted in a intron1 retention, which was noticed by the 579 bp fragment and suggests that the splicing 
blocking morpholino worked specifically. The intron retention causes a shift in the open reading frame of Xtcaspase-9 and 
results in an incorrectly translated protein and a premature stop. (NI, non injected)    
 
 
 
 
Figure S4. Confirmation of specific depletion of the primitive blood markers with additional caspase-9 
morpholinos (C9MOatg2 and C9MOE2I2).  
Embryos were injected in the two CD4 blastomeres at 16-cell stage with 3,5 ng C9MO
atg2
; 4 ng C9MO
E2I2
 or 4 ng CoMO in 
each blastomere. 10 pg RNA of cytoplasmic β-Gal was coinjected as lineage tracer. (A) Whole mount in situ hybridization 
analysis of T3 globin expression in the posterior part of the VBI (arrowheads). T3-globin expression was affected upon 
depletion of caspase-9 with these additional morpholinos. (B-C) Graphs represents the precentage of embryos exposing the 
defect in the observed marker expression. The embryos were scored using the phenotype in (A) as a reference. 
 
C9MOE2I2COMONI
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Figure S5. Whole mount TUNEL-staining did not show apoptotic cells at the ventral blood island (VBI). 
TUNEL-staining was based on the protocol described by Hensey and Gauthier (Hensey and Gautier, 1998). (A-B) Stage 32-34 
embryo revealed a great number of apoptotic cells at the otic vesicle (ov) and eye (ey). No TUNEL-positivity was seen at the 
VBI (C-E) Stage 32-34 embryo showed also apoptotic cells in the brain area (b) (clearly visible on the dorsal view in (E)). 
Again no apoptotic cells were present at the VBI (see ventral view in (D)).  
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Chapter I.4. Additional data and discussion 
I.4.1. Possible involvement of Survivin in blocking the effector 
caspases-3 and -7 in blood formation 
Our data demonstrate a novel role for caspase-9, independent of the effector caspases-3 and -7, in 
primitive erythropoiesis. Since the LEHD-reporter is activated at the site of the primitive blood 
formation, this suggests that the function of caspase-9 is dependent on its proteolytic activity. To 
date, only a few unique substrates are described for caspase-9 (MEROPS database). Interestingly, 
Cornelis et al. (2005) revealed RAF-1 as a putative substrate, where caspase-9 generates a truncated 
and activated RAF-1 fragment which is possibly implicated in promoting survival and proliferation of 
hematopoietic cells (Kolbus et al., 2002; Cornelis et al., 2005). Another published substrate is the 
tumor suppressor retinoblastoma protein (Rb) for which caspase-9 cleavage results in a protective 
truncated form p76Rb. Rather than just being a non-functional by-product of Rb degradation, this 
shortened protein displays an anti-apoptotic activity that antagonizes p53-mediated apoptosis 
(Lemaire et al., 2005). Although the role of Rb in erythropoiesis has been the subject of controversy 
for more than 15 years, it was recently showed that loss of Rb in the erythroid compartment of 
conditional knockout mice leads to a stable anemia that is attributable to an ineffective 
erythropoiesis (Sankaran et al., 2008). The authors further narrowed down the function of Rb in 
eythropoiesis and suggested that Rb is necessary for the terminal maturation of erythroblasts that 
occurs concomitantly with the cell cycle exist. Intriguingly, it appears that the role for Rb in 
erythropoiesis is mediated by the coupling of the process of mitochondrial biogenesis with the cell 
cycle exit (Sankaran et al., 2008). Thus, taken these observations into consideration it may very well 
be that the proteolytic cleavage of Rb turns out to be essential for blood formation.  Additional proof 
for a potential pro-survival role of capsase-9 comes from several studies that report on the existence 
of different endogenous isoforms with protective activity against apoptosis. One example is a natural 
occurring variant of caspase-9, named caspase-9S, that is lacking most of the large subunit including 
the catalytic site, but still contains the intact prodomain and the small subunit. Overexpression of 
caspase-9S inhibits apoptosis, indicating that it acts as an endogenous dominant-negative for 
caspase-9 through its interaction with Apaf1 (Seol and Billiar, 1999; Srinivasula et al., 1999). All these 
data support that caspase-9 is not only involved in pro-apoptotic pathways and should also be 
considered as a possible pro-survival determinant. Still the question remains how caspase-9 can be 
active without processing the downstream caspases-3, which is the well known substrate for 
caspase-9. One explanation is the implication of a regulator that has the ability to directly interact 
with caspases and keep them inactive as long as it is necessary. Several inhibitors of apoptosis (IAPs) 
are perfectly positioned to control the caspases and the continuation of their signaling cascade. 
Therefore, we investigated the possible involvement of an IAP in order to explain the apparent 
absence of effector caspase-3 and -7 activity in the VBI. IAPs are part of a versatile, evolutionary 
conserved family of intracellular proteins that are characterized by the presence of one to three zinc-
binding domains, the so-called baculovirus IAP-binding repeats (BIR) (reviewed in (O'Riordan et al., 
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2008)). To date, four Xenopus IAPs have been identified: the Xenopus orthologs of the X-linked IAP 
(xXIAP), egg or embryonic IAP (xEIAP), survivin-1 (xSvv1 or birc5.1) and survivin-2 (xSvv2 or birc5.2). 
Numerous studies have indicated that XIAP is the most potent IAP in mammals and describe its direct 
inhibition of the effector caspases (reviewed in (Deveraux and Reed, 1999; Goyal, 2001; Holcik and 
Korneluk, 2001; Salvesen and Duckett, 2002; Schimmer, 2004)). Interestingly, only xXIAP was shown 
to function as the inhibitor of apoptosis in egg extracts (Tsuchiya et al., 2005). However, XIAP has 
never been associated with hematopoiesis or erythroid differentiation. In contrast, expression of 
survivin was not only correlated with survival and proliferation of the hematopoietic progenitors 
cells, but it can also directly inhibit caspase-3/-7 through physical interaction (Tamm et al., 1998; Shin 
et al., 2001; Fukuda et al., 2002; Fukuda and Pelus, 2002; Ma et al., 2009). Furthermore, upon knock-
down of survivin in zebrafish, primitive erythropoiesis was clearly affected (Delvaeye et al., 2009). 
Therefore, we speculated that survivin is ideally positioned to antagonize the effector caspase 
activity during primitive blood formation in Xenopus.  
 
I.4.1.1. Xenopus Survivin proteins are expressed at the VBI during blood 
formation  
In higher vertebrates (human, mouse, rat, dog, chicken, pig, cattle) as well as in Ciona intestinalis and 
nematodes genomes (Caenorhabditis elegans, Pristionchus pacificus, and Meloidogyne hapla) there 
is a single survivin gene that generates several different protein products due to alternative pre-
mRNA splicing (reviewed in (Du Pasquier et al., 2006; Li and Ling, 2006)). In Xenopus, there are two 
survivin genes. Overexpression of xSvv2 induced endothelial proliferation, while augmented 
expression of the xSvv1 had inexplicable lethal effects (Du Pasquier et al., 2006). The authors also 
point out the differential spatiotemporal transcription patterns where xSvv2 mRNA is detected 
throughout early development, from the fertilized egg to the young tadpole (stage 42), while xSvv1 
mRNA is present at constant levels until gastrulation stages and decreases afterwards (Du Pasquier et 
al., 2006). Zebrafish also has 2 related survivin genes and Delvaeye et al. demonstrated that they 
have overlapping expression patterns during early development, especially in neural and vascular 
structures. Morpholino-induced depletion of Birc5a (homologous to xSvv2) causes profound neuro-
developmental, hematopoietic, cardiogenic, vasculogenic and angiogenic defects. Similar 
abnormalities, all less severe except for hematopoiesis, were evident with suppression of Birc5b 
(homologous to xSvv1). These abnormalities could be rescued with one and another, proving that the 
2 genes are redundant for each other. We performed a whole mount in situ staining at stages 30-32 
for the two Xenopus survivin genes (Fig.24A-B). Overall, their expression patterns are largely 
indistinguishable, and are predominantly localized to neural, and ocular structures. We also observed 
expression in the branchial arches, the somites and at the ventral side of the embryo. At the VBI 
region, the area where caspase-9 activity is present, there was more and consistent expression of the 
xSvv2 transcript, although the difference was subtle. Together with the data from zebrafish, this 
points out to a more predominant role for xSvv2 in hematopoiesis. To see whether xSvv2 prevents 
the activation of the executioner caspases in the VBI, we designed a splice blocking morpholino 
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directed to the exon3-intron3 boundary of xSvv2. The functionality of the splicing morpholino was 
monitored with RT-PCR, which showed a reduction of the wild type xSvv2 transcript (330 bp) and the 
appearance of a higher molecular weight fragment (1011bp), reflecting intron retention by the 
injected 15ng XtSvv2 MOE3I3 (Fig.24E). This intron retention caused a frame shift in the open reading 
frame of the xSvv2 mRNA, probably leading to an incorrectly translated protein. Doubling the XtSvv2 
MOE3I3 concentration to 30ng, generated a more severe reduction of the wild type xSvv2 transcript 
(330 bp) and no higher weight fragment anymore. The mRNA transcript containing the retained 
intron is likely very unstable, making it difficult to pick it up with RT-PCR.  
 
   
 
 
 
 
 
 
The XtSvv2 morpholino was targeted, together with a red lissamine marker, to the posterior part of 
the VBI in DEVD transgenic reporter embryos. As a result, an increase in the number of GFP-positive 
cells appeared in the targeted area of the VBI (Fig.25).This increased activity of caspase-3/-7 upon 
xSvv2 depletion might be associated with an increase in apoptotic cell death. Indeed, Delvaeye et al. 
already described an increase in TUNEL positive cells in the caudal vein plexus, the zebrafish ortholog 
for the VBI, after knock down of the survivin genes (Delvaeye et al., 2009). Although, this all fits with 
our theory of a protective IAP, which can act as a guardian for the caspase-activity, we have to take 
into account that this appearance of GFP cells in the targeted area might be the result of a secondary 
function of the survivin genes, which are also involved in vasculogenesis. Hence, survivin depletion 
could affect the functionality of the vasculature thereby blocking the entering of the primitive blood 
cells in the circulation. As a consequence, the resided blood cells might die, thus providing an 
alternative explanation for the manifestation of the caspase-activity. The late appearance of the GFP-
positivity in the DEVD transgenic reporter embryos injected with XtSvv2 MOEI (i.e. much later than 
the signal in the VBI of the LEHD reporter embryos), may actually favor the latter interpretation. It 
should be pointed out as well, that ideally Svv1 should be co-depleted with Svv2 in our experiments 
in order to prevent potential redundant activity of the two genes.  
Figure 24. The Xenopus Survivin genes are expressed at the VBI.  
(A-D) Whole mount in situ hybridization of stage 32 embryos with probes directed against the mRNA of Survivin1 (xSvv1) 
and Survivin2 (xSvv2). Both transcripts were expressed at the branchial arches (ba), somites (so), the otic vesicle (ov) and 
the ventral blood island (vbi, arrowheads). Expression was also observed in the head region, including the eye and brain.  
(C-D) Ventral views show a stronger signal for xSvv2 at the VBI. (E) RT-PCR analysis of the functionality of the xSvv2
E3I3
 
morpholino. Injecting 15 ng of  xSvv2
E3I3
MO resulted in a intron retention (arrowheads) and depleted effectively the wild 
type transcript (330 bp). Doubling the concentration of the morpholino almost completely depleted the wild type Survivin2 
transcript and proved the functionality of the designed morpholino.  
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I.4.2. Involvement of caspase-3, -7 and caspase-9 in myeloid cell 
lineage formation 
Non-apoptotic caspase activation was also demonstrated to be required for the selective proteolytic 
cleavage of proteins during the differentiation of monocytes into mature macrophages (see also 
section I.1.5.5). This event likely involves the proper activation of the two initiator caspases-8 and -9, 
which on their turn activate the effector caspase-3 (Sordet et al., 2002; Cathelin et al., 2006; Rebe et 
al., 2007). The existence of embryonic macrophage-like cells has been reported in all animal models 
and its evolutionary conservation suggests important roles during development (Bennett et al., 2001; 
Orkin and Zon, 2008). In Xenopus, primitive myeloid cells arise from the anterior ventral blood island 
(aVBI), the embryonic region equivalent to the zebrafish anterior lateral plate mesoderm (ALPM) and 
the mammalian yolk sac (Tashiro et al., 2006; Costa et al., 2008). The authors in (Costa et al., 2008) 
stated that these macrophage-like cells start to migrate out of the aVBI and subsequently colonize 
the entire embryo at stages 19 and 20. Their migratory behavior allows them to patrol the embryo 
and react properly in response to an injury or to an infectious threat before the functional 
vasculature is established.  
Using time-lapse fluorescence video microscopy of the LEHD transgenic reporter embryos we 
discovered, besides GFP-positive erythroid-like cells located at the VBI, also some migratory cells 
throughout the embryo which showed the hallmarks of patrolling primitive myeloid cells due to their 
migratory behavior (Fig.26).  
  
XtSvv2 MO
EI
GFP
GFP
stage 34-36DEVD
Lissamine
Lissamine
Figure 25. Depletion of xSvv2 leads to an increase of GFP positive cells in the VBI of DEVD-reporter 
embryos. Transgenic DEVD embryos were injected in the CD4 blastomeres at 16-cell stage with 3 ng of the splicing 
morpholino directed against xSvv2. 2 ng of the CoMo conjugated with the lissamine tracer (red) was included as a lineage 
tracer. Only at the posterior part of the VBI where Survivin2 was depleted, we observed an increase in GFP expressing 
cells. This suggests an activation of the Caspases-3 and -7 after Survivin2 depletion.    
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Figure 26. Time-lapse fluorescence video microscopy revealed migratory myeloid cells.  
Transgenic LEHD-reporter embryos at stages 28-30 were sedated and immobilized in a 1% low melting agarose, 0.02% 
MS222, 0,1x MMR imaging buffer. Fluorescent images were taken every 30 minutes for 12 hours. Yellow arrowhead points 
and tracks the same cell at three time intervals. Rectangular insets are 2x zooms. Time is shown in minutes. The stills from 
supplementary movies showed highly motile GFP-positive cells throughout the embryo.  
 
To further investigate this possible implication of caspases in differentiating myeloid cells, we 
targeted our caspase morpholinos to the anterior part of the VBI and used the mpo (myeloid 
peroxidase) probe for in situ hybridisation as a marker for the myeloid cell lineage. Depletion of 
caspase-3/-7 caused not only a severe reduction in the number of myeloid cells but also seriously 
hampered their migration throughout the embryo. Depletion of caspase-9 gave a comparable, 
though slightly weaker defect. The graph in Fig.27 is based on the number of embryos showing 
differences in the amount of mpo positive cells and does not take in to account the migratory defect.  
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Figure 27. Caspase depletion affects myelopoiesis.  
(A) Embryos were injected in CD1 blastomeres at 16-cell stage 
with 2 ng CoMO, 2 ng C9MO or a mix of 1,5 ng C3 MO and 1,5 ng 
C7MO in each blastomere. 10 pg RNA of cytoplasmic β-gal was 
used as lineage tracer. Embryos were fixed at stage 24, stained 
for β-gal and processed for WISH with the probe against mpo 
(myeloid marker). Mpo expression was completely abrogated 
upon Caspase-9 or Caspases-3/-7 depletion.  
(B) Graph representing the percentages of embryos exposing the 
defect in the observed marker expression. The embryos were 
scored using the phenotype in (A) as a reference.  
 
B 
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Several recent in vitro studies have exposed non-apoptotic functions (see also section I.1.5.5) for the 
effector caspases in human peripheral blood monocytes whose differentiation into macrophages is 
induced by macrophage colony-stimulating factor (M-CSF) or by exposure to 12-O-
tetradecanonylphorbol 13-acetate (TPA) (Pandey et al., 2000; Sordet et al., 2002). Apparently, the 
release of cytochrome c from the mitochondria followed by activation of caspase-9 and the 
downstream caspase-3 and -7, has been shown to be indispensable to preserve the differentiation 
process of these cells. Here, we confirmed the apparent involvement of caspases in this non-
apoptotic event and linked their expression directly with the in vivo myelopoiesis in the Xenopus 
model organism. How these enzymes contribute to specific lineage differentiation remains still highly 
speculative and therefore the authors in (Cathelin et al., 2006) performed a screen for putative 
caspase-substrates cleaved during differentiation of the human monocytic leukemic cell line U937 to 
macrophages by TPA. Comparable results were observed with M-CSF-treated monocytes undergoing 
differentiation into macrophages suggesting that the cleavage of these substrates was a 
characteristic event along macrophage differentiation. Several of the proteins whose cleavage or 
degradation was identified, are involved in cytoskeletal regulation and cell adhesion. One of these 
was the PAK-2 kinase, which belongs to the PAK family of proteins, and can be activated upon 
caspase-mediated cleavage. The full-length PAK-2 has been associated with the protection from cell 
death, in part by phosphorylation and inhibition of the pro-apoptotic Bcl-2 family member Bad 
(Jakobi et al., 2001). Nevertheless, picking up PAK-2 in the screen may indicate that its cleaved 
derivative may also be involved in cell differentiation. Interestingly PAK-2 demonstrates similarities 
with MST1 (Mammalian Sterile Twenty-like kinase 1), a target for caspase-3 that is activated by the 
proteolytic cleavage in skeletal myoblasts undergoing differentiation (Fernando et al., 2002). Another 
caspase target is the serine protease inhibitor (serpin) PAI-2. This multifunctional protein is secreted 
to regulate extracellular processes, such as intravascular fibrinolysis and turnover of extracellular 
matrix. As such it can affect several cellular events, such as adhesion, proliferation, differentiation, 
and apoptosis (Yu et al., 2002; Lian and Yang, 2004). These observed effects are directly related to its 
protease inhibitory property and suggested that PAI-2 is inhibiting the activity of a serine protease(s) 
central to these cellular processes. Furthermore, overexpression of PAI-2 protects human 
macrophages exposed to pathogens (Gan et al., 1995), and a caspase-mediated cleavage of PAI-2 
was identified in cells undergoing apoptosis (Jensen et al., 1994). Caspase-3, but not caspase-8, could 
generate a 35-kDa PAI-2 cleavage fragment in vitro (Ritchie and Fragoyannis, 2000), a size similar to 
that identified in monocytes undergoing M-CSF-induced differentiation. α-tubulin and vinculin are 
two cytoskeletal protein substrates related with this differentiation event. These proteins can be 
functionally linked to other cytoskeletal proteins, which are cleaved in various different 
differentiation processes associated with caspase activation, including spectrin (lens fibers), lamin B 
(erythropoiesis), gelsolin (megakaryopoiesis), suggesting a general role for caspases in 
differentiation-associated cytoskeletal changes (Lee et al., 2001; Zermati et al., 2001; De Botton et 
al., 2002). The authors in (Cathelin et al., 2006) also identified another important target for caspase-3 
cleavage during macrophage differentiation, namely the nucleophosmin (NPM) protein, which is 
often implicated in acute myeloid leukemia (Leong et al., 2010). This 38-kDa phosphoprotein 
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regulates various cellular functions, including centrosome duplication, gene transcription, and cell 
proliferation (Wang et al., 2005; Lim and Wang, 2006; Okuwaki, 2008). NPM is cleaved in cells 
undergoing apoptosis, and caspase-3 generates a 20-kDa N-terminal fragment of the protein in vitro 
(Chou and Yung, 2001). Recently, the function of nucleophosmin in macrophage differentiation was 
fine-tuned and it seems that proteolysis of the protein participates in the establishment of a mature 
macrophage phenotype. On the other hand, in response to inflammatory stimuli, the full-length 
protein negatively regulates inflammatory cytokine production (Guery et al., 2011).  
To summarize, we have demonstrated that caspase-9 and caspase-3/7 are indispensable for the 
proper formation of the myeloid cell lineage in Xenopus. The substrates involved in this process 
remains to be discovered. Interestingly, an increasing number of specific substrates of caspases are 
related with the differentiation process of various cell types, proving the importance of the highly 
underestimated non-apoptotic role of these proteolytic caspases. In addition, we speculate that the 
expression of the survivin genes may be responsible for the inhibition of the effector caspases during 
erythropoiesis. Taken together, our reporter systems seem to be an ideal tool to pick up these non-
apopototic events and will help us further to unravel the complex caspase signaling events and to 
uncover their roles during development. The understanding of how these caspases are tightly 
controlled will broaden our insights about the highly regulated hematopoietic program during early 
development and the balanced homeostasis of a multi-cellular organism.  
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I.4.3. Material and Methods additional data 
Whole mount in situ hybridization (WISH) and β-gal staining 
The X.laevis Survivin-1 (xSvv1) (EcoR1, T7) and Survivin-2 (xSvv2) (EcoR1, T7) constructs (pBluescript 
SK(-) vector) were a kind gift of Prof. Y. Tsuchiya (department of biochemistry, Toho University School 
of Medicine, Tokyo, Japan). For the mpo (xpox2) antisense probe synthesis, we used the IMAGE 
5336501 construct (gift from Prof. E. Amaya, University of Manchester, UK), linearized with Sal1, 
transcribed with T7. Antisense RNA probes were synthesized from cDNA using digoxygenin as a label 
(Roche Molecular Biochemicals). Embryos were prepared, hybridized and stained as described 
(Harland, 1991). For detection, BM purple was used as a substrate for the alkaline phosphatase. For 
β-gal staining, the embryos were histochemically stained at 37°C in 1x PBS containing 5 mM 
K3Fe(CN)6, 5 mMK4Fe(CN)6, 2 mM MgCl2, and 1 mg/mL Xgal. The embryos were then washed in 1x 
PBS, refixed for 1h in 1x MEMFA (0.1 M Mops pH 7.4, 2 mM EGTA, 1 mM MgSO4, and 3.7% 
formaldehyde), dehydrated in 100% MeOH, and either stored at -20°C or processed immediately for 
WISH. 
 
RNA Extraction and semiquantitative RT-PCR 
Total RNA was isolated using the Aurum Total RNA fatty and fibrous tissue kit (Biorad). For each RNA 
sample at least 10 embryos were pooled. cDNA was prepared with oligo (dT) and random hexamer 
primers using the iScript cDNA Synthesis Kit (Biorad) according to the manufacturer’s instructions. 
Sequences of forward and reverse primers were as follows (5’ to 3’ orientation): 
ATAATGAGCGCTTCTTTGATT and CATCTTGATTTTCGTACGCTC for xSvv2, CAGCCTCGACATTCAATGGA 
and TCAGGGAGAATGCCATGTTCT for ornithine decarboxylase (ODC) as a house keeping gene. 
Semiquantitive amplified fragments were seperated on a 2% agarose gel and visualized using a 
Molecular Imager FX (Bio-Rad). For all primer pairs, a “no-template control” was included. For 
measuring gene expression, a “no-amplification control” was also included and all values were 
normalized to the level of the housekeeping gene ornithine decarboxylase (ODC). 
 
Morpholino design and RNA injections 
 X. tropicalis embryos were collected from natural mating couples and dejellied in 3% cystein in 1× 
MMR buffer. Embryos were injected while submerged in 0.1× MMR/6% Ficol and cultured at 22 °C. 
The following antisense splice blocking morpholino (MO) was obtained against Xenopus tropicalis 
Survivin-2 (birc5.2) (GeneTools): xSvv2EI: GGCACACAGCAAACAATAACTTACA; As control, a standard 
morpholino CoMO (Genetools) was used. They were dissolved and stored according to the 
manufacturer’s instructions and in injected at the doses indicated in the figure legends. 
  
Time-lapse fluorescent miscroscopy 
Embryos were immobilized and sedated in a 1% low melting agarose, 0.02% MS222, 0,1x MMR 
imaging buffer at the desired stages. Fluorescent images were taken every 30 minutes for 12 hours 
with a stereomicroscope from Zeiss (Carl Zeiss, Germany).   
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Chapter I.5. General Discussion and Perspectives PART 1 
Exploring the role of caspases during Xenopus development 
Cell death is a fundamental aspect of embryonic and post-embryonic development of all multicellular 
organisms. Embryonic development is a dynamic, well-orchestrated and often species specific event. 
However, a common feature of the distinct developing programs in different species is that they all 
have a certain need to sacrifice cells during their development. In the early days, all the dying cells 
observed during development were considered to be sentenced to death by a regulated genetic 
suicide program, which led to the introduction of the term programmed cell death (PCD). Later, it 
became clear that the majority of PCD observed during development could be associated with 
apoptosis, a cell death modality which is mediated by the caspases. Caspases are cysteinyl aspartate 
proteases which cleave a great number of distinct cellular substrates that are contributing to the 
characteristic morphological features of apoptosis (i.e. cell shrinkage, chromatin condensation, 
nuclear fragmentation and membrane blebbing) (Pop and Salvesen, 2009). However, growing 
evidence shows that several apoptotic mediators exhibit functions unrelated to cell death. Especially, 
the caspases seem to also play indispensable roles in processes like proliferation and differentiation 
of various cell types (Lamkanfi et al., 2007). These studies have tremendously changed our classic 
perception of caspase function, and revealed a complete new field of research with many remaining 
questions about the underlying caspase-signaling mechanisms. So far, most of the evidence about 
the non-apoptotic functioning originated from mouse caspase knockouts or in vitro inhibition studies. 
Given that several caspases are functionally redundant with each other, the interpretation of the 
observed knockout phenotypes is sometimes complicated. On the other hand, in vitro studies cannot 
sufficiently compensate for the lack of biomedical context and preferably need to be confirmed by 
additional experiments within a living organism. Obviously, these disadvantages have delayed our 
understanding of the complex roles of the various cell death independent signaling events mediated 
by caspases. That is why there is a certain need for supplementary model systems where novel 
caspase actions can be readily explored. In PART I of this PhD thesis, we filled in this hiatus by the 
implementation of a non-invasive caspase-reporter system that allows us to detect caspase-activity 
throughout the embryonic development.  
 
Why Xenopus?   
The African clawed frog, Xenopus laevis, has been widely used as a model organism to study early 
embryonic development. The ease with which large numbers of transparent embryos can be 
obtained and the simplicity to manipulate them have been very instrumental in investigating multiple 
developmental signaling pathways (Beck and Slack, 2001). In addition, the recent development of 
transgenic techniques has added another value for amphibia as model organisms for genetic and 
functional studies. However, X. laevis possesses a pseudo-tetraploid genome and a long generation 
time (1-2 years) which make it a less favorable system for forward genetics. These disadvantages are 
largely solved by the introduction of X. tropicalis, a species closely related to X. laevis. While X. 
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tropicalis shares the positive features of X. laevis, it has the extra advantages of being a truly diploid 
species with a relatively short generation time (4-6 months) (Kashiwagi et al., 2010). Now there is a 
large expressed sequence tag (EST) database and a full genomic sequence available that adds an 
another constructive reason for functional and genetic studies in X. tropicalis (Carruthers and 
Stemple, 2006). Interestingly, it seems that the frog has a diversity of functionally conserved 
apoptosis-related genes comparable to those of mammals (Nakajima et al., 2000; Tsuchiya et al., 
2005). In addition, functional genomics approaches, especially using antisense morpholino 
oligonucleotides to knock down gene function transiently in embryos (Eisen and Smith, 2008), 
enables extensive characterization of processes mediated by the numerous apoptotic mediators 
during development. Thus, Xenopus and in particular Xenopus tropicalis turns out to be a vertebrate 
model that is suitable for experimental approaches with relatively high throughput that allows 
further exploration of caspase-signaling events.  
 
Monitoring the caspase-activity during the early embryonic development  
In the research project described in PART I, we have used transgenic X. tropicalis lines implementing 
a reporter system that is based on the generation of a fluorescent signal in the presence of specific 
caspase activity. A chimeric GAL4/VP16 transcription factor is anchored at the plasma membrane 
with the extracellular and transmembrane domains of the interleukin 2 receptor (IL2R). Between the 
transmembrane domain and the transcription factor, a tetra-peptide caspase-recognition sequence 
was inserted. This tetra-peptide can be cleaved by specific caspases which frees the TF and allows it 
to translocate to the nucleus, where it induces the expression of the eGFP reporter gene.  Because 
we were primarily interested in the activation patterns of the important executioner caspases-3 and -
7 and the initiator caspase-9, we have introduced the tetra-peptides DEVD and LEHD as putative 
substrates, respectively. A DEVA-containing reporter system served as a control for non-specific 
proteolytic cleavage and hence non-specific activation of the system. A cell-free reticulocyte-based 
transcription and translation assay showed that our designed reporter systems can be processed by 
the designated caspases. This was not the case for the DEVA control reporter system. We could also 
observe a concentration dependent response of the DEVD reporter system towards the 
overexpression of the caspases-3 and -7 in 293t HEK cells. Unfortunately, we could not document a 
similar response of the LEHD reporter to exogenous caspase-9 in transfected cells. We reasoned that 
this inability is the result of the rapid and massive cell death that follows the overexpression of 
caspase-9. We observed cleavage of the DEVD reporter in reticulocyte extracts supplemented with 
recombinant caspase-9. However, we believe this is due to the activation of endogenous executioner 
caspases by the recombinant caspase-9. Hence, ideally, the biochemical analysis of the reporter 
systems should be further optimized. For example, the use of wheat germ extracts instead of 
reticulocyte lysates, will greatly facilitate the interpretation of the caspase-mediated cleavages. 
Unlike the reticulocyte lysate, the wheat germ extracts do not contain endogenous caspases which 
exclude the possible interference of other caspases than the recombinant caspases.  
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Obviously, our main goal was to generate a non-invasive reporter system suited for the detection of 
caspase-activity in a living model organism. Hence, we have created transgenic Xenopus lines using  a 
slightly modified restriction-enzyme mediated integration (REMI) method. These lines exposed 
unique and highly reproducible patterns of GFP expression during embryonic development. The 
spatio-temporal GFP patterns of DEVD-reporter embryos were carefully documented and revealed at 
early stages (stage 12-40) GFP-positivity in several CNS derivatives. Most of these fluorescent regions 
correspond to the earlier described TUNEL-positive areas (Hensey and Gautier, 1998) and indicate a 
close relation with apoptotic cell death. At metamorphosis (stage 60-62), we observed GFP 
expression in the central zones of the long bones which may be associated with the region where 
chondrocytes die by apoptosis to allow differentiation of the osteoblasts (Xing and Boyce, 2005). 
However, we cannot distinguish whether the assumed DEVDase activity comes from the dying 
chondrocytes or from the differentiating osteoblasts, two processes where caspase-3 activation is 
reported to be involved (Miura et al., 2004).  
The dynamic capacity of the reporter system was also monitored in the developing eye. At stage 36, 
the GFP signals originated from all the retinal layers, which probably coincided with the three 
successive waves of cell death observed in the developing retina (Vecino et al., 2004). Later, when 
the retinal layers are established, the lens fiber cells start to differentiate whereby caspase-3 is 
possibly implicated (Weber and Menko, 2005). Analogous to the timing of the differentiating lens 
fiber cells, we picked up GFP expression in the flattened enucleated lens fiber cells. Thus, after 
evaluation of these distinct GFP regions, we already had a strong indication that our reporter system 
was able to detect caspase-activity during development. To obtain further proof we correlated our 
GFP signal with the known in situ cell death assays like the classic TUNEL staining and active caspase-
3 staining. Both assays showed clear, though not exclusive, co-localization with GFP-positive cells. 
We can explain the presence of cells which are caspase-3 or TUNEL positive but GFP-negative by the 
considerable interval between the proteolytic events and the full expression and maturation of the 
GFP protein in our reporter system. Vice versa, the TUNEL-negative and GFP-positive cells might be 
the ones where the DNA fragmentation has not occurred yet or where the caspase-activity does not 
lead to the downstream DNA fragmentation due to the non-apoptotic caspase signaling. Importantly, 
the DEVD tetra-peptide might also be recognized by other caspases like caspase-7, which could 
explain why we also observed GFP-positive cells, which were not stained by the active caspase-3 
antibody. In line with this interpretation, we could specifically abrogate the GFP expression in the 
Xenopus DEVD-reporter line by the targeted depletion of both caspase-3 and caspase-7, but not by 
depletion of either caspase alone. Taken together, we have proven to have a functional and useful 
reporter system that is able to detect caspase-activity in a living model organism without interfering 
with its development. Evidently, we recognize the obvious shortcoming that there will be no GFP 
signal generated if caspase activation leads to rapid shut down of the transcription and translation 
machinery. On the other hand, the amplification-mechanism combined with the half-life of the eGFP 
protein increases the sensitivity of our system, and allows us to detect low and transient levels of 
caspase-activity which are often associated with their non-apoptotic functions. The long stability of 
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the GFP protein implies that the reporter lines could also be used as a kind of lineage-tracking 
system, i.e. exposing those cells that have experienced (transient) caspase activity in course of their 
ontogeny.  
 
A non-apoptotic role for caspase-9 in primitive blood formation?   
Although the majority of GFP-positive regions generated by the LEHD reporter perfectly overlap with 
the ones generated by the DEVD reporter system, the LEHD reporter line also showed significant GFP 
expression at the ventral blood island (VBI), the place where the primitive blood, including the 
erythroid lineages, are formed (Ciau-Uitz et al., 2000). Indeed, only the LEHD reporter had GFP-
positive circulating blood cells, which indicated the possible involvement of caspase-9 in early blood 
formation. Therefore, we wanted to address the caspase-9 activity in blood formation using a 
knockdown approach. Indeed, targeted knockdown of caspase-9 with a translational blocking 
morpholino  consistently disrupted the expression of the early blood markers GATA-1 and T3 globin. 
This specific requirement of caspase-9 in X. tropicalis was further proven by rescuing the knockdown 
phenotype through co-injection of the X. laevis caspase-9 RNA, which is insensitive to the 
morpholino. Because we did not find DEVD activity and/or TUNEL staining at the VBI, we checked 
whether the involvement of caspase-9 in early blood formation was indeed independent of the 
executioner caspases-3 and -7. Combined depletion of these caspases in the posterior VBI did not 
affect the early blood markers, suggesting an autonomous non-apoptotic role of caspase-9 in 
primitive blood formation. 
In our additional data, we have further speculated on this pro-survival/pro-differentiation function of 
caspase-9 and we speculate that the caspase-9 activity can be linked to the functional Raf-1 or 
retinoblastoma (Rb) signaling (see Fig.28). As it turns out that Raf-1 is a known substrate for caspase-
9 and that the proteolytically processed Raf-1 influences survival and proliferation of hematopoietic 
cells (Kolbus et al., 2002; Cornelis et al., 2005), it fits perfectly as a putative downstream mediator of 
the non-apoptotic caspase-9 signaling. To investigate this hypothesis, we are currently analyzing 
whether co-injection of this processed form of Raf-1 is able to rescue the defects in erythropoiesis 
observed in caspase-9 morphants. Also, the possible caspase-9 mediated cleavage of the Rb protein 
and its implication during blood formation should be further explored in the future (Lemaire et al., 
2005; Sankaran et al., 2008). A possible experiment for the identification of novel caspase-9 
substrates in blood formation could be performing a proteome-wide screening of activin-treated 
expants in which the formation of primitive blood cells is induced (Nagamine et al., 2007). 
Confirmation of the interaction of caspase-9 with its substrate(s) with co-immunoprecipitation will 
shed light on the signaling mechanism leading to the formation of primitive blood cells.  
To date we still do not known why the downstream effector caspases-3 and -7 do not engage when 
caspase-9 is found to be active. We have speculated on the potential involvement of a member of 
the inhibitor of apoptosis (IAP) family (Fig.28). Because Survivin was already found to be essential for 
normal hematopoiesis (Fukuda et al., 2002; Delvaeye et al., 2009; Ma et al., 2009) and based on the 
literature, we have chosen to deplete the Survivin2 protein (in Xenopus there are two Survivin genes) 
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with a splice blocking morpholino in transgenic DEVD embryos. We have observed increased GFP 
expression at the targeted posterior VBI, which might point to the manifestation of apoptotic 
primitive blood cells. However, we did not exclude yet whether this increase in caspase-activity is the 
result of the relief of the inhibitory effect of Survivin on the caspases-3 and -7 or if it is due to the 
secondary function of Survivin in vasculogenesis. Disrupted vasculogenesis would likely lead to the 
induction of cell death in the blood precursors that are unable to leave their side of origin. Further 
research should discriminate between these two functions of Survivin to elucidate the actual role of 
Survivin in primitive blood formation.  
Besides the involvement of an IAP, we should also take potential Raf-1 dependent survival pathways 
into account that might restrain the downstream caspase-3 and -7 activation (Kolbus et al., 2002). 
One involves a Bcl-2 driven mitochondrial translocation of the Raf-1 kinase, followed by apoptosis 
suppression via a mechanism leading to the phosphorylation and thereby inactivation of the 
proapoptotic Bcl-2 family protein Bad (Wang et al., 1996; Salomoni et al., 1998). Another report 
suggests that Raf-1 may promote cell survival by antagonizing the pro-apoptotic apoptosis signal-
regulating kinase 1 (ASK1) through a direct inhibitory interaction with the N-terminal domain of ASK1 
(Chen et al., 2001).  In conclusion, although some regulatory mechanisms were previously reported, 
there are still many questions about the autonomous role of caspase-9  in erythropoiesis waiting to 
be resolved. 
 
Figure 28. Working hypothesis of caspase-9 activity in primitive blood formation. 
Triggering of caspase-9 by a still unknown receptor (Epo-R?) or an intracellular stimulus leads to the proteolytic activation 
of substrate X (X stands for RAF-1, Retinoblastoma (Rb) or other unidentified substrates). Once X is activated, it may induce 
a proliferation/differentiation pathway necessary for the formation of primitive blood cells. However, besides its 
downstream pro-survival signaling function, truncated X might also restrain the activation of caspase-3 and -7 and thereby 
prevent the caspase-3 mediated cleavage of the GATA-1 transcription factor and the engagement of apoptotic cell death. 
Another protective mechanism which might explain the caspase-3/7 independent function of caspase-9 in erythropoiesis is 
the involvement of an inhibitor of apoptosis (IAP) like Survivin. It could be that Survivin is ideally positioned to restrain 
directly the activation of caspase-3 and -7 which results in the inhibition of apoptosis.  
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A role for caspase-3,-7 and -9 in primitive myelopoiesis  
Using time-lapse fluorescence video microscopy we also obtained evidence for a possible role of 
caspases-3, -7 and -9 in establishment of the myeloid cell lineage. In the developing transgenic LEHD 
embryos we could clearly identify migrating GFP-positive cells with the typical characteristics of cells 
originating from the myeloid lineages. Furthermore, caspase-3,-7 and -9 depletion affected the 
expression of mpo (myeloid peroxidase), a marker for myelopoiesis (Costa et al., 2008). The 
depletion of the caspases did not only interfere with the global expression of mpo but also influenced 
the migration pattern of these early guardian cells. These data are in agreement with several in vitro 
studies where it was shown that non-apoptotic functions of several caspases are necessary for the 
proper differentiation of monocytes into functional macrophages (Pandey et al., 2000; Sordet et al., 
2002). The authors in (Cathelin et al., 2006) have already identified several putative substrates 
cleaved downstream of caspase-activation in monocytes undergoing macrophage differentiation and 
most of them seem to be involved in cytoskeletal regulation and cell adhesion. Also nucleophosmin 
(NPM) protein was picked up from the screen. This ubiquitous protein regulates various cellular 
functions, including centrosome duplication, gene transcription, and cell proliferation (Lim and 
Wang, 2006; Okuwaki, 2008). Recently, the function of nucleophosmin in macrophage differentiation 
was identified and it seems that proteolysis of the protein participates in the establishment of a 
mature macrophage phenotype (Guery et al., 2011). It may be interesting to see how nucleophosmin 
depletion affects myelopoietic differentiation in Xenopus.  
 
General conclusion PART I 
Despite the continuously growing number of caspase-substrates involved in differentiation 
processes, one can agree that there is still of lot of research needed to fully understand the 
underlying non-apoptotic signaling mechanisms of caspases. We strongly believe that our reporter 
systems can contribute to the functional characterization of putative targets involved in pro-survival 
processes during the early development of a vertebrate organism. Indeed, our transgenic lines not 
only seem to be ideally positioned to pick up novel non-apoptotic caspase-signaling events, but also 
can be used as a unique platform that allows simple manipulation of the different implicated 
mediators. We already made use of these transgenic lines and found a novel non-apoptotic role for 
caspase-9 in primitive blood formation. Unlike the requirement of both caspase-9 and the 
executioner caspases-3 and -7 in myelopoiesis, we have shown that caspase-9 seems to function 
independently of these executioner caspases in erythropoiesis. Although we were not able to clarify 
the underlying mechanism, we believe that we have given an important incentive for future research 
dealing with the non-apoptotic proteolytic events of caspases, and in particularly of caspase-9.  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II: Exploring the role of RIPK4 during 
Xenopus development  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
  
        Introduction to RIPK4 kinase signaling 
 Singling  
121 
Chapter II.1. Introduction to RIPK kinase signaling 
II.1.1. RIPK kinase family 
Since the discovery of the first member of the receptor-interacting protein (RIP) kinase family in 1995 
(Stanger et al., 1995), a great deal of progress has been made towards understanding the functions 
of the different RIP family members. They have not only emerged as essential mediators of pro-
survival, inflammatory and immune responses but as well as key components of cell death inducing 
pathways. Because their versatile capacity to transmit intracellular responses to various factors (i.e. 
pathogen infection, cytokine stimulation, inflammation, cellular differentiation and DNA damage), 
they are generally considered as important cellular stress regulators (Zhang et al., 2010). Although 
these stimuli trigger distinct signaling pathways, they converge to similar outcomes, namely the 
activation of transcription factors such as NF-κB or AP-1 or the induction of cell death. However, the 
various RIP members exert also non-redundant functions, partly reflected by the presence of RIPK-
member specific domains and by different knockout phenotypes (Meylan and Tschopp, 2005). The 
RIP kinases were classified according to sequence similarities in their conserved kinase domains, and 
designated as serine/threonine kinases. They are closely related to members of the interleukin-1-
receptor-associated kinase (IRAK) family, which have been extensively studied in the context of the 
interleukin-1β (IL-1β) and Toll-like receptor (TLR) signaling pathways (Janssens and Beyaert, 2003). 
The RIP members are further subdivided according to their domain organization. For instance, the 
RIP kinases (RIPK1, RIPK2, RIPK3 and RIPK4) share structurally two domains, including an N-terminal 
kinase domain and a Ser/Thr-rich intermediate domain (ID) (Fig.29). However, distinct protein-
protein interaction motif are present in their C-terminal domain that provides them with unique 
properties and allows them to be involved in distinct cellular processes.   
122 
  
 
Introduction to RIPK4 kinase signaling 
 
Figure 29. Domain organization of the RIPK family members.  
Schematic representation of the different domains found in the RIPK family. The number of amino acids is indicated. 
Abbreviations: ANK, ankyrin repeats; CARD, caspase acitivation and recruitment domain; DD, death domain; RHIM, RIP 
homotypic interaction motif; LRR, Leucine-rich repeats; Roc/COR, Ras of complex proteins/C-terminal of Roc.  
  
For instance, RIPK1 contains a death domain (DD) in its C-terminus, whereby it interacts with several 
members of the tumor necrosis factor (TNF) superfamily of receptors, like TNFR1, Fas, tumor necrosis 
factor-related apoptosis-inducing ligand receptor 1 (TRAILR1), and TRAILR2. It also associates with 
death domain-containing adaptor proteins, such as TNF-receptor-associated death domain (TRADD) 
and Fas-associated death domain (FADD), that are required for caspase-8 activation and apoptosis 
(Schutze et al., 2008; Wilson et al., 2009). However, when apoptotic cell death is blocked by pan-
caspase inhibitor (zVAD), the cell uses regulated necrosis or necroptosis as an alternative RIPK1 
dependent cell death pathway (Festjens et al., 2007; Degterev et al., 2008). The ubiquitination state 
of RIPK1 determines whether it functions as a prosurvival scaffold molecule or as a kinase that 
promotes cell death. Polyubiquitination (K63) of RIPK1 by the inhibitors of apoptosis proteins (IAPs) 
cIAP1 and cIAP2 leads to the downstream activation of mitogen-activated protein kinases (MAPKs) 
and NF-κB, which turn on the expression of prosurvival genes. For this pro-survival function, the 
kinase activity of RIPK1 is dispensable (Lee et al., 2004). Upon triggering necroptosis, RIP1 interacts 
with its RIP homotypic interaction motif (RHIM), located in the intermediate domain, with the RHIM 
domain of RIPK3 located in its unique C-terminus. Hence, RIPK1 and RIPK3 form a pro-necrotic 
complex, the necrosome, which is a crucial integrator for the downstream necrotic signaling events 
(Declercq et al., 2009). However, both RIP kinases have also distinct roles, illustrated by the distinct 
phenotypes of the corresponding knockout mice (Kelliher et al., 1998; Newton et al., 2004). RIPK1-
deficient mice die early after birth due to extensive apoptosis of lymphoid and adipose tissues 
(Kelliher et al., 1998), demonstrating the importance of its pro-survival functions. In contrast, RIPK3-
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deficient mice are born without any gross abnormalities (Newton et al., 2004) and the importance of 
RIPK3 functions becomes only prevalent in pathological conditions associated with necrosis, such as 
pancreatitis (Zhang et al., 2009) or viral infection (Cho et al., 2009).  
The closely related RIPK2 kinase has been alternatively called RIP-like-interacting caspase-like 
apoptotis-regulatory protein kinase (RICK) or CARD-containing IL-1β converting enzyme-associated 
kinase (CARDIAK) and is expressed in many tissues (Chin et al., 2002; Kobayashi et al., 2002). RIPK2 
possesses an N-terminal kinase domain, followed by an intermediate region and a C-terminal caspase 
activation and recruitment domain (CARD) that enables the interactions with other CARD-containing 
proteins, such as NOD1 and NOD2, two cytoplasmic pathogen-recognition receptors that sense 
intracellular peptidoglycans. This innate immune response leads to the activation of NF-κB signaling 
(Viala et al., 2004). Besides this RIPK2-mediated early elimination of pathogens via the TLR- and NOD 
dependent pathways, RIPK2 is also required Th1 polarization, T-cell proliferation and B-cell-isotype 
switching (Chin et al., 2002; Kobayashi et al., 2002; Ruefli-Brasse et al., 2004). RIPK2 may also interact 
with the CARD domain of caspase-1, resulting in maturation of IL-1β (Thome et al., 1998; Martinon 
and Tschopp, 2004). Analogous to RIPK1, the RIPK2 kinase activity is not necessary for NF-κB 
activation upon RIPK2 overexpression (Thome et al., 1998), although it seems critical for protein 
stability during NOD-mediated innate immune response (Nembrini et al., 2009).  
RIPK4 is characterized by a C-terminus harboring eleven ankyrin repeats that may negatively regulate 
its activity (Meylan et al., 2002). In the epidermis, RIPK4 functions through protein kinase C (PKC) 
specific pathways to regulate epidermal differentiation and cutaneous inflammation (Rountree et al., 
2009). Overexpression of RIPK4 leads to activation of JNK and NF-κB in a kinase-dependent manner, 
and PKC was suggested to act downstream or RIPK4 in the NF-κB pathway (Muto et al., 2002). 
Apart from the classical RIPK kinases with their typical domain organization, three additional related 
kinases were described (Manning et al., 2002). The RIPK5 kinase (or SgK288) is highly similar to 
RIPK4, not only sharing the N-terminal kinase domain, but also the C-terminal ankyrin repeats 
(Mosavi et al., 2004), with an overall identity of 35%. This high resemblance in overall structural 
organization suggests a function similar to that of RIPK4.  
Two other kinases RIPK6 and RIPK7, also termed the leucine-rich repeat (LRR) kinases LRRK1 and 
LRRK2 respectively, are closely related to the other RIPK kinases, although their domain organization 
is quite unique (Fig.29). RIPK6 is, like RIPK4, characterized by the presence of ankyrin repeats; 
however, unlike the other RIPK members, RIPK6 and RIPK7 also contain additional domains such as 
LRR, a Roc/COR domain, and WD40 repeats (Fig.29) (Meylan and Tschopp, 2005). Contrasting with 
the other RIPK members which only have orthologous in vertebrates, orthologous of RIPK6 and RIPK7 
are also found in Drosophila and C. elegans. Hence, RIPK6 and RIPK7 might have evolutionarily 
conserved functions. Furthermore, RIPK7 might be implicated in the pathogenesis of several 
neurodegenerative diseases associated with parkinsonism. Some dominantly inherited missense 
mutations in the gene encoding RIPK7 have been identified in several families that exhibit a broad 
spectrum of neuropathological features (Zimprich et al., 2004). Yet another feature of RIPK kinases is 
their processing during apoptosis. For example, RIPK1 is cleaved in the ID, after Asp324, by caspase-8 
during Fas ligand (FasL)-induced apoptosis (Lin et al., 1999; Martinon et al., 2000). This proteolytic 
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cleavage separates the DD from the kinase domain, generating a dominant negative version that 
efficiently blocks NF-κB anti-apoptotic signaling (Martinon et al., 2000). Similar caspase-dependent 
processing was seen with RIPK3 and RIPK4 (Meylan et al., 2002).  
 
Taken together, numerous studies unraveled a limited number of RIP kinases which can integrate 
many different upstream stress signals to initiate specific responses. Nevertheless, further 
identification of the various kinase substrates will broaden our understanding in the way how a cell 
reacts to stress conditions which are often the result of several pathologies. Because a profound 
description of the individual RIP kinases falls out of the scope of this thesis, we redirect the reader for 
more information to a recent review which provides a detailed analysis of the present knowledge 
concerning the different RIP kinases (Zhang et al., 2010). Here, we will reveal our current 
understanding of RIPK4 with the emphasis on its functional roles in differentiation processes during 
embryonic development.  
 
II.1.2. RIPK4 as a mediator of epidermal differentiation and 
inflammation 
RIPK4 was initially described as a protein that interacts with PKCβ1 and PKCδ in yeast two-hybrid 
assays, which led to its first name: protein kinase C-associated kinase (PKK) (Bähr et al., 2000; Chen et 
al., 2001). However, soon after its discovery, and because of the close similarity to the other 
members of the RIP family of kinases, it was given the name of RIPK4 (Meylan et al., 2002). Several 
groups have reported that overexpression of RIPK4 in 293t HEK cells activates NF-κB, c-Jun N-
terminal kinase (JNK) and activator protein-1 (AP-1). RIPK4 mutants whereby the kinase activity was 
abolished not only failed to activate these pro-survival mediators but also specifically inhibited NF-κB 
signaling induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and Ca2+ ionophore. As a 
consequence, the researchers suggested that RIPK4 may function primarily in a PKC-dependent 
signaling pathway (Meylan et al., 2002; Muto et al., 2002; Moran et al., 2003).  Co-expression of 
RIPK4 with the individual six tumor necrosis factor receptor-associated factor (TRAF) family members 
indicated that TRAF1, TRAF2, TRAF3 and TRAF5, but not TRAF4 and TRAF6 bound RIPK4. Dominant 
versions of TRAF1 and TRAF3 (but not TRAF2 and TRAF5) inhibited RIPK4-induced NF-κB activation. 
Thus, RIPK4 seems to physically and functionally interact with multiple TRAF-dependent pathways 
leading to NF-κB activation (Meylan et al., 2002). Interestingly, the intermediate domain (ID) of RIPK4 
contains two candidate caspase cleavage sites, SQLD340 and SSVD378. Mutation of both sites led to 
complete resistance of RIPK4 against Fas-induced cleavage. Together with the observed dominant 
negative effect of the C-terminal ankyrin domain of RIPK4, these data suggest that pro-apoptotic 
stimuli may lead to the caspase-dependent generation of a C-terminal RIPK4 fragment that inhibits 
NF-κB-dependent gene transcription. Indeed, the non-cleavable Asp/Glu 340/378 double mutant 
shows increased NF-κB activation (Meylan et al., 2002).  
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To assess the function of RIPK4 in vivo, Holland and coworkers generated mice whereby the exons 2-
7 of RIPK4 were replaced with a neomycin cassette (Holland et al., 2002). Interestingly, RIPK4-/- mice 
die shortly after birth and examination of RIPK4-/- fetuses at E17,5 and E18,5 revealed marked skin 
defects. The skin was significantly reduced in skin folds, and the hind limbs and tail were consistently 
shorter and partially fused to the body cavity (Fig.30). In addition, fusion of all external orifices, 
including the nose, mouth and anus was observed. As a consequence of oral fusion, the RIPK4-/-  
fetuses die at birth probably due to suffocation. It was also shown that fusion of the epithelium 
between the digits of the fetuses limb was not a result of defective apoptosis (Holland et al., 2002).  
 
 
Figure 30. Phenotypic analysis if RIPK-/- mice. 
(A and B) Gross appearance of wild-type and RIPK4
-/-
 fetuses. Frontal views of wild-type (A) and RIPK4
-/-
 (B) E18,5 fetuses. 
The RIPK4
-/-
 fetus has a fused mouth and lacks whiskers. (C and D) Hematoxylin-and-eosin (H&E)-stained coronal sections of 
E17,5 wild-type (C) and RIPK4
-/-
 (D) heads, 20x. Asterisks in (C) denote vibrissae. The RIPK4
-/-
 mouth is fused, and the 
vibrissae are poorly developed. Boxed regions are magnified in (E) and (F). (E and F) High magnification of oral mucosa in (C) 
and (D), 200x. (G and H) H&E-stained sagittal sections of E17,5 wild-type (G) and RIPK4
-/-
 (H) torso, 40x. The oesophagus 
from the RIPK4
-/-
 fetus contains no lumen. Abbreviations: Tr, trachea; E, oesophagus. (taken from (Holland et al., 2002)). 
 
 
The authors did not reveal any other defects in their histopathological analyses and concluded that 
only tissues composed of keratinized stratified epithelial cells depend on RIPK4 for normal 
differentiation. Therefore, they have been focusing their research on the epidermal defects and 
histologically examined dorsal skin sections of E18.5 wild-type and RIPK4-/- mice. The epidermis of the 
RIPK4 -/- mice is thickened with expanded spinous and granular layers, and contains an outermost 
layer of parakeratotic cells instead of enucleated squamous cells. The RIPK4-/- skin also exhibited 
misexpression of several keratins (i.e. K1 and K14) and differentiation markers (i.e. filaggrin, loricrin 
and involucrin), which suggests that the outermost “parakeratotic layers” are largely undifferentiated 
and display characteristics of basal cells (Holland et al., 2002) (Fig.31).  
Wild type RIP4-/- Wild type RIP4-/-
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Figure 31. Abnormal Keratinocyte differentiation in RIPK4-/- skin.  
Dorsal skin from the backs of E18.5 wild-type (A, C, E, and G) and RIPK4
-/-
 (B, D, F, and H) fetuses was sectioned and stained 
with the following: (A and B) H&E; (C and D) Keratin K14; (E and F) Keratin K1; and (G and H) Filaggrin. The white dashed 
line denotes the location of the basal layer. In (A) and (B), epidermal layers are B, basal; S, spinous; G, granular; and C, 
cornified. In (B), the RIPK4
-/-
 skin lacks a cornified layer that is replaced by a thick parakeratotic outer layer, P. (I and J) 
Electron micrographs of wild-type (I) and RIPK4
-/-
 (J) epidermis. Magnification is 1500x. Complete absence of the superficial 
corneal layer, C, is apparent in the mutant. The parakeratotic layer, P, and orthoparakeratotic layer, O, are visible above the 
granular layer, G, in RIPK4
-/-
 skin. (Taken form (Holland et al., 2002)). 
 
 
The RIPK4-/- phenotypes are remarkably reminiscent to two other mouse mutants, inhibitor κB kinase 
(IKK)α-/- and stratifin repeated epilation (SfnEr/Er) mice, which also die at birth with fusion of external 
orifices and a thickened epidermis (Hu et al., 1999; Li et al., 1999; Takeda et al., 1999; Herron et al., 
2005; Li et al., 2005). The similar epidermal phenotypes of these mutants might imply that RIPK4, 
IKKα, and Sfn function in either shared or independent pathways to promote epidermal 
differentiation. However, several lines of evidence indicate that RIPK4 is not positioned on a linear 
signaling pathway that includes IKKα. First, filaggrin expression is absent in IKKα-deficient skin and 
present, although in the inappropriate cell layer, in RIPK4-/- skin (Hu et al., 1999; Li et al., 1999). 
Second, grafting experiments have shown that epidermal differentiation can be rescued in IKKα-/- skin 
grafted onto a wild type host, but this was not the case for RIPK4-/- skin (Hu et al., 1999; Meylan et 
al., 2002). Finally, crossing K14-RIP4 mice with the IKKα-/- or SfnEr/Er mutants did not improve 
epidermal differentiation in these mutant backgrounds. However, this experiment did not exclude 
entirely the possibility that RIPK4 still can drive epidermal differentiation in IKKa-/- or SfnEr/Er animals, 
because only the transgenic expression of RIPK4 might not be sufficient to activate the necessary 
signaling events (Rountree et al., 2009).  
Several studies demonstrated that RIPK4 interacts with the classical PKCβ1 as well as with the novel 
PKCδ isoform of PKC, further suggesting that RIPK4 participates in PKC-dependent signaling pathways 
(Bähr et al., 2000; Chen et al., 2001). However, none of the reported null mutant mice lacking 
Wild type RIP4-/- Wild type RIP4-/-
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individual PKC genes develop defects in epidermal differentiation (Castrillo et al., 2001; Leitges et al., 
2001; Chida et al., 2003; Hara et al., 2005). The reason for this may be functional redundancy 
between the PKC isoforms. Of all the PKC isoforms that have been tested, only PKCα transgenic mice 
develop a neutrophilic inflammatory response after 12-O-tetradecanoylphorbol-13-acetate (TPA) 
treatment (Jansen et al., 2001; Cataisson et al., 2005). A similar outcome was observed when the 
K14-RIPK4 transgenic mice were treated with TPA. Furthermore, the neutrophilic inflammation of 
both K14-RIPK4 and K5-PKCα animals is TNFR1-independent (Cataisson et al., 2005). Together, these 
results may indicate that RIPK4 acts downstream of PKCα to promote epidermal inflammation. 
Inhibition of PKCα reduces the expression of differentiation markers in keratinocytes stimulated to 
differentiate in response to calcium (Lee et al., 1997; Yang et al., 2003). Therefore, PKCα is also a 
strong candidate for an interaction partner with RIPK4 during epidermal differentiation.  
 
II.1.3. Correlation between RIPK4 and IRF6.  
Besides the phenotypical reminiscence of the RIPK4 deficient mice with the IKKα-/- and stratifin 
(SfnEr/Er) mice, the RIPK4 mutants also seem to bear resemblance with the interferon regulatory 
factor 6 (IRF6) deficient mice, which are as well recognized by abnormal skin, limb and craniofacial 
development. As a consequence of the fusion of the external orifices, the IRF6 null mice also die at 
birth due to suffocation. The transcription factor IRF6 is an unique member of the IRF family because 
it plays, unlike the other members, no role in innate immunity but is instead essential for embryonic 
development. It has been suggested that the primary defect for the observed epithelial fusions in the 
IRF6 null fetuses (i.e. fusion of the oesophagus and cleft palate) are caused by an increase in 
adhesions between the oral epithelia (Ingraham et al., 2006). This inter-epithelial adhesion 
hypothesis was further supported by the ectopic E-cadherin localization at the apical side of the cells 
surrounding the oral cavity in the IRF6 deficient fetuses (IRF6R84C/R84C). In contrast, no luminal 
expression of this important mediator of cell adhesion was seen in the wild-type fetuses (Richardson 
et al., 2009) (Fig.32). As a consequence of this altered cell adhesion pattern, it appears that the 
palatal shelves adhere to the epithelia of the tongue and mandible whereby the palatal shelves fail to 
elevate and cause a cleft palate. Analogous to the RIPK4-/- mice, the IRF6 mutants also have defects in 
the differentiation and proliferation of keratinocytes (Ingraham et al., 2006; Richardson et al., 2009). 
In humans, mutations in the IRF6 gene cause the Van de Woude syndrome and popliteal pterygium 
syndrome, two mendelian orofacial clefting syndromes (Kondo et al., 2002; Wang et al., 2003). 
Together, the similarity between the reported epithelial defects of the IRF6 and RIPK4 mutants might 
point to a common regulating signaling pathway that involves both these two distinct proteins which,  
until today have not been functionally connected.  
Since IRF6 is implicated in the differentiation of several epithelial tissues, the authors in (Sabel et al., 
2009) wondered if IRF6 is as well implicated in the regulation of the primary superficial epithelium 
(PSE) in D. rerio and X. laevis. Indeed, it seemed that interfering with the maternal IRF6 function in 
both species affected the epibolic gastrulation movement resulting in a defective gastrulation 
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phenotype. The authors reasoned that this phenotype is likely due to a decrease in the mechanical 
strength in the PSE, which normally encloses the embryo during gastrulation. These observations in 
non-mammalian systems indicate that the controlling function of IRF6 on developing epithelial layers 
is conserved during evolution of vertebrates. However, the underlying mechanism of how IRF6 
regulates the epithelial cell-cell interactions during development, remains an open question.  
 
 
 
Figure 32. IRF6R84C/R84C embryos display abnormal oral periderm.  
 (A,B,D,E) Histological analysis of E13.5 wild-type (A) and IRF6
R84C/R84C
 mice (B) reveals abnormal lingual and palatal epithelia 
in mutant embryos (B). (D,E) Higher magnification views of the boxed areas in A and B. (D) In wild-type embryos, the 
epithelia consist of basal cuboidal cells and superficial, flattened periderm cells (D, arrowheads). (E) In contrast, IRF6
R84C/R84C
 
embryos display thickened oral epithelia with disorganized basal cells (arrows) and absence of periderm. (G) At E13.5, 
keratin 17 is expressed in the periderm and tooth germs of wild-type embryos. (H) In IRF6
R84C/R84C
 embryos, keratin 17 
expression is reduced. (J, K) Deconvolved images of immunofluorescence for keratin 17 (green) and E-cadherin (red) at 
E13.5. (J) In wild-type mice, keratin 17-expressing periderm cells are distinguishable from the basal cells and, whereas dual 
labeling is evident on the basal surface of the periderm cells, E-cadherin expression is absent from their apical surface. (K) In 
contrast, IRF6
R84C/R84C
 mice lack keratin 17 expression on the lingual and palatal epithelia and multiple regions of E-cadherin 
expression are present on the apical surface of the exposed basal cells (arrows). Abbreviations: p, palatal shelf; t, tongue. 
Scale bars: A–B, 100 μm; D–E, 50 μm; G–H, 300 μm; J–K, 20 μm (taken from (Richardson et al., 2009)). 
 
II.1.4. Gastrulation events in Xenopus 
The term gastrulation was first introduced by Haeckel and is derived from the Greek word ‘gaster’, 
which means belly or gut. The gastrulation process can be defined as an embryonic transition from a 
simple group of rather unorganized cells to a more complex organized and multilayered embryo 
containing the three germ layers: the ectoderm, endoderm and mesoderm (Leptin, 2005). 
Interestingly, although the morphogenetic movements during gastrulation processes often differ 
amongst diverse organisms, their definitive body plan seems very much alike. This seriously 
hampered the generalization of the principles underlying the gastrulation movements across diverse 
organisms. However, vertebrate gastrulation involves four evolutionarily conserved morphogenetic 
migratory movements: epiboly, internalization or emboly, convergence and extension (Solnica-
Krezel, 2005). Epiboly leads to an expansion of tissue, often accompanied by its thinning. The major 
Wild type IRF6
R84C/R84C Wild type IRF6
R84C/R84C
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mechanism of epiboly in Xenopus gastrulation appears to be an increase in cell number through 
division, coupled with a concurrent integration of several deep layers into one by the process of 
radial intercalation (Fig.33) (Keller, 1980). Internalization or emboly entails movements of 
mesodermal and endodermal precursors from the blastula surface beneath the ectodermal layer. 
Convergence movements narrow embryonic tissues mediolaterally, whereas extension movements 
elongate them from head to tail. 
 
 
Figure 33. Epiboly or spreading of the animal cap.  
Epiboly occurs by intercalation of several layers of deep mesenchymal cells between one another along the radius of the 
embryo (radial intercalation) to produce fewer layers of greater area while the cells in the overlying epithelial layer spread 
and divide. (A) multi-epithelial layer at the onset of gastrulation (B) radial intercalation (blue arrows) (C) and spreading of 
the epithelial layer during gastrulation (green arrows) (Based on Keller, 1978, 1980). 
 
 
Gastrulation in frog embryos is initiated on the future dorsal side of the embryo, at the marginal zone 
where the animal and vegetal hemispheres meet. At this region the cells invaginate to form a slit-like 
bastopore. These cells are called bottle cells, because the main body of each cell is displaced towards 
the inside of the embryo while the cell maintains contact with the outside surface by way of a 
slender neck (Hardin and Keller, 1988). The next phase of gastrulation involves the involution of the 
marginal zone cells while the animal cells undergo epiboly and converge at the blastopore. When the 
migrating marginal cells reach the dorsal lip of the blastopore, they turn inward and travel along the 
inner surface of the outer animal hemisphere cells. Thus, the bottle cells are the first cells that start 
to invaginate and form the leading edge of the archenteron. These cells become the pharyngeal cells 
of the foregut. The bottle cells are followed by the precursors cells of the head mesoderm which will 
form the prechordal plate. Subsequently, the chordamesoderm cells initiate their migration inwards 
and will constitute the notochord. As the new cells enter the embryo, the blastocoel is displaced to 
the opposite side of the dorsal lip of the blastopore. Meanwhile, the blastopore lip expands laterally 
and ventrally. As a consequence, the blastopore is widened and develops lateral and ventral lips 
whereby a ring around the large endodermal cells is shaped. The remaining exposed patch of 
endodermal cells is called the yolk plug and eventually gets internalized. At this point, all the 
endodermal precursors have been brought into the interior of the embryo, the ectoderm has 
encircled the surface, and the mesoderm has been brought between them (Fig.34) (Leptin, 2005; 
Solnica-Krezel, 2005).  
A
B
C
Epiboly
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Figure 34. Cell movements during frog gastrulation.  
The meridional sections are cut through the middle of the embryo and positioned so that the vegetal pole is tilted toward 
the observer and slightly to the left. The major cell movements are indicated by colored arrows. (stages 10-10,5) Early 
gastrulation. The bottle cells of the margin move inward to form the dorsal lip of the blastopore, and the mesodermal 
precursors involute under the roof of the blastocoel (dark red arrows). AP marks the position of the animal pole, which will 
change as gastrulation continues. At mid-gastrulation (stage 11-12) the archenteron forms and displaces the blastocoel, and 
cells migrate from the lateral and ventral lips of the blastopore into the embryo (dark red arrows). The cells of the animal 
hemisphere migrate down toward the vegetal region, moving the blastopore to the region near the vegetal pole (green 
arrows). At the end of gastrulation (stage 12,5), the blastocoel is obliterated, the embryo becomes surrounded by 
ectoderm, the endoderm has been internalized, and the mesodermal cells have been positioned between the ectoderm 
and endoderm. Abbreviations: AP, Animal Pole; VP, Vegetal Pole; bc, blastocoel (adapted from Developmental Biology, 6
th
 
edition by Gilbert GF).  
 
Many of these migration events are the results of strongly regulated changes in cell-cell adhesion 
because the establishment, maintenance and severing of contacts between cells during these 
movements is extremely important (Winklbauer and Keller, 1996; Marsden and DeSimone, 2003). 
The most prominent adhesion molecules during gastrulation are the cadherins. Cadherins comprise a 
large family of transmembrane glycoproteins that mediate calcium dependent cell-cell adhesion. A 
classification of the cadherin superfamily has been proposed, based on an extensive phylogenetic 
analysis of a database with 250 cadherin sequences from a wide variety of taxa (Hulpiau and van Roy, 
2009). The classic Xenopus C-cadherin is maternally inherited and the major mediator of cell-cell 
adhesion in blastula embryos (Heasman et al., 1994). The importance of properly balanced C-
cadherin activity was underlined by overexpressing full-length or dominant-negative forms of C-
cadherin that also disrupted the gastrulation movements (Lee and Gumbiner, 1995; Zhong et al., 
1999). Studies in the Gumbiner lab have shown that during gastrulation, the adhesive function of C-
cadherin is dynamic. Antibodies that keep C-cadherin in its active adhesive state abrogated the 
elongation of activin-induced animal cap tissue explants. This suggests that a decrease in the 
adhesive function of C-cadherin is essential to drive convergent extension (CE) movements (Zhong et 
al., 1999). Thus, proper execution of Xenopus gastrulation movements requires a tight regulation of 
C-cadherin adhesive activity. C-cadherin has also been associated with the epithelial to mesenchymal 
transition (EMT) of mesendodermal progenitor cells during early stages of gastrulation (Hay, 1995).  
Hence, it is possible that the observed defect in CE movements is due to an inappropriate separation 
of mesodermal cells from ectodermal cells within and between the different germ layers (Montero 
and Heisenberg, 2003). These studies clearly implicate C-cadherin in Xenopus gastrulation 
AP AP
VP VP
AP
AP
ectoderm mesoderm endoderm
VP
Blastula, stage 10 Early gastrula, stage 10,5 Gastrula, stage 11 Gastrula, stage 12
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movements, but they do not, however, exclude the possible role of other cadherins expressed at the 
gastrula stage. For example, U-cadherin/XB-cadherin is a more minor maternal cadherin that is 
present in the blastula and gastrula stages (Herzberg et al., 1991; Muller et al., 1994). Its sequence is 
90% similar to C-cadherin and possibly they interact in a heterophilic manner. Also, E-cadherin is 
expressed in the outer epithelial layers of late gastrulas (stage 13 - 13,5) (Levi et al., 1991). In fact, 
injection of a dominant-negative E-cadherin fragment with deletion of its cytoplasmic tail in the 
dorsal marginal zone resulted as well in gastrulation defects (Lee and Gumbiner, 1995). So one can 
conclude that cadherins are essential regulators of the diverse cell movements during gastrulation.   
  
II.1.5. Development of the primary mouth in Xenopus  
The primary mouth encompasses the initial opening between the gut and the outside of the 
deuterostome embryo. Deuterostomes (from the greek words deuteros: second and stoma: opening) 
are a superphylum of animals, including the vertebrates, where the neural crest cells grow around 
the primary mouth to shape the face that forms a ‘secondary mouth’. Ultimately the primary mouth 
becomes the pharyngeal opening. Unique to the region of the primary mouth is that it is located at 
the extreme anterior of the embryo where ectoderm and endoderm are directly juxtaposed and free 
from mesoderm (Dickinson and Sive, 2006). The first external characteristic of the primary mouth is a 
depression in the ectoderm and is called the stomodeum. As development proceeds, the number of 
cells in the stomodeum and underlying endodermal layer reduces. Eventually, a ‘buccopharyngeal 
membrane’ of one or two layers is formed. Finally, the membrane gets punctured by small 
perforations and collapses (Fig.35). In frog, the first signs of mouth formation start at mid-late 
tailbud, stage 26-27. The external region is still relatively flat but on an optical section the 
evagination of the most anterior endoderm was evident. The endoderm and ectoderm comprises 10-
12 cell layers at this stage. At late tailbud, stage 28-30 , the ectoderm becomes depressed slightly in 
the oral region, and this depression, more apparent at stages 32-33, is called the stomodeum. What 
follows is the gradual deepening of the stomodeum whereby a distinct circular invagination is shaped 
(stage 34-35). Coinciding with this presumptive primitive mouth formation, the thickness of the 
endoderm and ectoderm layers are reduced to 4-5 layers.  At stages 37-39, the perimeter of the 
stomodeum is oval shaped and extends more laterally. In the meantime, the thickness of the oral 
region is decreased to 1-2 cell layers. Because of intercalation, there is no clear distinction between 
the endoderm and ectoderm layers anymore. By the stages 39-40, the presumptive primary mouth 
appeared transparent in frontal view and is now called the buccopharyngeal membrane. Finally, the 
primary mouth opens due to small perforations initiating in the center of the membrane (Fig.35).  
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Figure 35. Time course of primary mouth development.  
(A) Frontal view of stages 26–27 embryos, black arrow indicates the posterior of the presumptive primary mouth, scale bar 
= 260 μm. (E) Optical fluorescent sagittal section at stages 26–27, white arrow indicates presumptive primary mouth and 
white arrowhead indicates the evaginated endoderm. Anterior is to the right, scale bar = 200 μm. (B) Frontal view of stages 
34–35 embryos, black arrow indicates invaginating presumptive primary mouth, scale bar = 260 μm. (F) Optical sagittal 
section of stages 34–35 embryos, white arrow indicates presumptive primary mouth. Note that, while the anterior most 
portion of the embryo in this figure is mid-sagittal, the more posterior of the embryo is not. This is due to curling of the 
embryo during processing, scale bar = 200 μm. (C) Frontal view of stages 38–39 embryos, black arrow indicates the deeply 
invaginated presumptive primary mouth, scale bar = 270 μm. (G) Optical sagittal of stages 38–39, white arrow indicates 
buccopharyngeal membrane, scale bar = 200 μm. (D) Frontal view of stages 40–41, black arrow indicates the primary 
mouth, scale bar = 270 μm. (H) Optical sagittal section of stages 40–41 embryos, white arrow indicates the opened primary 
mouth, scale bar = 200 μm, scale bar = 25 μm. Abbreviations: cg, cement gland (taken from Dickinson et al., 2006).  
 
During the final steps of mouth formation and in addition to cell death, the thinning also appears to 
be caused by intercalation of ectodermal and endodermal cells. Before intercalation can start, the 
two cell types have to lose their cell lineage specific identity. The molecular nature of this loss is still 
unknown, but may begin with removal of the intervening basement membrane, and later extend into 
a decline in differential adhesiveness. One compelling reason for basement membrane loss may be 
to permit direct contact and fusion between the ectodermal and endodermal cell layers. Another 
argument might be that it also facilitate the necessary cell movements during the process of 
invagination. It was also demonstrated that there is a period of increased apoptosis in the ectoderm 
layers correlating with ectodermal thinning (Dickinson and Sive, 2006). The cell death data in 
Xenopus laevis are consistent with the results of a study in the mouse, where it was shown that the 
largest percentage of apoptosis occurred many hours prior to perforation (Poelmann et al., 1985). 
Since the authors did not observe cell death at the buccopharyngeal membrane stage, other 
mechanisms are likely to be involved in perforation (Dickinson and Sive, 2006). One possibility is that 
loss of cell adhesion, or dissociation might be responsible for perforation (Waterman and Balian, 
1980).  
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The development of the cloaca holds several similarities to the formation of the primary mouth. 
Again the endoderm directly meets the ectoderm at the posterior proctodeum region, which is free 
from mesoderm. As the larval intestine develops at tailbud stage, a depression begins to form and is 
called the cloacal membrane. Eventually, the cloacal membrane thins and breaks whereby the cloacal 
opening is established. Because a detailed study about cloaca formation in vertebrates is lacking, I 
assume that the processes are comparable to the described formation of the primitive mouth. In 
frogs, the cloaca links the pronephric kidney to the exterior via the fusion of the pronephric duct with 
an outgrowth of the cloaca, called the rectal diverticulum (Brandli, 1999).  
In summary, the formation of external openings is a multistep event, which encompasses tightly 
regulated processes like invagination, cell death and intercalation. It is not unlikely that cell adhesion 
mediators are carefully controlled to allow proper cell movements required for the formation of the 
embryo-openings. Unfortunately, the underlying mechanisms which coordinate these processes are 
still fairly unknown.  
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Chapter II.2. Research Aims PART II 
RIPK4 was previously described as a member of the receptor-interacting protein (RIP) kinase family 
and was previously found to be required for proper skin differentiation (Holland et al., 2002).  
Besides its function in keratinocyte differentiation, RIPK4 signaling might also be implicated in cell 
adhesion considering that the RIPK4 deficient mice embryos display severe fusions of their external 
orifices that may be the result of abnormal interephitelial cell-cell adhesions (Holland et al., 2002). 
Although the RIPK4-/- mouse phenotype clearly shows that RIPK4 functioning is necessary for the 
development of the different orifices, the underlying etiology is unclear. It is also not known whether 
the kinase activity of RIPK4 is crucial for this developmental event (see section Chapter II.1.2). Since 
the RIPK4-/- mice fetuses develop in utero and die shortly after birth due to suffocation, it is rather 
complicated to perform experiments to assess the possible involvement of the RIPK4 kinase activity 
in vivo. Hence, our primary aim for this collaborative study was to investigate whether RIPK4 
depends on its kinase activity for its morphogenetic role during embryonic development. In order to 
determine this dependence, we have designed two morpholinos capable of depleting RIPK4 and 
performed rescue experiments with mRNAs coding for human RIPK4 (i.e wild type and kinase death 
mutant). Because depleting maternal XtRIPK4 resulted in a severe gastrulation phenotype which is 
intriguingly analogous to the IRF6-deficient phenotype observed in Xenopus and zebrafish (Sabel et 
al., 2009), the second aim of this part was to disclose the cellular mechanism underlying the 
gastrulation defects in RIPK4 depleted embryos.  As our last intended objective, we have studied the 
hampered mouth formation upon RIPK4 depletion with a splice-blocking morpholino. Because this 
fusion of the orifices reminded us of the similarity with the RIPK4 null mice, we were eager to 
contribute to the underlying mechanism of RIPK4 signaling in the formation of external openings.  
PART II functions as an entire separate section with its own discussion and will be partially enclosed 
in a bigger research framework as part of a collaboration.  
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Chapter II.3. Results - RIPK4 in Xenopus development 
II.3.1. Preface 
RIPK4 was previously described as a serine-threonine kinase which is involved in skin differentiation. 
The RIPK4 deficient fetuses exhibited major defects in the formation of external orifices, probably 
due to an increase in epithelial adhesions. Although the RIPK4-/- mouse phenotype clearly shows that 
RIPK4 functioning is necessary for the development of the different orifices, the underlying etiology 
is unclear. It is also not known whether the kinase activity of RIPK4 is crucial for this developmental 
event (see section II.1.2). The high phenotypical resemblance between the RIPK4 null fetuses and the 
IRF6 deficient mice together with the preserved functional involvement of IRF6 in Xenopus embryos 
endorses the importance to elucidate the potential role of RIPK4 in Xenopus.    
Since the RIPK4-/- fetuses develop in utero and die shortly after birth due to suffocation, it is rather 
complicated to perform experiments to assess the possible involvement of the RIPK4 kinase domain 
in vivo. This remaining question triggered also our curiosity to investigate the functionality of the 
RIPK4 kinase activity during Xenopus early development. In strong contrast to the mouse, the 
Xenopus model organism possesses all the tools and properties to allow straightforward genetic 
manipulation of the ex utero developing embryos. Hence, the frog is generally accepted as an ideal 
model to perform functional genomics studies of a practically uncharacterized protein that might 
play a role during vertebrate embryonic development (Kashiwagi et al., 2010).   
  
II.3.2. Results 
II.3.2.1. Sequence alignment and conservation analysis of RIPK4 
Until now, only studies on the orthologue of RIPK1 have been reported in Xenopus, showing that it  
signals through the death receptors via its C-terminal death domain (DD) (Ishizawa et al., 2006). A 
comparative analysis with a kinase-dead mutant of  XlRIPK4 further indicated that its kinase activity 
was required for the activation of AP-1 and NF-κB. These observations prove a strong functional 
conservation between XlRIPK1 and its homologues in mouse and human. Obviously, we wondered if 
we could demonstrate a similar conservation pattern for RIPK4 and its orthologues. For Xenopus 
laevis we have found two genes encoding RIPK4, namely XlRIPK4a en XlRIPK4b. Apparently, in the 
Xenopus laevis genome, a duplication of the ripk4 gene took place during evolution that could 
complicate the manipulation of this kinase by morpholinos. On the other hand, there was only one 
copy present in the Xenopus tropicalis genome: XtRIPK4. Therefore, we have chosen to work solely 
with the Xenopus tropicalis model and will further only use XtRIPK4 to describe our target kinase. The 
total protein sequence similarity between the frog XtRIPK4 and the mammalian orthologue (mouse 
and human) is 71% (Fig.36). If we just look at the N-terminal kinase domain, the similarity jumps up 
to approximately 80%. Also the first eight C-terminal ankyrin domains are present and show a overall 
similarity of 71%. A detailed sequence alignment between the several orthologues is given in figure 
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37, and demonstrates the high conservation of RIPK4 in vertebrates. Thus, given the high similarity it 
is likely that mechanistic insight in RIPK4 signaling in the frog can contribute to the overall knowledge 
how RIP4 regulates developmental processes.  
 
 
 
 
 
full HsRIPK4 MmRIPK4 XtRIPK4 XlRIPKa XlRIPK4b
HsRIPK4 100% 90% 71% 71% 71%
MmRIPK4 100% 71% 71% 71%
XtRIPK4 100% 93% 94%
XlRIPK4a 100% 94%
XlRIPK4b 100%
PK HsRIPK4 MmRipk4 Xtripk4 Xlripk4a Xlripkba
HsRIPK4 100% 94% 80% 81% 81%
MmRipk4 100% 79% 80% 80%
Xtripk4 100% 96% 98%
Xlripk4a 100% 96%
Xlripk4b 100%
Figure 36. High sequence similarity 
between the different RIPK4 
orthologues predicts a high functional 
conservation during evolution.  
The Xenopus RIPK4 orthologues have a 
general 70% sequence similarity with their 
mammalian counterparts (full). This 
similarity increases to 80% when only 
considering the kinase domain (PK). 
Abbreviations: Hs, Homo Sapiens; Mm, 
Mus Musculus; Xt, Xenopus tropicalis; Xl, 
Xenopus laevis. 
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Xlripk4a_NP_001080415    1 MVDKEGASPWDMGLLRTFDSREFCGWEKVGSGGFGQVYKVKHMNWKTWLAIKCPPSLHVD 
Xlripk4b_NP_001085647    1 MVDKEGASPWDMGLLRTFDSREFCGWEKVGSGGFGQVYKVKHISWKTWLAIKCPPSLHVD 
Xtripk4_XP_002941332     1 -MDKEGASPWDMGLLRTFDSREFCGWEKVGSGGFGQVYKVKHISWKTWLAIKCPPSLHVD 
HsRIPK4_NP_065690        1 -MEGDGGTPWALALLRTFDAGEFTGWEKVGSGGFGQVYKVRHVHWKTWLAIKCSPSLHVD 
MmRipk4_NP_076152        1 -MEGEGRGRWALGLLRTFDAGEFAGWEKVGSGGFGQVYKVRHVHWKTWLAIKCSPSLHVD 
                                                       <-------------- PKc ------------ 
 
Xlripk4a_NP_001080415   61 DKERVELVEEAKKMEMAKFRCILPVYGICSDPVGLVMEYMETGSLEKLLASECLPWDLRF 
Xlripk4b_NP_001085647   61 EKERIELLEEAKKMEMAKFRCILPVYGICSDPVGLVMEYMETGSLEKLLASECLPWDLRF 
Xtripk4_XP_002941332    60 EKERIELVEEAKKMEMAKFRCILPVYGICSDPVGLVMEYMETGSLEKLLASECLPWDLRF 
HsRIPK4_NP_065690       60 DRERMELLEEAKKMEMAKFRYILPVYGICREPVGLVMEYMETGSLEKLLASEPLPWDLRF 
MmRipk4_NP_076152       60 DRERMELLEEAKKMEMAKFRYILPVYGICQEPVGLVMEYMETGSLEKLLASEPLPWDLRF 
                           ------------------------- PKc ------------------------------ 
 
Xlripk4a_NP_001080415  121 RIIHETAVGMNFLHCMNPPLLHLDLKPANILLDGHYHVKISDFGLAKWNGLSNSHELSLD 
Xlripk4b_NP_001085647  121 RIIHETAVGMNFLHCMNPPLLHLDLKPANILLDGHYHVKISDFGLAKWNGLSNSHELSLD 
Xtripk4_XP_002941332   120 RIIHETAVGMNFLHCMNPPLLHLDLKPANILLDGHYHVKISDFGLAKWNGLSNSHELSLD 
HsRIPK4_NP_065690      120 RIIHETAVGMNFLHCMAPPLLHLDLKPANILLDAHYHVKISDFGLAKCNGLSHSHDLSMD 
MmRipk4_NP_076152      120 RIVHETAVGMNFLHCMSPPLLHLDLKPANILLDAHYHVKISDFGLAKCNGMSHSHDLSMD 
                           ------------------------- PKc ------------------------------ 
 
Xlripk4a_NP_001080415  181 GICGTIAYLPPERFKEKNRCFDTKHDVYSFAIVIWGILTQRKPFADEKNILHIMVKVGGG 
Xlripk4b_NP_001085647  181 GICGTIAYLPPERFKEKNRCFDTKHDVYSFAIVIWGILTQRKPFADEKNILHIMVKVGGG 
Xtripk4_XP_002941332   180 GICGTIAYLPPERFKEKNRSFDTKHDVYSFAIVIWGILAQRKPFAEEKNILHIMVKVGGG 
HsRIPK4_NP_065690      180 GLFGTIAYLPPERIREKSRLFDTKHDVYSFAIVIWGVLTQKKPFADEKNILHIMVKVVKG 
MmRipk4_NP_076152      180 GLFGTIAYLPPERIREKSRLFDTKHDVYSFAIVIWGVLTQKKPFADEKNILHIMMKVVKG 
                           ------------------------- PKc ------------------------------ 
 
Xlripk4a_NP_001080415  241 LRPDISQVPRVRPQQCQGMIQLMKECWHDKPDKRPTFQEITSETEHLCTKHEDETGSAQV 
Xlripk4b_NP_001085647  241 LRPDLSQIPRVRPQQCQGMIQLMKECWNDKPDKRPTFQEITSETEYLCTKHEDETSCVQT 
Xtripk4_XP_002941332   240 LRPDLSQIPRVRPQQCQGMIQLMKECWHDKPDKRPTFQEITSETEHLCTKHEDETSCVQA 
HsRIPK4_NP_065690      240 HRPELPPVCRARPRACSHLIRLMQRCWQGDPRVRPTFQEITSETEDLCEKPDDE--VKET 
MmRipk4_NP_076152      240 HRPELPPICRPRPRACASLIGLMQRCWHADPQVRPTFQEITSETEDLCEKPDEE--VKDL 
                           ------------------ PKc ----------------> 
 
Xlripk4a_NP_001080415  301 GQELQGKVGKEAEPQNMTSQAEGKRSPTPAFDKDYSLSELLSQLDSGISQTMEGPGCLSH 
Xlripk4b_NP_001085647  301 -QLLQGKVTQEAELEKVTSQAEGKRSSTPAFGKDYSLSELLSQLDSGISQTMEGPRCLSH 
Xtripk4_XP_002941332   300 QELHG-KGTLDAEAENVGSQAECKRSPTPAFDKDYSLSELLSQLDSGISQTMEGPGCLSH 
HsRIPK4_NP_065690      298 AHDLDVKSPPEPRSEVVP--ARLKRASAPTFDNDYSLSELLSQLDSGVSQAVEGPEELSR 
MmRipk4_NP_076152      298 AHEPGEKSSLESKSEARPESSRLKRASAPPFDNDCSLSELLSQLDSGISQTLEGPEELSR 
 
 
Xlripk4a_NP_001080415  361 SVSEPQLASS--DKRLSGVSSVDSAFSSRGSLSLSFEKDCSVLDISASDLQKKKLVDAIV 
Xlripk4b_NP_001085647  360 SVSEPQLASS--DKRLSGVSSVDSAFSSRGSLSLSFEKDCSVLDISASDIQKKKLVDAIV 
Xtripk4_XP_002941332   359 SVSEPQLASS--DKRLSGVSSVDSAFSSRGSLSLSFEKDCSVLDISANDIQKKKLIDAIA 
HsRIPK4_NP_065690      356 SSSESKLPSSGSGKRLSGVSSVDSAFSSRGSLSLSFEREPSTSDLGTTDVQKKKLVDAIV 
MmRipk4_NP_076152      358 SSSECKLPSSSSGKRLSGVSSVDSAFSSRGSLSLSFEREASTGDLGPTDIQKKKLVDAII 
 
 
Xlripk4a_NP_001080415  419 GGDTAKLLKILQPQDVDLVFEGRSSLLHLAVESGQEECAKLLLLYNASPNMTNLKGSTPL 
Xlripk4b_NP_001085647  418 GGDTTKLMKILQPQDVDLILEGRSSLLHLAVENGQEECAKLLLLYNASPNMTNLKGSTPL 
Xtripk4_XP_002941332   417 GGDTAKLMKILQPQDVDLVLEGRSSLLHLAVENGQEECAKLLLLYNASPNMTNLKGSTPL 
HsRIPK4_NP_065690      416 SGDTSKLMKILQPQDVDLALDSGASLLHLAVEAGQEECAKWLLLNNANPNLSNRRGSTPL 
MmRipk4_NP_076152      418 SGDTSRLMKILQPQDVDLVLDSSASLLHLAVEAGQEECVKWLLLNNANPNLTNRKGSTPL 
                                                <------------ ANK1 -------------><----- 
 
Xlripk4a_NP_001080415  479 HIASDKKLKNIVELLLGKKIHVNAKDEDLFTALHFSAQNGDECITRMLLEKNASLNEVDI 
Xlripk4b_NP_001085647  478 HIASDKKLKNIVELLLVKKINVNTKDEDHFTALHFSAQNGDECITRMLLEKNASLTEVDI 
Xtripk4_XP_002941332   477 HIAADKKLKNIVELLLGKKINVNAKDEDHFTALHFSAQNGDECITRMLLEKSASLNEVDI 
HsRIPK4_NP_065690      476 HMAVERRVRGVVELLLARKISVNAKDEDQWTALHFAAQNGDESSTRLLLEKNASVNEVDF 
MmRipk4_NP_076152      478 HMAVERKGRGIVELLLARKTSVNAKDEDQWTALHFAAQNGDEASTRLLLEKNASVNEVDF 
                           --------- ANK2 -----------><------------ ANK3 -------------> 
 
Xlripk4a_NP_001080415  539 KGRTPLHVACQHGQENIVRVFLRRGADLTFKGQDNWLALHYAAWQGHLNIVRLLAKQPGA 
Xlripk4b_NP_001085647  538 KGRTPLHVACQHGQENIVRVFIRRGADLTFKGQDNWLALHYAAWQGHLNIVKLLAKQPGA 
Xtripk4_XP_002941332   537 KGRTPLHVACQHGQENIVRVFLRREADLTFKGQDNWLALHYAAWQGHLNIVRLLAKQPGA 
HsRIPK4_NP_065690      536 EGRTPMHVACQHGQENIVRILLRRGVDVSLQGKDAWLPLHYAAWQGHLPIVKLLAKQPGV 
MmRipk4_NP_076152      538 EGRTPMHVACQHGQENIVRTLLRRGVDVGLQGKDAWLPLHYAAWQGHLPIVKLLAKQPGV 
                           <------------- ANK4 ------------><-------------- ANK5 ------ 
 
Xlripk4a_NP_001080415  599 NINAQTSDGRTPLHLAAQRGHYRVARILVDLHCDVNIPSNLMKTPLHVAAETGHTSTARF 
Xlripk4b_NP_001085647  598 NINAQTSDGRSPLHLAAQRGHYRVARILVDLRCDVNIPSNLMKTPLHVAAETGHTSTARF 
Xtripk4_XP_002941332   597 NINAQTSDGRTPLHLAAQRGHYRVARILVDLRCDVNIPSILMKTPLHVAAETGHTSTARF 
HsRIPK4_NP_065690      596 SVNAQTLDGRTPLHLAAQRGHYRVARILIDLCSDVNVCSLLAQTPLHVAAETGHTSTARL 
MmRipk4_NP_076152      598 SVNAQTLDGRTPLHLAAQRGHYRVARILIDLCSDVNICSLQAQTPLHVAAETGHTSTARL 
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Figure 37. Detailed amino acid alignment of different RIPK4 orthologues.  
Background shading indicates sequence conservation: standard black background for conserved residues outside the 
protein domains, red background highlights the protein kinase domain (PK) and alternating blue background marks the 
consecutive ankyrin repeats. Gray background is used for sequence similarity. Note that human and mouse RIP4 have 2 
additional C-terminal ankyrin domains. A CLUSTAL 2.0.10 multiple sequence alignment.  
 
 
II.3.2.2. Knocking down RIPK4 in Xenopus  
To test whether RIPK4 is required during early Xenopus development, we designed and evaluated 
two distinct antisense oligonucleotides or morpholinos. The first is a translation blocking morpholino 
(XtRIPK4 MOatg) directed against the ATG startcodon and the 22 following basepairs of the XtRIPK4 
transcript. The efficiency of this MO was evaluated by western blot analysis with a cross-reacting 
hRIPK4 antibody, showing efficient depletion of the endogenous RIPK4 protein (Fig.38B). The second 
morpholino is a splicing blocker (XtRIPK4 MOE2I2), which targets the boundary between exon 2 and 
intron 2 of the XtRIPK4 pre-mRNA. We monitored the efficacy of the splicing morpholino by RT-PCR. 
This analysis showed a concentration dependent reduction of the wild type XtRIPK4 transcript (630 
bp) together with the appearance of a higher molecular weight fragment (+/- 800 bp), and a lower 
molecular weight fragment (+/- 450 bp) (Fig.38A). Probably, besides exon deletion that causes the 
lower molecular weight fragment, there is also a proportion of intron retention which explains the 
higher molecular weight fragment. These two incorrect splicing outcomes are resulting in a shift in 
the open reading frame of the XtRIPK4 mRNA, leading to an incorrectly translated protein. The 
morpholinos were individually injected at two-cell stage and the embryos were followed throughout 
development. An important difference between the two morpholinos is that the translation blocking 
morpholino is able to deplete both the maternal inherited RIPK4 transcripts and the zygotic RIPK4 
transcripts. On the other hand, the splicing blocking solely targets the zygotic RIPK4 transcripts 
because the maternal transcripts already spliced out their introns. In frog, zygotic transcription is 
consistently initiated at the mid-blastula transition (MBT) at stage 8,5. But the degradation of the 
maternal mRNAs occurs only three divisions later at the onset of gastrulation. So it is not unlikely 
that certain maternal proteins are still required for the initiation of the gastrulation process. 
Therefore, the differential timing and mechanism of XtRIPK4 depletion by these two morpholinos, 
Xlripk4a_NP_001080415  659 LLSRGASINAVTTEGFTALDLASNLGHYSAVKLLMDEQSDVKLKDLTLEEHSFSSIESGQ 
Xlripk4b_NP_001085647  658 LLSRGASINAITTEGFTALDLASNLGHYSAVKLLMDEQSNVKLKDLTLEEDSFSSIESGQ 
Xtripk4_XP_002941332   657 LLSRGASVNAVTSEGFTALDLASNLGHYSAVKLLMDEQSNVKLKDSTEEDSFSSIESGRS 
HsRIPK4_NP_065690      656 LLHRGAGKEAMTSDGYTALHLAARNGHLATVKLLVEEKADVLARGPLNQTALHLAAAHGH 
MmRipk4_NP_076152      658 LLHRGAGKEALTSEGYTALHLAAQNGHLATVKLLIEEKADVMARGPLNQTALHLAAARGH 
                           - ANK7 -----><------------- ANK8 ------------><------ ANK9 - 
 
Xlripk4a_NP_001080415  719 SL---------------------------------------------------------- 
Xlripk4b_NP_001085647  718 SL---------------------------------------------------------- 
Xtripk4_XP_002941332   717 L----------------------------------------------------------- 
HsRIPK4_NP_065690      716 SEVVEELVSADVIDLFDEQGLSALHLAAQGRHAQTVETLLRHGAHINLQSLKFQGGHGPA 
MmRipk4_NP_076152      718 SEVVEELVSADLIDLSDEQGLSALHLAAQGRHSQTVETLLKHGAHINLQSLKFQGGQSSA 
                           --- ANK9 --------><------------ ANK10 ------------> 
 
Xlripk4a_NP_001080415      --------- 
Xlripk4b_NP_001085647      --------- 
Xtripk4_XP_002941332       --------- 
HsRIPK4_NP_065690      776 ATLLRRSKT 
MmRipk4_NP_076152      778 ATLLRRSKT 
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contributed to an unexpected contrasting phenotypic outcome. Loss of maternal RIPK4 resulted in a 
severe gastrulation phenotype, while tadpoles injected with the splice blocking morpholino survived 
fairly well but failed to form an open mouth and cloaca. Since the two morpholinos contribute to a 
diverse phenotype, we have decided to investigate each phenotype separately in closer detail.   
 
 
 
Figure 38. The two designed morpholinos were shown to function specifically and depleted their target 
RIPK4 transcripts. (A) RT-PCR analysis demonstrated the efficacy of the splicing XtRIPK4 MO
E2I2
  whereby the wild type 
zygotic RIPK4 transcripts (fragment 630 bp) were nicely depleted. Embryos were injected at 2-cell stage with 20 ng XtRIPK4 
MO
E2I2
, 30 ng XtRIPK4 MO
E2I2
 or 30 ng control MO (CoMO), lysed at stage 20 and subjected to RT-PCR. The outcome of the 
splicing blockage, was a concentration dependent  exon depletion (fragment 450 bp) combined with an intron retention 
(fragment 800 bp). Both are leading to an incorrect translated protein. (B) Western blot analysis of the protein levels of 
endogenous xRIPK4 after depletion with the translational blocking morpholino xRIPK4 MO
atg
. Embryos were injected at 2-
cell stage with 10 ng xRIPK4 MO
atg
 or 10 ng control MO (CoMO), lysed at stage 20, subjected to western blotting and 
detected with an antibody directed against human RIPK4. The translational blocking morpholino succeeded in depleting the 
endogenous xRIPK4.   
 
II.3.2.3.  RIPK4 is required for gastrulation 
The embryos depleted with the translation blocking morpholino XtRIPK4 MOatg, developed normally 
through cleavage and blastula stages, but were delayed at gastrulation and formed wide open 
blastopores (Fig.39).The embryos did not pass gastrulation and therefore failed to continue with the 
next phase, i.e. neurulation. This 100% penetrant phenotype was not observed when a random 
missense control morpholino was injected.  
 
 
Figure 39. Maternal xRIPK4 is required for proper gastrulation. 
Phenotypic analysis of Xenopus tropicalis embryos injected at the 2-cell stage with 10 ng XtRIPK4 MO
atg
, 20 ng XtRIPK4 
MO
E2I2
 or 20 ng Control MO (CoMO). Depletion of both the maternal and zygotic RIPK4 transcripts with the translational 
blocking MO resulted in an open blastoporus phenotype (arrowheads show the exposed endodermal mass). These RIPK4 
depleted embryos failed to complete gastrulation. In contrast, the splice blocking morpholino XtRIPK4 MO
E2I2
 caused no 
block in gastrulation and the embryos seemed to normally normally through neurula stages.   
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As mentioned in section II.1.4, vertebrate gastrulation comprises 4 migratory movements: epiboly, 
internalization or emboly, convergence and extension. Likely, one (or more) of these movements is 
affected and might cause this gastrulation phenotype. Trying to clarify which movement is involved, 
the RIPK4 depleted embryos were cross-sectioned at the end of gastrulation (stage 12,5). What 
directly stood out was the pronounced vegetal localization of the bastocoel (Fig.40). Normally, the 
blastocoel gets displaced to the anterior end of the embryo by the gastrulation process and 
eventually disappears through major rearrangements of the internalized endodermal cells. During 
the displacement of the blastocoel, the archenteron is formed and will constitute half of the embryo 
at the end of gastrulation (see also Fig.34). When RIPK4 was lost, no archenteron was formed and the 
blastocoel did not disappear but instead has moved to the vegetal side. However, it seems that the 
invaginating mesoendodermal cells in the vegetal region are still able to surge inwards because the 
space underneath the blastocoel roof (BCR) is filled (Fig.40).  Another driving force of gastrulation are 
the epibolic movements of the cell layers in the BCR. Before the onset of gastrulation, the Xenopus 
BCR is composed of three to four layers in the animal pole and five to six layers in the lateral margins 
of the BCR. The outermost superficial layer of cells is a true epithelium while the inner ‘deep’ cell 
layers are free to intercalate (Chalmers et al., 2003). As gastrulation progresses, the three to six deep 
cell layers rearrange into two layers by radial intercalation whereby the BCR thins and expands. This 
thinning ultimately leads to a BCR constituted of a superficial layer and one or two deep cell layers 
(Longo et al., 2004). Remarkably, the BCR of RIPK4 depleted embryos showed no reduction in the 
number of cell layers (Fig.40). This failure of BCR thinning might be the onset of a disrupted epiboly 
movement which deregulates other gastrulation events. For instance, epiboly is necessary for the 
proper formation of the blastopore lips. Absence of these blastopore lips could explain why the 
outermost vegetal cells (yolk plug) are not moved inwards, which is indeed one characteristic of the 
RIPK4 depleted phenotype.  
Together, we demonstrate the prevalence of a major gastrulation defect upon maternal knockdown 
of RIPK4. However, these data cannot pinpoint the determinative morphogenetic defect responsible 
for the gastrulation arrest. Nevertheless, we  can conclude that in Xenopus a certain level of RIPK4, 
probably of maternal origin, is needed to regulate proper cell movements necessary to complete 
gastrulation.    
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II.3.2.4. RIPK4 interferes with C-cadherin and cell-cell adhesion 
In order to understand the role of RIPK4 during gastrulation, we analyzed its potential effect on cell 
adhesion. Like we have introduced in section II.1.3, there is a great phenotypical resemblance 
between the IRF6 null fetuses and the RIPK4 null fetuses whereby a possible involvement of the 
important mediator of cell adhesion, E-cadherin was postulated. Immunostainings on sections of 
IRF6 null fetuses showed an abnormal apical localization of E-cadherin at the epithelial layers 
(Richardson et al., 2009) (see also Fig.33). This apical expression pattern of E-cadherin likely 
contributes to the severe inter-epithelial fusions, seen in the orifices of the analyzed fetuses (see also 
section II.1.3). Since C-cadherin is the major regulator of cell-cell adhesion at the onset of 
gastrulation, we wondered if we could also detect any abnormality in C-cadherin expression. We 
used a monoclonal antibody against C-terminal domain of human E-cadherin, which seems to cross-
react with the Xenopus C-terminal domain of C-cadherin (F. Fagotto, personal communication). 
RIPK4-depleted gastrula stage embryos, embedded in fish gelatin, were sectioned and stained. Again, 
the vegetal localization of the blastocoel was clearly visible. The overview given in Fig.40 confirmed 
the still occurring movement of the invaginating mesoendodermal cells, which invade the blastocoel 
located at the animal pole. As concluded earlier, the BCR is obviously thickened and contains 6-8 cell 
layers whereas the BCR of the control embryos exists out of 3-4 cell layers. In control embryos C-
cadherin was found to be completely absent at the apical side of the superficial layer in the BCR. In 
sharp contrast, apical C-cadherin was frequently found in the superficial cell layer of the RIPK4 
depleted BCR (Fig.40). Slightly less pronounced was the apical localization of C-cadherin at the 
luminal side of the BCR. Since we had the impression that the total amount of the C-cadherin 
expression is also generally increased in RIPK4 depleted embryos, we have checked the C-cadherin 
protein levels on western blotting. However, no changes in overall C-cadherin levels could be 
detected upon RIPK4 depletion, suggesting that RIPK4 is principally required for the correct 
localization of C-cadherin and not for the regulation of C-cadherin levels in the gastrulating embryo.  
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Figure 40. Depletion of maternal xRIPK4 affects gastrulation movements and C-cadherin expression 
pattern. Embryos were injected at the 2-cell stage with 10 ng XtRIPK4
atg
 or 10 ng control MO (CoMO) and stained with 
human E-cadherin antibody, which cross-reacts with the Xenopus C-cadherin protein present during the gastrulation stages. 
(A-B) Injected embryos were cutted at stage 12,5 in halves and imaged with a stereomicroscope. (B) RIPK4 depleted 
embryos revealed the absence of an archenteron (Arch) and a vegetal located blastocoel (bc). Still, it appears that the 
inward migration of the endomesodermal cells is properly occurring because the space underneath the blastocoel roof 
(BCR) is filled up. (C-F) At stage 10,5, injected embryos were E-cadherin immunostained and imaged with a confocal laser 
scanning microscope TCS SP5 (Leica). (D-F) Besides the displacement of the blastocoel to the vegetal pole, stage 10,5 RIPK4 
morphants contained also a thickened blastocoel roof. C-cadherin was found to be apically localized (arrowheads) in the 
blastocoel roof (F) and suggests a role for RIPK4 in the regulation of the cell adhesion mediator C-cadherin. The failure in 
the thinning of the blastocoel roof indicates a defect in the intercalation process which is responsible for the essential 
epiboly movement during gastrulation.  
 
In order to determine whether RIPK4 interferes with the function of C-cadherin, we investigated how 
RIPK4 is affecting the cell-cell adhesion. In order to evaluate the adhesion properties of the BCR, a 
cell adhesion assay was performed with dissociated animal cap cells, isolated at stage 8,5. The animal 
cap cells were seeded on a C-cadherin coated adhesion chamber. After cell attachment, the cells 
were counted, shaken and counted again (Ogata and Cho, 2007). The graph in Fig.41 illustrates the 
relative number of cells that have attached to the adhesion chamber. Animal cap cells isolated from 
RIPK4 depleted embryos, appear to stick better to the C-cadherin in the adhesion chamber then the 
control animal cap cells. Hence, the increased stickiness after knockdown of RIPK4, implies that RIPK4 
is a negative regulator of cell-cell adhesion.  
In conclusion, the gastrulation defects seen upon RIPK4 loss could be the consequence of an 
increased cell-cell adhesion combined with aberrant localization of C-cadherin during the 
gastrulation events.  
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Figure 41. xRIPK4 depletion leads to an increased adhesiveness in a cell adhesion assay. 
Cell adhesion analysis of dissociated animal cap cells, isolated at stage 8,5 and plated on a C-cadherin coated slide. Embryos 
were injected at 2-cell stage with 10 ng XtRIPK4 MO or 10 ng Control Mo (CoMO). Cell adhesion assay was carried out as 
described (Ogata and Cho, 2007). After each 5 min shake, pictures were taken and processed. The total number of cells 
present on the slide was counted automatically with the Volocity program (PerkinElmer Life Sciences). Slides were shaken 
on a vertical shaker with 50 rpm, followed by a 1 min shake at 200 rpm. Depletion of RIPK4 leads to a slight increase in 
adhesiveness.  
 
II.3.2.5. RIPK4 kinase activity is crucial for its role during gastrulation 
Several reports have agreed that RIPK4 requires its kinase activity for NF-κB activation by multiple 
stimuli (Meylan et al., 2002; Moran et al., 2003). In addition, De Groote et al. showed that RIPK4 
induces scattering of keratinocytes in a kinase dependent manner (unpublished results). To 
determine whether the function of RIPK4 during  gastrulation is specifically dependent on its kinase 
domain, we performed rescue experiments with human RIPK4 and a kinase death mutant. Mutation 
of the critical lysine (K) within the ATP-binding domain of RIPK4 ablates the ability of the kinase to 
associate with ATP, which is crucial for its kinase function (Carrera et al., 1993; Taylor et al., 1993). 
First, the human (mutant (K51R) and wild type) RIPK4 sequences were cloned into a pCS2-Myc 
gateway compatible vector via the gateway technology. The Myc-tagged fusion transcripts were 
prepared in vitro and injected in fertilized eggs. Total embryos were lysed at stage 13-14 and used for 
western blotting. Both the overexpression of the wild type myc-tagged hRIPK4 as the mutant myc-
tagged hRIPK4-K51R did not affect the early developmental stages, including gastrulation. The 
expressed protein levels of the mutant hRIPk4 K51R protein were consistently higher than those of 
the wild type protein (Fig.42). The reason for these distinct expression levels is unknown. After this 
positive evaluation of the hRIPk4 constructs, rescue experiments could be executed. Combined 
injections with the morpholino were performed, followed by phenotypical analysis. The target site of 
the XtRIPk4atg morpholino is little conserved in the human orthologue, thus  rendering the exogenous 
hRIPk4 transcripts resistant to knockdown.  
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Figure 42. hRIPK4 transcripts (wild type or K51R mutant) are nicely expressed in Xenopus tropicalis.  
Western blot analysis of the myc-tagged hRIPK4 levels after overexpression experiments. Embryos were injected at 2-cell 
stage with 250 pg or 500 pg of RNA coding for the myc-tagged human RIPK4 proteins (wild type or K51R mutant). Lysates 
were made  at stage 20 and subjected to western blotting with antibodies directed against human RIPK4 (A) and the myc-
tag (B). Both analyses showed a consistent higher expression of the mutant hRIPK4 transcripts in comparison to the wild 
type hRIPK4 transcripts.  
 
Strikingly, the wild type hRIPk4 was able to rescue successfully the open blastopore phenotype from 
100% (n = 125) affected embryos to 28% (n = 137) affected embryos (Fig.43B). Thus, catalytic active 
human RIPk4 rescues the RIPK4 depleted embryos, demonstrating that the observed mushroom-like 
phenotype is specifically due to the loss of RIPK4. In strong contrast, identical experiments with the 
catalytic inactive mutant hRIPk4 K51R could not rescue the gastrulating embryos. None of the 
injected embryos (n = 168) showed any improvement of the mushroom-like phenotype (Fig.43). So a 
single amino acid mutation seems to be sufficient to interfere with the RIPk4 kinase activity and its 
function during gastrulation.    
As a summary, this in vivo rescue study provides the first undeniable prove that the kinase activity of 
RIPK4 is indispensable for  gastrulation movements in Xenopus. 
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II.3.2.6. Zygotic RIPK4 is indispensable for the development of external 
orifices   
As mentioned in section II.1.2, the RIPK4 -/- mouse fetuses exhibited fused external orifices including 
the mouth and the anus. This phenotype was entirely reproduced in Xenopus embryos by depletion 
of RIPK4 with the splicing blocking morpholino (XtRIPK4E2I2). The xRIPk4 depleted embryos developed 
normally through gastrulation and reached the tadpole stages 38-40 without gross developmental 
defects. Passing stage 40, we consistently started to notice a swelling of the cloacal tube, sometimes 
leading to a bulb at its distal end. The inability to clear the pronephric filtrate indicates that the 
cloaca opening is malformed and possibly fused. Also the primary mouth formation appeared to be 
affected (Fig.44).  
xRIP4 Mo atg
xRIP4 MoE2I2
CoMO xRIPK4MO
atg
xRIPK4MO + hRIP4K WTatg xRIPk4MO + hRIP4k atg K51R
Figure 43. Maternal xRIPK4 depends on its kinase activity for its function during gastrulation.  
Rescue analysis of the gastrulation defect after RIPK4 depletion by the translation blocking morpholino xRIPK4 MO
atg
. (A) 
Embryos were injected at the 2-cell stage with 10 ng xRIPK4 MO
atg
 or 10 ng control MO (CoMO), combined with 250 pg RNA 
coding for the myc-tagged human RIPK4 proteins (wild type or K51R mutant). The open blastopore phenotype (arrow heads) 
caused by the loss of RIPK4, could only be rescued by the overexpression of the wild type hRIPK4 transcript and not by the 
kinase death mutant transcript. This  suggests that xRIPK4 depends on its kinase function for its role during gastrulation in 
Xenopus. (B) Graph summarizing the percentages of the injected embryos. The embryos were scored using the phenotype in 
(A) as a reference. 
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Figure 44. Zygotic xRIPK4 depleted embryos failed to form external openings.  
Phenotypic analysis of embryos injected at the 2-cell stage with 20 ng XtRIPK4 MO
E2I2
 or 20 ng control MO (CoMO). (A-B) 
Frontal views on the primitive mouth of stage 43 embryos. Zygotic xRIPK4 depleted embryos failed to form a mouth 
opening (B). (C-D) Lateral views on the cloaca formation of stage 43 embryos. No cloacal opening was observed and fluid 
builds up in the cloaca of in the xRIPK4 morphants (D). These observations suggested that zygotic xRIPK4 plays a role in 
primitive mouth and cloaca formation during the development of Xenopus. Abbreviations:  m, mouth; cg; cement gland; cl, 
cloaca. 
 
The embryos at stage 40 failed to create a functional perforated mouth opening. Hematoxylin and 
eosin (H&E) stainings on sagittal paraffin sections revealed a better insight into the affected mouth 
(Fig.45). It seems that the invagination and the subsequent thinning of the stomodeum proceeded 
flawless and shaped the 1-2 layered buccopharyngeal membrane. The random organization of the 
endodermal and ectodermal cells suggests that intercalation between these two layers is more or 
less occurring. However, small perforations that normally lead to the actual opening were not 
observed. In some embryos, a cell plug containing endodermal and ectodermal cells was obstructing 
the mouth opening. Inspired by the mislocalization of C-cadherin in RIPK4-depleted  gastrulating 
embryos, we have analyzed the expression of E-cadherin in the presumptive mouth region. The 
control embryos were fixed and sectioned at stages around mouth perforation (stages 40-41) 
showing  normal basolateral E-cadherin localization in this anterior region. We fixed the RIPK4 
depleted embryos when they reached beyond stage 41, to make sure the primitive mouth is fully 
formed. The cement gland, a ventral anteriorly structure, was used to determine the midline of the 
embryos. Unlike the situation during gastrulation, we could not obviously detect the ectoptic apical 
expression of E-cadherin at the oral cavity of RIPK4 depleted tadpoles (Fig.45). In the residing 
membrane plug of RIPK4 morphants, we detected in some embryos a close network of E-cadherin 
expressing cells of which the cell-cell adhesions are severely disorganised.  
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Figure 45. Primary mouth perforation defect upon knockdown xRIPK4. 
Sagittal paraffin sections of the mouth cavity were stained with H&E (A-D) or the human E-cadherin antibody (E-H). 
Embryos were injected at 2-cell stage with 20 ng xRIPK4
E2I2
 or 20 ng control MO (CoMO) and fixed at stage 40-41 when 
primitive mouth perforation had taken place. (C-D) Stage 41+ embryos depleted with the splice blocking morpholino 
revealed substantial defects in the mouth formation. It seems that the embryos can form the two-cell layered 
buccopharyngeal membrane, but fail to form the actual mouth opening (black arrowheads). (E-F) Immunostainings of the 
oral cavity of controle embryos at stage 40 (E) and stage 41 (F), were used to compare the E-cadherin localization with the 
RIPK4 morphants. (G-H) Immunostainings of the oral cavity of RIPK4 depleted embryos at stage 41+ showed no apical E-
cadherin localization of the cell-adhesion mediator at this stage, but nicely demonstrated the intact two-cell layered 
membrane plug.  
    
Together, we have phenocopied the fusion of the external orifices in Xenopus upon knockdown of 
RIPK4 with our splicing blocking morpholino. We have reconfirmed that RIPK4 function is 
indispensable for proper perforation of the external openings during embryonic development. And 
although we do not have definitive prove for an increased or affected interepithelial cell adhesion, 
we suspect that also here RIPK4 negatively regulates cell-cell adhesion.     
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II.3.3. Discussion  
RIPK4, a member of the RIP kinase family, was independently discovered in human and mouse 
whereby the kinase was found to interact with PKCδ and PKCβ1, respectively (Chen et al., 2001; 
Meylan et al., 2002). Overexpression studies showed the ability of RIPK4 to activate NF-κB, the c-Jun 
N-terminal kinase (JNK), and hence the activator protein-1 (AP-1).  Surprisingly, knock-out studies in 
the mouse have shown that RIPK4 has an important role in skin differentiation and development 
(Holland et al., 2002; Rountree et al., 2009). Because the external orifices of RIPK4 -/- fetuses are 
fused, they die shortly after birth due to suffocation. The underlying mechanism is unknown but 
histological analysis of the embryos suggests that an increased interepithelial adhesion causes this 
developmental phenotype. In the present study, we have not only phenocopied the fusion of the 
external openings in Xenopus upon knockdown of xRIPK4, but also found a gastrulation phenotype. 
The latter phenotype is likely controlled by maternally deposited RIPK4 since it was manifested by a 
translation-blocking morpholino, but not by a morpholino that prevented the correct splicing of the 
zygotic transcripts. Rescue experiments further showed that gastrulation is  strictly dependent on the 
kinase activity of the xRIPK4 kinase protein. Interestingly, depletion of xRIPK4 with the translation 
blocking morREsREscupholino led to ectopic apical localization of C-cadherin in the cells of the 
blastocoel roof and resulted in an increased adhesiveness in a cell-adhesion assay.  
In order to comprehend which abnormal gastrulation movement could contribute to this 
exogastrulation phenotype, we took a closer look at the mechanism of how the endoderm and the 
mesoderm are actually moving inward. Upon sectioning the exogastrulating embryos, two 
abnormalities stood out. The first was the impaired thinning of the cells in the blastocoel roof. This 
thinning is mediated by radial intercalation of several layers of cells in the animal pole and is required 
for the expansion of the ectoderm. This expansion, is necessary to allow the ectoderm to spread over 
the mesoderm and endoderm during gastrulation, a process called epiboly. A second morphogenetic 
abnormality was the frequent vegetal displacement of the blastocoel. Winklbauer and coworkers 
have shown that during gastrulation, cells of the endoderm undergo a so called vegetal rotation.  
This early gastrulation movement results in narrowing of the lower and the concomitant expansion 
of the upper vegetal region that borders the floor of the blastocoel. This active rotation of the 
peripheral vegetal cell mass in the radial plane, progresses from dorsal to ventral roughly in parallel 
to blastopore formation. The vegetal rotation, leads to a dramatic expansion of the blastocoel floor 
and an associated turning around of the marginal zone, which constitutes the first and major step of 
mesoderm involution (Winklbauer and Schurfeld, 1999). We believe this rotation might partially 
explain why the blastocoel is displaced to the vegetal side. Because it seems that the invaginating 
marginal cells (i.e. mesoendodermal cells) are still able to surge inwards, we assume the active 
vegetal rotation is still occurring. However, usually this vegetal rotation is accompanied by the 
thinning of the blastocoel roof, which is impaired in the RIPK4-depleted embryos. Normally the 
epibolic expansion of the primary superficial epithelial (PSE) layer generates, together with the 
convergent extension (CE) movements, a vegetal-dorsal directed force, which embraces the inward 
migrating marginal cells and closes the dorsal bastoporus. Thus, the morphogenetic forces of an 
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active occurring vegetal rotation and impeded epibolic and CE movements might lead to a rupture of 
the mesoendodermal cell mass in the blastocoel floor. As a consequence a second vegetal localized 
blastocoel appears.  
While the closed mouth and anus/cloaca in RIPK4 depleted frog embryos and RIPK4 knockout mice is 
very similar, the actual underlying cellular disturbances may be different, at least for the mouth. In 
the mouse knockouts, the mouth is initially opened but later on closes, likely by fusion of the apical 
epithelial surfaces. In contrast, in Xenopus morphants, the aberrant mouth or cloaca formation is 
likely the result of an impaired intercalation between the ectodermal and endodermal cell layers. 
Interestingly, several studies assured that during gastrulation, a tight regulation of C-cadherin is 
necessary for mesodermal CE movements, which are also dependent on the process of intercalation 
(Lee and Gumbiner, 1995; Zhong et al., 1999; Skoglund et al., 2008). Because the two distinct 
phenotypes point to a defect in the mechanism of intercalation, we believe that xRIPK4 regulates the 
dynamic cell-cell adhesion that is required for the process of intercalation during embryonic 
development. However, it remains an open question which mediators act downstream or upstream 
of RIPK4 signaling.  
A possible candidate involved in xRIPK4 signaling is the Interferon Regulatory Factor 6 (IRF6). IRFs are 
a family of transcription factors with a shared structure including an N-terminal DNA binding domain 
and a C-terminal Interferon Association Domain (IAD). As reviewed in Paun et al. (Paun and Pitha, 
2007), a pathogenic stimulus leads for most IRF family members to phosphorylation of the IAD, 
thereby stimulating nuclear translocation, dimerization, and transcription of target genes including 
interferon genes. IRF6 is considered as an outsider because it plays no role in innate immunity but is 
instead essential for embryonic development. Interestingly, genetic variation in IRF6 has been 
associated with syndromic and non-syndromic forms of cleft lip and palate (Kondo et al., 2002; 
Zucchero et al., 2004), suggesting a role in the epithelia covering palatal shelves where IRF6 is highly 
expressed (Knight et al., 2006). Analogous to the RIPK4 null mice, the mouse embryos homozygous 
for targeted mutations in the irf6 gene display not only defects in differentiation of keratinocytes but 
also exhibits adhesion between the tongue and maxillary prominence, which indicates a defect in the 
differentiation of oral epithelia (Ingraham et al., 2006; Richardson et al., 2006). Even more intriguing 
is the finding that IRF6 activity is as well required for gastrulation in D. rerio and X. laevis (Sabel et al., 
2009). This recent study demonstrated in both species that interfering with maternal IRF6 function 
stalled the epibolic movement and resulted in a mushroom-like exogastrulating phenotype. The 
authors proposed that this phenotype may reflect a loss of mechanical strength in the PSE, the layer 
which surrounds the gastrulating embryo (Sabel et al., 2009). In Xenopus, there are two IRF6 
paralogues (IRF6.1 and IRF6.2) described (Sabel et al., 2009). Their mRNA expression is not restricted 
to specific layers of the early ectoderm, which is consistent with the inheritance of IRF6 transcripts 
from the egg. In order to investigate if the IRF6 transcripts are influenced by xRIPK4 depletion, we 
have analyzed the expression of the IRF6.1 and IRF6.2 in X. tropicalis by means of quantitative PCR 
(Fig.46). We could not detect any difference in mRNA levels of the xRIPK4 depleted embryos 
compared to the control embryos. Although this observation eliminates a potential regulation of the 
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IRF6 mRNA levels by xRIPK4, it does not exclude the possibility that the IRF6 protein is a downstream 
targets of xRIPK4 signaling. We have also performed rescue experiments using different 
concentrations of IRF6.2 RNA. Unfortunately, these injections have failed to rescue the xRIPK4-
depleted phenotype. This was not unexpected because rescue injections with a wide range of IRF6.2 
RNA amounts into IRF6-depleted embryos exacerbated the embryonic phenotype rather than 
rescuing it (Sabel et al., 2009). This suggests that levels of IRF6 activity must be precisely controlled 
for normal development and hence does not exclude the possibility that IRF6 activity is required 
downstream of xRIPK4 signaling.  
 
 
  
 
 
 
 
 
 
 
 
An interesting avenue for future work will be to test whether IRF6 is directly regulated by xRIPK4-
mediated phosphorylation. Another possibility could be that xRIPK4 indirectly activates IRF6 
dependent transcription. For example, through interaction with another kinase. Intriguingly enough, 
the RIPK4 kinase was discovered through its interaction with PKCδ in the human and with PKCβ1in 
mouse (Bähr et al., 2000; Chen et al., 2001). Besides these reported kinases, the atypical protein 
kinase C (aPKC) might be the missing link because it is not only required for differentiation of basal 
keratinocytes in mouse (Helfrich et al., 2007), aPKC is also sufficient to upregulate expression of PSE 
layer markers in deep layer cells (Ossipova et al., 2007), similar to knock down of IRF6. Another 
attractive possibility might be that IRF6 signaling is upstream of RIPK4. This would not only explain 
our failure in rescuing the RIPK4-depleted phenotype by the overexpression of IRF6.2 protein, but 
also the absence of a decrease in IRF6 mRNA levels upon depletion by RIPK4 (Fig.46). The upstream 
positioning of IRF6 can be possibly sorted out in the future by means of a rescue experiment 
whereby the IRF6 genes are depleted together with the overexpression of RIPK4.   
If it turns out that there actually is a direct link between RIPK4 and IRF6, it will be crucial to 
determine which genes could be involved downstream of IRF6? Loss of adhesion between X. laevis 
blastomeres is observed upon misexpression of the small GTPases Rac, Cdc42, and Rnd1 
(Wunnenberg-Stapleton et al., 1999; Choi and Han, 2002; Hens et al., 2002) and also after disruption 
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Figure 46. No significant reduction in the mRNA levels of IRF6.1 and IRF6.2 upon RIPK4 depletion. 
Quantitative PCR analysis of the IRF6 transcript levels in Xenopus. Embryos were injected at 2-cell stage with 10 ng XtRIPK4 
MO or 10 ng control MO (CoMO), lysed at stage 20, followed by RNA extraction and cDNA synthesis. No significant reduction 
was observed in both the expression of IRF6.1 and IRF6.2 after RIPK4 depletion. This suggest that if RIPK4 interferes with the 
IRF6 transcription factor, it is likely not on the level of the mRNA.   
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of p21-activated kinase (PAK) (Faure et al., 2005). The GTPases Rac and Rho also control cell 
intercalation by mediating distinct cytoskeletal changes necessary for the convergent extension 
movements during Xenopus gastrulation (Tahinci and Symes, 2003). Basically, all these genes 
implicated in cell adhesion in early embryonic development could be potential targets of IRF6.  
Until here we have been assuming that RIPK4 signaling involves IRF6 activation. But several PKCs 
have also been directly associated with cell adhesion mediators like E-cadherin and C-cadherin. For 
instance, PKCδ binds E-cadherin and mediates E-cadherin internalization after growth factor signaling 
(Singh et al., 2009). Recently, it has been shown that the cytoplasmic domain of C-cadherin can 
interact with aPKC, which is at least partially mediated by β-catenin (Seifert et al., 2009). This 
interaction allows the full-length C-cadherin to regulate the activation status of aPKC. As a 
consequence, C-cadherin might influence the local cellular position of aPKC, which is responsible for 
the convergent extension movements during Xenopus gastrulation. A plausible hypothesis could be 
that xRIPK4 phosphorylates aPKC and regulates its functional interaction with C-cadherin. Or maybe 
xRIPK4 phosphorylates directly the cytoplasmic tail of cadherins, which creates a platform for 
proteins like aPKC or p120 catenin that coordinate the process of cadherin trafficking (Xiao et al., 
2007; Sato et al., 2011). By means of cadherin trafficking the cell is able to modify the amount of 
cadherins residing at the plasma membrane. After internalization in endosomes, the cadherins can 
be recycled and shuttle back to the membrane, or they can be degraded in lysosomes. A theory in 
line with our observed ectopic apical localization of C-cadherin upon xRIPK4 knock down, may well be 
that RIPK4 contributes to this cadherin trafficking and stimulates the internalization of cadherins 
during the process of intercalation. In order to intercalate, the cells have to lose their cell-cell 
adhesions, which is tightly controlled by the trafficking process. Indeed, direct evidence for the 
modulation of intracellular trafficking during intercalation comes from a study about the developing 
trachea in the fly (Shaye et al., 2008).  
Since RIPK4 signaling likely interferes with epithelial cell adhesions, we have to consider the possible 
implication of RIPK4 in carcinogenesis, and more particularly in tumor progression. Accumulating 
evidence suggests a critical role for the epithelial-mesenchymal transition (EMT) in the progression of 
cancer cells through which tissue epithelial cancers invade and metastasize. During the induction of 
EMT, levels of cadherins, especially E-cadherin, are often down-regulated (Jeanes et al., 2008). As a 
consequence, E-cadherin is generally considered to be an important invasion suppressor. Therefore, 
all the signaling pathways, including RIPK4 signaling, which contribute to the regulation of cadherin 
expression, trafficking or localization may be implicated in malignant cancer progression (Voulgari 
and Pintzas, 2009). However, there is no direct evidence available in the literature for a possible link 
between RIPK4 and cadherin-mediated cancer progression. One possible cancer link is a recently 
suggested role for RIPK4 in the formation of diffuse large B-cell lymphomas (DLBCLs) (Kim et al., 
2008). Apparently, RIPK4 activates NF-κB signaling in DLBCL cells through the B-cell-activating factor 
of tumor necrosis factor family (BAFF). Importantly, knockdown of RIPK4 impairs the survival of 
DLBCL cells in vitro and inhibits tumor growth of xenograted DLBCL cells in mice (Jeanes et al., 2008).  
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Because ectopic apical localization of cadherins in the mouse IRF6 knockout and Xenopus RIPK4 
morphant may result from defects in cell polarization and since aPKC is also a major regulator of 
apicobasal polarity, we wondered if proper cell polarization is still occurring in xRIPK4 morphants. 
Indeed, expression of a dominant-negative aPKC construct causes loss of apical identity and 
expansion of basolateral identity into the apical side (Chalmers et al., 2005). Unfortunately, our aPKC 
stainings did not reveal any distinct cellular expression pattern compared to the control embryos and 
suggests that the cell polarity is not affected (data not shown). However, it is still possible that stage 
10 embryos, which were used for our immunostaining, are too late for proper analysis of aPKC 
localization. The authors in (Chalmers et al., 2005), succeeded to show an enrichment of aPKC in the 
apical membranes of embryos at stage 8. This is definitely something that should be re-addressed.  
As a conclusion, we have a strong indication that xRIPK4 acts as a negative regulator of cell-cell 
adhesion during Xenopus development. Because the obtained functional data in the frog seem to 
correlate with the mouse model, we might broaden our conclusion by saying that RIPK4 functions as 
an essential modulator of cell-cell adhesion in vertebrates. In the future, it will be essential to 
identify the distinct interaction partners of xRIPK4 during embryonic development. Finding these 
interaction partners will expand our insights in xRIPK4 signaling and should help us to unravel the 
involved up- and downstream mediators.  
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II.3.4. Materials and Methods 
Cell adhesion assay  
Cell adhesion assay was carried out as described (Ogata and Cho, 2007). Briefly, embryos were 
injected at the two-cell stage with COMO or XtRIPK4 MOatg. 15-20 animal caps were excised at stages 
9-10 and dissociated to a single cell suspension in Ca2+/Mg2+-free Modified Barth’s Solution (CMF-
MBS, 88 mM NaCl, 1 mM KCl, 2.4mM NaHCO3, 10 mM Hepes, pH 7.4) for approximately 1 h. 
Dissociated cells were subsequently seeded on a adhesion chamber (coated with recombinant C-
cadherin (10 mg/ml)) in 1x MBS-H (same as CMF-MBS but with 4 mM Ca2+) with sigmacoated and 
chopped-off tips. After 45 - 90 min of incubation the cells were attached and pictured with the 
AZ100M Nikon stereomicroscope. Next, the slides were placed in a plastic bucket with 1 L of MBS-H 
buffer and shaken with an orbital shaker (50 rpm) for 5-15 min. Again pictures of the slides were 
taken with the same settings. Cells were automatically counted with the Volocity program 
(PerkinElmer Life Sciences). Cell adhesion was analyzed by calculating the percentage of remaining 
cells attached after the wash/shake step.  
  
Immunostaining cryo-sections 
Early gastrulating embryos were fixed in Dent’s fixative and embedded in gelatin as described 
(Fagotto and Gumbiner, 1994) (Fagotto and Gumbiner, 1994). Serial 10 mm frozen transverse 
sections of the entire embryos were collected. Sections were immunolabeled (Fagotto and 
Gumbiner, 1994) using the mouse anti-E-cadherin monoclonal antibody (1:2000, BD Transduction 
Laboratories, Cat.No. 610181) and the secondary anti-mouse IgG Alexa 488 antibody. Nucleï were 
stained with Hoechst (1:10000). All coverslips were mounted with 1% n-propylgallate glycerol and 
imaged with a confocal laser scanning microscope TCS SP5 (Leica). 
 
Immunostaining paraffin sections and H&E staining 
Tadpoles were fixed 4% paraformaldehyde overnight at 4°C, dehydrated and embedded in paraffin. 5 
μm sagittal sections were prepared, mounted on slides and stained with haematoxylin and eosin. For 
immunostaining, the paraffin sections were incubated with the mouse anti-E-cadherin monoclonal 
antibody (1:2000, BD Transduction Laboratories, Cat.No. 610181) and visualized with the secondary 
anti-mouse IgG Alexa 594 antibody.  
 
Morpholino design and RNA injections 
 X. tropicalis embryos were collected from natural mating couples and dejellied in 3% cystein in 1× 
MMR buffer. Embryos were injected while submerged in 0.1× MMR/6% Ficol and cultured at 22 °C. 
The following antisense morpholino oligonucleotides (MO) were obtained against Xenopus tropicalis 
RIP4 (GeneTools): XtRIPK4 MOatg: ATGCGCCCTCCTTATCCATGGTGCC; XtRIP4K MOE2I2: 
AGATATAACAGTCACTTACCTTCAC and against Xenopus laevis RIPK4: XtRIPK4 MOatg: 
GGACGCGCCCTCCTTATCCACCATA As control, a standard morpholino CoMO (Genetools) was used. 
They were dissolved and stored according to the manufacturer’s instructions and in injected at the 
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doses indicated in the figure legends. The expression constructs pCS2-Myc-hRIPK4 WT and pCS2-
Myc-hRIPK4 K51R were constructed with the Gateway technology (Technologies Invitrogen, 
Merelbeke, Belgium) starting from the entry vectors pENTR3C-hRIPK4 WT and pENTR3C-hRIPK4 
K51R. The expression constructs were linearized with Not I, and in vitro synthesis of capped RNA was 
performed using the SP6 mMESSAGE mMACHINE® High Yield Capped RNA Transcription kit (Cat# 
AM1340 Applied Biosystems).  
 
RNA Extraction and semiquantitative and quantitative RT-PCR 
Total RNA was isolated using the Aurum Total RNA fatty and fibrous tissue kit (Biorad). For each RNA 
sample at least 10 embryos were pooled. cDNA was prepared with oligo (dT) and random hexamer 
primers using the iScript cDNA Synthesis Kit (Biorad) according to the manufacturer’s instructions. 
Sequences of forward and reverse primers were as follows (5’ to 3’ orientation): 
TATGGGGCTGCTCAGGACCTT and GTACACGTCGTGTTTGGTGTC for XtRIP4k, 
CAGCCTCGACATTCAATGGA and TCAGGGAGAATGCCATGTTCT for ornithine decarboxylase (ODC) as a 
house keeping gene.  
Real-time qPCR analysis was performed using the SYBR green PCR master mix (Applied Biosystems) 
on a LightCycler® 480 Real-Time PCR System (Roche). Primers for measuring gene expression levels 
were designed using Primer express 1.0 software (Perkin-Elmer applied Biosystems). Sequences of 
forward and reverse primers were as follows (5’ to 3’ orientation): AGGCAAAAAGGTTCCAAATCC for 
and TCTCAACAGCCCAGGCCTTA for IRF6.1, CCCAGGTTCCACAGGATCTG and 
AGTTAAAGGGCTCTTGGATTGGTA for IRF6.2. For all primer pairs, a “no-template control” was 
included. For measuring gene expression, a “no-amplification control” was also included and all 
values were normalized to the level of the housekeeping gene ornithine decarboxylase (ODC). 
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Chapter II.4. General Discussion and Perspectives PART II 
Exploring the role of RIPK4 during Xenopus development 
As part of a fruitful collaboration within the department, we also explored the role of RIPK4 in 
Xenopus tropicalis development (Part II). RIPK4 was initially described as a protein that interacts with 
PKCβ1 and PKCδ in yeast two-hybrid assays, and led to its first name: protein kinase C-associated 
kinase (PKK) (Bähr et al., 2000; Chen et al., 2001). However, soon after its discovery, and because of 
the close similarity to the other members of the RIP serine/threonine kinase family, it was given the 
name of RIPK4 (Meylan et al., 2002). RIPK4 consists of an N-terminal kinase domain, a 
serine/threonine rich intermediate domain and C-terminal region harboring several ankyrin repeats, 
which allow intimate protein-protein interactions (Meylan and Tschopp, 2005). Several studies have 
reported that RIPK4 signaling can result in the activation of different pro-survival mediators like NF-
κB, c-Jun N-terminal kinase (JNK) and activator protein-1 (AP-1) (Meylan et al., 2002; Muto et al., 
2002; Moran et al., 2003). Interestingly, RIPK4-/- mice die shortly after birth and the examination of 
the pre-born fetuses revealed marked skin defects (Holland et al., 2002). The RIPK4-/- mice die 
probably due to suffocation, which is a consequence of the observed fusion of all external orifices 
(i.e. mouth, anus and nose). The epidermis of RIPK4-/- mice is thickened with expanded spinous and 
granular layers, and an outermost layer of parakeratotic cells, implicating that RIPK4 signaling is 
required for proper skin differentiation. This was confirmed by the misexpression of several keratins 
and differentiation markers in the epidermis when RIPK4 was depleted (Holland et al., 2002). 
Comparison of the RIPK4 null mice phenotype with the IRF6 deficient mice, revealed that in both 
cases the fused mouth is likely the result of severe inter-epithelial adhesions. The palatal epithelia of 
RIPK4-/- mice appear to adhere to the epithelia of the tongue and mandible. This may prevent the 
palatal shelves to elevate, hence causing a cleft palate phenotype. In IRF6 depleted mice, it was 
found that E-cadherin, an important mediator of cell-cell adhesion, is ectopically expressed at the 
luminal side of the oral periderm cells. A similar situation may be present in the RIPK4 null mice. 
Thus, besides its function in skin differentiation, RIPK4 could also be a regulator of cell-cell adhesion 
during development.  
To date, it has not been reported that the kinase activity of RIPK4 is required for its function in vivo. 
Evidently, the question raises if RIPK4 trusts on its kinase activity or rather functions independently 
of its kinase activity, analogues to the kinase-independent pro-survival functions of RIPK1, RIPK2 and 
RIPK3? To resolve this question, the main goal of our collaboration was to assess the functional 
dependence of RIPK4 on its kinase activity during embryonic development. 
 
Characterization of RIPK4 in Xenopus 
As mentioned earlier, we made use of the Xenopus model organism that allows us to address both 
the morphogenetic and signaling functions of RIPK4. We have found high protein sequence similarity 
between the functional domains of Xenopus tropicalis RIPK4 and its mammalian orthologues (i.e. 
mouse and human) and conclude that RIPK4 is strongly conserved during the evolution of these 
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vertebrates. We have designed two distinct morpholinos which deplete the Xenopus tropicalis RIPK4 
protein in a different manner. The first is a translation blocking morpholino directed against the 
startcodon of the XtRIPK4 transcripts and depletes both the maternal and the zygotic RIPK4 
transcripts. The second, a splice blocking morpholino, targets solely the exon2-intron2 boundary of 
the zygotic RIPK4 transcripts because the maternal transcripts have already spliced out their introns 
at the time of fertilization. Unexpectedly, the outcome of both morpholinos was remarkably 
different. This is likely the result of the differential timing of RIPK4 depletion by these two 
morpholinos. Loss of maternal RIPK4 resulted in a severe gastrulation phenotype, while tadpoles 
injected with the splice blocking morpholino survived fairly well but failed to form an open mouth 
and cloaca. These two dissimilar phenotypes were investigated in closer detail.  
 
Maternal RIPK4 is required for gastrulation movements 
To comprehend the open blastopore phenotype, which is caused by the translation blocking 
morpholino, we first had to understand the various and complicated cell movements that occur 
during the gastrulation process. The gastrulation process can be defined as an embryonic transition 
from a simple group of rather unorganized cells to a more complex organized and multilayered 
embryo containing the three germ layers: the ectoderm, endoderm and mesoderm (Leptin, 2005). 
Vertebrate gastrulation involves four evolutionarily conserved morphogenetic migratory movements: 
epiboly, internalization or emboly, convergence and extension (Solnica-Krezel, 2005). Epiboly leads to 
an expansion of tissue, often accompanied by its thinning. The major mechanism of epiboly in 
Xenopus gastrulation appears to be an increase in cell number through division, coupled with a 
concurrent integration of several deep cell layers into the outer layer by the process of radial 
intercalation (Keller, 1980). The epiboly movement of the animal cap cells is necessary to allow the 
concomitant invagination of the endomesodermal precursors from the blastula surface to the 
blastocoel cavity underneath the ectodermal superficial layers. These cell movements are tightly 
coordinated and connected to each other. Basically, the correct proceeding of these movements 
determines the success of the gastrulation process. Many of these migration events are the results of 
dynamic changes in cell-cell adhesion because the establishment, maintenance and severing of 
contacts between cells during these movements is extremely important (Winklbauer and Keller, 
1996; Marsden and DeSimone, 2003). Several studies in Xenopus suggested an essential role for the 
dynamic regulation of the maternal inherited C-cadherin during the cell movements in the 
gastrulation process (Lee and Gumbiner, 1995; Zhong et al., 1999). Therefore, we have performed 
immunostainings on sections of XtRIPK4-depleted gastrula stage embryos with a human E-cadherin 
antibody that is cross-reacting with the Xenopus C-terminal domain of C-cadherin. Remarkably, we 
consistently observed a vegetal localization of the blastocoel and a thickened animal blastocoel 
roof (BCR). Normally, as seen in the control embryos, the blastocoel gets first displaced to the 
anterior end of the embryo and eventually disappears through major rearrangements of the 
internalized endodermal cells. We also found apically expressed C-cadherin in the superficial cell 
layer of the RIPK4 depleted BCR, which was never the case in the control embryos. We believe that 
these data point to a severe disturbance in the epiboly movement whereby the radial intercalation of 
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the deep ectodermal layers is affected. Also the convergent extension movements, which depend as 
well on the intercalation process, might be hampered. Because of these malfunctions, there is no or 
less expansion of the ectodermal layers, which usually enclose the gastrulating embryo, eventually 
leading to the closure of the dorsal blastopore. We believe that the displacement of the blastocoel to 
the vegetal region is caused by the morphogenetic forces of the still occurring vegetal rotation of the 
invaginating endomesodermal cells together with the lack of the vegetal-dorsal directed epibolic 
movement. Our observations, combined with the increased interepithelial adhesions in the RIPK4 
null mice fetuses, indicate that RIPK4 acts as a negative regulator of the epithelial cell-cell adhesions. 
In order to confirm this negative role, we have executed a cell adhesion assay with dissociated animal 
cap cells and found that RIPK4 indeed negatively interferes with the cell-cell adhesion mediators. 
Future research should further dissect how RIPK4 is exactly modulating cell-cell adhesion during 
development.  
 
A kinase dependent role of RIPK4 during development 
We performed rescue experiments with hRIPK4 transcripts (i.e. wild type or kinase death mutant) to 
show that gastrulation is strictly dependent on the kinase activity of the xRIPK4 kinase protein. The 
importance of kinase activity is not that obvious for the other members of the RIP kinase family 
(Meylan and Tschopp, 2005). However, our data provide undeniable evidence that RIPK4 needs its 
kinase activity at least for its developmental function.This points to the possible interaction of RIPK4 
with a substrate that is functionally regulated by its phosphorylation. Additional exploration of the 
interaction partners of RIPK4 will help to clarify the underlying mechanisms of RIPK4 signaling. 
Because of the high phenotypical reminiscence of the RIPK4 depleted Xenopus embryos with the IRF6 
mutants and morphants (in mice, zebrafish and frog), it will be fundamental to determine whether 
IRF6 is indeed involved in RIPK4 signaling. The perspective of interfering with the function of IRF6 
with a dominant-negative IRF6 variant in combination with the overexpression of RIPK4 in future in 
vivo experiments, may resolve this remaining question and pinpoint the position (up- or 
downstream) of IRF6 in relation to RIPK4 signaling.     
  
Zygotic RIPK4 is necessary for the formation of external openings in Xenopus  
In the final section of the RIPK4 part, we investigated the role of RIPK4 in mouth formation. Since the 
splicing XtRIPK4 morpholino only interfered with the mouth and cloaca development, we examined 
on sagittal sections which step of the mouth formation could be influenced by the depletion of 
RIPK4. Principally, the primary mouth originates from of small depression in the ectoderm, called the 
stomodeum. As development proceeds, the number of cells in the stomodeum and underlying 
endodermal layer decreases, probably by apoptotic cell death. Eventually, a ‘buccopharyngeal 
membrane’ of one or two layers is formed by intercalation. Finally, the membrane gets punctured by 
small perforations and collapses (Dickinson and Sive, 2006). Considering the fact that the RIPK4 
depleted tadpoles were more or less able to form a buccopharyngeal membrane, we suppose that 
the eventual phenotype could be due to an impaired intercalation between the ectodermal and 
endodermal cell layers in the latest phase of mouth formation. We have to keep in mind that 
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although the closed mouth and anus/cloaca phenotype in RIPK4 depleted frog embryos and RIPK4 
knockout mice is very similar, the actual underlying cellular disturbances may be different, at least 
for the mouth. In the mouse knockouts, the mouth is initially opened but later on closes, likely by 
fusion of the apical epithelial surfaces. In contrast, in Xenopus morphants, the aberrant mouth or 
cloaca formation is likely the result of an impaired intercalation.  
A great opportunity for future research lays in the confirmation of the necessity of the RIPK4 kinase 
activity during mouth formation. Similar rescue experiments with hRIPK4 transcripts (i.e. wild type or 
kinase death mutant) could prove this dependence.  
 
General conclusion PART II 
We effectively underlined the necessity of RIPK4 signaling during early development. In Xenopus, it 
appears that maternal RIPK4 is required for the execution of proper gastrulation movements, 
whereas zygotic RIPK4 seems to be indispensable for mouth or cloaca formation. Interestingly, the 
two distinct Xenopus phenotypes point to a similar cellular defect in the mechanism of intercalation. 
Hence, we suggest that xRIPK4 regulates the dynamic cell-cell adhesions, which are required for the 
process of intercalation during embryonic development. However, it remains an open question which 
mediators act downstream or upstream of this RIPK4 regulation. 
Furthermore, using rescue experiments with mutant proteins, we could prove for the first time that 
RIPK4 depends on its kinase activity for its function during gastrulation. We trust that our results on 
the role of RIPK4 during development are a major contribution to the general understanding of RIPK4 
signaling. Future research should put emphasis on the possible interaction partners of RIPK4, which 
should uncover the exact integrated molecular signaling network of RIPK4. 
 
 
 
  
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
References 
 
  
References 175 
Adams, D. S., Keller, R. and Koehl, M. A. (1990). "The mechanics of notochord elongation, straightening and 
stiffening in the embryo of Xenopus laevis." Development 110(1): 115-30. 
Adams, J. M. and Cory, S. (2007). "Bcl-2-regulated apoptosis: mechanism and therapeutic potential." Curr 
Opin Immunol 19(5): 488-96. 
Adams, J. M. and Cory, S. (2007). "The Bcl-2 apoptotic switch in cancer development and therapy." Oncogene 
26(9): 1324-37. 
Amano, T. (1998). "Isolation of genes involved in intestinal remodeling during anuran metamorphosis." Wound 
Repair Regen 6(4): 302-13. 
Aouacheria, A., Brunet, F. and Gouy, M. (2005). "Phylogenomics of life-or-death switches in multicellular 
animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators." Mol Biol Evol 22(12): 2395-
416. 
Arnold, R., Frey, C. R., Muller, W., Brenner, D., Krammer, P. H. and Kiefer, F. (2007). "Sustained JNK 
signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic 
differentiation." Cell Death Differ 14(3): 568-75. 
Bähr, C., Rohwer, A., Stempka, L., Rincke, G., Marks, F. and Gschwendt, M. (2000). "DIK, a novel protein 
kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis." J Biol 
Chem 275(46): 36350-7. 
Bardet, P. L., Kolahgar, G., Mynett, A., Miguel-Aliaga, I., Briscoe, J., Meier, P. and Vincent, J. P. (2008). 
"A fluorescent reporter of caspase activity for live imaging." Proc Natl Acad Sci U S A 105(37): 13901-
5. 
Beck, C. W. and Slack, J. M. (2001). "An amphibian with ambition: a new role for Xenopus in the 21st 
century." Genome Biol 2(10): REVIEWS1029. 
Beisner, D. R., Ch'en, I. L., Kolla, R. V., Hoffmann, A. and Hedrick, S. M. (2005). "Cutting edge: innate 
immunity conferred by B cells is regulated by caspase-8." J Immunol 175(6): 3469-73. 
Bennett, C. M., Kanki, J. P., Rhodes, J., Liu, T. X., Paw, B. H., Kieran, M. W., Langenau, D. M., 
Delahaye-Brown, A., Zon, L. I., Fleming, M. D. and Look, A. T. (2001). "Myelopoiesis in the 
zebrafish, Danio rerio." Blood 98(3): 643-51. 
Berger, A. B., Sexton, K. B. and Bogyo, M. (2006). "Commonly used caspase inhibitors designed based on 
substrate specificity profiles lack selectivity." Cell Res 16(12): 961-3. 
Bergeron, L., Perez, G. I., Macdonald, G., Shi, L., Sun, Y., Jurisicova, A., Varmuza, S., Latham, K. E., 
Flaws, J. A., Salter, J. C., Hara, H., Moskowitz, M. A., Li, E., Greenberg, A., Tilly, J. L. and 
Yuan, J. (1998). "Defects in regulation of apoptosis in caspase-2-deficient mice." Genes Dev 12(9): 
1304-14. 
Bergmann, A. and Steller, H. (2010). "Apoptosis, stem cells, and tissue regeneration." Sci Signal 3(145): re8. 
Berry, D. L., Schwartzman, R. A. and Brown, D. D. (1998). "The expression pattern of thyroid hormone 
response genes in the tadpole tail identifies multiple resorption programs." Dev Biol 203(1): 12-23. 
Bertrand, J. Y., Giroux, S., Golub, R., Klaine, M., Jalil, A., Boucontet, L., Godin, I. and Cumano, A. 
(2005). "Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their 
site of origin." Proc Natl Acad Sci U S A 102(1): 134-9. 
Bever, M. M. and Fekete, D. M. (1999). "Ventromedial focus of cell death is absent during development of 
Xenopus and zebrafish inner ears." J Neurocytol 28(10-11): 781-93. 
Bhuyan, A. K., Varshney, A. and Mathew, M. K. (2001). "Resting membrane potential as a marker of 
apoptosis: studies on Xenopus oocytes microinjected with cytochrome c." Cell Death Differ 8(1): 63-9. 
Biehlmaier, O., Neuhauss, S. C. and Kohler, K. (2001). "Onset and time course of apoptosis in the developing 
zebrafish retina." Cell Tissue Res 306(2): 199-207. 
Black, S., Kadyrov, M., Kaufmann, P., Ugele, B., Emans, N. and Huppertz, B. (2004). "Syncytial fusion of 
human trophoblast depends on caspase 8." Cell Death Differ 11(1): 90-8. 
Blanchard, H., Donepudi, M., Tschopp, M., Kodandapani, L., Wu, J. C. and Grutter, M. G. (2000). 
"Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex." 
J Mol Biol 302(1): 9-16. 
176 
  
 
References 
Blaschke, A. J., Staley, K. and Chun, J. (1996). "Widespread programmed cell death in proliferative and 
postmitotic regions of the fetal cerebral cortex." Development 122(4): 1165-74. 
Blaschke, A. J., Weiner, J. A. and Chun, J. (1998). "Programmed cell death is a universal feature of 
embryonic and postnatal neuroproliferative regions throughout the central nervous system." J Comp 
Neurol 396(1): 39-50. 
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. and Lipton, S. A. (1995). "Apoptosis and necrosis: 
two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or 
nitric oxide/superoxide in cortical cell cultures." Proc Natl Acad Sci U S A 92(16): 7162-6. 
Bonneville, M. A. (1963). "Fine Structural Changes in the Intestinal Epithelium of the Bullfrog during 
Metamorphosis." J Cell Biol 18: 579-97. 
Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., Adams, J. M. and 
Strasser, A. (1999). "Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, 
leukocyte homeostasis, and to preclude autoimmunity." Science 286(5445): 1735-8. 
Boya, P. and de la Rosa, E. J. (2005). "Cell death in early neural life." Birth Defects Res C Embryo Today 
75(4): 281-93. 
Brand, A. H. and Perrimon, N. (1993). "Targeted gene expression as a means of altering cell fates and 
generating dominant phenotypes." Development 118(2): 401-15. 
Brandli, A. W. (1999). "Towards a molecular anatomy of the Xenopus pronephric kidney." Int J Dev Biol 
43(5): 381-95. 
Bratton, S. B. and Salvesen, G. S. (2010). "Regulation of the Apaf-1-caspase-9 apoptosome." J Cell Sci 123(Pt 
19): 3209-14. 
Braun, T., Dar, S., Vorobiov, D., Lindenboim, L., Dascal, N. and Stein, R. (2003). "Expression of Bcl-x(S) in 
Xenopus oocytes induces BH3-dependent and caspase-dependent cytochrome c release and apoptosis." 
Mol Cancer Res 1(3): 186-94. 
Buchholz, D. R., Heimeier, R. A., Das, B., Washington, T. and Shi, Y. B. (2007). "Pairing morphology with 
gene expression in thyroid hormone-induced intestinal remodeling and identification of a core set of 
TH-induced genes across tadpole tissues." Dev Biol 303(2): 576-90. 
Buckbinder, L. and Brown, D. D. (1992). "Thyroid hormone-induced gene expression changes in the 
developing frog limb." J Biol Chem 267(36): 25786-91. 
Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., 
Brundin, P., Englund, E., Venero, J. L. and Joseph, B. (2011). "Caspase signalling controls 
microglia activation and neurotoxicity." Nature 472(7343): 319-24. 
Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L. and Zon, L. I. (2005). "Hematopoietic stem cell fate is 
established by the Notch-Runx pathway." Genes Dev 19(19): 2331-42. 
Canovas, P. M. and Guadagno, T. M. (2007). "Functional analysis of Survivin in spindle assembly in Xenopus 
egg extracts." J Cell Biochem 100(1): 217-29. 
Caprioli, A., Minko, K., Drevon, C., Eichmann, A., Dieterlen-Lievre, F. and Jaffredo, T. (2001). 
"Hemangioblast commitment in the avian allantois: cellular and molecular aspects." Dev Biol 238(1): 
64-78. 
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S. and 
Reed, J. C. (1998). "Regulation of cell death protease caspase-9 by phosphorylation." Science 
282(5392): 1318-21. 
Carlile, G. W., Smith, D. H. and Wiedmann, M. (2004). "Caspase-3 has a nonapoptotic function in erythroid 
maturation." Blood 103(11): 4310-6. 
Carrera, A. C., Alexandrov, K. and Roberts, T. M. (1993). "The conserved lysine of the catalytic domain of 
protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring 
ATP." Proc Natl Acad Sci U S A 90(2): 442-6. 
Carruthers, S. and Stemple, D. L. (2006). "Genetic and genomic prospects for Xenopus tropicalis research." 
Semin Cell Dev Biol 17(1): 146-53. 
  
References 177 
Castrillo, A., Pennington, D. J., Otto, F., Parker, P. J., Owen, M. J. and Bosca, L. (2001). "Protein kinase 
Cepsilon is required for macrophage activation and defense against bacterial infection." J Exp Med 
194(9): 1231-42. 
Cataisson, C., Pearson, A. J., Torgerson, S., Nedospasov, S. A. and Yuspa, S. H. (2005). "Protein kinase C 
alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF 
alpha signaling in mouse skin in vivo." J Immunol 174(3): 1686-92. 
Cathelin, S., Rebe, C., Haddaoui, L., Simioni, N., Verdier, F., Fontenay, M., Launay, S., Mayeux, P. and 
Solary, E. (2006). "Identification of proteins cleaved downstream of caspase activation in monocytes 
undergoing macrophage differentiation." J Biol Chem 281(26): 17779-88. 
Cecconi, F., Alvarez-Bolado, G., Meyer, B. I., Roth, K. A. and Gruss, P. (1998). "Apaf1 (CED-4 homolog) 
regulates programmed cell death in mammalian development." Cell 94(6): 727-37. 
Cen, H., Mao, F., Aronchik, I., Fuentes, R. J. and Firestone, G. L. (2008). "DEVD-NucView488: a novel 
class of enzyme substrates for real-time detection of caspase-3 activity in live cells." FASEB J 22(7): 
2243-52. 
Chai, J., Wu, Q., Shiozaki, E., Srinivasula, S. M., Alnemri, E. S. and Shi, Y. (2001). "Crystal structure of a 
procaspase-7 zymogen: mechanisms of activation and substrate binding." Cell 107(3): 399-407. 
Chalmers, A. D., Pambos, M., Mason, J., Lang, S., Wylie, C. and Papalopulu, N. (2005). "aPKC, Crumbs3 
and Lgl2 control apicobasal polarity in early vertebrate development." Development 132(5): 977-86. 
Chalmers, A. D., Strauss, B. and Papalopulu, N. (2003). "Oriented cell divisions asymmetrically segregate 
aPKC and generate cell fate diversity in the early Xenopus embryo." Development 130(12): 2657-68. 
Chang, L., Kamata, H., Solinas, G., Luo, J. L., Maeda, S., Venuprasad, K., Liu, Y. C. and Karin, M. 
(2006). "The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by 
inducing c-FLIP(L) turnover." Cell 124(3): 601-13. 
Chautan, M., Chazal, G., Cecconi, F., Gruss, P. and Golstein, P. (1999). "Interdigital cell death can occur 
through a necrotic and caspase-independent pathway." Curr Biol 9(17): 967-70. 
Chen, J., Fujii, K., Zhang, L., Roberts, T. and Fu, H. (2001). "Raf-1 promotes cell survival by antagonizing 
apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism." Proc Natl Acad 
Sci U S A 98(14): 7783-8. 
Chen, L., Haider, K., Ponda, M., Cariappa, A., Rowitch, D. and Pillai, S. (2001). "Protein kinase C-
associated kinase (PKK), a novel membrane-associated, ankyrin repeat-containing protein kinase." J 
Biol Chem 276(24): 21737-44. 
Cheng, E. H., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T. and Korsmeyer, S. J. (2001). 
"BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated 
mitochondrial apoptosis." Mol Cell 8(3): 705-11. 
Chida, K., Hara, T., Hirai, T., Konishi, C., Nakamura, K., Nakao, K., Aiba, A., Katsuki, M. and Kuroki, 
T. (2003). "Disruption of protein kinase Ceta results in impairment of wound healing and enhancement 
of tumor formation in mouse skin carcinogenesis." Cancer Res 63(10): 2404-8. 
Chin, A. I., Dempsey, P. W., Bruhn, K., Miller, J. F., Xu, Y. and Cheng, G. (2002). "Involvement of 
receptor-interacting protein 2 in innate and adaptive immune responses." Nature 416(6877): 190-4. 
Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M. and Chan, F. K. (2009). 
"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and 
virus-induced inflammation." Cell 137(6): 1112-23. 
Choi, S. C. and Han, J. K. (2002). "Xenopus Cdc42 regulates convergent extension movements during 
gastrulation through Wnt/Ca2+ signaling pathway." Dev Biol 244(2): 342-57. 
Chou, C. C. and Yung, B. Y. (2001). "Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras 
during serum deprivation." Mol Pharmacol 59(1): 38-45. 
Chun, H. J., Zheng, L., Ahmad, M., Wang, J., Speirs, C. K., Siegel, R. M., Dale, J. K., Puck, J., Davis, J., 
Hall, C. G., Skoda-Smith, S., Atkinson, T. P., Straus, S. E. and Lenardo, M. J. (2002). "Pleiotropic 
defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency." 
Nature 419(6905): 395-9. 
178 
  
 
References 
Ciau-Uitz, A., Walmsley, M. and Patient, R. (2000). "Distinct origins of adult and embryonic blood in 
Xenopus." Cell 102(6): 787-96. 
Clarke, M. C., Savill, J., Jones, D. B., Noble, B. S. and Brown, S. B. (2003). "Compartmentalized 
megakaryocyte death generates functional platelets committed to caspase-independent death." J Cell 
Biol 160(4): 577-87. 
Cleaver, O., Seufert, D. W. and Krieg, P. A. (2000). "Endoderm patterning by the notochord: development of 
the hypochord in Xenopus." Development 127(4): 869-79. 
Coen, L., du Pasquier, D., Le Mevel, S., Brown, S., Tata, J., Mazabraud, A. and Demeneix, B. A. (2001). 
"Xenopus Bcl-X(L) selectively protects Rohon-Beard neurons from metamorphic degeneration." Proc 
Natl Acad Sci U S A 98(14): 7869-74. 
Coen, L., Le Blay, K., Rowe, I. and Demeneix, B. A. (2007). "Caspase-9 regulates apoptosis/proliferation 
balance during metamorphic brain remodeling in Xenopus." Proceedings of the National Academy of 
Sciences of the United States of America 104(20): 8502-7. 
Cohen, G. M. (1997). "Caspases: the executioners of apoptosis." Biochem J 326 ( Pt 1): 1-16. 
Cole, L. K. and Ross, L. S. (2001). "Apoptosis in the developing zebrafish embryo." Dev Biol 240(1): 123-42. 
Conlon, I. and Raff, M. (1999). "Size control in animal development." Cell 96(2): 235-44. 
Cooke, J. and Smith, J. C. (1990). "Measurement of developmental time by cells of early embryos." Cell 60(6): 
891-4. 
Cornelis, S., Bruynooghe, Y., Van Loo, G., Saelens, X., Vandenabeele, P. and Beyaert, R. (2005). 
"Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 
mediated cleavage of Raf-1." Oncogene 24(9): 1552-62. 
Costa, R. M., Soto, X., Chen, Y., Zorn, A. M. and Amaya, E. (2008). "spib is required for primitive myeloid 
development in Xenopus." Blood 112(6): 2287-96. 
Courchesne, C. L. and Bantle, J. A. (1985). "Analysis of the activity of DNA, RNA, and protein synthesis 
inhibitors on Xenopus embryo development." Teratog Carcinog Mutagen 5(3): 177-93. 
Crawford, E. D. and Wells, J. A. (2011). "Caspase substrates and cellular remodeling." Annu Rev Biochem 80: 
1055-87. 
Cruz-Reyes, J. and Tata, J. R. (1995). "Cloning, characterization and expression of two Xenopus bcl-2-like 
cell-survival genes." Gene 158(2): 171-9. 
Cumano, A. and Godin, I. (2007). "Ontogeny of the hematopoietic system." Annu Rev Immunol 25: 745-85. 
Cunliffe, V. T. and Ingham, P. W. (1999). "Switching on the notochord." Genes Dev 13(13): 1643-6. 
D'Amelio, M., Cavallucci, V. and Cecconi, F. "Neuronal caspase-3 signaling: not only cell death." Cell Death 
Differ 17(7): 1104-14. 
Dahm, R. (1999). "Lens fibre cell differentiation - A link with apoptosis?" Ophthalmic Res 31(3): 163-83. 
Danial, N. N. and Korsmeyer, S. J. (2004). "Cell death: critical control points." Cell 116(2): 205-19. 
Das, B., Cai, L., Carter, M. G., Piao, Y. L., Sharov, A. A., Ko, M. S. and Brown, D. D. (2006). "Gene 
expression changes at metamorphosis induced by thyroid hormone in Xenopus laevis tadpoles." Dev 
Biol 291(2): 342-55. 
Das, B., Schreiber, A. M., Huang, H. and Brown, D. D. (2002). "Multiple thyroid hormone-induced muscle 
growth and death programs during metamorphosis in Xenopus laevis." Proc Natl Acad Sci U S A 
99(19): 12230-5. 
Dasse, E., Bridoux, L., Baranek, T., Lambert, E., Salesse, S., Sowa, M. L., Martiny, L., Trentesaux, C. and 
Petitfrere, E. (2007). "Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation 
via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway." Leukemia 21(4): 595-603. 
De Botton, S., Sabri, S., Daugas, E., Zermati, Y., Guidotti, J. E., Hermine, O., Kroemer, G., Vainchenker, 
W. and Debili, N. (2002). "Platelet formation is the consequence of caspase activation within 
megakaryocytes." Blood 100(4): 1310-7. 
  
References 179 
de Graaf, A. O., van den Heuvel, L. P., Dijkman, H. B., de Abreu, R. A., Birkenkamp, K. U., de Witte, T., 
van der Reijden, B. A., Smeitink, J. A. and Jansen, J. H. (2004). "Bcl-2 prevents loss of 
mitochondria in CCCP-induced apoptosis." Exp Cell Res 299(2): 533-40. 
de la Rosa, E. J. and de Pablo, F. (2000). "Cell death in early neural development: beyond the neurotrophic 
theory." Trends Neurosci 23(10): 454-8. 
De Marco, N., Iannone, L., Carotenuto, R., Biffo, S., Vitale, A. and Campanella, C. "p27(BBP)/eIF6 acts as 
an anti-apoptotic factor upstream of Bcl-2 during Xenopus laevis development." Cell Death Differ 
17(2): 360-72. 
De Maria, R., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S. M., 
Alnemri, E. S., Testa, U. and Peschle, C. (1999). "Negative regulation of erythropoiesis by caspase-
mediated cleavage of GATA-1." Nature 401(6752): 489-93. 
De Pietri Tonelli, D., Pulvers, J. N., Haffner, C., Murchison, E. P., Hannon, G. J. and Huttner, W. B. 
(2008). "miRNAs are essential for survival and differentiation of newborn neurons but not for 
expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex." 
Development 135(23): 3911-21. 
Declercq, W., Vanden Berghe, T. and Vandenabeele, P. (2009). "RIP kinases at the crossroads of cell death 
and survival." Cell 138(2): 229-32. 
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., 
Yuan, C., Wagner, G., Hedrick, S. M., Gerber, S. A., Lugovskoy, A. and Yuan, J. (2008). 
"Identification of RIP1 kinase as a specific cellular target of necrostatins." Nat Chem Biol 4(5): 313-21. 
Delvaeye, M., De Vriese, A., Zwerts, F., Betz, I., Moons, M., Autiero, M. and Conway, E. M. (2009). "Role 
of the 2 zebrafish survivin genes in vasculo-angiogenesis, neurogenesis, cardiogenesis and 
hematopoiesis." BMC Dev Biol 9: 25. 
Deming, P. and Kornbluth, S. (2006). "Study of apoptosis in vitro using the Xenopus egg extract reconstitution 
system." Methods Mol Biol 322: 379-93. 
Demon, D., Van Damme, P., Vanden Berghe, T., Deceuninck, A., Van Durme, J., Verspurten, J., Helsens, 
K., Impens, F., Wejda, M., Schymkowitz, J., Rousseau, F., Madder, A., Vandekerckhove, J., 
Declercq, W., Gevaert, K. and Vandenabeele, P. (2009). "Proteome-wide substrate analysis indicates 
substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity." Mol Cell 
Proteomics 8(12): 2700-14. 
Denayer, T., Van Roy, F. and Vleminckx, K. (2006). "In vivo tracing of canonical Wnt signaling in Xenopus 
tadpoles by means of an inducible transgenic reporter tool." FEBS Lett 580(2): 393-8. 
Denver, R. J., Pavgi, S. and Shi, Y. B. (1997). "Thyroid hormone-dependent gene expression program for 
Xenopus neural development." J Biol Chem 272(13): 8179-88. 
Deuchar, E. M. (1975). "Regeneration of the tail bud in Xenopus embryos." J Exp Zool 192(3): 381-90. 
Deveraux, Q. L. and Reed, J. C. (1999). "IAP family proteins--suppressors of apoptosis." Genes Dev 13(3): 
239-52. 
Dickinson, A. J. and Sive, H. (2006). "Development of the primary mouth in Xenopus laevis." Dev Biol 295(2): 
700-13. 
Dieterlen-Lievre, F. (1975). "On the origin of haemopoietic stem cells in the avian embryo: an experimental 
approach." J Embryol Exp Morphol 33(3): 607-19. 
Diwan, A., Koesters, A. G., Odley, A. M., Pushkaran, S., Baines, C. P., Spike, B. T., Daria, D., Jegga, A. 
G., Geiger, H., Aronow, B. J., Molkentin, J. D., Macleod, K. F., Kalfa, T. A. and Dorn, G. W., 2nd 
(2007). "Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic 
modulation of erythropoiesis." Proc Natl Acad Sci U S A 104(16): 6794-9. 
Dix, M. M., Simon, G. M. and Cravatt, B. F. (2008). "Global mapping of the topography and magnitude of 
proteolytic events in apoptosis." Cell 134(4): 679-91. 
Dolznig, H., Habermann, B., Stangl, K., Deiner, E. M., Moriggl, R., Beug, H. and Mullner, E. W. (2002). 
"Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary 
erythroblasts." Curr Biol 12(13): 1076-85. 
180 
  
 
References 
Domen, J. and Weissman, I. L. (2000). "Hematopoietic stem cells need two signals to prevent apoptosis; BCL-
2 can provide one of these, Kitl/c-Kit signaling the other." J Exp Med 192(12): 1707-18. 
Dorn, A. R. and Broyles, R. H. (1982). "Erythrocyte differentiation during the metamorphic hemoglobin switch 
of Rana catesbeiana." Proc Natl Acad Sci U S A 79(18): 5592-6. 
Droin, N., Jacquel, A., Guery, L., Dufour, E., Garrido, C. and Solary, E. (2009). "Various functions of 
caspases in hematopoiesis." Front Biosci 14: 2358-71. 
Du Pasquier, D., Chesneau, A., Ymlahi-Ouazzani, Q., Boistel, R., Pollet, N., Ballagny, C., Sachs, L. M., 
Demeneix, B. and Mazabraud, A. (2007). "tBid mediated activation of the mitochondrial death 
pathway leads to genetic ablation of the lens in Xenopus laevis." Genesis 45(1): 1-10. 
Du Pasquier, D., Phung, A. C., Ymlahi-Ouazzani, Q., Sinzelle, L., Ballagny, C., Bronchain, O., Du 
Pasquier, L. and Mazabraud, A. (2006). "Survivin increased vascular development during Xenopus 
ontogenesis." Differentiation 74(5): 244-53. 
Du Pasquier, D., Rincheval, V., Sinzelle, L., Chesneau, A., Ballagny, C., Sachs, L. M., Demeneix, B. and 
Mazabraud, A. (2006). "Developmental cell death during Xenopus metamorphosis involves BID 
cleavage and caspase 2 and 8 activation." Dev Dyn 235(8): 2083-94. 
Duprez, L., Wirawan, E., Vanden Berghe, T. and Vandenabeele, P. (2009). "Major cell death pathways at a 
glance." Microbes Infect 11(13): 1050-62. 
Dzierzak, E. and Speck, N. A. (2008). "Of lineage and legacy: the development of mammalian hematopoietic 
stem cells." Nat Immunol 9(2): 129-36. 
Eckhart, L., Declercq, W., Ban, J., Rendl, M., Lengauer, B., Mayer, C., Lippens, S., Vandenabeele, P. and 
Tschachler, E. (2000). "Terminal differentiation of human keratinocytes and stratum corneum 
formation is associated with caspase-14 activation." J Invest Dermatol 115(6): 1148-51. 
Edgar, B. A. and Datar, S. A. (1996). "Zygotic degradation of two maternal Cdc25 mRNAs terminates 
Drosophila's early cell cycle program." Genes Dev 10(15): 1966-77. 
Eimon, P. M. and Ashkenazi, A. (2010). "The zebrafish as a model organism for the study of apoptosis." 
Apoptosis 15(3): 331-49. 
Eisen, J. S. and Smith, J. C. (2008). "Controlling morpholino experiments: don't stop making antisense." 
Development 135(10): 1735-43. 
Endo, T., Odb, A., Satoh, I., Haseyama, Y., Nishio, M., Koizumi, K., Takashima, H., Fujimoto, K., 
Amasaki, Y., Fujita, H., Koike, T. and Sawada, K. (2001). "Stem cell factor protects c-kit+ human 
primary erythroid cells from apoptosis." Exp Hematol 29(7): 833-41. 
Estabel, J., Mercer, A., Konig, N. and Exbrayat, J. M. (2003). "Programmed cell death in Xenopus laevis 
spinal cord, tail and other tissues, prior to, and during, metamorphosis." Life Sci 73(25): 3297-306. 
Evan, G. I., Brown, L., Whyte, M. and Harrington, E. (1995). "Apoptosis and the cell cycle." Curr Opin Cell 
Biol 7(6): 825-34. 
Fagotto, F. and Gumbiner, B. M. (1994). "Beta-catenin localization during Xenopus embryogenesis: 
accumulation at tissue and somite boundaries." Development 120(12): 3667-79. 
Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J. and Dinarello, C. A. (1998). "Interleukin-18 
regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-
converting enzyme (caspase-1)-deficient mice." Blood 91(6): 2118-25. 
Faure, S., Cau, J., de Santa Barbara, P., Bigou, S., Ge, Q., Delsert, C. and Morin, N. (2005). "Xenopus p21-
activated kinase 5 regulates blastomeres' adhesive properties during convergent extension movements." 
Dev Biol 277(2): 472-92. 
Ferkowicz, M. J., Starr, M., Xie, X., Li, W., Johnson, S. A., Shelley, W. C., Morrison, P. R. and Yoder, M. 
C. (2003). "CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine 
embryo." Development 130(18): 4393-403. 
Ferkowicz, M. J. and Yoder, M. C. (2005). "Blood island formation: longstanding observations and modern 
interpretations." Exp Hematol 33(9): 1041-7. 
Fernando, P., Brunette, S. and Megeney, L. A. (2005). "Neural stem cell differentiation is dependent upon 
endogenous caspase 3 activity." FASEB J 19(12): 1671-3. 
  
References 181 
Fernando, P., Kelly, J. F., Balazsi, K., Slack, R. S. and Megeney, L. A. (2002). "Caspase 3 activity is required 
for skeletal muscle differentiation." Proc Natl Acad Sci U S A 99(17): 11025-30. 
Fernando, P. and Megeney, L. A. (2007). "Is caspase-dependent apoptosis only cell differentiation taken to the 
extreme?" FASEB J 21(1): 8-17. 
Festjens, N., Vanden Berghe, T., Cornelis, S. and Vandenabeele, P. (2007). "RIP1, a kinase on the crossroads 
of a cell's decision to live or die." Cell Death Differ 14(3): 400-10. 
Finkielstein, C. V., Lewellyn, A. L. and Maller, J. L. (2001). "The midblastula transition in Xenopus embryos 
activates multiple pathways to prevent apoptosis in response to DNA damage." Proc Natl Acad Sci U S 
A 98(3): 1006-11. 
Fischer, J. A., Giniger, E., Maniatis, T. and Ptashne, M. (1988). "GAL4 activates transcription in 
Drosophila." Nature 332(6167): 853-6. 
Fischer, U., Janicke, R. U. and Schulze-Osthoff, K. (2003). "Many cuts to ruin: a comprehensive update of 
caspase substrates." Cell Death Differ 10(1): 76-100. 
Fleming, A., Keynes, R. J. and Tannahill, D. (2001). "The role of the notochord in vertebral column 
formation." J Anat 199(Pt 1-2): 177-80. 
Friedlander, R. M., Gagliardini, V., Hara, H., Fink, K. B., Li, W., MacDonald, G., Fishman, M. C., 
Greenberg, A. H., Moskowitz, M. A. and Yuan, J. (1997). "Expression of a dominant negative 
mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced 
by trophic factor withdrawal and ischemic brain injury." J Exp Med 185(5): 933-40. 
Frost, V., Al-Mehairi, S. and Sinclair, A. J. (2001). "Exploitation of a non-apoptotic caspase to regulate the 
abundance of the cdkI p27(KIP1) in transformed lymphoid cells." Oncogene 20(22): 2737-48. 
Fu, G., Chumanevich, A. A., Agniswamy, J., Fang, B., Harrison, R. W. and Weber, I. T. (2008). "Structural 
basis for executioner caspase recognition of P5 position in substrates." Apoptosis 13(11): 1291-302. 
Fuentes-Prior, P. and Salvesen, G. S. (2004). "The protein structures that shape caspase activity, specificity, 
activation and inhibition." Biochem J 384(Pt 2): 201-32. 
Fujita, J., Crane, A. M., Souza, M. K., Dejosez, M., Kyba, M., Flavell, R. A., Thomson, J. A. and Zwaka, 
T. P. (2008). "Caspase activity mediates the differentiation of embryonic stem cells." Cell Stem Cell 
2(6): 595-601. 
Fukuda, S., Foster, R. G., Porter, S. B. and Pelus, L. M. (2002). "The antiapoptosis protein survivin is 
associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and 
proliferation of mouse hematopoietic progenitor cells." Blood 100(7): 2463-71. 
Fukuda, S. and Pelus, L. M. (2002). "Elevation of Survivin levels by hematopoietic growth factors occurs in 
quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry." Cell Cycle 1(5): 
322-6. 
Galloway, J. L. and Zon, L. I. (2003). "Ontogeny of hematopoiesis: examining the emergence of hematopoietic 
cells in the vertebrate embryo." Curr Top Dev Biol 53: 139-58. 
Galluzzi, L., Joza, N., Tasdemir, E., Maiuri, M. C., Hengartner, M., Abrams, J. M., Tavernarakis, N., 
Penninger, J., Madeo, F. and Kroemer, G. (2008). "No death without life: vital functions of apoptotic 
effectors." Cell Death Differ 15(7): 1113-23. 
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L. and Kroemer, G. (2007). "Cell 
death modalities: classification and pathophysiological implications." Cell Death Differ 14(7): 1237-43. 
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. 
M., Dawson, V. L., El-Deiry, W. S., Fulda, S., Gottlieb, E., Green, D. R., Hengartner, M. O., 
Kepp, O., Knight, R. A., Kumar, S., Lipton, S. A., Lu, X., Madeo, F., Malorni, W., Mehlen, P., 
Nunez, G., Peter, M. E., Piacentini, M., Rubinsztein, D. C., Shi, Y., Simon, H. U., Vandenabeele, 
P., White, E., Yuan, J., Zhivotovsky, B., Melino, G. and Kroemer, G. (2011). "Molecular definitions 
of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012." Cell 
Death Differ. 
Gan, H., Newman, G. W. and Remold, H. G. (1995). "Plasminogen activator inhibitor type 2 prevents 
programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4." J 
Immunol 155(3): 1304-15. 
182 
  
 
References 
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W. and Thornberry, N. A. (1998). 
"Inhibition of human caspases by peptide-based and macromolecular inhibitors." J Biol Chem 273(49): 
32608-13. 
Gardiner, D. M., Endo, T. and Bryant, S. V. (2002). "The molecular basis of amphibian limb regeneration: 
integrating the old with the new." Semin Cell Dev Biol 13(5): 345-52. 
Glucksmann, A. (1965). "Cell death in normal development." Arch Biol (Liege) 76(2): 419-37. 
Goyal, L. (2001). "Cell death inhibition: keeping caspases in check." Cell 104(6): 805-8. 
Grabher, C. and Wittbrodt, J. (2004). "Efficient activation of gene expression using a heat-shock inducible 
Gal4/Vp16-UAS system in medaka." BMC Biotechnol 4: 26. 
Green, D. and Kroemer, G. (1998). "The central executioners of apoptosis: caspases or mitochondria?" Trends 
Cell Biol 8(7): 267-71. 
Green, D. R. and Kroemer, G. (2004). "The pathophysiology of mitochondrial cell death." Science 305(5684): 
626-9. 
Greenwood, J. and Gautier, J. (2005). "From oogenesis through gastrulation: developmental regulation of 
apoptosis." Semin Cell Dev Biol 16(2): 215-24. 
Greenwood, J. and Gautier, J. (2007). "XLX is an IAP family member regulated by phosphorylation during 
meiosis." Cell Death Differ 14(3): 559-67. 
Growney, J. D. and Dietrich, W. F. (2000). "High-resolution genetic and physical map of the Lgn1 interval in 
C57BL/6J implicates Naip2 or Naip5 in Legionella pneumophila pathogenesis." Genome Res 10(8): 
1158-71. 
Guerin, M. B., McKernan, D. P., O'Brien, C. J. and Cotter, T. G. (2006). "Retinal ganglion cells: dying to 
survive." Int J Dev Biol 50(8): 665-74. 
Guery, L., Benikhlef, N., Gautier, T., Paul, C., Jego, G., Dufour, E., Jacquel, A., Cally, R., Manoury, B., 
Vanden Berghe, T., Vandenabeele, P., Droin, N. and Solary, E. (2011). "Fine-tuning nucleophosmin 
in macrophage differentiation and activation." Blood. 
Gurbuxani, S., Xu, Y., Keerthivasan, G., Wickrema, A. and Crispino, J. D. (2005). "Differential 
requirements for survivin in hematopoietic cell development." Proc Natl Acad Sci U S A 102(32): 
11480-5. 
Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. 
L., Kagi, D., Khoo, W., Potter, J., Yoshida, R., Kaufman, S. A., Lowe, S. W., Penninger, J. M. and 
Mak, T. W. (1998). "Differential requirement for caspase 9 in apoptotic pathways in vivo." Cell 94(3): 
339-52. 
Halpern, M. E., Rhee, J., Goll, M. G., Akitake, C. M., Parsons, M. and Leach, S. D. (2008). "Gal4/UAS 
transgenic tools and their application to zebrafish." Zebrafish 5(2): 97-110. 
Hara, T., Saito, Y., Hirai, T., Nakamura, K., Nakao, K., Katsuki, M. and Chida, K. (2005). "Deficiency of 
protein kinase Calpha in mice results in impairment of epidermal hyperplasia and enhancement of 
tumor formation in two-stage skin carcinogenesis." Cancer Res 65(16): 7356-62. 
Hardin, J. and Keller, R. (1988). "The behaviour and function of bottle cells during gastrulation of Xenopus 
laevis." Development 103(1): 211-30. 
Harland, R. M. (1991). "In situ hybridization: an improved whole-mount method for Xenopus embryos." 
Methods Cell Biol 36: 685-95. 
Harris, W. A. and Hartenstein, V. (1991). "Neuronal determination without cell division in Xenopus 
embryos." Neuron 6(4): 499-515. 
Hawkins, C. J., Wang, S. L. and Hay, B. A. (1999). "A cloning method to identify caspases and their 
regulators in yeast: identification of Drosophila IAP1 as an inhibitor of the Drosophila caspase DCP-1." 
Proc Natl Acad Sci U S A 96(6): 2885-90. 
Hay, E. D. (1995). "An overview of epithelio-mesenchymal transformation." Acta Anat (Basel) 154(1): 8-20. 
  
References 183 
Heasman, J., Ginsberg, D., Geiger, B., Goldstone, K., Pratt, T., Yoshida-Noro, C. and Wylie, C. (1994). "A 
functional test for maternally inherited cadherin in Xenopus shows its importance in cell adhesion at the 
blastula stage." Development 120(1): 49-57. 
Helbing, C. C., Werry, K., Crump, D., Domanski, D., Veldhoen, N. and Bailey, C. M. (2003). "Expression 
profiles of novel thyroid hormone-responsive genes and proteins in the tail of Xenopus laevis tadpoles 
undergoing precocious metamorphosis." Mol Endocrinol 17(7): 1395-409. 
Helfrich, I., Schmitz, A., Zigrino, P., Michels, C., Haase, I., le Bivic, A., Leitges, M. and Niessen, C. M. 
(2007). "Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier 
formation." J Invest Dermatol 127(4): 782-91. 
Hens, M. D., Nikolic, I. and Woolcock, C. M. (2002). "Regulation of Xenopus embryonic cell adhesion by the 
small GTPase, rac." Biochem Biophys Res Commun 298(3): 364-70. 
Hensey, C. and Gautier, J. (1997). "A developmental timer that regulates apoptosis at the onset of 
gastrulation." Mech Dev 69(1-2): 183-95. 
Hensey, C. and Gautier, J. (1998). "Programmed cell death during Xenopus development: a spatio-temporal 
analysis." Dev Biol 203(1): 36-48. 
Herron, B. J., Liddell, R. A., Parker, A., Grant, S., Kinne, J., Fisher, J. K. and Siracusa, L. D. (2005). "A 
mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice." Nat Genet 37(11): 
1210-2. 
Herzberg, F., Wildermuth, V. and Wedlich, D. (1991). "Expression of XBcad, a novel cadherin, during 
oogenesis and early development of Xenopus." Mech Dev 35(1): 33-42. 
Hirata, M. and Hall, B. K. (2000). "Temporospatial patterns of apoptosis in chick embryos during the 
morphogenetic period of development." Int J Dev Biol 44(7): 757-68. 
Holcik, M. and Korneluk, R. G. (2001). "XIAP, the guardian angel." Nat Rev Mol Cell Biol 2(7): 550-6. 
Holland, P., Willis, C., Kanaly, S., Glaccum, M., Warren, A., Charrier, K., Murison, J., Derry, J., Virca, 
G., Bird, T. and Peschon, J. (2002). "RIP4 is an ankyrin repeat-containing kinase essential for 
keratinocyte differentiation." Curr Biol 12(16): 1424-8. 
Hong, J. R., Lin, G. H., Lin, C. J., Wang, W. P., Lee, C. C., Lin, T. L. and Wu, J. L. (2004). 
"Phosphatidylserine receptor is required for the engulfment of dead apoptotic cells and for normal 
embryonic development in zebrafish." Development 131(21): 5417-27. 
Hoste, E., Kemperman, P., Devos, M., Denecker, G., Kezic, S., Yau, N., Gilbert, B., Lippens, S., De Groote, 
P., Roelandt, R., Van Damme, P., Gevaert, K., Presland, R. B., Takahara, H., Puppels, G., 
Caspers, P., Vandenabeele, P. and Declercq, W. (2011). "Caspase-14 is required for filaggrin 
degradation to natural moisturizing factors in the skin." J Invest Dermatol 131(11): 2233-41. 
Houde, C., Banks, K. G., Coulombe, N., Rasper, D., Grimm, E., Roy, S., Simpson, E. M. and Nicholson, D. 
W. (2004). "Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain 
phenotype of caspase-3-null mice." J Neurosci 24(44): 9977-84. 
Howe, J. A. and Newport, J. W. (1996). "A developmental timer regulates degradation of cyclin E1 at the 
midblastula transition during Xenopus embryogenesis." Proc Natl Acad Sci U S A 93(5): 2060-4. 
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999). 
"Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB 
kinase." Science 284(5412): 316-20. 
Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F. F., O'Sullivan, B., He, Z., Peng, Y., Tan, A. C., Zhou, L., 
Shen, J., Han, G., Wang, X. J., Thorburn, J., Thorburn, A., Jimeno, A., Raben, D., Bedford, J. S. 
and Li, C. Y. (2011). "Caspase 3-mediated stimulation of tumor cell repopulation during cancer 
radiotherapy." Nat Med 17(7): 860-6. 
Hulpiau, P. and van Roy, F. (2009). "Molecular evolution of the cadherin superfamily." Int J Biochem Cell 
Biol 41(2): 349-69. 
Iijima, N. and Yokoyama, T. (2007). "Apoptosis in the medaka embryo in the early developmental stage." Acta 
Histochem Cytochem 40(1): 1-7. 
184 
  
 
References 
Ikegami, R., Hunter, P. and Yager, T. D. (1999). "Developmental activation of the capability to undergo 
checkpoint-induced apoptosis in the early zebrafish embryo." Dev Biol 209(2): 409-33. 
Ikegami, R., Zhang, J., Rivera-Bennetts, A. K. and Yager, T. D. (1997). "Activation of the metaphase 
checkpoint and an apoptosis programme in the early zebrafish embryo, by treatment with the spindle-
destabilising agent nocodazole." Zygote 5(4): 329-50. 
Ingley, E., Tilbrook, P. A. and Klinken, S. P. (2004). "New insights into the regulation of erythroid cells." 
IUBMB Life 56(4): 177-84. 
Ingraham, C. R., Kinoshita, A., Kondo, S., Yang, B., Sajan, S., Trout, K. J., Malik, M. I., Dunnwald, M., 
Goudy, S. L., Lovett, M., Murray, J. C. and Schutte, B. C. (2006). "Abnormal skin, limb and 
craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)." Nat Genet 
38(11): 1335-40. 
Inman, K. E. and Downs, K. M. (2007). "The murine allantois: emerging paradigms in development of the 
mammalian umbilical cord and its relation to the fetus." Genesis 45(5): 237-58. 
Inoue, J., Yagi, S., Ishikawa, K., Azuma, S., Ikawa, S. and Semba, K. (2005). "Identification and 
characterization of Xenopus laevis homologs of mammalian TRAF6 and its binding protein TIFA." 
Gene 358: 53-9. 
Ishizaki, Y., Jacobson, M. D. and Raff, M. C. (1998). "A role for caspases in lens fiber differentiation." J Cell 
Biol 140(1): 153-8. 
Ishizawa, Y. H., Tamura, K., Yamaguchi, T., Matsumoto, K., Komiyama, M., Takamatsu, N., Shiba, T. 
and Ito, M. (2006). "Xenopus death-domain-containing proteins FADD and RIP1 synergistically 
activate JNK and NF-kappaB." Biol Cell 98(8): 465-78. 
Ishizuya-Oka, A. (2011). "Amphibian organ remodeling during metamorphosis: insight into thyroid hormone-
induced apoptosis." Dev Growth Differ 53(2): 202-12. 
Ishizuya-Oka, A., Hasebe, T. and Shi, Y. B. "Apoptosis in amphibian organs during metamorphosis." 
Apoptosis 15(3): 350-64. 
Ishizuya-Oka, A., Li, Q., Amano, T., Damjanovski, S., Ueda, S. and Shi, Y. B. (2000). "Requirement for 
matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in 
Xenopus laevis." J Cell Biol 150(5): 1177-88. 
Ishizuya-Oka, A. and Shimozawa, A. (1992). "Programmed cell death and heterolysis of larval epithelial cells 
by macrophage-like cells in the anuran small intestine in vivo and in vitro." J Morphol 213(2): 185-95. 
Ishizuya-Oka, A. and Ueda, S. (1996). "Apoptosis and cell proliferation in the Xenopus small intestine during 
metamorphosis." Cell Tissue Res 286(3): 467-76. 
Izutsu, Y. and Yoshizato, K. (1993). "Metamorphosis-dependent recognition of larval skin as non-self by 
inbred adult frogs (Xenopus laevis)." J Exp Zool 266(2): 163-7. 
Jacobson, M. D., Weil, M. and Raff, M. C. (1997). "Programmed cell death in animal development." Cell 
88(3): 347-54. 
Jakobi, R., Moertl, E. and Koeppel, M. A. (2001). "p21-activated protein kinase gamma-PAK suppresses 
programmed cell death of BALB3T3 fibroblasts." J Biol Chem 276(20): 16624-34. 
Jansen, A. P., Dreckschmidt, N. E., Verwiebe, E. G., Wheeler, D. L., Oberley, T. D. and Verma, A. K. 
(2001). "Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different 
skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice." 
Int J Cancer 93(5): 635-43. 
Janssens, S. and Beyaert, R. (2003). "Functional diversity and regulation of different interleukin-1 receptor-
associated kinase (IRAK) family members." Mol Cell 11(2): 293-302. 
Jeanes, A., Gottardi, C. J. and Yap, A. S. (2008). "Cadherins and cancer: how does cadherin dysfunction 
promote tumor progression?" Oncogene 27(55): 6920-9. 
Jensen, P. H., Cressey, L. I., Gjertsen, B. T., Madsen, P., Mellgren, G., Hokland, P., Gliemann, J., 
Doskeland, S. O., Lanotte, M. and Vintermyr, O. K. (1994). "Cleaved intracellular plasminogen 
activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis." Br J Cancer 70(5): 834-
40. 
  
References 185 
Johnson, C. E., Freel, C. D. and Kornbluth, S. (2009). "Features of programmed cell death in intact Xenopus 
oocytes and early embryos revealed by near-infrared fluorescence and real-time monitoring." Cell 
Death Differ 17(1): 170-9. 
Johnson, C. E., Freel, C. D. and Kornbluth, S. (2010). "Features of programmed cell death in intact Xenopus 
oocytes and early embryos revealed by near-infrared fluorescence and real-time monitoring." Cell 
Death Differ 17(1): 170-9. 
Johnston, J., Chan, R., Calderon-Segura, M., McFarlane, S. and Browder, L. W. (2005). "The roles of Bcl-
xL in modulating apoptosis during development of Xenopus laevis." BMC Dev Biol 5: 20. 
Jones, E. A., Baron, M. H., Fraser, S. E. and Dickinson, M. E. (2004). "Measuring hemodynamic changes 
during mammalian development." Am J Physiol Heart Circ Physiol 287(4): H1561-9. 
Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y., Sasaki, T., Elia, A. J., Cheng, H. 
Y., Ravagnan, L., Ferri, K. F., Zamzami, N., Wakeham, A., Hakem, R., Yoshida, H., Kong, Y. Y., 
Mak, T. W., Zuniga-Pflucker, J. C., Kroemer, G. and Penninger, J. M. (2001). "Essential role of 
the mitochondrial apoptosis-inducing factor in programmed cell death." Nature 410(6828): 549-54. 
Kaluzhny, Y., Yu, G., Sun, S., Toselli, P. A., Nieswandt, B., Jackson, C. W. and Ravid, K. (2002). "BclxL 
overexpression in megakaryocytes leads to impaired platelet fragmentation." Blood 100(5): 1670-8. 
Kang, S. J., Wang, S., Hara, H., Peterson, E. P., Namura, S., Amin-Hanjani, S., Huang, Z., Srinivasan, A., 
Tomaselli, K. J., Thornberry, N. A., Moskowitz, M. A. and Yuan, J. (2000). "Dual role of caspase-
11 in mediating activation of caspase-1 and caspase-3 under pathological conditions." J Cell Biol 
149(3): 613-22. 
Kang, T. B., Ben-Moshe, T., Varfolomeev, E. E., Pewzner-Jung, Y., Yogev, N., Jurewicz, A., Waisman, A., 
Brenner, O., Haffner, R., Gustafsson, E., Ramakrishnan, P., Lapidot, T. and Wallach, D. (2004). 
"Caspase-8 serves both apoptotic and nonapoptotic roles." J Immunol 173(5): 2976-84. 
Kashiwagi, K., Kashiwagi, A., Kurabayashi, A., Hanada, H., Nakajima, K., Okada, M., Takase, M. and 
Yaoita, Y. (2010). "Xenopus tropicalis: an ideal experimental animal in amphibia." Exp Anim 59(4): 
395-405. 
Kau, C. L. and Turpen, J. B. (1983). "Dual contribution of embryonic ventral blood island and dorsal lateral 
plate mesoderm during ontogeny of hemopoietic cells in Xenopus laevis." J Immunol 131(5): 2262-6. 
Keller, R. E. (1980). "The cellular basis of epiboly: an SEM study of deep-cell rearrangement during 
gastrulation in Xenopus laevis." J Embryol Exp Morphol 60: 201-34. 
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z. and Leder, P. (1998). "The death domain 
kinase RIP mediates the TNF-induced NF-kappaB signal." Immunity 8(3): 297-303. 
Kerr, J. F., Harmon, B. and Searle, J. (1974). "An electron-microscope study of cell deletion in the anuran 
tadpole tail during spontaneous metamorphosis with special reference to apoptosis of striated muscle 
fibers." J Cell Sci 14(3): 571-85. 
Kerr, J. F., Wyllie, A. H. and Currie, A. R. (1972). "Apoptosis: a basic biological phenomenon with wide-
ranging implications in tissue kinetics." Br J Cancer 26(4): 239-57. 
Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J. C., Ihle, J. N., Beug, H. and Decker, T. 
(2000). "Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation." 
Genes Dev 14(2): 232-44. 
Kim, S. W., Oleksyn, D. W., Rossi, R. M., Jordan, C. T., Sanz, I., Chen, L. and Zhao, J. (2008). "Protein 
kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell 
lymphoma cells." Blood 111(3): 1644-53. 
Kloc, M., Shirato, Y., Bilinski, S., Browder, L. W. and Johnston, J. (2007). "Differential subcellular 
sequestration of proapoptotic and antiapoptotic proteins and colocalization of Bcl-x(L) with the germ 
plasm, in Xenopus laevis oocytes." Genesis 45(8): 523-31. 
Knight, A. S., Schutte, B. C., Jiang, R. and Dixon, M. J. (2006). "Developmental expression analysis of the 
mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome." Dev Dyn 
235(5): 1441-7. 
186 
  
 
References 
Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Nunez, G., Janeway, C. A., Medzhitov, R. and 
Flavell, R. A. (2002). "RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and 
adaptive immune systems." Nature 416(6877): 194-9. 
Kolbus, A., Pilat, S., Husak, Z., Deiner, E. M., Stengl, G., Beug, H. and Baccarini, M. (2002). "Raf-1 
antagonizes erythroid differentiation by restraining caspase activation." J Exp Med 196(10): 1347-53. 
Kominami, K., Takagi, C., Kurata, T., Kitayama, A., Nozaki, M., Sawasaki, T., Kuida, K., Endo, Y., 
Manabe, N., Ueno, N. and Sakamaki, K. (2006). "The initiator caspase, caspase-10beta, and the BH-
3-only molecule, Bid, demonstrate evolutionary conservation in Xenopus of their pro-apoptotic 
activities in the extrinsic and intrinsic pathways." Genes Cells 11(7): 701-17. 
Kondo, S., Schutte, B. C., Richardson, R. J., Bjork, B. C., Knight, A. S., Watanabe, Y., Howard, E., de 
Lima, R. L., Daack-Hirsch, S., Sander, A., McDonald-McGinn, D. M., Zackai, E. H., Lammer, E. 
J., Aylsworth, A. S., Ardinger, H. H., Lidral, A. C., Pober, B. R., Moreno, L., Arcos-Burgos, M., 
Valencia, C., Houdayer, C., Bahuau, M., Moretti-Ferreira, D., Richieri-Costa, A., Dixon, M. J. 
and Murray, J. C. (2002). "Mutations in IRF6 cause Van der Woude and popliteal pterygium 
syndromes." Nat Genet 32(2): 285-9. 
Kondo, S., Senoo-Matsuda, N., Hiromi, Y. and Miura, M. (2006). "DRONC coordinates cell death and 
compensatory proliferation." Mol Cell Biol 26(19): 7258-68. 
Kornbluth, S. (1997). "Apoptosis in Xenopus egg extracts." Methods Enzymol 283: 600-14. 
Koster, R. W. and Fraser, S. E. (2001). "Tracing transgene expression in living zebrafish embryos." Dev Biol 
233(2): 329-46. 
Koury, M. J. and Bondurant, M. C. (1990). "Erythropoietin retards DNA breakdown and prevents 
programmed death in erythroid progenitor cells." Science 248(4953): 378-81. 
Krauss, S. W., Lo, A. J., Short, S. A., Koury, M. J., Mohandas, N. and Chasis, J. A. (2005). "Nuclear 
substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase 
cleavage of major nuclear substructural proteins." Blood 106(6): 2200-5. 
Krieser, R. J. and White, K. (2009). "Inside an enigma: do mitochondria contribute to cell death in 
Drosophila?" Apoptosis 14(8): 961-8. 
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, 
M. V., El-Deiry, W. S., Golstein, P., Green, D. R., Hengartner, M., Knight, R. A., Kumar, S., 
Lipton, S. A., Malorni, W., Nunez, G., Peter, M. E., Tschopp, J., Yuan, J., Piacentini, M., 
Zhivotovsky, B. and Melino, G. (2009). "Classification of cell death: recommendations of the 
Nomenclature Committee on Cell Death 2009." Cell Death Differ 16(1): 3-11. 
Kuan, C. Y., Roth, K. A., Flavell, R. A. and Rakic, P. (2000). "Mechanisms of programmed cell death in the 
developing brain." Trends Neurosci 23(7): 291-7. 
Kuida, K., Haydar, T. F., Kuan, C. Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S., Rakic, P. and Flavell, 
R. A. (1998). "Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking 
caspase 9." Cell 94(3): 325-37. 
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. and Flavell, R. A. (1995). 
"Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme." 
Science 267(5206): 2000-3. 
Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P. and Flavell, R. A. (1996). 
"Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice." Nature 384(6607): 
368-72. 
Kuranaga, E. and Miura, M. (2007). "Nonapoptotic functions of caspases: caspases as regulatory molecules 
for immunity and cell-fate determination." Trends Cell Biol 17(3): 135-44. 
Kurata, S. (2010). "Fly immunity: recognition of pathogens and induction of immune responses." Adv Exp Med 
Biol 708: 205-17. 
Kwan, T. T., Liang, R., Verfaillie, C. M., Ekker, S. C., Chan, L. C., Lin, S. and Leung, A. Y. (2006). 
"Regulation of primitive hematopoiesis in zebrafish embryos by the death receptor gene." Exp Hematol 
34(1): 27-34. 
  
References 187 
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S. and Korneluk, R. G. (2008). "IAP-
targeted therapies for cancer." Oncogene 27(48): 6252-75. 
Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Jr., Booth, C. J., Mehal, W. Z., Inayat, I. and Flavell, 
R. A. (2006). "Caspases 3 and 7: key mediators of mitochondrial events of apoptosis." Science 
311(5762): 847-51. 
Lamkanfi, M., Declercq, W., Kalai, M., Saelens, X. and Vandenabeele, P. (2002). "Alice in caspase land. A 
phylogenetic analysis of caspases from worm to man." Cell Death Differ 9(4): 358-61. 
Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T. and Vandenabeele, P. (2007). "Caspases in 
cell survival, proliferation and differentiation." Cell Death Differ 14(1): 44-55. 
Lamkanfi, M. and Kanneganti, T. D. (2010). "Caspase-7: a protease involved in apoptosis and inflammation." 
Int J Biochem Cell Biol 42(1): 21-4. 
Lang, H., Bever, M. M. and Fekete, D. M. (2000). "Cell proliferation and cell death in the developing chick 
inner ear: spatial and temporal patterns." J Comp Neurol 417(2): 205-20. 
Lee, A., Morrow, J. S. and Fowler, V. M. (2001). "Caspase remodeling of the spectrin membrane skeleton 
during lens development and aging." J Biol Chem 276(23): 20735-42. 
Lee, C. H. and Gumbiner, B. M. (1995). "Disruption of gastrulation movements in Xenopus by a dominant-
negative mutant for C-cadherin." Dev Biol 171(2): 363-73. 
Lee, T. H., Shank, J., Cusson, N. and Kelliher, M. A. (2004). "The kinase activity of Rip1 is not required for 
tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the 
ubiquitination of Rip1 by Traf2." J Biol Chem 279(32): 33185-91. 
Lee, Y. S., Dlugosz, A. A., McKay, R., Dean, N. M. and Yuspa, S. H. (1997). "Definition by specific antisense 
oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal 
and neoplastic mouse epidermal keratinocytes." Mol Carcinog 18(1): 44-53. 
Leibowitz, B. and Yu, J. (2010). "Mitochondrial signaling in cell death via the Bcl-2 family." Cancer Biol Ther 
9(6): 417-22. 
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J. F., Camacho, F., Diaz-Meco, M. T., 
Rennert, P. D. and Moscat, J. (2001). "Targeted disruption of the zetaPKC gene results in the 
impairment of the NF-kappaB pathway." Mol Cell 8(4): 771-80. 
Lemaire, C., Godefroy, N., Costina-Parvu, I., Rincheval, V., Renaud, F., Trotot, P., Bouleau, S., Mignotte, 
B. and Vayssiere, J. L. (2005). "Caspase-9 can antagonize p53-induced apoptosis by generating a 
p76(Rb) truncated form of Rb." Oncogene 24(20): 3297-308. 
Leonard, J. R., Klocke, B. J., D'Sa, C., Flavell, R. A. and Roth, K. A. (2002). "Strain-dependent 
neurodevelopmental abnormalities in caspase-3-deficient mice." J Neuropathol Exp Neurol 61(8): 673-
7. 
Leong, S. M., Tan, B. X., Bte Ahmad, B., Yan, T., Chee, L. Y., Ang, S. T., Tay, K. G., Koh, L. P., Yeoh, A. 
E., Koay, E. S., Mok, Y. K. and Lim, T. M. (2010). "Mutant nucleophosmin deregulates cell death 
and myeloid differentiation through excessive caspase-6 and -8 inhibition." Blood 116(17): 3286-96. 
Leptin, M. (2005). "Gastrulation movements: the logic and the nuts and bolts." Dev Cell 8(3): 305-20. 
Leung, C. G., Xu, Y., Mularski, B., Liu, H., Gurbuxani, S. and Crispino, J. D. (2007). "Requirements for 
survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and 
progenitor cells." J Exp Med 204(7): 1603-11. 
Levi, G., Gumbiner, B. and Thiery, J. P. (1991). "The distribution of E-cadherin during Xenopus laevis 
development." Development 111(1): 159-69. 
Li, F. and Ling, X. (2006). "Survivin study: an update of "what is the next wave"?" J Cell Physiol 208(3): 476-
86. 
Li, K., Li, Y., Shelton, J. M., Richardson, J. A., Spencer, E., Chen, Z. J., Wang, X. and Williams, R. S. 
(2000). "Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis." 
Cell 101(4): 389-99. 
188 
  
 
References 
Li, L., Qiu, L., Song, L., Song, X., Zhao, J., Wang, L., Mu, C. and Zhang, H. (2009). "First molluscan TNFR 
homologue in Zhikong scallop: molecular characterization and expression analysis." Fish Shellfish 
Immunol 27(5): 625-32. 
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, 
L., Salfeld, J. and et al. (1995). "Mice deficient in IL-1 beta-converting enzyme are defective in 
production of mature IL-1 beta and resistant to endotoxic shock." Cell 80(3): 401-11. 
Li, P., Allen, H., Banerjee, S. and Seshadri, T. (1997). "Characterization of mice deficient in interleukin-1 beta 
converting enzyme." J Cell Biochem 64(1): 27-32. 
Li, Q., Lu, Q., Estepa, G. and Verma, I. M. (2005). "Identification of 14-3-3sigma mutation causing cutaneous 
abnormality in repeated-epilation mutant mouse." Proc Natl Acad Sci U S A 102(44): 15977-82. 
Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K. F., Izpisua-Belmonte, J. C. and Verma, I. M. (1999). 
"IKK1-deficient mice exhibit abnormal development of skin and skeleton." Genes Dev 13(10): 1322-8. 
Lian, X. and Yang, T. (2004). "Plasminogen activator inhibitor 2: expression and role in differentiation of 
epidermal keratinocyte." Biol Cell 96(2): 109-16. 
Lim, M. J. and Wang, X. W. (2006). "Nucleophosmin and human cancer." Cancer Detect Prev 30(6): 481-90. 
Lin, Y., Devin, A., Rodriguez, Y. and Liu, Z. G. (1999). "Cleavage of the death domain kinase RIP by 
caspase-8 prompts TNF-induced apoptosis." Genes Dev 13(19): 2514-26. 
Lindsten, T. and Thompson, C. B. (2006). "Cell death in the absence of Bax and Bak." Cell Death Differ 
13(8): 1272-6. 
Lippens, S., Kockx, M., Knaapen, M., Mortier, L., Polakowska, R., Verheyen, A., Garmyn, M., Zwijsen, 
A., Formstecher, P., Huylebroeck, D., Vandenabeele, P. and Declercq, W. (2000). "Epidermal 
differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-
14 induction and processing." Cell Death Differ 7(12): 1218-24. 
Liu, F., Walmsley, M., Rodaway, A. and Patient, R. (2008). "Fli1 acts at the top of the transcriptional network 
driving blood and endothelial development." Curr Biol 18(16): 1234-40. 
Longo, D., Peirce, S. M., Skalak, T. C., Davidson, L., Marsden, M., Dzamba, B. and DeSimone, D. W. 
(2004). "Multicellular computer simulation of morphogenesis: blastocoel roof thinning and matrix 
assembly in Xenopus laevis." Dev Biol 271(1): 210-22. 
Lui, J. C. and Kong, S. K. (2006). "Erythropoietin activates caspase-3 and downregulates CAD during 
erythroid differentiation in TF-1 cells - a protection mechanism against DNA fragmentation." FEBS 
Lett 580(8): 1965-70. 
Luo, K. Q., Yu, V. C., Pu, Y. and Chang, D. C. (2001). "Application of the fluorescence resonance energy 
transfer method for studying the dynamics of caspase-3 activation during UV-induced apoptosis in 
living HeLa cells." Biochem Biophys Res Commun 283(5): 1054-60. 
Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X. (1998). "Bid, a Bcl2 interacting protein, 
mediates cytochrome c release from mitochondria in response to activation of cell surface death 
receptors." Cell 94(4): 481-90. 
Ma, A. C., Chung, M. I., Liang, R. and Leung, A. Y. (2009). "The role of survivin2 in primitive hematopoiesis 
during zebrafish development." Leukemia 23(4): 712-20. 
Maeno, M., Tochinai, S. and Katagiri, C. (1985). "Differential participation of ventral and dorsolateral 
mesoderms in the hemopoiesis of Xenopus, as revealed in diploid-triploid or interspecific chimeras." 
Dev Biol 110(2): 503-8. 
Mahrus, S., Trinidad, J. C., Barkan, D. T., Sali, A., Burlingame, A. L. and Wells, J. A. (2008). "Global 
sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini." Cell 
134(5): 866-76. 
Malikova, M. A., Van Stry, M. and Symes, K. (2007). "Apoptosis regulates notochord development in 
Xenopus." Dev Biol 311(2): 434-48. 
Malladi, S., Challa-Malladi, M., Fearnhead, H. O. and Bratton, S. B. (2009). "The Apaf-1*procaspase-9 
apoptosome complex functions as a proteolytic-based molecular timer." EMBO J 28(13): 1916-25. 
  
References 189 
Mangia, F., Procicchiami, G. and Manelli, H. (1970). "On the development of the blood island in Xenopus 
laevis embryos: light and electron microscope study." Acta Embryol Exp (Palermo) 2: 163-84. 
Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002). "The protein kinase 
complement of the human genome." Science 298(5600): 1912-34. 
Marsden, M. and DeSimone, D. W. (2003). "Integrin-ECM interactions regulate cadherin-dependent cell 
adhesion and are required for convergent extension in Xenopus." Curr Biol 13(14): 1182-91. 
Marshall, J. A. and Dixon, K. E. (1978). "Cell specialization in the epithelium of the small intestine of feeding 
Xenopus laevis tadpoles." J Anat 126(Pt 1): 133-44. 
Martinon, F., Holler, N., Richard, C. and Tschopp, J. (2000). "Activation of a pro-apoptotic amplification 
loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of 
RIP." FEBS Lett 468(2-3): 134-6. 
Martinon, F. and Tschopp, J. (2004). "Inflammatory caspases: linking an intracellular innate immune system 
to autoinflammatory diseases." Cell 117(5): 561-74. 
Martinon, F. and Tschopp, J. (2007). "Inflammatory caspases and inflammasomes: master switches of 
inflammation." Cell Death Differ 14(1): 10-22. 
Martinou, J. C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., 
Albertini, P., Talabot, D., Catsicas, S., Pietra, C. and et al. (1994). "Overexpression of BCL-2 in 
transgenic mice protects neurons from naturally occurring cell death and experimental ischemia." 
Neuron 13(4): 1017-30. 
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. 
G., Metcalf, D., Roberts, A. W., Huang, D. C. and Kile, B. T. (2007). "Programmed anuclear cell 
death delimits platelet life span." Cell 128(6): 1173-86. 
Mawaribuchi, S., Tamura, K., Okano, S., Takayama, S., Yaoita, Y., Shiba, T., Takamatsu, N. and Ito, M.  
(2008). "Tumor necrosis factor-alpha attenuates thyroid hormone-induced apoptosis in vascular 
endothelial cell line XLgoo established from Xenopus tadpole tails." Endocrinology 149(7): 3379-89. 
Mayordomo, R., Valenciano, A. I., de la Rosa, E. J. and Hallbook, F. (2003). "Generation of retinal ganglion 
cells is modulated by caspase-dependent programmed cell death." Eur J Neurosci 18(7): 1744-50. 
McAvoy, J. W. and Dixon, K. E. (1978). "Cell specialization in the small intestinal epithelium of adult 
Xenopus laevis: functional aspects." J Anat 125(Pt 2): 237-45. 
McStay, G. P., Salvesen, G. S. and Green, D. R. (2008). "Overlapping cleavage motif selectivity of caspases: 
implications for analysis of apoptotic pathways." Cell Death Differ 15(2): 322-31. 
Medvinsky, A. and Dzierzak, E. (1996). "Definitive hematopoiesis is autonomously initiated by the AGM 
region." Cell 86(6): 897-906. 
Medvinsky, A. L., Samoylina, N. L., Muller, A. M. and Dzierzak, E. A. (1993). "An early pre-liver 
intraembryonic source of CFU-S in the developing mouse." Nature 364(6432): 64-7. 
Melino, G., Bernassola, F., Knight, R. A., Corasaniti, M. T., Nistico, G. and Finazzi-Agro, A. (1997). "S-
nitrosylation regulates apoptosis." Nature 388(6641): 432-3. 
Meylan, E., Martinon, F., Thome, M., Gschwendt, M. and Tschopp, J. (2002). "RIP4 (DIK/PKK), a novel 
member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis." EMBO 
Rep 3(12): 1201-8. 
Meylan, E. and Tschopp, J. (2005). "The RIP kinases: crucial integrators of cellular stress." Trends Biochem 
Sci 30(3): 151-9. 
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C. and Grutter, 
M. G. (2002). "The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling 
complex." J Biol Chem 277(47): 45162-71. 
Mikawa, T., Poh, A. M., Kelly, K. A., Ishii, Y. and Reese, D. E. (2004). "Induction and patterning of the 
primitive streak, an organizing center of gastrulation in the amniote." Dev Dyn 229(3): 422-32. 
Milan, M., Campuzano, S. and Garcia-Bellido, A. (1997). "Developmental parameters of cell death in the 
wing disc of Drosophila." Proc Natl Acad Sci U S A 94(11): 5691-6. 
190 
  
 
References 
Miura, M., Chen, X. D., Allen, M. R., Bi, Y., Gronthos, S., Seo, B. M., Lakhani, S., Flavell, R. A., Feng, X. 
H., Robey, P. G., Young, M. and Shi, S. (2004). "A crucial role of caspase-3 in osteogenic 
differentiation of bone marrow stromal stem cells." J Clin Invest 114(12): 1704-13. 
Mollereau, B. (2009). "Cell death: what can we learn from flies? Editorial for the special review issue on 
Drosophila apoptosis." Apoptosis 14(8): 929-34. 
Montero, J. A. and Heisenberg, C. P. (2003). "Adhesive crosstalk in gastrulation." Dev Cell 5(2): 190-1. 
Montesanti, A., Deignan, K. and Hensey, C. (2007). "Cloning and characterization of Xenopus laevis 
Smac/DIABLO." Gene 392(1-2): 187-95. 
Moore, M. A. and Metcalf, D. (1970). "Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in 
vitro colony forming cells in the developing mouse embryo." Br J Haematol 18(3): 279-96. 
Moran, S. T., Haider, K., Ow, Y., Milton, P., Chen, L. and Pillai, S. (2003). "Protein kinase C-associated 
kinase can activate NFkappaB in both a kinase-dependent and a kinase-independent manner." J Biol 
Chem 278(24): 21526-33. 
Morgan, R., Nalliah, A. and Morsi El-Kadi, A. S. (2004). "FLASH, a component of the FAS-CAPSASE8 
apoptotic pathway, is directly regulated by Hoxb4 in the notochord." Dev Biol 265(1): 105-12. 
Morita, Y., Maravei, D. V., Bergeron, L., Wang, S., Perez, G. I., Tsutsumi, O., Taketani, Y., Asano, M., 
Horai, R., Korsmeyer, S. J., Iwakura, Y., Yuan, J. and Tilly, J. L. (2001). "Caspase-2 deficiency 
prevents programmed germ cell death resulting from cytokine insufficiency but not meiotic defects 
caused by loss of ataxia telangiectasia-mutated (Atm) gene function." Cell Death Differ 8(6): 614-20. 
Mosavi, L. K., Cammett, T. J., Desrosiers, D. C. and Peng, Z. Y. (2004). "The ankyrin repeat as molecular 
architecture for protein recognition." Protein Sci 13(6): 1435-48. 
Motoyama, N., Kimura, T., Takahashi, T., Watanabe, T. and Nakano, T. (1999). "bcl-x prevents apoptotic 
cell death of both primitive and definitive erythrocytes at the end of maturation." J Exp Med 189(11): 
1691-8. 
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S. 
and et al. (1995). "Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient 
mice." Science 267(5203): 1506-10. 
Mukaigasa, K., Hanasaki, A., Maeno, M., Fujii, H., Hayashida, S., Itoh, M., Kobayashi, M., Tochinai, S., 
Hatta, M., Iwabuchi, K., Taira, M., Onoe, K. and Izutsu, Y. (2009). "The keratin-related Ouroboros 
proteins function as immune antigens mediating tail regression in Xenopus metamorphosis." Proc Natl 
Acad Sci U S A 106(43): 18309-14. 
Muller, A. M., Medvinsky, A., Strouboulis, J., Grosveld, F. and Dzierzak, E. (1994). "Development of 
hematopoietic stem cell activity in the mouse embryo." Immunity 1(4): 291-301. 
Muller, H. A., Kuhl, M., Finnemann, S., Schneider, S., van der Poel, S. Z., Hausen, P. and Wedlich, D. 
(1994). "Xenopus cadherins: the maternal pool comprises distinguishable members of the family." 
Mech Dev 47(3): 213-23. 
Murray, T. V., McMahon, J. M., Howley, B. A., Stanley, A., Ritter, T., Mohr, A., Zwacka, R. and 
Fearnhead, H. O. (2008). "A non-apoptotic role for caspase-9 in muscle differentiation." J Cell Sci 
121(Pt 22): 3786-93. 
Muto, A., Ruland, J., McAllister-Lucas, L. M., Lucas, P. C., Yamaoka, S., Chen, F. F., Lin, A., Mak, T. 
W., Nunez, G. and Inohara, N. (2002). "Protein kinase C-associated kinase (PKK) mediates Bcl10-
independent NF-kappa B activation induced by phorbol ester." J Biol Chem 277(35): 31871-6. 
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. and Dixit, V. M. (1998). "An induced 
proximity model for caspase-8 activation." J Biol Chem 273(5): 2926-30. 
Nagamine, K., Furue, M., Fukui, A., Matsuda, A., Hori, T. and Asashima, M. (2007). "Blood cell and vessel 
formation following transplantation of activin-treated explants in Xenopus." Biol Pharm Bull 30(10): 
1856-9. 
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. and Yuan, J. (2000). "Caspase-12 
mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta." Nature 
403(6765): 98-103. 
  
References 191 
Nakajima, K., Fujimoto, K. and Yaoita, Y. (2005). "Programmed cell death during amphibian 
metamorphosis." Semin Cell Dev Biol 16(2): 271-80. 
Nakajima, K., Takahashi, A. and Yaoita, Y. (2000). "Structure, expression, and function of the Xenopus 
laevis caspase family." J Biol Chem 275(14): 10484-91. 
Nakajima, K. and Yaoita, Y. (2003). "Dual mechanisms governing muscle cell death in tadpole tail during 
amphibian metamorphosis." Dev Dyn 227(2): 246-55. 
Nehme, R. and Conradt, B. (2008). "egl-1: a key activator of apoptotic cell death in C. elegans." Oncogene 27 
Suppl 1: S30-40. 
Nembrini, C., Kisielow, J., Shamshiev, A. T., Tortola, L., Coyle, A. J., Kopf, M. and Marsland, B. J. 
(2009). "The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-
mediated immune responses." J Biol Chem 284(29): 19183-8. 
Newmeyer, D. D., Farschon, D. M. and Reed, J. C. (1994). "Cell-free apoptosis in Xenopus egg extracts: 
inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria." Cell 79(2): 
353-64. 
Newport, J. and Kirschner, M. (1982). "A major developmental transition in early Xenopus embryos: II. 
Control of the onset of transcription." Cell 30(3): 687-96. 
Newton, K., Sun, X. and Dixit, V. M. (2004). "Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling 
by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4." 
Mol Cell Biol 24(4): 1464-9. 
Nicotera, P., Bernassola, F. and Melino, G. (1999). "Nitric oxide (NO), a signaling molecule with a killer 
soul." Cell Death Differ 6(10): 931-3. 
Nishikawa, A., Murata, E., Akita, M., Kaneko, K., Moriya, O., Tomita, M. and Hayashi, H. (1998). "Roles 
of macrophages in programmed cell death and remodeling of tail and body muscle of Xenopus laevis 
during metamorphosis." Histochem Cell Biol 109(1): 11-7. 
Nishikawa, M., Tahara, T., Hinohara, A., Miyajima, A., Nakahata, T. and Shimosaka, A. (2001). "Role of 
the microenvironment of the embryonic aorta-gonad-mesonephros region in hematopoiesis." Ann N Y 
Acad Sci 938: 109-16. 
Nutt, L. K., Buchakjian, M. R., Gan, E., Darbandi, R., Yoon, S. Y., Wu, J. Q., Miyamoto, Y. J., Gibbons, 
J. A., Andersen, J. L., Freel, C. D., Tang, W., He, C., Kurokawa, M., Wang, Y., Margolis, S. S., 
Fissore, R. A. and Kornbluth, S. (2009). "Metabolic control of oocyte apoptosis mediated by 14-3-
3zeta-regulated dephosphorylation of caspase-2." Dev Cell 16(6): 856-66. 
Nutt, L. K., Margolis, S. S., Jensen, M., Herman, C. E., Dunphy, W. G., Rathmell, J. C. and Kornbluth, S. 
(2005). "Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of 
caspase-2." Cell 123(1): 89-103. 
O'Riordan, M. X., Bauler, L. D., Scott, F. L. and Duckett, C. S. (2008). "Inhibitor of apoptosis proteins in 
eukaryotic evolution and development: a model of thematic conservation." Dev Cell 15(4): 497-508. 
Oberst, A., Bender, C. and Green, D. R. (2008). "Living with death: the evolution of the mitochondrial 
pathway of apoptosis in animals." Cell Death Differ 15(7): 1139-46. 
Ogata, S. and Cho, K. W. (2007). "Dissection of organizer and animal pole explants from Xenopus laevis 
embryos and assembly of a cell adhesion assay." J Vis Exp(3): 187. 
Ogilvy, S., Metcalf, D., Print, C. G., Bath, M. L., Harris, A. W. and Adams, J. M. (1999). "Constitutive Bcl-
2 expression throughout the hematopoietic compartment affects multiple lineages and enhances 
progenitor cell survival." Proc Natl Acad Sci U S A 96(26): 14943-8. 
Okuwaki, M. (2008). "The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar 
acidic protein." J Biochem 143(4): 441-8. 
Okuyama, R., Nguyen, B. C., Talora, C., Ogawa, E., Tommasi di Vignano, A., Lioumi, M., Chiorino, G., 
Tagami, H., Woo, M. and Dotto, G. P. (2004). "High commitment of embryonic keratinocytes to 
terminal differentiation through a Notch1-caspase 3 regulatory mechanism." Dev Cell 6(4): 551-62. 
Oomman, S., Strahlendorf, H., Dertien, J. and Strahlendorf, J. (2006). "Bergmann glia utilize active 
caspase-3 for differentiation." Brain Res 1078(1): 19-34. 
192 
  
 
References 
Opferman, J. T., Iwasaki, H., Ong, C. C., Suh, H., Mizuno, S., Akashi, K. and Korsmeyer, S. J. (2005). 
"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells." Science 307(5712): 
1101-4. 
Orkin, S. H. (2000). "Diversification of haematopoietic stem cells to specific lineages." Nat Rev Genet 1(1): 57-
64. 
Orkin, S. H. and Zon, L. I. (2008). "Hematopoiesis: an evolving paradigm for stem cell biology." Cell 132(4): 
631-44. 
Ossipova, O., Tabler, J., Green, J. B. and Sokol, S. Y. (2007). "PAR1 specifies ciliated cells in vertebrate 
ectoderm downstream of aPKC." Development 134(23): 4297-306. 
Ottersbach, K. and Dzierzak, E. (2009). "Analysis of the mouse placenta as a hematopoietic stem cell niche." 
Methods Mol Biol 538: 335-46. 
Paik, E. J. and Zon, L. I. (2010). "Hematopoietic development in the zebrafish." Int J Dev Biol 54(6-7): 1127-
37. 
Palis, J. and Yoder, M. C. (2001). "Yolk-sac hematopoiesis: the first blood cells of mouse and man." Exp 
Hematol 29(8): 927-36. 
Pandey, P., Nakazawa, A., Ito, Y., Datta, R., Kharbanda, S. and Kufe, D. (2000). "Requirement for caspase 
activation in monocytic differentiation of myeloid leukemia cells." Oncogene 19(34): 3941-7. 
Park, K., Ahn, J., Yi, S. Y., Kim, M. and Chung, B. H. (2008). "SPR imaging-based monitoring of caspase-3 
activation." Biochem Biophys Res Commun 368(3): 684-9. 
Patel, S. R., Hartwig, J. H. and Italiano, J. E., Jr. (2005). "The biogenesis of platelets from megakaryocyte 
proplatelets." J Clin Invest 115(12): 3348-54. 
Patterson, L. J., Gering, M. and Patient, R. (2005). "Scl is required for dorsal aorta as well as blood formation 
in zebrafish embryos." Blood 105(9): 3502-11. 
Paun, A. and Pitha, P. M. (2007). "The IRF family, revisited." Biochimie 89(6-7): 744-53. 
Peault, B. and Tavian, M. (2003). "Hematopoietic stem cell emergence in the human embryo and fetus." Ann N 
Y Acad Sci 996: 132-40. 
Peden, E., Killian, D. J. and Xue, D. (2008). "Cell death specification in C. elegans." Cell Cycle 7(16): 2479-
84. 
Penaloza, C., Lin, L., Lockshin, R. A. and Zakeri, Z. (2006). "Cell death in development: shaping the 
embryo." Histochem Cell Biol 126(2): 149-58. 
Peter, M. E. and Krammer, P. H. (2003). "The CD95(APO-1/Fas) DISC and beyond." Cell Death Differ 
10(1): 26-35. 
Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S. F., D'Agati, V., Orkin, S. H. and Costantini, 
F. (1991). "Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for 
transcription factor GATA-1." Nature 349(6306): 257-60. 
Poelmann, R. E., Dubois, S. V., Hermsen, C., Smits-van Prooije, A. E. and Vermeij-Keers, C. (1985). "Cell 
degeneration and mitosis in the buccopharyngeal and branchial membranes in the mouse embryo." Anat 
Embryol (Berl) 171(2): 187-92. 
Pop, C. and Salvesen, G. S. (2009). "Human caspases: activation, specificity, and regulation." J Biol Chem 
284(33): 21777-81. 
Pop, C., Timmer, J., Sperandio, S. and Salvesen, G. S. (2006). "The apoptosome activates caspase-9 by 
dimerization." Mol Cell 22(2): 269-75. 
Rebe, C., Cathelin, S., Launay, S., Filomenko, R., Prevotat, L., L'Ollivier, C., Gyan, E., Micheau, O., 
Grant, S., Dubart-Kupperschmitt, A., Fontenay, M. and Solary, E. (2007). "Caspase-8 prevents 
sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation." Blood 
109(4): 1442-50. 
Ribeil, J. A., Zermati, Y., Vandekerckhove, J., Cathelin, S., Kersual, J., Dussiot, M., Coulon, S., Moura, I. 
C., Zeuner, A., Kirkegaard-Sorensen, T., Varet, B., Solary, E., Garrido, C. and Hermine, O. 
  
References 193 
(2007). "Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1." 
Nature 445(7123): 102-5. 
Richardson, R. J., Dixon, J., Jiang, R. and Dixon, M. J. (2009). "Integration of IRF6 and Jagged2 signalling is 
essential for controlling palatal adhesion and fusion competence." Hum Mol Genet 18(14): 2632-42. 
Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R. P., Shore, P., 
Whitmarsh, A. and Dixon, M. J. (2006). "Irf6 is a key determinant of the keratinocyte proliferation-
differentiation switch." Nat Genet 38(11): 1329-34. 
Riedl, S. J., Fuentes-Prior, P., Renatus, M., Kairies, N., Krapp, S., Huber, R., Salvesen, G. S. and Bode, W. 
(2001). "Structural basis for the activation of human procaspase-7." Proc Natl Acad Sci U S A 98(26): 
14790-5. 
Riedl, S. J., Li, W., Chao, Y., Schwarzenbacher, R. and Shi, Y. (2005). "Structure of the apoptotic protease-
activating factor 1 bound to ADP." Nature 434(7035): 926-33. 
Ritchie, H. and Fragoyannis, A. (2000). "Thrombin inhibits apoptosis of monocytes and plasminogen activator 
inhibitor 2 (PAI-2) is not responsible for this inhibition." Exp Cell Res 260(1): 20-9. 
Roberts, A. and Clarke, J. D. (1982). "The neuroanatomy of an amphibian embryo spinal cord." Philos Trans R 
Soc Lond B Biol Sci 296(1081): 195-212. 
Rodriguez, J. and Lazebnik, Y. (1999). "Caspase-9 and APAF-1 form an active holoenzyme." Genes Dev 
13(24): 3179-84. 
Rollins-Smith, L. A. and Blair, P. (1990). "Contribution of ventral blood island mesoderm to hematopoiesis in 
postmetamorphic and metamorphosis-inhibited Xenopus laevis." Dev Biol 142(1): 178-83. 
Rountree, R. B., Willis, C. R., Dinh, H., Blumberg, H., Bailey, K., Dean, C., Jr., Peschon, J. J. and 
Holland, P. M. (2009). "RIP4 regulates epidermal differentiation and cutaneous inflammation." J 
Invest Dermatol 130(1): 102-12. 
Rowe, I., Coen, L., Le Blay, K., Le Mevel, S. and Demeneix, B. A. (2002). "Autonomous regulation of muscle 
fibre fate during metamorphosis in Xenopus tropicalis." Dev Dyn 224(4): 381-90. 
Rowe, I., Le Blay, K., Du Pasquier, D., Palmier, K., Levi, G., Demeneix, B. and Coen, L. (2005). "Apoptosis 
of tail muscle during amphibian metamorphosis involves a caspase 9-dependent mechanism." Dev Dyn 
233(1): 76-87. 
Ruefli-Brasse, A. A., Lee, W. P., Hurst, S. and Dixit, V. M. (2004). "Rip2 participates in Bcl10 signaling and 
T-cell receptor-mediated NF-kappaB activation." J Biol Chem 279(2): 1570-4. 
Ruiz i Altaba, A. (1994). "Pattern formation in the vertebrate neural plate." Trends Neurosci 17(6): 233-43. 
Sabel, J. L., d'Alencon, C., O'Brien, E. K., Van Otterloo, E., Lutz, K., Cuykendall, T. N., Schutte, B. C., 
Houston, D. W. and Cornell, R. A. (2009). "Maternal Interferon Regulatory Factor 6 is required for 
the differentiation of primary superficial epithelia in Danio and Xenopus embryos." Dev Biol 325(1): 
249-62. 
Sachs, L. M., Abdallah, B., Hassan, A., Levi, G., De Luze, A., Reed, J. C. and Demeneix, B. A. (1997). 
"Apoptosis in Xenopus tadpole tail muscles involves Bax-dependent pathways." FASEB J 11(10): 801-
8. 
Sadowski-Debbing, K., Coy, J. F., Mier, W., Hug, H. and Los, M. (2002). "Caspases--their role in apoptosis 
and other physiological processes as revealed by knock-out studies." Arch Immunol Ther Exp (Warsz) 
50(1): 19-34. 
Saelens, X., Kalai, M. and Vandenabeele, P. (2001). "Translation inhibition in apoptosis: caspase-dependent 
PKR activation and eIF2-alpha phosphorylation." J Biol Chem 276(45): 41620-8. 
Saitoh, T., Tsuchiya, Y., Kinoshita, T., Itoh, M. and Yamashita, S. (2009). "Pro-apoptotic activity and mono-
/diubiquitylation of Xenopus Bid in egg extracts." Biochem Biophys Res Commun 384(4): 491-4. 
Saka, Y. and Smith, J. C. (2001). "Spatial and temporal patterns of cell division during early Xenopus 
embryogenesis." Dev Biol 229(2): 307-18. 
Sakamaki, K., Takagi, C., Kominami, K., Sakata, S., Yaoita, Y., Kubota, H. Y., Nozaki, M., Yonehara, S. 
and Ueno, N. (2004). "The adaptor molecule FADD from Xenopus laevis demonstrates evolutionary 
conservation of its pro-apoptotic activity." Genes Cells 9(12): 1249-64. 
194 
  
 
References 
Salmena, L., Lemmers, B., Hakem, A., Matysiak-Zablocki, E., Murakami, K., Au, P. Y., Berry, D. M., 
Tamblyn, L., Shehabeldin, A., Migon, E., Wakeham, A., Bouchard, D., Yeh, W. C., McGlade, J. 
C., Ohashi, P. S. and Hakem, R. (2003). "Essential role for caspase 8 in T-cell homeostasis and T-
cell-mediated immunity." Genes Dev 17(7): 883-95. 
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skorski, T. and Calabretta, B. (1998). 
"Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic 
potential of a transformation-deficient BCR/ABL mutant." J Exp Med 187(12): 1995-2007. 
Salvesen, G. S. and Duckett, C. S. (2002). "IAP proteins: blocking the road to death's door." Nat Rev Mol Cell 
Biol 3(6): 401-10. 
Salvesen, G. S. and Riedl, S. J. (2008). "Caspase mechanisms." Adv Exp Med Biol 615: 13-23. 
Sanders, E. J., Torkkeli, P. H. and French, A. S. (1997). "Patterns of cell death during gastrulation in chick 
and mouse embryos." Anat Embryol (Berl) 195(2): 147-54. 
Sankaran, V. G., Orkin, S. H. and Walkley, C. R. (2008). "Rb intrinsically promotes erythropoiesis by 
coupling cell cycle exit with mitochondrial biogenesis." Genes Dev 22(4): 463-75. 
Santambrogio, L., Potolicchio, I., Fessler, S. P., Wong, S. H., Raposo, G. and Strominger, J. L. (2005). 
"Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in 
maturing dendritic cells." Nat Immunol 6(10): 1020-8. 
Sato, K., Watanabe, T., Wang, S., Kakeno, M., Matsuzawa, K., Matsui, T., Yokoi, K., Murase, K., 
Sugiyama, I., Ozawa, M. and Kaibuchi, K. (2011). "Numb controls E-cadherin endocytosis through 
p120 catenin with aPKC." Mol Biol Cell 22(17): 3103-3119. 
Schielke, G. P., Yang, G. Y., Shivers, B. D. and Betz, A. L. (1998). "Reduced ischemic brain injury in 
interleukin-1 beta converting enzyme-deficient mice." J Cereb Blood Flow Metab 18(2): 180-5. 
Schimmer, A. D. (2004). "Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice." 
Cancer Res 64(20): 7183-90. 
Schreiber, A. M. and Brown, D. D. (2003). "Tadpole skin dies autonomously in response to thyroid hormone at 
metamorphosis." Proc Natl Acad Sci U S A 100(4): 1769-74. 
Schreiber, A. M., Das, B., Huang, H., Marsh-Armstrong, N. and Brown, D. D. (2001). "Diverse 
developmental programs of Xenopus laevis metamorphosis are inhibited by a dominant negative 
thyroid hormone receptor." Proc Natl Acad Sci U S A 98(19): 10739-44. 
Schutze, S., Tchikov, V. and Schneider-Brachert, W. (2008). "Regulation of TNFR1 and CD95 signalling by 
receptor compartmentalization." Nat Rev Mol Cell Biol 9(8): 655-62. 
Schweizer, A., Briand, C. and Grutter, M. G. (2003). "Crystal structure of caspase-2, apical initiator of the 
intrinsic apoptotic pathway." J Biol Chem 278(43): 42441-7. 
Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D. and Zauli, G. 
(2002). "Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of 
leukemic and normal myeloid precursors through a caspase-dependent pathway." Blood 100(7): 2421-9. 
Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A. and Zauli, G. (2004). 
"TRAIL regulates normal erythroid maturation through an ERK-dependent pathway." Blood 103(2): 
517-22. 
Seifert, K., Ibrahim, H., Stodtmeister, T., Winklbauer, R. and Niessen, C. M. (2009). "An adhesion-
independent, aPKC-dependent function for cadherins in morphogenetic movements." J Cell Sci 122(Pt 
14): 2514-23. 
Seol, D. W. and Billiar, T. R. (1999). "A caspase-9 variant missing the catalytic site is an endogenous inhibitor 
of apoptosis." J Biol Chem 274(4): 2072-6. 
Shaye, D. D., Casanova, J. and Llimargas, M. (2008). "Modulation of intracellular trafficking regulates cell 
intercalation in the Drosophila trachea." Nat Cell Biol 10(8): 964-70. 
Shi, Y. (2002). "Mechanisms of caspase activation and inhibition during apoptosis." Mol Cell 9(3): 459-70. 
Shi, Y. (2004). "Caspase activation: revisiting the induced proximity model." Cell 117(7): 855-8. 
Shi, Y. (2006). "Mechanical aspects of apoptosome assembly." Curr Opin Cell Biol 18(6): 677-84. 
  
References 195 
Shi, Y. B. and Brown, D. D. (1993). "The earliest changes in gene expression in tadpole intestine induced by 
thyroid hormone." J Biol Chem 268(27): 20312-7. 
Shin, S., Sung, B. J., Cho, Y. S., Kim, H. J., Ha, N. C., Hwang, J. I., Chung, C. W., Jung, Y. K. and Oh, B. 
H. (2001). "An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7." 
Biochemistry 40(4): 1117-23. 
Shiokawa, K., Kai, M., Higo, T., Kaito, C., Yokoska, J., Yasuhiko, Y., Kajita, E., Nagano, M., Yamada, Y., 
Shibata, M., Muto, T., Shinga, J., Hara, H., Takayama, E., Fukamachi, H., Yaoita, Y. and 
Igarashi, K. (2000). "Maternal program of apoptosis activated shortly after midblastula transition by 
overexpression of S-adenosylmethionine decarboxylase in Xenopus early embryos." Comp Biochem 
Physiol B Biochem Mol Biol 126(2): 149-55. 
Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R. 
and Shi, Y. (2003). "Mechanism of XIAP-mediated inhibition of caspase-9." Mol Cell 11(2): 519-27. 
Sible, J. C., Anderson, J. A., Lewellyn, A. L. and Maller, J. L. (1997). "Zygotic transcription is required to 
block a maternal program of apoptosis in Xenopus embryos." Dev Biol 189(2): 335-46. 
Singh, R., Lei, P. and Andreadis, S. T. (2009). "PKC-delta binds to E-cadherin and mediates EGF-induced cell 
scattering." Exp Cell Res 315(17): 2899-913. 
Skoglund, P., Rolo, A., Chen, X., Gumbiner, B. M. and Keller, R. (2008). "Convergence and extension at 
gastrulation require a myosin IIB-dependent cortical actin network." Development 135(14): 2435-44. 
Socolovsky, M., Fallon, A. E., Wang, S., Brugnara, C. and Lodish, H. F. (1999). "Fetal anemia and apoptosis 
of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction." Cell 98(2): 
181-91. 
Solnica-Krezel, L. (2005). "Conserved patterns of cell movements during vertebrate gastrulation." Curr Biol 
15(6): R213-28. 
Sordet, O., Rebe, C., Plenchette, S., Zermati, Y., Hermine, O., Vainchenker, W., Garrido, C., Solary, E. 
and Dubrez-Daloz, L. (2002). "Specific involvement of caspases in the differentiation of monocytes 
into macrophages." Blood 100(13): 4446-53. 
Spanos, S., Rice, S., Karagiannis, P., Taylor, D., Becker, D. L., Winston, R. M. and Hardy, K. (2002). 
"Caspase activity and expression of cell death genes during development of human preimplantation 
embryos." Reproduction 124(3): 353-63. 
Srinivasula, S. M., Ahmad, M., Guo, Y., Zhan, Y., Lazebnik, Y., Fernandes-Alnemri, T. and Alnemri, E. 
S. (1999). "Identification of an endogenous dominant-negative short isoform of caspase-9 that can 
regulate apoptosis." Cancer Res 59(5): 999-1002. 
Srinivasula, S. M., Gupta, S., Datta, P., Zhang, Z., Hegde, R., Cheong, N., Fernandes-Alnemri, T. and 
Alnemri, E. S. (2003). "Inhibitor of apoptosis proteins are substrates for the mitochondrial serine 
protease Omi/HtrA2." J Biol Chem 278(34): 31469-72. 
Stack, J. H. and Newport, J. W. (1997). "Developmentally regulated activation of apoptosis early in Xenopus 
gastrulation results in cyclin A degradation during interphase of the cell cycle." Development 124(16): 
3185-95. 
Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. and Seed, B. (1995). "RIP: a novel protein containing a death 
domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death." Cell 81(4): 513-23. 
Stemple, D. L. (2005). "Structure and function of the notochord: an essential organ for chordate development." 
Development 132(11): 2503-12. 
Stennicke, H. R., Renatus, M., Meldal, M. and Salvesen, G. S. (2000). "Internally quenched fluorescent 
peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8." Biochem J 350 
Pt 2: 563-8. 
Su, H., Bidere, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S. and 
Lenardo, M. (2005). "Requirement for caspase-8 in NF-kappaB activation by antigen receptor." 
Science 307(5714): 1465-8. 
Sui, X., Krantz, S. B. and Zhao, Z. J. (2000). "Stem cell factor and erythropoietin inhibit apoptosis of human 
erythroid progenitor cells through different signalling pathways." Br J Haematol 110(1): 63-70. 
196 
  
 
References 
Swirski, F. K. (2011). "The spatial and developmental relationships in the macrophage family." Arterioscler 
Thromb Vasc Biol 31(7): 1517-22. 
Szymczyk, K. H., Freeman, T. A., Adams, C. S., Srinivas, V. and Steinbeck, M. J. (2006). "Active caspase-3 
is required for osteoclast differentiation." J Cell Physiol 209(3): 836-44. 
Tahinci, E. and Symes, K. (2003). "Distinct functions of Rho and Rac are required for convergent extension 
during Xenopus gastrulation." Dev Biol 259(2): 318-35. 
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., 
Terada, N. and Akira, S. (1999). "Limb and skin abnormalities in mice lacking IKKalpha." Science 
284(5412): 313-6. 
Talanian, R. V., Quinlan, C., Trautz, S., Hackett, M. C., Mankovich, J. A., Banach, D., Ghayur, T., Brady, 
K. D. and Wong, W. W. (1997). "Substrate specificities of caspase family proteases." J Biol Chem 
272(15): 9677-82. 
Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T. and Reed, J. C. (1998). "IAP-
family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, 
and anticancer drugs." Cancer Res 58(23): 5315-20. 
Tamura, K., Mawaribuchi, S., Yoshimoto, S., Shiba, T., Takamatsu, N. and Ito, M. (2010). "Tumor necrosis 
factor-related apoptosis-inducing ligand 1 (TRAIL1) enhances the transition of red blood cells from the 
larval to adult type during metamorphosis in Xenopus." Blood 115(4): 850-9. 
Tamura, K., Noyama, T., Ishizawa, Y. H., Takamatsu, N., Shiba, T. and Ito, M. (2004). "Xenopus death 
receptor-M1 and -M2, new members of the tumor necrosis factor receptor superfamily, trigger apoptotic 
signaling by differential mechanisms." J Biol Chem 279(9): 7629-35. 
Tanida, I. (2010). "Autophagosome formation and molecular mechanism of autophagy." Antioxid Redox Signal 
14(11): 2201-14. 
Tashiro, S., Sedohara, A., Asashima, M., Izutsu, Y. and Maeno, M. (2006). "Characterization of myeloid 
cells derived from the anterior ventral mesoderm in the Xenopus laevis embryo." Dev Growth Differ 
48(8): 499-512. 
Tata, J. R. (1993). "Gene expression during metamorphosis: an ideal model for post-embryonic development." 
Bioessays 15(4): 239-48. 
Taylor, S. S., Knighton, D. R., Zheng, J., Sowadski, J. M., Gibbs, C. S. and Zoller, M. J. (1993). "A 
template for the protein kinase family." Trends Biochem Sci 18(3): 84-9. 
Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C. and Tschopp, J. (1998). 
"Identification of CARDIAK, a RIP-like kinase that associates with caspase-1." Curr Biol 8(15): 885-8. 
Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, 
V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T. and Nicholson, D. W. 
(1997). "A combinatorial approach defines specificities of members of the caspase family and 
granzyme B. Functional relationships established for key mediators of apoptosis." J Biol Chem 272(29): 
17907-11. 
Timmer, J. C. and Salvesen, G. S. (2007). "Caspase substrates." Cell Death Differ 14(1): 66-72. 
Tober, J., Koniski, A., McGrath, K. E., Vemishetti, R., Emerson, R., de Mesy-Bentley, K. K., Waugh, R. 
and Palis, J. (2007). "The megakaryocyte lineage originates from hemangioblast precursors and is an 
integral component both of primitive and of definitive hematopoiesis." Blood 109(4): 1433-41. 
Tracey, W. D., Jr., Pepling, M. E., Horb, M. E., Thomsen, G. H. and Gergen, J. P. (1998). "A Xenopus 
homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic 
blood." Development 125(8): 1371-80. 
Tran, H. T., Sekkali, B., Van Imschoot, G., Janssens, S. and Vleminckx, K. (2010). "Wnt/beta-catenin 
signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate 
embryo." Proc Natl Acad Sci U S A 107(37): 16160-5. 
Tribulo, C., Aybar, M. J., Sanchez, S. S. and Mayor, R. (2004). "A balance between the anti-apoptotic 
activity of Slug and the apoptotic activity of msx1 is required for the proper development of the neural 
crest." Dev Biol 275(2): 325-42. 
  
References 197 
Troy, C. M., Rabacchi, S. A., Hohl, J. B., Angelastro, J. M., Greene, L. A. and Shelanski, M. L. (2001). 
"Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death 
induced by nerve growth factor deprivation." J Neurosci 21(14): 5007-16. 
Tschopp, J., Irmler, M. and Thome, M. (1998). "Inhibition of fas death signals by FLIPs." Curr Opin Immunol 
10(5): 552-8. 
Tseng, A. S., Adams, D. S., Qiu, D., Koustubhan, P. and Levin, M. (2007). "Apoptosis is required during 
early stages of tail regeneration in Xenopus laevis." Dev Biol 301(1): 62-9. 
Tsuchiya, Y., Murai, S. and Yamashita, S. (2005). "Apoptosis-inhibiting activities of BIR family proteins in 
Xenopus egg extracts." FEBS J 272(9): 2237-50. 
Tsuchiya, Y. and Yamashita, S. (2011). "Anti-apoptotic activity and proteasome-mediated degradation of 
Xenopus Mcl-1 protein in egg extracts." J Biol Chem 286(18): 15806-14. 
Turpen, J. B., Kelley, C. M., Mead, P. E. and Zon, L. I. (1997). "Bipotential primitive-definitive 
hematopoietic progenitors in the vertebrate embryo." Immunity 7(3): 325-34. 
Turpen, J. B. and Knudson, C. M. (1982). "Ontogeny of hematopoietic cells in Rana pipiens: precursor cell 
migration during embryogenesis." Dev Biol 89(1): 138-51. 
Turpen, J. B., Knudson, C. M. and Hoefen, P. S. (1981). "The early ontogeny of hematopoietic cells studied 
by grafting cytogenetically labeled tissue anlagen: localization of a prospective stem cell compartment." 
Dev Biol 85(1): 99-112. 
Valenciano, A. I., Boya, P. and de la Rosa, E. J. (2009). "Early neural cell death: numbers and cues from the 
developing neuroretina." Int J Dev Biol 53(8-10): 1515-28. 
van Criekinge, W., Cornelis, S., Van De Craen, M., Vandenabeele, P., Fiers, W. and Beyaert, R. (1999). 
"GAL4 is a substrate for caspases: implications for two-hybrid screening and other GAL4-based 
assays." Mol Cell Biol Res Commun 1(2): 158-61. 
van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J. and Vandenabeele, P. (2002). "The 
role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet." Cell Death 
Differ 9(10): 1031-42. 
van Wassenaer, A. G. and Kok, J. H. (2004). "Hypothyroxinaemia and thyroid function after preterm birth." 
Semin Neonatol 9(1): 3-11. 
Vande Walle, L., Lamkanfi, M. and Vandenabeele, P. (2008). "The mitochondrial serine protease 
HtrA2/Omi: an overview." Cell Death Differ 15(3): 453-60. 
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. and Kroemer, G. (2010). "Molecular mechanisms of 
necroptosis: an ordered cellular explosion." Nat Rev Mol Cell Biol 11(10): 700-14. 
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., 
Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., 
Avraham, K. B., Goncharov, T., Holtmann, H., Lonai, P. and Wallach, D. (1998). "Targeted 
disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, 
and DR3 and is lethal prenatally." Immunity 9(2): 267-76. 
Vecino, E., Hernandez, M. and Garcia, M. (2004). "Cell death in the developing vertebrate retina." Int J Dev 
Biol 48(8-9): 965-74. 
Viala, J., Sansonetti, P. and Philpott, D. J. (2004). "Nods and 'intracellular' innate immunity." C R Biol 
327(6): 551-5. 
Voulgari, A. and Pintzas, A. (2009). "Epithelial-mesenchymal transition in cancer metastasis: mechanisms, 
markers and strategies to overcome drug resistance in the clinic." Biochim Biophys Acta 1796(2): 75-
90. 
Walensky, L. D., Pitter, K., Morash, J., Oh, K. J., Barbuto, S., Fisher, J., Smith, E., Verdine, G. L. and 
Korsmeyer, S. J. (2006). "A stapled BID BH3 helix directly binds and activates BAX." Mol Cell 
24(2): 199-210. 
Walker, J. C. and Harland, R. M. (2009). "microRNA-24a is required to repress apoptosis in the developing 
neural retina." Genes Dev 23(9): 1046-51. 
198 
  
 
References 
Walmsley, M., Ciau-Uitz, A. and Patient, R. (2002). "Adult and embryonic blood and endothelium derive 
from distinct precursor populations which are differentially programmed by BMP in Xenopus." 
Development 129(24): 5683-95. 
Walmsley, M., Cleaver, D. and Patient, R. (2008). "Fibroblast growth factor controls the timing of Scl, Lmo2, 
and Runx1 expression during embryonic blood development." Blood 111(3): 1157-66. 
Walsh, J. G., Cullen, S. P., Sheridan, C., Luthi, A. U., Gerner, C. and Martin, S. J. (2008). "Executioner 
caspase-3 and caspase-7 are functionally distinct proteases." Proc Natl Acad Sci U S A 105(35): 12815-
9. 
Wang, C. and Youle, R. J. (2009). "The role of mitochondria in apoptosis*." Annu Rev Genet 43: 95-118. 
Wang, H. G., Rapp, U. R. and Reed, J. C. (1996). "Bcl-2 targets the protein kinase Raf-1 to mitochondria." 
Cell 87(4): 629-38. 
Wang, S., Miura, M., Jung, Y. K., Zhu, H., Li, E. and Yuan, J. (1998). "Murine caspase-11, an ICE-
interacting protease, is essential for the activation of ICE." Cell 92(4): 501-9. 
Wang, W., Budhu, A., Forgues, M. and Wang, X. W. (2005). "Temporal and spatial control of nucleophosmin 
by the Ran-Crm1 complex in centrosome duplication." Nat Cell Biol 7(8): 823-30. 
Wang, X., Liu, J., Zhang, H., Xiao, M., Li, J., Yang, C., Lin, X., Wu, Z., Hu, L. and Kong, X. (2003). 
"Novel mutations in the IRF6 gene for Van der Woude syndrome." Hum Genet 113(5): 382-6. 
Wang, Z. and Brown, D. D. (1993). "Thyroid hormone-induced gene expression program for amphibian tail 
resorption." J Biol Chem 268(22): 16270-8. 
Wang, Z. Q., Liao, J. and Diwu, Z. (2005). "N-DEVD-N'-morpholinecarbonyl-rhodamine 110: novel caspase-3 
fluorogenic substrates for cell-based apoptosis assay." Bioorg Med Chem Lett 15(9): 2335-8. 
Watanabe, C., Shu, G. L., Zheng, T. S., Flavell, R. A. and Clark, E. A. (2008). "Caspase 6 regulates B cell 
activation and differentiation into plasma cells." J Immunol 181(10): 6810-9. 
Waterman, R. E. and Balian, G. (1980). "Indirect immunofluorescent staining of fibronectin associated with 
the floor of the foregut during formation and rupture of the oral membrane in the chick embryo." Anat 
Rec 198(4): 619-35. 
Weber, G. F. and Menko, A. S. (2005). "The canonical intrinsic mitochondrial death pathway has a non-
apoptotic role in signaling lens cell differentiation." J Biol Chem 280(23): 22135-45. 
Wei, Y., Fox, T., Chambers, S. P., Sintchak, J., Coll, J. T., Golec, J. M., Swenson, L., Wilson, K. P. and 
Charifson, P. S. (2000). "The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and 
inhibitor selectivity." Chem Biol 7(6): 423-32. 
Weil, M., Raff, M. C. and Braga, V. M. (1999). "Caspase activation in the terminal differentiation of human 
epidermal keratinocytes." Curr Biol 9(7): 361-4. 
Wells, B. S., Yoshida, E. and Johnston, L. A. (2006). "Compensatory proliferation in Drosophila imaginal 
discs requires Dronc-dependent p53 activity." Curr Biol 16(16): 1606-15. 
Wheeler, G. N. and Brandli, A. W. (2009). "Simple vertebrate models for chemical genetics and drug 
discovery screens: lessons from zebrafish and Xenopus." Dev Dyn 238(6): 1287-308. 
White, L. J., Declercq, W., Arfuso, F., Charles, A. K. and Dharmarajan, A. M. (2009). "Function of 
caspase-14 in trophoblast differentiation." Reprod Biol Endocrinol 7: 98. 
Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. 
F., Fairlie, W. D., Bouillet, P., Strasser, A., Kluck, R. M., Adams, J. M. and Huang, D. C. (2007). 
"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak." Science 
315(5813): 856-9. 
Wilson, N. S., Dixit, V. and Ashkenazi, A. (2009). "Death receptor signal transducers: nodes of coordination in 
immune signaling networks." Nat Immunol 10(4): 348-55. 
Winklbauer, R. and Keller, R. E. (1996). "Fibronectin, mesoderm migration, and gastrulation in Xenopus." 
Dev Biol 177(2): 413-26. 
Winklbauer, R. and Schurfeld, M. (1999). "Vegetal rotation, a new gastrulation movement involved in the 
internalization of the mesoderm and endoderm in Xenopus." Development 126(16): 3703-13. 
  
References 199 
Woo, M., Hakem, R., Furlonger, C., Hakem, A., Duncan, G. S., Sasaki, T., Bouchard, D., Lu, L., Wu, G. 
E., Paige, C. J. and Mak, T. W. (2003). "Caspase-3 regulates cell cycle in B cells: a consequence of 
substrate specificity." Nat Immunol 4(10): 1016-22. 
Woo, M., Hakem, R., Soengas, M. S., Duncan, G. S., Shahinian, A., Kagi, D., Hakem, A., McCurrach, M., 
Khoo, W., Kaufman, S. A., Senaldi, G., Howard, T., Lowe, S. W. and Mak, T. W. (1998). 
"Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes." Genes Dev 
12(6): 806-19. 
Wride, M. A., Parker, E. and Sanders, E. J. (1999). "Members of the bcl-2 and caspase families regulate 
nuclear degeneration during chick lens fibre differentiation." Dev Biol 213(1): 142-56. 
Wu, Y., Xing, D., Luo, S., Tang, Y. and Chen, Q. (2006). "Detection of caspase-3 activation in single cells by 
fluorescence resonance energy transfer during photodynamic therapy induced apoptosis." Cancer Lett 
235(2): 239-47. 
Wunnenberg-Stapleton, K., Blitz, I. L., Hashimoto, C. and Cho, K. W. (1999). "Involvement of the small 
GTPases XRhoA and XRnd1 in cell adhesion and head formation in early Xenopus development." 
Development 126(23): 5339-51. 
Xiao, K., Oas, R. G., Chiasson, C. M. and Kowalczyk, A. P. (2007). "Role of p120-catenin in cadherin 
trafficking." Biochim Biophys Acta 1773(1): 8-16. 
Xing, L. and Boyce, B. F. (2005). "Regulation of apoptosis in osteoclasts and osteoblastic cells." Biochem 
Biophys Res Commun 328(3): 709-20. 
Xu, L., Schaffner, W. and Rungger, D. (1993). "Transcriptional activation by recombinant GAL4-VP16 in the 
Xenopus oocyte." Nucleic Acids Res 21(11): 2775. 
Yang, L. C., Ng, D. C. and Bikle, D. D. (2003). "Role of protein kinase C alpha in calcium induced 
keratinocyte differentiation: defective regulation in squamous cell carcinoma." J Cell Physiol 195(2): 
249-59. 
Yang, M. Y., Chuang, H., Chen, R. F. and Yang, K. D. (2002). "Reversible phosphatidylserine expression on 
blood granulocytes related to membrane perturbation but not DNA strand breaks." J Leukoc Biol 71(2): 
231-7. 
Yang, Q. H., Church-Hajduk, R., Ren, J., Newton, M. L. and Du, C. (2003). "Omi/HtrA2 catalytic cleavage 
of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in 
apoptosis." Genes Dev 17(12): 1487-96. 
Yaoita, Y. and Nakajima, K. (1997). "Induction of apoptosis and CPP32 expression by thyroid hormone in a 
myoblastic cell line derived from tadpole tail." J Biol Chem 272(8): 5122-7. 
Yeh, W. C., Pompa, J. L., McCurrach, M. E., Shu, H. B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., 
Khoo, W., Mitchell, K., El-Deiry, W. S., Lowe, S. W., Goeddel, D. V. and Mak, T. W. (1998). 
"FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis." 
Science 279(5358): 1954-8. 
Yeo, W. and Gautier, J. (2003). "A role for programmed cell death during early neurogenesis in xenopus." Dev 
Biol 260(1): 31-45. 
Yoshida, H., Kong, Y. Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M. and Mak, T. 
W. (1998). "Apaf1 is required for mitochondrial pathways of apoptosis and brain development." Cell 
94(6): 739-50. 
Youle, R. J. and Strasser, A. (2008). "The BCL-2 protein family: opposing activities that mediate cell death." 
Nat Rev Mol Cell Biol 9(1): 47-59. 
Yu, H., Maurer, F. and Medcalf, R. L. (2002). "Plasminogen activator inhibitor type 2: a regulator of 
monocyte proliferation and differentiation." Blood 99(8): 2810-8. 
Yu, J. and Zhang, L. (2008). "PUMA, a potent killer with or without p53." Oncogene 27 Suppl 1: S71-83. 
Yuan, J. and Horvitz, H. R. (2004). "A first insight into the molecular mechanisms of apoptosis." Cell 116(2 
Suppl): S53-6, 1 p following S59. 
200 
  
 
References 
Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. and Horvitz, H. R. (1993). "The C. elegans cell death gene 
ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme." Cell 75(4): 641-
52. 
Zamai, L., Secchiero, P., Pierpaoli, S., Bassini, A., Papa, S., Alnemri, E. S., Guidotti, L., Vitale, M. and 
Zauli, G. (2000). "TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal 
human erythropoiesis." Blood 95(12): 3716-24. 
Zandy, A. J., Lakhani, S., Zheng, T., Flavell, R. A. and Bassnett, S. (2005). "Role of the executioner caspases 
during lens development." J Biol Chem 280(34): 30263-72. 
Zauli, G., Bassini, A., Vitale, M., Gibellini, D., Celeghini, C., Caramelli, E., Pierpaoli, S., Guidotti, L. and 
Capitani, S. (1997). "Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of 
megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase." Blood 89(3): 883-95. 
Zermati, Y., Garrido, C., Amsellem, S., Fishelson, S., Bouscary, D., Valensi, F., Varet, B., Solary, E. and 
Hermine, O. (2001). "Caspase activation is required for terminal erythroid differentiation." J Exp Med 
193(2): 247-54. 
Zhang, C., Carl, T. F., Trudeau, E. D., Simmet, T. and Klymkowsky, M. W. (2006). "An NF-kappaB and 
slug regulatory loop active in early vertebrate mesoderm." PLoS One 1: e106. 
Zhang, D., Lin, J. and Han, J. (2010). "Receptor-interacting protein (RIP) kinase family." Cell Mol Immunol 
7(4): 243-9. 
Zhang, D. W., Shao, J., Lin, J., Zhang, N., Lu, B. J., Lin, S. C., Dong, M. Q. and Han, J. (2009). "RIP3, an 
energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis." Science 
325(5938): 332-6. 
Zhang, J., Cado, D., Chen, A., Kabra, N. H. and Winoto, A. (1998). "Fas-mediated apoptosis and activation-
induced T-cell proliferation are defective in mice lacking FADD/Mort1." Nature 392(6673): 296-300. 
Zhang, L., Xu, Q., Xing, D., Gao, C. and Xiong, H. (2009). "Real-time detection of caspase-3-like protease 
activation in vivo using fluorescence resonance energy transfer during plant programmed cell death 
induced by ultraviolet C overexposure." Plant Physiol 150(4): 1773-83. 
Zhang, Y., Xing, D. and Liu, L. (2009). "PUMA promotes Bax translocation by both directly interacting with 
Bax and by competitive binding to Bcl-X L during UV-induced apoptosis." Mol Biol Cell 20(13): 3077-
87. 
Zheng, T. S. and Flavell, R. A. (2000). "Divinations and surprises: genetic analysis of caspase function in 
mice." Exp Cell Res 256(1): 67-73. 
Zheng, T. S., Hunot, S., Kuida, K. and Flavell, R. A. (1999). "Caspase knockouts: matters of life and death." 
Cell Death Differ 6(11): 1043-53. 
Zheng, T. S., Hunot, S., Kuida, K., Momoi, T., Srinivasan, A., Nicholson, D. W., Lazebnik, Y. and Flavell, 
R. A. (2000). "Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation." Nat 
Med 6(11): 1241-7. 
Zheng, T. S., Schlosser, S. F., Dao, T., Hingorani, R., Crispe, I. N., Boyer, J. L. and Flavell, R. A. (1998). 
"Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in 
vivo." Proc Natl Acad Sci U S A 95(23): 13618-23. 
Zhong, Y., Brieher, W. M. and Gumbiner, B. M. (1999). "Analysis of C-cadherin regulation during tissue 
morphogenesis with an activating antibody." J Cell Biol 144(2): 351-9. 
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., 
Uitti, R. J., Calne, D. B., Stoessl, A. J., Pfeiffer, R. F., Patenge, N., Carbajal, I. C., Vieregge, P., 
Asmus, F., Muller-Myhsok, B., Dickson, D. W., Meitinger, T., Strom, T. M., Wszolek, Z. K. and 
Gasser, T. (2004). "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic 
pathology." Neuron 44(4): 601-7. 
Zinkel, S. S., Ong, C. C., Ferguson, D. O., Iwasaki, H., Akashi, K., Bronson, R. T., Kutok, J. L., Alt, F. W. 
and Korsmeyer, S. J. (2003). "Proapoptotic BID is required for myeloid homeostasis and tumor 
suppression." Genes Dev 17(2): 229-39. 
  
References 201 
Zou, J., Bird, S., Minter, R., Horton, J., Cunningham, C. and Secombes, C. J. (2000). "Molecular cloning of 
the gene for interleukin-1beta from Xenopus laevis and analysis of expression in vivo and in vitro." 
Immunogenetics 51(4-5): 332-8. 
Zucchero, T. M., Cooper, M. E., Maher, B. S., Daack-Hirsch, S., Nepomuceno, B., Ribeiro, L., Caprau, D., 
Christensen, K., Suzuki, Y., Machida, J., Natsume, N., Yoshiura, K., Vieira, A. R., Orioli, I. M., 
Castilla, E. E., Moreno, L., Arcos-Burgos, M., Lidral, A. C., Field, L. L., Liu, Y. E., Ray, A., 
Goldstein, T. H., Schultz, R. E., Shi, M., Johnson, M. K., Kondo, S., Schutte, B. C., Marazita, M. 
L. and Murray, J. C. (2004). "Interferon regulatory factor 6 (IRF6) gene variants and the risk of 
isolated cleft lip or palate." N Engl J Med 351(8): 769-80. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Addendum 
  
Addendum 205 
Developmental time table of X. laevis at 23°C 
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Figure A1. Developmental timetable of Xenopus laevis. (Source: http://www.xenbase.org) 
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Life cycle of Xenopus 
 
 
 
Figure A2. Representation of the life cycle of Xenopus. Adapted from Memorial University, department of 
biology. Abbreviations: v, ventral; d, dorsal; a, anterior; p, posterior; ap, animal pole; vp, vegetal pole.  
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